,ticker,content
0,ESRX,important metric look stock be higher relative strength rating express script esrx now clear threshold jump friday look best stock buy watch keep close eye relative price strength exclusive rating investor business daily track market leadership worst best score score show stock price performance last week hold other stock database history reveal top perform stock often have better rs rating early stage move look best stock buy watch start herewhile now be not ideal time jump see stock manage establish enter buy range heavy trade express script see earning sale growth rise last quarter earning share increase revenue rise company hold rank peer medical service industry group tivity health tvty biotelemetry beat ikang healthcare kang be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
1,ESRX,walgreen boot alliance rl announce stock buyback raise dividend drug store giant report issue first quarterly earning dow jone industrial average component xwalgreen earning rise share sale grow top analyst view ep revenue accord zack investment research pharmacy same store sale fall other same store sale slide walgreen boot alliance raise lower end guidance fiscal year cent share now expect adjust ep analyst have expect company board authorize stock buyback hefty sum give market cap wednesday close walgreen also announce dividend hike cent share quarter get newsletter deliver inbox more info product service privacy policy term useshare fall premarket trade stock market today rival cvs health cvs stock be not yet active walgreen debut dow jone industrial average tuesday have poor ibd composite rating choice replace embattled industrial giant general electric ge suffering walgreen stock confound investor dow jone index help determine composition index say inclusion make dow more representative consumer health care sector economy walgreen tumble jan amazon com amzn berkshire hathaway brkb jpmorgan chase jpm announce healthcare partnership name atul gawande ceo last week partnership potentially threaten walgreen also manage prescription drug plan provide health care store customer industry consolidate walgreen have buy nearly store rite aid expand group purchasing effort express script esrx meanwhile cvs health be buy insurer aetna aet get instant access more trading idea exclusive stock list ibd proprietary rating only be interested invest stock free new apps aim beginnerslook best stock buy watch start here
2,ESRX,tuesday express script esrx reach important technical milestone see relative strength rs rating jump percentile improvement day proprietary rating track market leadership used worst best score show stock price performance last week match other publicly trade company decade market research reveal stock go make biggest gain typically have rs rating launch biggest run look best stock buy watch start herewhile stock be not ideal buy range right now see manage form break proper consolidation express script report earning growth last quarter revenue increase company earn rank peer medical service industry group laboratory corporation america lh tivity health tvty china cord blood co be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
3,ESRX,federal judge rule late tuesday takeover time warner go ahead precondition send time warner slew other medium company sharply higher knock be acquire company such comcast cmcsa antitrust clearance also give hope pair big health care merger cvs health cvs aetna aet cigna ci express script esrx gain medium health care stock give small lift open stock market today index last year health insurance merger deal cigna anthem antm aetna humana hum fall apart antitrust objection be horizontal merger reduce number big insurer cvs health aetna cigna express script deal be vertical combine different company health care food chain cvs health drug store pharmacy benefit manager aim team insurer aetna insurer cigna be grab pure play pbm express script time warner deal also be vertical merger combine wireless giant pay tv operator content maker time warner condition approval be positive sign health care takeover get newsletter deliver inbox more info product service privacy policy term use first major antitrust case current administration first time doj have try vertical merger case year judge ruling favor twx deal have positive readthrough ci esrx merger accord evercore isi analyst note time warner ruling cvs health stock rise shortly open aetna stock gain cigna stock edge express script leap meanwhile stock sank time warner pop also ibd stock day flash key technical signal sell take profit hold here be several guideline followchart read basic buy point mark time real buy watch top ipos big small cap growth stock
4,ESRX,stock future buzz tightly mixed action wednesday court ruling washington late tuesday electrify early trade time warner twx discovery communication disca st century fox fox express script esrx be just few name spun motion ruling gain loss telecom stock bracket tuesday late trade st century fox discovery communication lead nasdaq future index slip fractional decline comcast cmcsa take largest loss nasdaq stock block hrb fall furthest name dow jone future be fraction struggle heavy loss walt disney court decision nasdaq future rise fraction future be less time warner scale more follow ruling district judge allow move forward acquisition company decision cap month effort earn approval deal make top distributor pay tv see deal essential effort compete advertising dollar internet content provider lead facebook fb alphabet googl google department justice be reportedly consider filing appeal ruling trade comcast drop walt disney dip discovery communication have jolted higher late tuesday be inactive early wednesday st century fox surge fox end tuesday session top buy range buy point have initially clear ruling also send handful health care name higher pharmacy benefit manager express script scramble higher regulatory resistance deal lead investor grow wary cigna ci effort take express script cigna share be unchanged early wednesday tuesday ruling also ease investor concern cvs health cvs bid acquire aetna aet aetna rise cvs health climb late trade tuesday stock be inactive ahead wednesday open time warner ruling market return standard lay low typically strike ahead key federal reserve decision market be gear quarter point hike mark fed seventh increase view be split fed be likely hoist rate more time second half fed offer official policy announcement et fed chairman jerome powell press conference schedule et provide additional detail fed strategy play remainder year european central bank meet discuss rate policy possible wind monetary stimulus program thursday friday bank japan have monthly monetary policy meeting japan be expect maintain rate policy year government bond target yield block swoon more report fiscal fourth quarter sale earning comfortably analyst target full year revenue guidance be just consensus expectation however company say discount pricing affect top line performance stock have be climb right side month base pivotal software pvtl report tuesday close share jump more late trade be inactive early wednesday fiscal first quarter revenue blast past consensus expectation loss be less forecast san francisco base company also hoist ep revenue guidance estimate stock be extend clear ipo base june end tuesday april ipo share staffing service leader korn ferry kfy china bitauto hold bita be schedule report quarterly result wednesday morning korn ferry share be extend clear flat base march oil price be factor wednesday trade slip late tuesday follow weekly datum american petroleum institute europe brent crude benchmark be west texas intermediate dip hold barrel early wednesday datum release api show barrel draw oil inventory well consensus expectation barrel drawdown earlier tuesday news report say saudi arabia have boost production back barrel day have plan increase additional barrel june energy information administration release official oil inventory datum et wednesday related big be time warner ruling even stock be rallyingat time warner ruling set big medium stockstesla help nasdaq gain twitter lead growth stock shine
5,ESRX,esperion therapeutic espr lose third value wednesday ldl cholesterol lower drug underperform bullish expectation late stage study needham analyst chad messer call result strong esperion drug call bempedoic acid lower bad ldl cholesterol additional patient add maximally tolerate statin therapy be lower bound have see previous datum be much larger study say note datum often revert mean large study so actually view strong result context investor disagree vehemently stock market today esperion crash close get newsletter deliver inbox more info product service privacy policy term useesperion test bempedoic acid patient week drug lower ldl cholesterol level additional add maximally tolerate statin base therapy patient also experience reduction high sensitivity reactive protein hscrp protein be important marker underlie inflammation associate cardiovascular disease messer note study enrolled high risk patient only other option be injectable drug call pcsk inhibitor amgen amgn make call repatha regeneron pharmaceutical regn partner sanofi sny make dub praluent drug cost ten thousand dollar year say payer patient alike have so far be reluctant adopt therapy significant way bempedoic acid be once daily pill anticipate be sell few dollar month notably regeneron sanofi say tuesday have strike deal express script esrx cut net price drug praluent exchange simplify patient insurance process praluent repatha also work lower bad ldl cholesterol messer keep strong buy rating price target esperion esperion also report first quarter result loss share narrow share loss year earlier period miss consensus project share loss related chart read basic buy point mark time real invest stock free new apps aim beginnerslook next nvidia start simple routine
6,ESRX,walmart wmt be early talk humana hum possible takeover accord multiple report late thursday walmart humana deal push world largest retailer deep health care be midst major consolidation binge gain scope cut cost humana stock shot late trading initial wall street journal report reuter also confirm talk closer link even acquisition walmart slide walmart humana deal follow cvs health cvs aetna aet combination cigna ci buy express script esrx deal be effort match surpass unitedhealth unh well fend amazon amzn get newsletter deliver inbox more info product service privacy policy term usewalmart have thousand pharmacy namesake sam club store buy humana offer same potential benefit drugstore giant cvs acquire aetna drive drug prescription location walmart already have relationship humana humana member get many prescription walmart location humana be major medicare advantage insurer also own pharmacy benefit manager cvs also be pbm express script be pure play pbm amazon have hint enter pharmacy drug distribution business fashion commerce giant also recently team jpmorgan chase jpm berkshire hathaway brkb joint venture rein health care cost employee walmart enter health care field complicate effort compete amazon online sale grocery delivery other retail area be interested cigna buy express script even pharmacy benefit manager come firecvs re go deliver amazon jpmorgan berkshire seek doamazon health care disruption fear clash reality
7,ESRX,stock fall start gate tuesday global market suffer day loss new partnership announce amazon com amzn rattle stock health care field nasdaq composite open maxim integrate product mxim expressscript esrx put heavy loss trade dow jone industrial average drop nearly unitedhealth group unh hard caterpillar cat apple aapl chevron cvx half dozen other dow jone name clocking early loss greater international market be also post loss bond market remain pressure dollar continue slide lead benchmark tokyo hong kong fall more tuesday stock europe also show deepen loss afternoon trade london ftse frankfurt dax diving furthest federal open market committee swing day meeting washington tuesday morning last fomc gathering federal reserve chair janet yellen preside policy announcement be set et wednesday rate hike be expect time other economic news day be thin case shiller housing price index november rise be unchanged october read just consensus view gain january consumer confidence survey conference board expect et health care stock be react briskly news amazon partner berkshire hathaway brka jpmorgan chase jpm chart new way provide health care employee independent company be free profit make incentive constraint deal suggest amazon effect impact deep pocket massive online scale company bring effort begin assert impact health care insurance industry way have retail shipping other market amazon drop jpmorgan slip berkshire hathaway be flat amazon share be extend almost buy point follow early january dow unitedhealth group dove nearly open action other manage care provider respond similarly anthem antm cigna ci slide aetna aet slip humana hum subtract more share also dive pharmacy benefit manager pharmacy chain express script careen lower bottom nasdaq cvs health cvs crumble nearly walgreen boot alliance wba rite aid rad fall apple trade news report detailed company plan reduce production iphone march report say be weaker expect demand other say move be seasonal occur time year apple spend third session week move average monday start tuesday test prior low early december just ahead fiscal first quarter report wednesday early earning report be also factor early trade mcdonald mcd fourth quarter report homebuilder pulte group phm drop almost quarterly result life insurer metlife meet tumble announce late monday postpone fourth quarter earning report company wrestle foul potentially left ten thousand worker monthly pension benefit company say increase reserve order deal problem reveal security exchange commission be investigate matter maxim integrate dive nearly reverse much monday gain follow news report company be possible takeover target japanese rival renesa report monday close renesa deny be takeover discussion maxim callidus software cald spiked open announce german software giant sap sap acquire company dublin calif base callidus operate calliduscloud provide cloud base sale marketing program sap also report forecast fourth quarter sale earning full year guidance share gain other important market news tuesday big picture sign market be ready breakthese china stock leader be get more volatile time sell trump state union move market
8,ESRX,express script esrx thursday offer profit guidance outstripped wall street estimate amazon amzn cvs health cvs aetna aet threaten shake drug sector pharmacy benefit manager expect adjust earning share consensus estimate analyst survey zack investment research represent growth midpoint express script new guidance be revise previous estimate range zack consensus next year earning growth benefit pending evicore acquisition evicore purchase generate ebitda express script say purchase well pending sale unite biosource be expect be complete december company add share express script rise stock market today hit intraday highest level march other drug related stock walgreen boot alliance wba fall cvs health give aetna dip amazon rise ibd take medtech space have be less affected drug pricing worry pharma biotech space space climb higher still year industry snapshot take closer look group strong stock pharma stock get whack october report amazon wade online prescription drug sale blow express script month health insurer anthem athm say tie cvs pharmacy benefit management current contract express script end express script stock have re-cover speculation amazon be hunting pharmacy benefit manager gain foothold business nov express script ceo tim wentworth say be open deal right price wasn actively look tell bloomberg don need sell be very successful future be always open other sudden conclude want have add partnership amazon drug distribution arrangement be also possible cvs be major pharmacy benefit manager own right say earlier month buy health insurer aetna deal come brace amazon enter retail prescription business analyst also say deal give combine company edge rival stronger negotiating leverage vs drug manufacturer related amazon new online drug retailer cvs walgreen bewarestock buy watch top ipos big small cap growth daily update stock potential big gain
9,ESRX,monday diplomat pharmacy dplo earn positive adjustment relative strength rs rating ibd unique rs rating identify technical performance show stock price movement last week measure other stock database year market history show best perform stock typically have rs rating begin new climb see ibd help make more money stocksdiplomat pharmacy be buy zone clear buy point consolidation proper buy range extend initial entry once stock hit benchmark best hold investing set buy opportunity term fundamental health company have post rise ep growth last quarters sale gain have be less impressive come latest report company hold rank peer medical service industry group laboratory corporation america lh express script esrx be also group highest rate stock related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
10,ESRX,express script esrx say tuesday buy privately hold medical benefit management service company even amazon amzn reportedly eye online pharmaceutical sale market xexpress script say purchase evicore healthcare together evicore express script be even more powerful partner manage cost patient payer bring closer goal become nation lead patient benefit manager express script ceo tim wentworth say statement express script share rise premarket news fall stock market today nearly undercut april year low ibd take medtech space be outperform pharma biotech space drug pricing concern year check industry snapshot closer look group strong performer monday express script be downgrade underperform market perform rating raymond james escalate competitive pressure amazon be reportedly look expand selling prescription drug online express script tumble monday friday loss cvs health cvs share climb skid prior session amazon news cvs health be drugstore giant major pharmacy benefit manager express script walgreen boot alliance wba lose related amazon rumor just win die
11,ESRX,stock market weaken almost close monday give little prior week gain nasdaq close lower dow jone industrial average ease russell fall rare day lag performance small cap benchmark volume fall friday total accord early number dow component apple aapl have sputter breaking past buy point aug company strong earning report more week stock have be trading day move average apple have be consolidate long enough be new flat base potential buy point course apple need get back day line improve woeful accumulation distribution rating health care retail be sector have multiple industry group bottom monday performance table drugstore fall more drug wholesaler analyst downgrade express script esrx fear amazon com amzn disrupt pharmaceutical industry venture online prescription drug sale express script share slide lowest level april amazon share be little change monday best industry group include few defensive area such tobacco gold mining meat product energy sector be strong too price crude oil rise barrel broader perspective market outlook be positive investor look add exposure market couple breakout be interesting atlassian team rise buy point cup handle base volume more double average good sign stock seek extend week rally despegar com desp surge past buy point ipo base shorter normal pattern often develop new issue argentina base despegar com close slightly buy point so watch stock climb back entry despegar mean take spanish be discuss ipo leader column ibd weekly company be online provider travel service related highly rate atlassian buy zone next earning reportargentina base new issue see heavy demand set ipo baseexpress cvs spiraling possible amazon wild card drug
12,ESRX,dow industrial rally strongly thank ibm ibm turnaround johnson johnson jnj several other blue chip earning general electric ge be big miss adobe system adbe also be big winner bullish outlook netflix nflx hit new high boom subscriber growth ipos be hot dow industrial rise week fuel ibm predict return revenue growth johnson johnson unitedhealth unh be also notable blue chip contributor general electric crash big ep miss have little impact price weight dow rise nasdaq help senate first step big tax cut adobe system soar outlook paypal pypl beat netflix pull back record high high subscriber gain unite airline ual crash carrier have few answer question few new ipos impressed internet television network netflix cheer investor third quarter subscriber addition trounce expectation earning growth miss view sign net new stream subscriber third quarter beating wall street target december quarter netflix expect add new subscriber edge consensus view end september quarter stream subscriber worldwide netflix share hit record high tuesday morning sank week remain buy range related netflix stock fall third quarter subscriber beatadobe system share surge record high maker digital medium marketing software announce upbeat sale earning target fiscal san jose calif base adobe be target adjust earning share year year sale wall street be modele related adobe system rocket outlookibm share soar tech icon report quarterly earning beat estimate indicated sale growth return first time more year ibm do not provide formal quarterly guidance management indicated revenue snap quarter string revenue decline related ibm get price target hike earning report outlookgeneral electric earn just cent share far cent expect revenue rise more expect organic industrial revenue dip industrial operate margin shrank ge power business be big drag industrial cash flow operate activity plunge adjust due weakness power business ge slash full year earning cash flow guidance raise concern dividend cut ge share fall soon friday open close related ge earning miss badly cash flow dive add dividend fearsunited airline tumble more management carrier third quarter earning call be unable provide detail longer term plan drive profit lack clarity lead analyst believe carrier be walking back target outlined last year grow earning higher expect cost be also concern drop fare compete ultra low cost carrier morgan stanley ms top estimate help strong stable wealth management business rival investment bank goldman sachs gs also beat analyst raise concern result be help more volatile capital intensive line business goldman trading result continue struggle morgan outperformed other big bank morgan stanley rise retake buy point goldman sachs climb dow component johnson johnson top wall street view report adjust earning share sale pharmaceutical sale jump worldwide medical device revenue rise miss estimate abbott laboratory narrowly beat expectation early wednesday lion share beat come abbott establish pharmaceutical diabetes care cardiovascular neuromodulation product share rise clear buy point hit record high abbott advanced also time best related dow component pop top view pharma strengthqudian qd china base online credit firm backed alibaba baba rise debut raise pricing expect range singapore base online gaming company sea backed chinese internet giant tencent tcehy edge higher debut raise upsized ipo mongodb mdb provide open source database software platform business pop ipo top just raise price range qudian be profitable sea be poise start make money related sea upsized ipo raise millionmongodb price high qudian strong debut play new ipostop semiconductor industry player deliver generally upbeat report september quarter past week taiwan semiconductor manufacturing tsm beat target third quarter sale earning guide higher current quarter sale maxim integrate product mxim beat wall street target earning sale be tad short however maxim guide earning sale december quarter be well view chip gear vendor lam research lrcx beat view guide higher current quarter rival asml asml beat sale earning target third quarter revenue guidance be light unitedhealth group unh share vault record high tuesday then keep climb insurer report earning growth cent ahead estimate show enviable strategic position have exit obamacare exchange unitedhealth say benefit president trump executive order make low cost plan more widely available amazon com amzn want enter retail prescription business analyst say unitedhealth be ideal partner company signale willing meanwhile anthem antm insurer follow example unitedhealth announce broaden offer include pharmacy benefit management anthem share near buy point news dump express script esrx utilize cvs health cvs process retail distribution start related anthem jump prescription business amazon speculation signal openness amazon partnership earning beatpaypal report september quarter profit revenue top view forecast current quarter sale estimate send share commerce payment processor paypal say adjust earning be cent share year revenue rise current quarter paypal forecast revenue growth midpoint guidance gaap profit cent vs consensus estimate cent paypal jump friday new record high related paypal earning revenue top expectation share slb say friday investment demand north america be moderate baker hughe bhge warn challenge year end customer remain cautious spending due volatile oil price suggest shale other operator be rein production growth plan schlumberger meet ep view gain baker hughe report first quarter merger general electric oil gas unit july crude price hold barrel inventory fall yet again production plunge due gulf shutdown hurricane nate charle schwab schw trade etfc beat wall street consensus third quarter earning schwab miss revenue trade meet expectation schwab report ep cent revenue trade post earning cent share revenue schwab undercut buy point report sharp fall trading revenue share rebound friday trade share fall be still buy range past entry ebay ebay meet third quarter earning estimate revenue be slightly forecast online marketplace fourth quarter ep outlook fall short estimate share sank close day move average recent buy point undercut intraday thursday related ebay meet earning view share tumble weak outlooksap sap report quarterly earning top estimate german enterprise software giant raise guidance year base cloud compute strength bombardier bdrbf agree sell stake struggle series jet airbus eadsy commerce department call tariff narrow body jet deliver boee ba accuse canadian company receive unfair government subsidy gilead science gild win fda approval car drug dub yescarta treat aggressive form hodgkin lymphoma yescarta come gilead recent kite pharma deal gilead rise thursday be little change weekcelgene celg scrap trial crohn disease drug win start third cite internal futility review celgene fall friday intuitive surgical isrg top expectation late thursday report sale adjust profit share share rise friday atlassian team surge maker project management software report fiscal first quarter sale profit handily top estimate atlassian up full year revenue guidance midpoint guidance earlier forecast share surge nearly verizon communication vz add more postpaid wireless phone subscriber expect revenue also top estimate proofpoint pfpt report earning revenue top estimate fiscal outlook disappoint share rise friday video game publisher electronic art ea disappoint news be delay star war action adventure game have be set release fiscal run april march do not give new release time frame ea share be so far week rv maker winnebago wgo exceed forecast profit growth cent share revenue increase company also approve share buyback share close american express axp exceed earning estimate longtime ceo kenneth chenault retire stephen squeri set take place feb unite rental uri steamrolled estimate cent share ep rise revenue boost hurricane rebuild be reason nation largest equipment rental company boost guidance capital spending plan procter gamble pg profit grow share top view cent organic sale rise just result follow narrow proxy fight trian fund management nelzon peltz share fall friday unilever report weak sale thursday european consumer food product giant fall week related stock buy watch top ipos big small cap growth stockslooking best stock buy watch start here
13,ESRX,amazon amzn be reportedly mull entry pharmacy market commerce giant be less threat establish player wall street fear accord equity analyst amazon strength ongoing retail carnage be link innovation such prime now home delivery service have make shopping cheaper more convenient consumer however amazon be unlikely garner generic discount greater cvs walgreen already offer american already enjoy mail order drug delivery major pharmacy benefit manager mizuho security ann hyne say note wednesday amazon certainly have financial mean make investment hyne write question have be not investment garner enough return invest capital amazon typically enjoy matter expect add amazon face daunting task expand delivery service stateside include drug sale retail pharmacy industry be significantly more regulate foreign market anticipate be significant barrier entry say be buyer cvs wba today weakness hyne write walgreen boot alliance wba largest drugstore chain give afternoon trade stock market today cvs health cvs lose rite aid rad shed pharmacy benefit manager express script esrx dip drug distributor abc fall amazon slide broad market retreat president trump string crisis weigh investor ibd take amazon pharmacy ambition consumer electronic initiative show company continue innovate leaderboard stock be extend well buy point rise high deductible plan consumer assume more own health care cost be see catalyst online retail giant pharmacy ambition amazon have reportedly hire general manager multibillion dollar pharmacy market view entry business have not be finalize think amazon introduce lot transparency drug really cost stephen buck co founder goodrx service cost conscious prescription drug consumer tell cnbc first report news buck estimate amazon get roughly spend prescription drug year amazon japanese site have expand prime now service include drug sale be prelude similar move retailer often test new initiative foreign market roll domestically cnbc say amazon have toyed idea online retail pharmacy business backed drugstore com bid nearly decade take brick mortal rival deal soon fizzle walgreen snap drugstore com eventually shut related here more thing amazon be kill
14,ESRX,cvs health cvs share retreat tuesday drug store pharmacy benefit management giant top first quarter earning estimate report pharmacy sale guidance fail live forecast estimate profit drop share revenue rise result cvs earn share adjust revenue pharmacy same store sale slide more estimate cvs lose key pharmacy contract past year outlook cvs see ep share midpoint estimate stock share fall stock market today still key day move average breach support level last august stock be find hold day line retake key level april matter cvs pharmacy benefit manager unit pbm be see potentially gain express script esrx expect loss anthem customer anthem antm give mixed signal walgreen boot alliance wba rite aid rad multibillion dollar merger struggle continue drag new york post report friday walgreen be expect certify compliance day move put ball federal trade commission court deal day time frame related rite aid finally get good news walgreen deal doubtwalgreen ceo rite aid be still positive deal
15,ESRX,tuesday express script esrx get positive adjustment relative strength rs rating ibd unique rating measure price movement worst best score score show stock price performance trail week compare other stock database history reveal top perform stock typically have rs rating early stage move see ibd help make more money stock be not ideal buy point right now see be able form break proper consolidation company post earning growth last quarter sale growth come company hold rank peer medical service industry group diplomat pharmacy dplo be rank stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
16,ESRX,just health care investor thought be safe dive back retail pharmacy stock amazon com amzn deliver jolt thursday buy pillpack online pharmacy deliver prescription presort dose move send share cvs health cvs walgreen boot alliance wba tumble drug distributor abc cardinal health cah mckesson mck also retreat pharmacy benefit manager express script esrx april walmart wmt have reportedly be close deal buy pillpack nudge aside amazon meanwhile amazon fear shake health care longer look quite so scary company shelved plan deliver medical supply now again be focus just big threat amazon represent prescription retail industry already cvs have moved same day delivery major market next day delivery cvs health walgreen be just add dow jone be develop new drugstore model deliver broader array medical service get newsletter deliver inbox more info product service privacy policy term immediate reaction be sell cvs stock sank walgreen stock fall stock market today amazon rise cardinal health mckesson lose respectively express script fall walmart slide health insurer also sell perhaps understandably aetna aet be be buy cvs health sank cigna ci be buy express script lose unitedhealth unh retreat earlier thursday walgreen boost dividend share buyback plan top earning expectation term amazon pillpack deal be expect close later year weren disclose get instant access more trading idea exclusive stock list ibd proprietary rating only also dow jone future try rally key tech sector flash big warningif want buy more apple nvidia share read thisstock market today track market trend best stock watch
17,ESRX,here be investing action plan thursday need know investor come day nike nke walgreen boot alliance wba report earning do accenture acn stock be form base investor also be wait dividend buyback deluge likely follow second round federal reserve annual bank
18,ESRX,weight watcher international wtw express script hold esrx lithium play albemarle alb report better expect fourth quarter earning late tuesday xestimate share profit climb cent revenue accord zack investment research result weight watcher earn cent share revenue climb subscriber swell outlook weight watcher see ep well analyst view expect revenue grow almost approach full year rate operate profit growth exceed rate revenue growth say cfo nick hotchkin statement stock stock initially jump late trade close stock market today be recent high have vault past year thank part oprah winfrey effect medium mogul talk show queen buy stake weight loss company also become business public face estimate ep increase sale edge higher result earning rise share revenue climb management also announce pay eligible worker tax cut bonuse base tenure outlook express see ep vs analyst view stock share rise early hour action stock close tuesday build week rally have see come well early february low news health care pact jpmorgan chase jpm amazon com amzn berkshire hathaway brkb pummeled medical supplier stock include pharmacy benefit manager express script sell fear corporate giant try slash cost reduce demand service smaller rival estimate ep increase sale grow result earning leap share revenue outlook albemarle see ep net sale net sale analyst expect ep stock share rise late stock finished be mired november high lithium play albemarle chilean peer sociedad quimica minera sqm report wednesday other lithium stock sell hard monday worry surge output meet demand tesla tsla other maker electric vehicle weigh price legal uncertainty tie key chilean lease also pound stock hard january ibd take buy hold stock be risky head earning report here earning option strategy help cash post earning stock gain minimize risk weak quarter be interested lgi home toll bro top earning view housing stock shakyinflation fed rate hike outlook need knowchart read basic find correct buy point lead stocksbitcoin blockchain private industry ain see nothing yetwhy bull market rally be time review stock selling smartsai news artificial intelligence trend lead stock
19,ESRX,cigna ci just make bid join elite group health care industry titan deal buy drug benefit manager express script esrx yet takeover include assume debt come something shock express script pharmacy benefit manager general have be fire unloved wall street extent cigna be jump fry pan cigna pay share express script share wednesday close be equal premium express script wall street initial reaction deal be skeptical share cigna close stock market today meanwhile express script jump competitor unitedhealth unh dip cvs health rise humana hum lose cigna see combination give scale skill set deliver value customer hold health cost compete world competitor unitedhealth cvs complete merger aetna own increasingly formidable array health care asset cigna tell analyst thursday deal immediately add earning provide significant boost intermediate term company raise ep target share yet industry analyst worry amazon com amzn disrupt prescription industry amazon have flirted enter retail drug business just launch venture jpmorgan chase jpm berkshire hathaway brkb aim lower health care cost washington have amp rhetoric lack transparency drug pricing pbms be see prime suspect top express script have fall anthem antm biggest customer accuse not pass drug manufacturer rebate use ibd marketsmith free march
20,ESRX,see stock buy point get chart pattern recognition run custom screen start nowexpress script have purchasing alliance walgreen boot alliance wba so merger cigna create same kind scale cvs health aetna walgreen recently mulled buy drug distributor abc doesn already own accord report cvs acquire pharmacy benefit manager caremark unitedhealth acquire catamaran pbm unitedhealth week announce optumrx pbm directly provide drug rebate insure member employer plan apparent response pressure industry customer politician industry player have increasingly see stand alone pbm model meaning pharmacy benefit manager be not own directly major insurer be threat anthem be set own house pbm temporarily contract cvs analyst have speculate recent month amazon bid express script ease entry highly regulate complex prescription industry yet cigna deal suggest amazon wasn interested least not anything close price cigna be willing pay be interested dow jone stock be buy point fang make bullish movecvs re go deliver amazon jpmorgan berkshire seek doamazon health care disruption fear clash big picture be real news investorshere be chip stock breaking hit new high set upwhat do facebook grubhub salesforce epam have common
21,ESRX,nasdaq composite hit record high friday index dow jone industrial average reclaim key support just right job report well investor relief president donald trump exempt canada mexico steel tariff cigna ci buy express script esrx wave health care industry deal change target tgt dollar tree dltr headline bad week discount retailer american eagle outfitter aeo hit trendy apparel chain chinese internet have mixed result hot iposcasa system casa okta okta report stock be whipsaw trump economic advisor gary cohn resign tuesday night fan fear wider trade war major average rebound president trump exempt canada mexico steel aluminum tariff then boom friday hot job growth married tame wage gain nasdaq hit record high soar week index dow jone reclaim day move average advance respectively chip stock be big winner week several semiconductor new crop breakout health insurer buy pharmacy benefit manager aim size scope fast change health care landscape even pbms come fire cigna ci pay share express script esrx share equal friday close cigna share tumble more thursday express script jump cigna express script tie follow deal drugstore pbm cvs health cvs acquire aetna aet amazon amzn begin move health care use ibd marketsmith free march
22,ESRX,see stock buy point get chart pattern recognition run custom screen start nowseveral lead chip stock have break buy zone be approach include chip equipment maker apply material amat asml asml lam research lrcx lam hike quarterly dividend share double share repurchase authorization marvell technology group mrvl clear double bottom base then report better expect earning micron technology mu already top double bottom buy point clear alternate entry soar year high continue strong memory chip demand pricing target tgt plan hike minimum wage hour miss profit view fall short consensus ep guidance membership warehouse costco cost also miss ep estimate discounter dollar tree dltr disappoint board profit sale guidance figure price chain ross store rost beat comfortably comp grow offer cautious guidance weigh share peer burlington store burl get bump solid quarter big lot big tumble surprise drop same store sale be much better expect december january payroll be revise combine jobless rate hold labor force participation rate soar real story be wage average hourly earning rise just vs year earlier view january wage gain initially report be revise so job report didn fan fear federal reserve rate hike series earning beat be not enough stop america trendiest clothing retailer suffering steep loss thursday american eagle outfitter aeo sell thursday match earning estimate guide earning view thursday earn cent share fourth quarter vs year earlier net revenue climb rival abercrombie fitch anf beat profit revenue view wednesday fourth quarter comp strong same store sale hollister chain jump stock jump wednesday then sank american eagle urban outfitter urbn announce ep swell cent share revenue tuesday urban outfitter fall buy point thursday share baozun bzun help western brand adapt online sale strategy china sky-rocket strong result guidance yy yy plunge livestream service provider present outlook estimate date site livestream operator momo momo jump better expect earning auto athm fall sharply then re-cover earning report weak outlook com wuba call craigslist china be beating estimate guide low casa system casa report adjust earning revenue top view andover mass base casa expect adjust earning share vs estimate supplier cable tv network software forecast full year revenue line estimate casa come public mid december jump new high cybersecurity provider okta okta pre announce earning feb provide stellar additional financial report full result okta add customer january quarter year earlier billing sale growth metric jump okta raise fiscal revenue guidance earlier outlook okta hit record high maker computer aid design software rocket record high better expect fiscal fourth quarter result show move cloud compute subscription model be pay annualize recur revenue key metric reach increase year year also more autodesk adsk customer shift individual product software suite call industry collection last quarter boost annualize revenue subscription committee foreign investment unite state say propose broadcom avgo takeover rival chipmaker qualcomm qcom say deal national security risk cast doubt hostile takeover get regulatory approval cfius say be trouble broadcom relationship foreign entity especially china cfius order qualcomm delay annual shareholder meeting least month investigate further shareholder be set vote march broadcom bid proxy challenge annual oil gas industry conference houston begin international energy agency prediction shale production continue boom next several year squeeze opec ally russia be expect serve bulk world additional oil demand opec russian energy official also indicated cooperation oil production continue even agreement curb output expire year ceo oil production pipeline company also speak trump tariff gm ceo mary barra say automaker boost production bolt ev meet increase demand mcdonald mcd say roughly restaurant have begin serve fresh beef patty be cook order quarter pounder signature craft recipe burger other participate restaurant much be set start serve share kroger kr plummet match ep view surpass sale view concern gross margin pressure light full year profit outlook walmart wmt weight watcher wtw separately announce foray meal kit space walmart roll product more location year weight watcher team freshrealm sell kit grocery store latter half blue apron aprn tumble new low top view be not enough stop thor industry tho stock stumbling announce earning wednesday thor earn share revenue rise rev group revg make rvs other specialty vehicle report better expect fiscal earning same day sale come little short earn cent share revenue grow
23,ESRX,key stock index fund extend gain apple aapl amazon amzn alphabet goog boost tech heavy qqqs powershare qqq trust qqq rise spdr dow jone industrial average dium advanced spdr spy add stock market today emerge market small cap underperform qqq notch fifth straight session big cap techs move include amazon alphabet also extend streak day amazon gain alphabet apple rise end session loss iphone maker share remain day move average level be stick past week utility consumer staple health care lead upside sector fund health care select sector spdr xlv advanced head back day move average top component johnson johnson jnj pfizer pfe be dow top gainer express script esrx pop news health insurer cigna ci acquire pharmacy benefit manager metal miner bank retail lag spdr metal mining xme fall continue test support day line apple amazon facebook fb be top name hold big cap growth fund set possible buy opportunity similar etfs featured recently schwab large cap growth schg remain day move average retake line monday put fund potential buy zone important note purchase be higher normal risk market uptrend pressure etf also be form base potential buy point share advanced late september bounce line jan high then fall much february correction recover loss consolidate day line fund track dow jone large cap growth total stock market index marked eighth anniversary december offer market cap weight exposure big cap equity exhibit growth trait information technology represent nearly third total asset tuesday consumer discretionary be next health care industrial financial real estate consumer staple energy material service make less use ibd marketsmith free march
24,ESRX,see stock buy point get chart pattern recognition run custom screen start nowtop holding account stock portfolio include apple amazon facebook berkshire hathaway brkb alphabet amazon lead year date gain wednesday boee ba top name be next return apple have be trading day line past few week be feb intraday peak etf year date gain tuesday be ahead return accord morningstar direct average annual return past year respectively also lead index gain period schg carry expense ratio wednesday pick vanguard total stock market vti be hold support day move average also be interested dow stock extend loss apple fall china bitcoin dropsdow back apple reversal gold shine bitcoin fallsapple extend gain dow stock rally bitcoin play set
25,ESRX,xdrugstore chain rite aid rad report fiscal fourth quarter result tuesday top view takeover walgreen boot alliance wba remain doubt estimate wall street expect cent share loss profit cent share year revenue be see roughly flat result rite aid report break even result adjust basis revenue same store sale slide stock share climb stock market today hit year low monday walgreen boot alliance rise nearly move day line fred fred climb naming new board member late monday cvs health cvs rise due cvs pharmacy benefit manager side possibly benefit express script esrx likely lose anthem antm key customer ibd take deutsche bank believe rite aid stock dive more rite aid merger walgreen doesn go walgreen originally agree pay share rite aid deal worth time come wave health industry move consolidate keep expense check affordable care act bring insurance more person agreement be strike bloomberg note walgreen modernize rite aid store gear more beauty wellness walgreen gain access drug benefit management market employer insurer cvs health compete pass antitrust muster walgreen plan sell rite aid store fred still wasn enough ease regulator concern tie hurt competition so earlier year walgreen slash takeover new price dependent many store rite aid have divest federal trade commission reportedly consider block deal potential number rite aid store be sell have be bump many regulator doubt have grow fred ability absorb many store early month walgreen ceo stefano pessina say be still optimistic bring deal successful conclusion be doubt process get clear transaction be take longer expect last week bloomberg cite report trade publication capitol forum say federal trade commission be consider sue block walgreen attempt buy company merger expiration extension suggest walgreen keep fight ftc perhaps president trump get new commissioner fill empty seat related walgreen ceo rite aid be still positive deal new walgreen report send rite aid stock plunge again
26,ESRX,walgreen boot alliance wba use unitedhealth unh optumrx pharmacy benefit need save company consumer billion pact likely negate need walgreen make expensive purchase large pharmacy benefit manager pbm express script esrx wall street have speculate express script share fall fall low week low walgreen agreement unitedhealth optumrx give ability provide similar service cost saving arch rival cvs health cvs combine drugstore pbm pharmaceutical care management association separately launch ad campaign thursday tout saving pbms trade group say statement pbms negotiate price other term pharmacy drugmaker distributor be project save employer union government program consumer combine drug benefit cost next decade currently drugstore chain revenue walgreen be buy rite aid rad have own pbm estimate deal go walgreen choose expand use pbm combine company walgreen say statement unitedhealth optumrx agreement include day prescription option walgreen nearly pharmacy optumrx home delivery access pharmacist drugstore company plan integrate optumrx pharmacy care service walgreen current drugstore service agreement go effect start jan share walgreen boot alliance operate nearly location country rise stock market today walgreen stock have be first stage consolidation more month buy point rise low point trough share cvs have also be more month first stage consolidation be thursday rite aid distant third annual revenue cvs walgreen rise too unitedhealth slide close well intraday lows
27,ESRX,beleaguered specialty specialty drugmaker valeant pharmaceutical international rise sharply tuesday make deal walgreen boot alliance sell product have previously sell now defunct philidor also say deal deliver board price cut year agreement go effect early next year cover variety dermatology
28,ESRX,horizon pharma hznp stock rise depome depo fall friday morning court ruling lead horizon abandon hostile pursuit fellow specialty drugmaker horizon announce late thursday be withdraw stock offer california court grant depome motion injunctive relief base depome say be horizon misuse confidential information
29,ESRX,cvs health cvs announcement monday cover amgen amgn cholesterol drug repatha exclusively regeneron regn sanofi sny rival version praluent put pressure praluent maker deliver same say analyst repatha be only pcsk inhibitor cvs caremark commercial formulary say nation drugstore chain
30,ESRX,specialty drugmaker horizon pharma hznp fall sharply early trading wednesday pharmacy benefit manager express script esrx sue allegedly unpaid rebate cut specialty pharmacy horizon have be used network express script have be review call captive specialty pharmacy ever allegation misconduct emerge last month philidor specialty
31,ESRX,stock seesaw lower finish veteran day wednesday dow jone industrial average nasdaq end accord preliminary datum volume be lower board stock market today close share popeye louisiana kitchen plki jump more company post result beat view fried chicken chain report earning cent share sale view be cent share revenue also slightly raise full year profit outlook range share vs view regular session horizon pharma hznp gap plunge nearly pharmacy benefit manager express script esrx file lawsuit company contract dispute amtrust financial service afsi gap day line slump pricing secondary offer share insurance firm say take expense intraday fall more buy point cup handle base rather lackluster session tal education xrs rally score new high fast trade follow wednesday clear buy point late stage cup handle tuesday company provide tutor china luxoft lxft gap jump beating view raise guidance late tuesday company report adjust fiscal earning cent share year earlier profit growth have now accelerate quarters sale rise luxoft lift full year profit outlook nickel share stock be now extend past buy point flat base weekly jobless claim be thursday morning host central bank official be speaking day include fed chairwoman janet yellen st loui fed chief james bullard richmond fed president jeffrey lacker advance auto part aap cisco system csco be couple notable company report earning thursday follow vincent mao twitter ibd_vmao
32,ESRX,specialty drugmaker horizon pharma hznp jump friday trade pound wall street estimate raise guidance horizon adjust earning soar year earlier quarter cent share cent analyst consensus accord thomson reuter sale triple more past consensus horizon add
33,ESRX,beleaguered drug giant valeant pharmaceutical international vrx say friday sever ty specialty pharmacy philidor say be shut completely criticism mount business practice philidor first hit headline oct new york time mentioned article specialty pharmacy few day later short seller citron
34,ESRX,beleaguered drug giant valeant pharmaceutical international vrx say friday sever ty specialty pharmacy philidor say be shut completely criticism mount business practice philidor first hit headline oct new york time mentioned article specialty pharmacy few day later short seller citron
35,ESRX,cvs health cvs express script esrx nation largest pharmacy benefit manager axed valeant pharmaceutical vrx link philidor rx service network
36,ESRX,valeant share plunge hour trading stock market today drugmaker have be hit question drug pricing method well accounting business practice
37,ESRX,stock have plunge hit time intraday high aug have be trading steadily day move average
38,ESRX,cite former employee internal document bloomberg report earlier week philidor worker be give written instruction doctor prescription get more reimbursement insurer
39,ESRX,blue cross blue shield health insurer be examine valeant specialty pharmacy source tell bloomberg
40,ESRX,thursday cvs say statement decision terminate philidor come monitoring review result recent audit philidor practice several week express script say statement be evaluate other valeant related pharmacy addition terminate philidor network
41,ESRX,last week citron research note claim valeant prop sale expensive drug used network specialty mail order pharmacy
42,ESRX,valeant aim be keep patient health insurer switch less expensive generic medication citron allege call valeant pharmaceutical enron
43,ESRX,valeant call report erroneous ask security exchange commission investigate citron
44,ESRX,follow ciaran mcevoy twitter ibd_cmcevoy facebook cvs health cvs express script esrx nation largest pharmacy benefit manager axed valeant pharmaceutical vrx link philidor rx service network valeant share plunge hour trading stock market today drugmaker have be hit question drug pricing method well accounting business practice stock have plunge hit time intraday high aug have be trading steadily day move average cite former employee internal document bloomberg report earlier week philidor worker be give written instruction doctor prescription get more reimbursement insurer blue cross blue shield health insurer be examine valeant specialty pharmacy source tell bloomberg thursday cvs say statement decision terminate philidor come monitoring review result recent audit philidor practice several week express script say statement be evaluate other valeant related pharmacy addition terminate philidor network last week citron research note claim valeant prop sale expensive drug used network specialty mail order pharmacy valeant aim be keep patient health insurer switch less expensive generic medication citron allege call valeant pharmaceutical enron valeant call report erroneous ask security exchange commission investigate citron follow ciaran mcevoy twitter ibd_cmcevoy facebook
45,ESRX,company head record year share repurchase expert be split buyback be logical result excess capital come expense growth initiative
46,ESRX,number high profile company have implement aggressive buyback program recent quarters span sector economy
47,ESRX,include tech giant such apple aapl microsoft msft health care leader express script esrx abbvie abbv manufacturer boee ba general motor gm financial leader well fargo wfc consumer stock such nike nke wendy wen
48,ESRX,nike announce buyback program thursday dividend hike
49,ESRX,apple buy back share fiscal buy stock
50,ESRX,not surprisingly buyback have become focus intense medium coverage recent week
51,ESRX,critic say more money be reinvest research development initiative well new product technology service contribute long term growth feed economic expansion say critic also say executive use buyback flatter financial result
52,ESRX,defender say return money shareholder be good use money left capital have already be allocate normal business expense
53,ESRX,today environment many company be still left large amount excess capital even investing growth initiative say michael arone chief investment strategist state street global advisor intermediary business group
54,ESRX,be choose redeploy money investor tell ibd do right way buyback be good capital allocation be lot misperception share buyback
55,ESRX,record buyback pace
56,ESRX,certain be whole lot money be go buyback dividend lately
57,ESRX,total dollar amount dividend stock buyback be track reach new high year soar first time accord industry estimate
58,ESRX,percentage operate cash flow used buy back share be highest level arone say call watersh year buyback be also just fall sharp recession bear market
59,ESRX,look kind peak year say year percentage operate cash flow used buyback be still be largest year time absolute dollar term
60,ESRX,recent investigative report reuter note nearly publicly trade financial company examine have buy back share
61,ESRX,fiscal spending buyback dividend surpass company combine net income first time outside recessionary period reuter say spending keep climb higher company have already report fiscal suggest corporation be rely more heavily cheap interest rate use debt fund buyback dividend
62,ESRX,factset research report company buy back share paid dividend trail month end second quarter most recent datum available be spend firm share repurchase same period
63,ESRX,information technology sector spend most money buyback second quarter factset say lead apple microsoft qualcomm qcom oracle orcl
64,ESRX,meanwhile company issue dividend be establish new record accord datum henderson global investor
65,ESRX,be money go buyback dividend
66,ESRX,most basic answer be money be something have be do
67,ESRX,have low interest rate record profit arone say have result corporation peak level term have lot cash hand
68,ESRX,case activist investor be pressure company reward investor money analyst say other executive be simply gun shy investing product service not pay long term
69,ESRX,reason company be buy back outstanding share be do so fatten share earning
70,ESRX,innovation shortchange
71,ESRX,worry quarters be buyback come expense product development innovation long term growth
72,ESRX,be production everything flat panel tvs semiconductor solar photovoltaic cell gary pisano professor harvard business school tell reuter also author produce prosperity america need manufacturing renaissance
73,ESRX,reuter report so firm track buy back share report spending share net income spend innovation have averaged less com pare
74,ESRX,not datum show such grim view arone say bunch datum show grow fastest level year misperception company be not reinvest spending business growth many company do continue reinvest business
75,ESRX,also say buyback boost company ep research dow jone index show weight basis recent ep gain be build profit not buyback
76,ESRX,recent report deutsche bank find share profit have rise annually average just percentage point be buyback fall point
77,ESRX,misperception buyback be due couple factor arone say
78,ESRX,global economic growth have be sluggish therefore folk equate sluggishness lack business investment say also be lack meaningful wage growth view be accelerate much more quickly have business be investing more not convince accurate
79,ESRX,economic growth be sluggish return capital be low so return cash shareholder be sound decision
80,ESRX,not say aren case company issue buyback dividend detriment
81,ESRX,company be borrow aggressively levering balance sheet buy back stock be not necessarily good strategy arone say company buy back stock offset dilutive effect stock base compensation employee not good strategy
82,ESRX,be exception rather rule say say happen broadly be mind exaggeration company head record year share repurchase expert be split buyback be logical result excess capital come expense growth initiative number high profile company have implement aggressive buyback program recent quarters span sector economy include tech giant such apple aapl microsoft msft health care leader express script esrx abbvie abbv manufacturer boee ba general motor gm financial leader well fargo wfc consumer stock such nike nke wendy wen nike announce buyback program thursday dividend hike apple buy back share fiscal buy stock not surprisingly buyback have become focus intense medium coverage recent week critic say more money be reinvest research development initiative well new product technology service contribute long term growth feed economic expansion say critic also say executive use buyback flatter financial result defender say return money shareholder be good use money left capital have already be allocate normal business expense today environment many company be still left large amount excess capital even investing growth initiative say michael arone chief investment strategist state street global advisor intermediary business group be choose redeploy money investor tell ibd do right way buyback be good capital allocation be lot misperception share buyback record buyback pacewhat certain be whole lot money be go buyback dividend lately total dollar amount dividend stock buyback be track reach new high year soar first time accord industry estimate percentage operate cash flow used buy back share be highest level arone say call watersh year buyback be also just fall sharp recession bear market look kind peak year say year percentage operate cash flow used buyback be still be largest year time absolute dollar term recent investigative report reuter note nearly publicly trade financial company examine have buy back share fiscal spending buyback dividend surpass company combine net income first time outside recessionary period reuter say spending keep climb higher company have already report fiscal suggest corporation be rely more heavily cheap interest rate use debt fund buyback dividend factset research report company buy back share paid dividend trail month end second quarter most recent datum available be spend firm share repurchase same period information technology sector spend most money buyback second quarter factset say lead apple microsoft qualcomm qcom oracle orcl meanwhile company issue dividend be establish new record accord datum henderson global investor be money go buyback dividend most basic answer be money be something have be do have low interest rate record profit arone say have result corporation peak level term have lot cash hand case activist investor be pressure company reward investor money analyst say other executive be simply gun shy investing product service not pay long term reason company be buy back outstanding share be do so fatten share earning innovation shortchange worry quarters be buyback come expense product development innovation long term growth be production everything flat panel tvs semiconductor solar photovoltaic cell gary pisano professor harvard business school tell reuter also author produce prosperity america need manufacturing renaissance reuter report so firm track buy back share report spending share net income spend innovation have averaged less com pare not datum show such grim view arone say bunch datum show grow fastest level year misperception company be not reinvest spending business growth many company do continue reinvest business also say buyback boost company ep research dow jone index show weight basis recent ep gain be build profit not buyback recent report deutsche bank find share profit have rise annually average just percentage point be buyback fall point misperception buyback be due couple factor arone say global economic growth have be sluggish therefore folk equate sluggishness lack business investment say also be lack meaningful wage growth view be accelerate much more quickly have business be investing more not convince accurate economic growth be sluggish return capital be low so return cash shareholder be sound decision not say aren case company issue buyback dividend detriment company be borrow aggressively levering balance sheet buy back stock be not necessarily good strategy arone say company buy back stock offset dilutive effect stock base compensation employee not good strategy be exception rather rule say say happen broadly be mind exaggeration
83,ESRX,specialty drugmaker horizon pharma hznp batter stock rise sharply friday company issue statement counter takeover target depome depo charge regard drug pricing policy horizon have be hot water monday valeant pharmaceutical vrx be subject new york time article say company be used specialty
84,ESRX,fda say thursday require warning liver damage be put label abbvie abbv hepatitis treatment viekira pak technivie send abbvie share plunge month low gilead science gild sharply review adverse event report fda adverse event report system faer database
85,ESRX,stock loss picked late tuesday federal reserve appear less keen enact round stimulus spur economy apple aapl hold gain minute central bank march meeting show only couple bank member policy board thought third round stimulus know quantitative ease
86,ESRX,stock stumble rise volume disappointing durable good report market pare loss afternoon
87,ESRX,nasdaq dow jone industrial average lose nasdaq have fall much day low dow come back drop
88,ESRX,volume climb nasdaq nyse accord preliminary datum
89,ESRX,durable good order rise february shy expectation gain still report show solid improvement january decline
90,ESRX,biggest loss be suffer hottest stock
91,ESRX,invensense invn sank heavy volume compound monday drop move put maker motion process chip software used mostly video game console smartphone back high prior sharp pullback week move average stock accumulation distribution rating have fall past day sell
92,ESRX,drugmaker alexion pharmaceutical alxn fall time average trade stock have fall much pare loss alexion now stand buy point flat base
93,ESRX,oil gas producer continental resource clr fall thank nearly drop crude price continental slice week line volume finished just average total
94,ESRX,medco health mhs express script esrx gap higher express script rise have be much medco add pharmacy benefit manager say close merger early next week
95,ESRX,apple aapl moved fraction have be trading column most day even broad market session lows stock stumble rise volume disappointing durable good report market pare loss afternoon nasdaq dow jone industrial average lose nasdaq have fall much day low dow come back drop volume climb nasdaq nyse accord preliminary datum durable good order rise february shy expectation gain still report show solid improvement january decline biggest loss be suffer hottest stock invensense invn sank heavy volume compound monday drop move put maker motion process chip software used mostly video game console smartphone back high prior sharp pullback week move average stock accumulation distribution rating have fall past day sell drugmaker alexion pharmaceutical alxn fall time average trade stock have fall much pare loss alexion now stand buy point flat base oil gas producer continental resource clr fall thank nearly drop crude price continental slice week line volume finished just average total medco health mhs express script esrx gap higher express script rise have be much medco add pharmacy benefit manager say close merger early next week apple aapl moved fraction have be trading column most day even broad market session lows
96,ESRX,monday economic headline have be mixed market reaction be not decent gain be logged volume increase
97,ESRX,nasdaq rise gain dow jone industrial average add
98,ESRX,first good news institute supply management manufacturing index rise point march beating estimate move further boom bust level sign growth be pick steam manufacturing activity china hit month high
99,ESRX,now bad news manufacturing member euro zone shrank eighth straight month unemployment bloc tick year high
100,ESRX,also construction spending unexpectedly slip february accord census bureau
101,ESRX,apple aapl monday ibd jump recoup friday drop climb back mark volume run slightly average stock be far nearest buy point
102,ESRX,loss friday tibco software tibx rebound strong volume stage upside reversal process stock be find support day line be now buy point
103,ESRX,tibco sport composite rating maximum
104,ESRX,meanwhile casino game maker shuffle master shfl jump close new high follow low volume pullback
105,ESRX,express script esrx climb volume jump time average federal trade commission approve company purchase medco health solution mhs company say monday vote be final step month process complete deal announce july combine company reportedly handle prescription third population expect annual cost saving merger
106,ESRX,monday gain put express script just buy point month cup handle base buy point appear monday economic headline have be mixed market reaction be not decent gain be logged volume increase nasdaq rise gain dow jone industrial average add first good news institute supply management manufacturing index rise point march beating estimate move further boom bust level sign growth be pick steam manufacturing activity china hit month high now bad news manufacturing member euro zone shrank eighth straight month unemployment bloc tick year high also construction spending unexpectedly slip february accord census bureau apple aapl monday ibd jump recoup friday drop climb back mark volume run slightly average stock be far nearest buy point loss friday tibco software tibx rebound strong volume stage upside reversal process stock be find support day line be now buy point tibco sport composite rating maximum meanwhile casino game maker shuffle master shfl jump close new high follow low volume pullback express script esrx climb volume jump time average federal trade commission approve company purchase medco health solution mhs company say monday vote be final step month process complete deal announce july combine company reportedly handle prescription third population expect annual cost saving merger monday gain put express script just buy point month cup handle base buy point appear
107,ESRX,stock be mixed midday tuesday investor look release fed minute afternoon nasdaq rise apple aapl climb more double average daily volume dow jone industrial average be volume be lower nyse nasdaq compare same
108,ESRX,drug store chain pharmacy benefit management company cvs caremark cvs say impasse competitor boost earning first quarter possibly cvs report fourth quarter earning share cent year line analyst forecast total sale climb pharmacy service business climb
109,ESRX,drugstore chain wag see steeper expect decline february drug volume second month hasn filled prescription customer express script esrx network
110,ESRX,drug chain say total february sale climb include year extra day general merchandise sale store open least year climb slight decrease traffic
111,ESRX,same store prescription sale fall steeper drop analyst have expect same store figure back extra leap year day
112,ESRX,company say new generic drug milder flu season cause part decline vast majority be expiration contract express script network account prescription filled february
113,ESRX,share be intraday trading
114,ESRX,cease fill prescription patient express script pharmacy benefit management network dec fail agree new contract
115,ESRX,drugstore chain cvs caremark cvs earlier guide fiscal first quarter result higher cent share base business be winning impasse other include rite aid rad have be aggressively court customer
116,ESRX,total sale fiscal second quarter end feb climb sale first month cover length express script impasse be announce full second quarter result march
117,ESRX,cvs report fiscal first quarter result
118,ESRX,cvs also operate pharmacy benefit management business caremark division pbms be hire insurance company handle prescription drug plan caremark express script medco health solution mhs be top space
119,ESRX,separately federal regulator continue review express script acquisition medco close week
120,ESRX,lawmaker large supermarket have urge regulator scuttle deal medco share have surge close deal price sign investor think pass muster drugstore chain wag see steeper expect decline february drug volume second month hasn filled prescription customer express script esrx network drug chain say total february sale climb include year extra day general merchandise sale store open least year climb slight decrease traffic same store prescription sale fall steeper drop analyst have expect same store figure back extra leap year day company say new generic drug milder flu season cause part decline vast majority be expiration contract express script network account prescription filled february share be intraday trading cease fill prescription patient express script pharmacy benefit management network dec fail agree new contract drugstore chain cvs caremark cvs earlier guide fiscal first quarter result higher cent share base business be winning impasse other include rite aid rad have be aggressively court customer total sale fiscal second quarter end feb climb sale first month cover length express script impasse be announce full second quarter result march cvs report fiscal first quarter result cvs also operate pharmacy benefit management business caremark division pbms be hire insurance company handle prescription drug plan caremark express script medco health solution mhs be top space separately federal regulator continue review express script acquisition medco close week lawmaker large supermarket have urge regulator scuttle deal medco share have surge close deal price sign investor think pass muster
121,ESRX,stock be support wednesday positive economic datum market friendly nugget fed policymaker minute succumb late day nervous investor
122,ESRX,dow jone industrial average be star tuesday session fall do nasdaq slide volume climb major exchange accord preliminary datum
123,ESRX,minute federal open market committee october meeting show plenty support continue easy posture several voting member fed policymaking board want see extension action dec expiration operation twist fed have be selling short term security buy longer date aim be push liquidity addition further maturity range lower mortgage rate support housing market
124,ESRX,also discuss be idea link current super easy policy economic result include unemployment inflation rate rather set expiration date
125,ESRX,meanwhile president obama call congress extend middle class tax break say least do agree say washington then move negotiating handle taxe wealthy work avoid fiscal cliff
126,ESRX,economic datum be mixed producer price index fall october prior month far cry gain expect bloomberg survey economist rate rise year earlier retail sale fall last month bit expect negative turnaround september gain auto sale be major culprit disappointment
127,ESRX,high profile gain couldn save day
128,ESRX,cisco system csco jump strong turnover power better expect earning report late tuesday stock remain day day move average well april high cisco have weak ibd composite rating remain tech sector bellwether
129,ESRX,facebook fb gain big volume big lock expiration day ipo social network remain peak still have poor ibd composite rating
130,ESRX,market be dominate seller
131,ESRX,catamaran ctrx slide strong volume pharmacy benefit manager service provider wednesday ibd slice day move average consolidate level last few week rival pharmacy benefit manager express script esrx be also heavy volume slide
132,ESRX,michael kor kor wednesday ibd fall active turnover clothing accessory maker december ipo have undercut support prior buy point
133,ESRX,chico fas ch fall fast trade drop further day line woman clothing retailer isn ibd have ibd composite rating best possible grade
134,ESRX,sandstorm sand dive giant volume slice day move average gold play come public august sport highest possible ibd composite rating late tuesday cnbc jim cramer indicated be bearish sandstorm stock be support wednesday positive economic datum market friendly nugget fed policymaker minute succumb late day nervous investor dow jone industrial average be star tuesday session fall do nasdaq slide volume climb major exchange accord preliminary datum minute federal open market committee october meeting show plenty support continue easy posture several voting member fed policymaking board want see extension action dec expiration operation twist fed have be selling short term security buy longer date aim be push liquidity addition further maturity range lower mortgage rate support housing market also discuss be idea link current super easy policy economic result include unemployment inflation rate rather set expiration date meanwhile president obama call congress extend middle class tax break say least do agree say washington then move negotiating handle taxe wealthy work avoid fiscal cliff economic datum be mixed producer price index fall october prior month far cry gain expect bloomberg survey economist rate rise year earlier retail sale fall last month bit expect negative turnaround september gain auto sale be major culprit disappointment high profile gain couldn save day cisco system csco jump strong turnover power better expect earning report late tuesday stock remain day day move average well april high cisco have weak ibd composite rating remain tech sector bellwether facebook fb gain big volume big lock expiration day ipo social network remain peak still have poor ibd composite rating market be dominate seller catamaran ctrx slide strong volume pharmacy benefit manager service provider wednesday ibd slice day move average consolidate level last few week rival pharmacy benefit manager express script esrx be also heavy volume slide michael kor kor wednesday ibd fall active turnover clothing accessory maker december ipo have undercut support prior buy point chico fas ch fall fast trade drop further day line woman clothing retailer isn ibd have ibd composite rating best possible grade sandstorm sand dive giant volume slice day move average gold play come public august sport highest possible ibd composite rating late tuesday cnbc jim cramer indicated be bearish sandstorm
135,ESRX,stock notch solid open tuesday tech transportation stock lead energy mining issue bring rear
136,ESRX,nasdaq climb add dow jone industrial average tack gain
137,ESRX,volume be briskly mixed stock market today nasdaq nyse inverse early trading action monday
138,ESRX,air transport issue lead fedex fdx unite parcel service up notch best early gain industry group track ibd gold coal oil group post worst loss list
139,ESRX,commerce department report construction spending surge october reversed revise decline september easily outpaced economist expectation increase
140,ESRX,early stock action showedbiogen biib skip company report positive result phase study alzheimer treatment plan aggressively move phase trial gain lift share back converge week move average left stock still month consolidation
141,ESRX,cypress semiconductor cy power punch month high agree be acquire sunnyvale calif base spansion code stock deal value cypress share have be wallow consolidation mid spansion share fire ahead well new high
142,ESRX,leader ambarella amba celgene celg jump front ibd list
143,ESRX,ambarella pop start trade retake portion tumble take monday video chip maker be trading friday high extend strong october rebound week support
144,ESRX,biotech drug maker celgene climb nearly move new high now buy point double bottom base stock notch solid open tuesday tech transportation stock lead energy mining issue bring rear nasdaq climb add dow jone industrial average tack gain volume be briskly mixed stock market today nasdaq nyse inverse early trading action monday air transport issue lead fedex fdx unite parcel service up notch best early gain industry group track ibd gold coal oil group post worst loss list commerce department report construction spending surge october reversed revise decline september easily outpaced economist expectation increase early stock action showedbiogen biib skip company report positive result phase study alzheimer treatment plan aggressively move phase trial gain lift share back converge week move average left stock still month consolidation cypress semiconductor cy power punch month high agree be acquire sunnyvale calif base spansion code stock deal value cypress share have be wallow consolidation mid spansion share fire ahead well new high leader ambarella amba celgene celg jump front ibd list ambarella pop start trade retake portion tumble take monday video chip maker be trading friday high extend strong october rebound week support biotech drug maker celgene climb nearly move new high now buy point double bottom base
145,ESRX,express script esrx turn wag offer continue fill prescription military service member family retiree pentagon tricare program company haven be able agree overall contract renewal meaning patient get pharmacy benefit express script win be able get order fill dec share
146,ESRX,drug wholesaler mckesson mck be buy medical product distributor pss world medical pssi sector merger consolidation continue mckesson also report better expect fiscal second quarter earning share rise hit month high pss share surge late session just share cash offer preserve
147,ESRX,stock jab healthy early gain quiet pre holiday trade wednesday nasdaq scale dow jone industrial average volume be weak stock market today nasdaq nyse chicago region manufacturing ease less expect november send kingsbury international chicago pmi
148,ESRX,sector lead stock end mostly lower tuesday major average sell weak earning report renew concern europe alexion pharmaceutical alxn take biggest hit sector leader second straight day fall more double average daily volume stock have fall straight session
149,ESRX,stock push new session high tuesday halftime election day blue chip lead techs lag
150,ESRX,dow jone industrial average rally boost caterpillar cat unite technology utx climb nasdaq hold back weakness telecom internet issue rise just volume be tracking sharply higher nasdaq slightly lower nyse
151,ESRX,vitamin shoppe vsi gap day line bolt release report easily top view stock clear buy point flat base larger consolidation open supplement retailer say earning jump cent share sale grow analyst have expect cent share revenue
152,ESRX,rival gnc holding gnc rise near day line
153,ESRX,ellie mae elli jump extend comeback effort stock accumulation distribution have weaken worst possible indicate institutional selling ellie mae be still week high
154,ESRX,downside express script esrx be session low still reaction late monday disappointing sale outlook stock gap day line erased gain july past buy point
155,ESRX,nationstar mortgage nsm extend loss near oct low stock have already fall day row be track fourth open mortgage service deliver profit cent share vs year loss cent miss view penny sale top view bolt monday highflier close day line first time go public march stock push new session high tuesday halftime election day blue chip lead techs lag dow jone industrial average rally boost caterpillar cat unite technology utx climb nasdaq hold back weakness telecom internet issue rise just volume be tracking sharply higher nasdaq slightly lower nyse vitamin shoppe vsi gap day line bolt release report easily top view stock clear buy point flat base larger consolidation open supplement retailer say earning jump cent share sale grow analyst have expect cent share revenue rival gnc holding gnc rise near day line ellie mae elli jump extend comeback effort stock accumulation distribution have weaken worst possible indicate institutional selling ellie mae be still week high downside express script esrx be session low still reaction late monday disappointing sale outlook stock gap day line erased gain july past buy point nationstar mortgage nsm extend loss near oct low stock have already fall day row be track fourth open mortgage service deliver profit cent share vs year loss cent miss view penny sale top view bolt monday highflier close day line first time go public march
156,ESRX,stock future show narrow gain tuesday quiet economic calendar left focus earning report presidential election dow future trade point nasdaq future be higher future rise point hush overall market lead stock be highly active premarket trade systemsddd bonanza creek
157,ESRX,cvs caremark cvs say poise benefit contract fight wag express script esrx beat profit expectation main business make solid gain drugstore chain pharmacy benefit manager earn cent share third quarter increase year cent better
158,ESRX,recent slide manage care stock unitedhealth unh follow wag announcement shift employee medical coverage private exchange have be premature manage care provider see revenue gain related announcement citigroup analyst carl mcdonald say research note monday argue single biggest structural positive think
159,ESRX,health insurer cigna ci acquire pharmacy benefit manager express script hold esrx include assume debt company announce thursday morning come drugstore pbm giant cvs health cvs be process buy insurer aetna aet health player scramble size scope amazon amzn move space cigna pay share express script share equal wednesday close premium express script cigna fall soon open bell stock market today express script shot cvs health aetna hope wring cost lock loyalty deal cigna express script deal do same amazon recently announce joint venture jpmorgan chase jpm warren buffett berkshire hathaway brkb try curb medical cost employee use ibd marketsmith free march
160,ESRX,see stock buy point get chart pattern recognition run custom screen start nowamazon also reportedly have be mull move pharmacy business way amazon face regulatory hurdle cvs aetna cigna express recently announce albertson deal acquire rite aid rad amazon ability use make big splash be narrowing amazon stock rise early be interested cvs re go deliver amazon jpmorgan berkshire seek doamazon health care disruption fear clash reality
161,ESRX,dow industrial nasdaq composite snap quick gain thursday open chip stock book positive early move express script esrx surge merger deal earning result drive burlington store burl sharply higher nasdaq composite climb add bolster express script huge early leap dow jone industrial average swung nasdaq intel intc boee ba battle early lead thursday market have eye washington legislator continue wrestle white house tariff set be sign action late today entire northeast also be area concern airline cancele report flight region response ongoing snowstorm overseas market stock surge hong kong official datum show china export growth accelerate february highest level year gain send hang seng index benchmark attempt stem week decline japan tokyo nikkei post more modest gain europe trade shift higher open cac paris rally frankfurt dax afternoon trade use ibd marketsmith free march
162,ESRX,see stock buy point get chart pattern recognition run custom screen start nowin thursday economic news open monthly job cut report challenger gray christmas show employer announce layoff february be january level number layoff announce year number layoff have now remain consecutive month longest gauge history economy be almost full employment company be hold workforce report note weekly unemployment claim rebound week end march labor department estimate rise be prior week tally year low be also well analyst consensus view new application chip stock be early motion intel gain lead dow advanced micro device amd add intel end wednesday new high straight day extend buy point flat base amd be testing resistance day move average end just level pare early gain wednesday express script open higher health insurer cigna ci confirm pay acquire pharmacy benefit manager cigna say expect deal include debt close end year year court block propose merger cigna fellow health insurer anthem antm still move continue recent round massive reorganization sector include cvs health cvs purchase aetna aet launch apple aapl health clinic employee joint venture amazon com amzn berkshire hathaway brka jpmorgan jpm more efficiently provide healthcare service employee cigna share drop open trade earning news burlington store button early gain new jersey base retailer report late wednesday fourth quarter sale earning same store sale consensus projection burlington store also raise full year earning guidance analyst target early gain haul share back week move average sixth week consolidation thor industry tho fiscal second quarter sale beat analyst estimate earning apparently come short view company say industry be benefit healthy lend standard credit availability low rate charge off thor share rise thursday open then reversed slight loss trade still january high just resistance week move average related big picture be real news investorshere be chip stock breaking hit new high set upwhat do facebook grubhub salesforce epam have common stock bounce white house say tariff exempt canada mexicoapple iphone sale bite year dog china
163,ESRX,stock market be slightly higher afternoon trading thursday wall street await president trump decision steel aluminum tariff et trump initially announce tariff steel import tariff aluminum stock market be cheer late wednesday news mexico canada be exclude dow jone industrial average volume nyse be pace be lower wednesday level nasdaq volume be higher johnson johnson jnj mcdonald mcd coca cola ko be top performer dow gain stock market today steel producer tenaris ts add look weekly chart show big cup handle base buy point earning news burlington store burl be high still rise early thursday retailer smash earning expectation surge quarterly profit help accelerate sale rise burlington be work flat base entry ibd square sq extend gain imperfect cup handle base buy point share picked pullback left side base form wasn extreme correction handle be deep use ibd marketsmith free march
164,ESRX,see stock buy point get chart pattern recognition run custom screen start nowin biotech space ligand pharmaceutical lgnd look poise extend winning streak session share jump nearly still buy range buy point ligand be featured today new america news cigna ci announce plan acquire pharmacy benefit manager express script esrx cigna say deal be immediately accretive earning wall street still seem skeptical send cigna share lower express script initially jump be session low december cvs health cvs agree combine aetna aet close watch earning upland software upld many fast grow enterprise software name ibd database share break powerfully monday clear buy point share edge higher ahead result related look best stock buy watch start heretop chinese internet stock jump earning beat then intelligence be surge priority big oil company
165,ESRX,biotech stock pharmaceutical company add recent market gain monday trump top health aide deliver speech largely spare brunt drug pricing reform health human service secretary alex azar deliver speech drug pricing reform monday trump speech be light impact biotech company pharmaceutical company instead white house be consider change medicare cap pocket spending most proposal impact so call middleman include pharmacy benefit manager pbms drug distributor include like express script esrx cvs cvs abc azar be critical pharmaceutical company high list price lack transparency direct consumer advertising look forward work industry build better system say industry isn willing work lower price president trump administration keep turn pressure system finally put american patient first get newsletter deliver inbox more info product service privacy policy term useshare pharmaceutical company have rally ultimately slip marginally close biotech company stock gain stock market today follow speech nasdaq biotechnology nbi be flat ishare nasdaq biotechnology ibb index rise proposal rbc analyst see change medicare part part have biggest impact biotech stock still write note client even still be relatively benign overall part cover physician administer drug part cover prescription drug proposal negotiation part drug be more similar part negotiation more broadly president be call part merge part azar say inflation capped price increase part be likely most impactful proposal biotech well pocket transparency part vs part drug infusion vs self injectable unify part bill code rbc analyst say regeneron pharmaceutical regn have largest exposure large cap biotechs part eye disease drug call eylea celgene celg biogen biib amgen amgn also be expose further sage therapeutic sage aldr dynavax dvax face difficulty azar also suggest change pbms issue negotiate rebate propose end so call gag clause pharmacist prevent pharmacist tell consumer actually save money pay pocket medicine right now re ask pretty straightforward question instead current system drug company get paid rebate middleman take cut just have fix price discount azar say fix situation even pharmacy benefit manager be hire help keep price low make money higher list price also suggest pharmaceutical company include list price advertising go directly consumer further azar say center medicare medicaid service be develop incentive lower list price most change be long term further action raymond james analyst michael baker say note change part contract prevent pharmacist explain pocket cost be cheaper likely not have meaningful impact related biotech stock fly trump speech see more bark bite much money do need start investing long term retirement investing strategy buy stock ahead earning report
166,ESRX,cvs health cvs say make progress regulatory review deal buy health insurer aetna aet first quarter earning come higher analyst anticipate cvs rival express script esrx be try get mega merger approve regulator drug middleman combine large insurer offer larger suite medical service roof deal be be review justice department be move forward regulatory integration plan front support close second half year efficient integration operation cvs health chief executive officer larry merlo say statement wednesday earning be be share exclude item cvs health say compare average analyst prediction compile bloomberg revenue rise line average estimate get newsletter deliver inbox more info product service privacy policy term share gain stock market trading cvs propose takeover aetna bring together cvs store health insurer customer central plank deal be transform store health hub consumer get care pick drug buy cosmetic stay hospital sign ambition last month cvs hire senior executive startup specialize primary care clinic oversee expand health care service company aetna report first quarter earning surpass estimate tuesday aetna be fire cylinder validate cvs gain pristine health insurance asset deal go write jason mcgorman analyst bloomberg intelligence concern amazon com amzn start directly compete cvs selling prescription drug have recede recently follow cnbc report april internet retailer have shelved plan too sell drug hospital other business
167,ESRX,regeneron pharmaceutical regn tumble year low tuesday prod rival amgen amgn also dip announce deal express script esrx cut net price cholesterol drug praluent express script list praluent exclusive psck inhibitor national formulary july exchange pay lower price drug pcsk inhibitor praluent amgen repatha work reduce bad ldl cholesterol blood also benefit cardiovascular outcome move be effort expand access cholesterol drug praluent regeneron partner sanofi sny say report suggest prescription request be reject insurer be part due price praluent repatha go north year regeneron chief executive leonard schleifer praise deal written statement see agreement set new standard model medicine praluent get newsletter deliver inbox more info product service privacy policy term use paradigm shift agreement be design break gridlock so praluent be finally able reach patient most need say cardiologist have experience unprecedented challenge secure access praluent patient be clearly appropriate be deny coverage investor weren keen deal afternoon trading stock market today regeneron slip amgen drop sanofi lose fraction agreement significantly reduce documentation necessary secure express script insurance coverage cholesterol drug regeneron sanofi say press release physician submit simplified attestation form confirm patient be appropriate praluent express script also agree pass portion saving patient enrolled other plan patient see lower pocket cost praluent prescription company say analyst be largely positive deal note specific price cut aren public likely praluent be price line recent report suggest be cost effective higher risk patient annually rbc analyst brian william say note price volume announcement leave lot financial benefit air william say pcsk market be particularly attractive give massive size type deal further incentivize insurer implement complicate utilization process say further deal price cholesterol drug closer annual target represent cut net price william say do not view pricing race bottom give potential annual compound lifetime treatment create distinct difference vs price volume contract curative time treatment hepatitis space add now battle other insurer william say amgen be negotiation payer likely leverage expertise winning contract agreement seek deal unite health unh cvs health cvs anthem antm aetna aet cigna ci humana hum say amgen estimate express script formulary decision impact repatha patient piper jaffray analyst christopher raymond say report client keep model praluent intact first quarter earning conference call thursday just do back envelope math repatha patient switch praluent july be tailwind praluent second half formulary decision alone say related do spot major market top easy look heavy distributionnew option strategy limit risk earningsstill rule stock investor always cut loss short
168,ESRX,welcome move express script esrx see relative strength rating improve tuesday ibd proprietary rating identify market leadership worst best score grade show stock price behavior trail week hold other stock database year market history show stock go make biggest gain often have rs rating north launch biggest price move see express script continue show renew price strength clear threshold look winning stock try simple routineexpres script be not currently potential buy area see stock go form promising consolidation spark new run company report earning growth last quarter sale growth come company hold rank peer medical service industry group china cord blood co be top rank stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
169,ESRX,here weekly investing action plan need know investor come week more tech darling report earning come week time apple aapl tesla tsla alibaba baba be due mcdonald mcd also report top shale company facebook fb hold annual developer conference spotify spot
170,ESRX,amazon amzn have shelved plan become wholesale distributor prescription drug due cost complexity cnbc report news lit fire share beaten drug retailer distributor cvs health cvs shot walgreen boot alliance wba jump stock market today be session high drug distributor mckesson mck rise abc cardinal health cah amazon share didn react negatively news rise monday get newsletter deliver inbox more info product service privacy policy term report seem have most direct connection trio major drug distributor handle logistic major drug manufacturer big revenue low margin business complexity such handle temperature sensitive product lack interest hospital switch purchasing relationship keep amazon business investor seem interpret move decrease likelihood amazon enter retail prescription business give boost cvs walgreen so then amazon investor apparently don think internet retail giant need prescription drug keep customer loyalty amazon still enter prescription business such acquisition walgreen start small just online pharmacy meanwhile walmart wmt appear be increasingly focuse health care pharmacy key boost sale loyalty walmart be reportedly talk merge deepen partnership humana hum manage care business be focuse medicare population share walmart climb didn see much uptick amazon news break cigna ci manage care provider be buy pharmacy benefit manager express script esrx rise share unitedhealth unh largest manage care provider rise unitedhealth report open tuesday be interested unitedhealth lam research ibm goldman unite airline earning due investing action planapple stock face sell news reaction quarterly earningsmarket uptrend feature leader set upwhat do ibd stock have common netflix nvidia grubhub look best stock buy watch start step routinestock market today track market trend best stock watch
171,ESRX,recent week have not be friendly pharmaceutical industry stock sector such valeant pharmaceutical vrx horizon pharma hznp wither criticism industry drug pricing practice fear greater regulation biotechs top fundamental gilead science gild regeneron pharmaceutical regn focus screen day have maintain strong rating hold stock market furor company top fundamental ibd definition have year ep sale growth rate least gilead science have face raft criticism price hepatitis wonder drug sovaldi have year ep growth rate year sale growth rate company handily beat estimate last month raise full year sale guidance be just shy expectation gilead other pharma stock fall democratic presidential hopeful hillary clinton say introduce plan crack call price gouge industry clinton announcement come turing pharmaceutical be harshly criticize decision buy decade old drug quickly raise price more gilead breach day line day sank further month clear day day line stock have find support day move average share close stock market today regeneron pharmaceutical regn make cholesterol fighter praluent sanofi sny have year ep growth rate year sale growth rate sale praluent see possible blockbuster be less half analyst expect ep overall sale beat forecast regeneron fall day clinton announcement finished higher next day then descend day line stock have climb day line regeneron stock dip thursday stock form handle month consolidation regeneron gilead have turn stronger showing recently stock such valeant pharmaceutical mallinckrodt mnk horizon pharma have be hit hard short seller citron research last month accuse valeant shady sale practice criticize drugmaker price hike acquire drug citron month attack mallinckrodt say sale drug acthar have lag question gel effectiveness express script esrx wednesday sue horizon pharma say owe million unpaid drug rebate cut network specialty pharmacy horizon be used valeant also have be hammer specialty pharmacy ty mallinckrodt valeant horizon be trading day day line valeant share end thursday horizon lose mallinckrodt fall express script slide follow bill peter twitter ibd_bpeter
172,ESRX,stock future build early gain ahead wednesday open dow future be ahead point climb nasdaq future trade point future rise strong point
173,ESRX,stock market today be open bond trader be observe veteran day holiday overseas market asia post tightly mixed session stock europe be knock healthy gain midday
174,ESRX,most government office be close make sparse economic calendar labor department report job opening labor turnover survey thursday friday commerce department report october retail sale labor department give october producer price datum university michigan deliver initial read november consumer sentiment
175,ESRX,stock action early wednesday show cisco system csco lead dow gain coal miner consol energy cnx drop worst premarket loss stock
176,ESRX,belgium anheuser busch inbev bud be flat announce have agree buy base brewing peer sabmiller deal miller share rise nearly london exchange
177,ESRX,jcpenney jcp spiked third quarter earning beat macy dive nearly earning top expectation revenue guidance be weak
178,ESRX,leader number big tech name be motion facebook fb linkedin lnkd alphabet googl lean higher open apple aapl show fractional premarket loss follow gap loss tuesday
179,ESRX,overall lead stock be generally quiet clear exception be horizon pharma hznp tank bell pharmacy benefit manager express script holding esrx announce have end relation linden care claim pharmacy dispense only horizon pharma medication fail meet contract distribution agreement
180,ESRX,express script also say be investigate other pharmacy tie horizon horizon share have be fight recover steep month sell express script share dip premarket trade
181,ESRX,upside regeneron pharmaceutical regn briefly flash premarket gain top ibd list then return flat trade drug maker partner sanofi sny report positive result phase clinical trial injectable ldl cholesterol treatment praluent regeneron end tuesday buy point double bottom base stock future build early gain ahead wednesday open dow future be ahead point climb nasdaq future trade point future rise strong point stock market today be open bond trader be observe veteran day holiday overseas market asia post tightly mixed session stock europe be knock healthy gain midday most government office be close make sparse economic calendar labor department report job opening labor turnover survey thursday friday commerce department report october retail sale labor department give october producer price datum university michigan deliver initial read november consumer sentiment stock action early wednesday show cisco system csco lead dow gain coal miner consol energy cnx drop worst premarket loss stock belgium anheuser busch inbev bud be flat announce have agree buy base brewing peer sabmiller deal miller share rise nearly london exchange jcpenney jcp spiked third quarter earning beat macy dive nearly earning top expectation revenue guidance be weak leader number big tech name be motion facebook fb linkedin lnkd alphabet googl lean higher open apple aapl show fractional premarket loss follow gap loss tuesday overall lead stock be generally quiet clear exception be horizon pharma hznp tank bell pharmacy benefit manager express script holding esrx announce have end relation linden care claim pharmacy dispense only horizon pharma medication fail meet contract distribution agreement express script also say be investigate other pharmacy tie horizon horizon share have be fight recover steep month sell express script share dip premarket trade upside regeneron pharmaceutical regn briefly flash premarket gain top ibd list then return flat trade drug maker partner sanofi sny report positive result phase clinical trial injectable ldl cholesterol treatment praluent regeneron end tuesday buy point double bottom base
182,ESRX,stock trade bit lower yesterday wednesday fed induced rally trader consider language odd december rate hike selling be subdue be get here tone action
183,ESRX,mkt pause really investor now thought latest gdp report come great be positive compare qtr look bit pale yesterday report be more drop qtr qtr time fed suggest economy be poise explode rate rise december
184,ESRX,addition yesterday report be disappointment consider year year growth last year rd qtr growth rate be so say be economy continue be hold hostage dynamic weakness home abroad journal point economy slog soft patch consumer spending business spending home build contribute positive report face headwind abroad
185,ESRX,do not be blindside consumer spending be mislead include consumer spend healthcare be not something many person consider read story health consumer spending consumer healthcare represent gdp bil gov include head consumer spending make appear consumer spending be stronger reality prove otherwise remember spending healthcare be not really option family budget so get file pay budget line mean discretionary spending get cut back semantic really far obama be concern consumer spending matter be still consumer spending so good
186,ESRX,now other news break corporate tax structure have create opportunity huge merger pfizer pfe allergan agn consider hook avoid taxe see allergan be base ireland ireland be bit friendlier big corporation so pfizer get bed allergan ireland cut corporate tax liability be know inversion trade company buy smaller foreign rival then move corporate headquarters abroad boom just cut tax obligation million dollar make point pfe ceo ian read make bone say corporate tax rate have put company disadvantage foreign rival be fight hand tie back pfizer be do need do ensure continue innovate
187,ESRX,washington wake many more inversion trade see bozo congress recognize be nothing bunch clown evidence new yr budget deal lift debt ceiling even higher roll back fiscal austerity remove risk debt limit default risk yr so mkt embrace
188,ESRX,other pharma story continue keep glue seat valeant pharma vrx continue make headline cvs health corp cvs express script esrx unite health be cut ty philidor rx pharmacy have help propel vrx international fame stock close pt be now pt early pre mkt trading remember old quote smoke fire question now be be fire just log whole house
189,ESRX,future be pt global mkts be bit pressure boj bank japan do not increase qe program catch surprise do not cause negative mkt reaction europe eu eco datum be mixed cpi do rise german retail sale miss expectation inflation figure be better still low have impact ecb plan more stimulus
190,ESRX,be last day month so sure have window dressing undress take place asset manager close book october earning continue weigh stock overall season be not bad originally expect so nervousness permeate mkts early october seem have subside expect see mkt challenge today then back churn line eco datum today derail doubt pers income pers spend ism milwaukee chicago purch manager
191,ESRX,earning front look oil chevron cvx exxon mobil xom phillip psx cvs health corp cvs colgate palmolive cl weyerhaeuser co wy
192,ESRX,have good weekend take good care kp
193,ESRX,kenny polcari be vice president director nyse floor operation behalf neil security inc sister company investor business daily market commentary be opinion author be base decade industry market experience however guarantee be make imply respect opinion commentary be not be intend be rely authoritative take substitution exercise judgment comment note herein not be construe offer sell solicitation offer buy sell financial product official statement endorsement neil security incorporate affiliate stock trade bit lower yesterday wednesday fed induced rally trader consider language odd december rate hike selling be subdue be get here tone action mkt pause really investor now thought latest gdp report come great be positive compare qtr look bit pale yesterday report be more drop qtr qtr time fed suggest economy be poise explode rate rise december addition yesterday report be disappointment consider year year growth last year rd qtr growth rate be so say be economy continue be hold hostage dynamic weakness home abroad journal point economy slog soft patch consumer spending business spending home build contribute positive report face headwind abroad do not be blindside consumer spending be mislead include consumer spend healthcare be not something many person consider read story health consumer spending consumer healthcare represent gdp bil gov include head consumer spending make appear consumer spending be stronger reality prove otherwise remember spending healthcare be not really option family budget so get file pay budget line mean discretionary spending get cut back semantic really far obama be concern consumer spending matter be still consumer spending so good now other news break corporate tax structure have create opportunity huge merger pfizer pfe allergan agn consider hook avoid taxe see allergan be base ireland ireland be bit friendlier big corporation so pfizer get bed allergan ireland cut corporate tax liability be know inversion trade company buy smaller foreign rival then move corporate headquarters abroad boom just cut tax obligation million dollar make point pfe ceo ian read make bone say corporate tax rate have put company disadvantage foreign rival be fight hand tie back pfizer be do need do ensure continue innovate washington wake many more inversion trade see bozo congress recognize be nothing bunch clown evidence new yr budget deal lift debt ceiling even higher roll back fiscal austerity remove risk debt limit default risk yr so mkt embrace other pharma story continue keep glue seat valeant pharma vrx continue make headline cvs health corp cvs express script esrx unite health be cut ty philidor rx pharmacy have help propel vrx international fame stock close pt be now pt early pre mkt trading remember old quote smoke fire question now be be fire just log whole house future be pt global mkts be bit pressure boj bank japan do not increase qe program catch surprise do not cause negative mkt reaction europe eu eco datum be mixed cpi do rise german retail sale miss expectation inflation figure be better still low have impact ecb plan more stimulus be last day month so sure have window dressing undress take place asset manager close book october earning continue weigh stock overall season be not bad originally expect so nervousness permeate mkts early october seem have subside expect see mkt challenge today then back churn line eco datum today derail doubt pers income pers spend ism milwaukee chicago purch manager earning front look oil chevron cvx exxon mobil xom phillip psx cvs health corp cvs colgate palmolive cl weyerhaeuser co wy have good weekend take good care kpkenny polcari be vice president director nyse floor operation behalf neil security inc sister company investor business daily market commentary be opinion author be base decade industry market experience however guarantee be make imply respect opinion commentary be not be intend be rely authoritative take substitution exercise judgment comment note herein not be construe offer sell solicitation offer buy sell financial product official statement endorsement neil security incorporate affiliate
194,ESRX,big biotechs amgen amgn regeneron pharmaceutical regn be trading wednesday morning pharmacy benefit manager express script esrx say late tuesday include new cholesterol bust drug prefer formulary express script have long be say make effort keep price amgen repatha regeneron praluent
195,ESRX,walgreen boot alliance wba be reportedly close deal acquire rival drugstore chain rite aid rad announcement be expect wednesday accord report reuter financial time wall street journal deal store chain be worth more say reuter share walgreen have store country finished regular session stock market tuesday rite aid share be briefly halter follow report ultimately close merger square country largest drugstore chain cvs health cvs cvs health share rise cvs have retail location report later week jump mckesson deal buzz also roil drug distributor pharmacy benefit manager abc rise spiking high have distribution deal walgreen mckesson mck meanwhile have distribution agreement rite aid mckesson stock dive pharmacy benefit manager express script esrx once speculate takeover target walgreen share close express script report earning tuesday market close walgreen report earning wednesday follow elaine low twitter ibd_elow related walgreen up cost cut eye consolidation
196,ESRX,walgreen boot alliance confirm late tuesday be acquire smaller rival drugstore chain rite aid share cash deal worth total enterprise value include assume debt be see add adjust share earning first full year completion say walgreen wba also expect synergy exceed
197,ESRX,columbus day holiday result quiet low volume session stock market monday dow jone industrial average add nasdaq be mostly unchanged
198,ESRX,investor have more fedspeak digest atlanta fed president dennis lockhart say improve job market warrant rate hike end year
199,ESRX,advance stock have slight edge decliner exchange new york mercantile exchange crude oil future slump
200,ESRX,stock market today emc emc add more company agree merger privately hold dell
201,ESRX,elsewhere skywest skyw clear base base pattern soar ibd airline group be day top performer rise utility tobacco stock also outperformed
202,ESRX,ibd universal insurance uve rise additional now wear crown first gainer follow day oct stock have be tear clear cup handle buy point
203,ESRX,biotech space ibd name regeneron regn jump try clear resistance day move average sharp pullback regeneron strength be help news eli lilly lly be end late stage development experimental cholesterol drug last week share regeneron rise help news pharmacy benefit manager express script esrx be cover pcsk inhibitor cholesterol drug alirocumbab praluent
204,ESRX,ipo news pure storage pstg soar inauspicious debut last week company make flash chip base storage product enterprise customer columbus day holiday result quiet low volume session stock market monday dow jone industrial average add nasdaq be mostly unchanged investor have more fedspeak digest atlanta fed president dennis lockhart say improve job market warrant rate hike end year advance stock have slight edge decliner exchange new york mercantile exchange crude oil future slump stock market today emc emc add more company agree merger privately hold dell elsewhere skywest skyw clear base base pattern soar ibd airline group be day top performer rise utility tobacco stock also outperformed ibd universal insurance uve rise additional now wear crown first gainer follow day oct stock have be tear clear cup handle buy point biotech space ibd name regeneron regn jump try clear resistance day move average sharp pullback regeneron strength be help news eli lilly lly be end late stage development experimental cholesterol drug last week share regeneron rise help news pharmacy benefit manager express script esrx be cover pcsk inhibitor cholesterol drug alirocumbab praluent ipo news pure storage pstg soar inauspicious debut last week company make flash chip base storage product enterprise customer
205,ESRX,strong open stock fade mixed performance midday wednesday nasdaq fall weigh weakness adobe system adbe tesla motor tsla dow jone industrial average add johnson johnson jnj merck mrk boee ba be early leader dow
206,ESRX,nyse volume be tracking higher tuesday level stock market today nasdaq volume be tracking close tuesday level
207,ESRX,adobe gap day move average fall company issue lukewarm fiscal guidance
208,ESRX,tesla slump negative analyst chatter
209,ESRX,amgen amgn be high still rise pharmacy benefit manager express script esrx name amgen repatha prefer supplemental cholesterol reduction treatment other praluent be make sanofi sny regeneron pharmaceutical regn sanofi share slip regeneron climb early trade
210,ESRX,ipo news pure storage pstg price last night midpoint propose range provider flash memory base enterprise storage hardware open share be recently trading
211,ESRX,earning winner include ibd firm global payment gpn share gap week base rise result top expectation outlook be solid company also declare stock split
212,ESRX,follow ken shreve twitter ibd_kshreve facebook strong open stock fade mixed performance midday wednesday nasdaq fall weigh weakness adobe system adbe tesla motor tsla dow jone industrial average add johnson johnson jnj merck mrk boee ba be early leader dow nyse volume be tracking higher tuesday level stock market today nasdaq volume be tracking close tuesday level adobe gap day move average fall company issue lukewarm fiscal guidance tesla slump negative analyst chatter amgen amgn be high still rise pharmacy benefit manager express script esrx name amgen repatha prefer supplemental cholesterol reduction treatment other praluent be make sanofi sny regeneron pharmaceutical regn sanofi share slip regeneron climb early trade ipo news pure storage pstg price last night midpoint propose range provider flash memory base enterprise storage hardware open share be recently trading earning winner include ibd firm global payment gpn share gap week base rise result top expectation outlook be solid company also declare stock split follow ken shreve twitter ibd_kshreve facebook
213,ESRX,stock pull together nice gain early wednesday investor ignore weak housing datum ahead afternoon release fed minute
214,ESRX,dow jone industrial nasdaq climb grab gain
215,ESRX,volume be quietly mixed nasdaq lower nyse relative trade same time tuesday
216,ESRX,stock market today get reasonably healthy start commerce department datum show october housing start slump month low market be tune et release minute federal open market committee oct meeting seek sign timing interest rate increase
217,ESRX,dow stock be mostly positive apple aapl pound gain top group be add goldman sachs conviction buy list
218,ESRX,norfolk southern nsc lead nearly canadian pacific railway cp offer buy rail peer cash stock deal value more
219,ESRX,conagra cag rally more omaha neb base package food giant announce strip frozen potato business separate lamb weston name begin next year
220,ESRX,base oil driller ensco esv be close gain nearly energy stock make strong show early action oil price rise modestly
221,ESRX,array retail stock post mixed early move follow quarterly report energy information administration report weekly inventory datum
222,ESRX,china base vipshop vip spiked jack box jack climb staple spls slip target tgt give premarket gain slump report third quarter result
223,ESRX,leader healthcare staffing agency amn healthcare rumble start trade san diego base operation say late tuesday agree buy privately hold cash amn say deal be immediately accretive adjust ep stock have be scrawl erratic pattern attempt regain support week move average
224,ESRX,citrix system ctxs shed early action developer enterprise software solution announce late tuesday lay worker spin goto unit separate business company say move result pretax charge create saving year loss send share week move average heavy trade buy point cup handle base stock pull together nice gain early wednesday investor ignore weak housing datum ahead afternoon release fed minute dow jone industrial nasdaq climb grab gain volume be quietly mixed nasdaq lower nyse relative trade same time tuesday stock market today get reasonably healthy start commerce department datum show october housing start slump month low market be tune et release minute federal open market committee oct meeting seek sign timing interest rate increase dow stock be mostly positive apple aapl pound gain top group be add goldman sachs conviction buy list norfolk southern nsc lead nearly canadian pacific railway cp offer buy rail peer cash stock deal value more conagra cag rally more omaha neb base package food giant announce strip frozen potato business separate lamb weston name begin next year base oil driller ensco esv be close gain nearly energy stock make strong show early action oil price rise modestly array retail stock post mixed early move follow quarterly report energy information administration report weekly inventory datum china base vipshop vip spiked jack box jack climb staple spls slip target tgt give premarket gain slump report third quarter result leader healthcare staffing agency amn healthcare rumble start trade san diego base operation say late tuesday agree buy privately hold cash amn say deal be immediately accretive adjust ep stock have be scrawl erratic pattern attempt regain support week move average citrix system ctxs shed early action developer enterprise software solution announce late tuesday lay worker spin goto unit separate business company say move result pretax charge create saving year loss send share week move average heavy trade buy point cup handle base
225,ESRX,almost sector lead stock fall friday many reverse lower major average most leader be still get support day line aircraft component maker transdigm tdg be only gainer cleveland base company rise end just record high stock be extend aug
226,ESRX,express script esrx say economic stagnation be cause person pull back medical spending reduce profit outlook less expect
227,ESRX,pharmacy benefit manager also spend more prepare acquisition rival medco health solution mhs expiration contract wag express script be upbeat long term
228,ESRX,share leap more medco rise pharmacy benefit manager sxc health solution scxi catalyst health solution chsi be also rally
229,ESRX,express script now see full year earning wall street view better analyst predict company also expect cash flow growth forecast
230,ESRX,analyst be alert last month company warn prescription growth have be practically nil recently economy wasn expect improve much
231,ESRX,express script now see total adjust claim year fall previously expect express script esrx say economic stagnation be cause person pull back medical spending reduce profit outlook less expect pharmacy benefit manager also spend more prepare acquisition rival medco health solution mhs expiration contract wag express script be upbeat long term share leap more medco rise pharmacy benefit manager sxc health solution scxi catalyst health solution chsi be also rally express script now see full year earning wall street view better analyst predict company also expect cash flow growth forecast analyst be alert last month company warn prescription growth have be practically nil recently economy wasn expect improve much express script now see total adjust claim year fall previously expect
232,ESRX,person castoff be treasure so go catalyst health solution chsi acquisition pharmacy benefit management business wag longer want walgreen health initiative drugstore chain soon be discard business be call be distraction prefer focus retail drugstore chain catalyst bring scale
233,ESRX,year end rally give average stock fund best december return add more third total return
234,ESRX,world stock fund december barely edge domestic fund rise world stock fund gain trail considerably equity
235,ESRX,final month year small cap value fund outpaced size style fund large cap growth be laggard
236,ESRX,small cap value also lead quarter gain large cap value trail
237,ESRX,year small cap growth overshadowed category large cap value bring rear
238,ESRX,investor miss small cap ride look leap sector group outperform year be unlikely do again next year
239,ESRX,outsize return small cap be unsustainable new year say dave winter manager fund large cap valuation be cheap small cap be speculative level
240,ESRX,month leader lead fund various category
241,ESRX,lynch see small cap return roughly trail large cap valuation be too high currently extreme do not bode well performance analyst write equity strategy year ahead report estimate be too high need be revise lower reflect slower economy
242,ESRX,third year bear market end small mid cap post high single digit gain same be true year recession analyst write small cap strategy report
243,ESRX,fund category performance fund category rank performance
244,ESRX,double dip fall recession again small cap get more revenue domestically large cap decline analyst add
245,ESRX,deutsche bank also favor investing large cap small year person be underinvested equity overinvest bond favor large cap quality liquidity deutsche say
246,ESRX,quarterly leader lead fund quarter past month
247,ESRX,even gain march low year return remain year low suggest stock be just begin long period strong performance deutsche say
248,ESRX,equity value be also cheap historical basis relative treasury credit deutsche analyst write outlook report price earning growth peg ratio be year low
249,ESRX,goldman sachs project reach open new year see gdp growth accelerate mid
250,ESRX,earning rise share goldman analyst write equity outlook report financial tech energy account half earning forecast
251,ESRX,sector fund return
252,ESRX,december financial service book biggest month gain april basic material commodity be only other post double digit return last month consumer service be laggard
253,ESRX,quarter natural resource basic material lead sector
254,ESRX,rise most year be precious metal consumer service real estate only sector not reach double digit be utility health biotech
255,ESRX,oliver pursche portfolio manager gmg defensive beta say cut back basic material agricultural commodity run buy health care name such abbott lab cvs cvs express script esrx novartis nvs teva pharmaceutical teva
256,ESRX,equity strategy report credit suisse analyst recommend overweighting health care telecom consumer staple market rotate company average dividend yield relatively low imply earning growth rate
257,ESRX,analyst recommend significantly underweight consumer discretionary financial basic material have opposite scenario relatively high earning growth rate average dividend yield
258,ESRX,base study third year previous market cycle believe health care become market leader be consumer discretionary underperform be rare outperform year row
259,ESRX,foreign fund
260,ESRX,december european region lead china lag
261,ESRX,fourth quarter japanese fund be previous quarter loser outpaced foreign fund china return least
262,ESRX,pacific ex japan fund rise outshine world europe trail
263,ESRX,emerge market fund rise december
264,ESRX,contrary popular sentiment gerald jordan manager jordan opportunity fund believe emerge market return fall europe think food inflation prompt government raise interest rate control economy
265,ESRX,historically faster economy grow stock market do say jordan manage asset have growth too fast country have raise rate be negative equity
266,ESRX,more massive inflow emerge market past year mean few bull remain drive price higher
267,ESRX,lynch recommend overweighting germany emerge market especially india taiwan singapore brazil
268,ESRX,year end rally give average stock fund best december return add more third total return world stock fund december barely edge domestic fund rise world stock fund gain trail considerably equity final month year small cap value fund outpaced size style fund large cap growth be laggard small cap value also lead quarter gain large cap value trail year small cap growth overshadowed category large cap value bring rear investor miss small cap ride look leap sector group outperform year be unlikely do again next year outsize return small cap be unsustainable new year say dave winter manager fund large cap valuation be cheap small cap be speculative level
269,ESRX,month leader lead fund various category
270,ESRX,lynch see small cap return roughly trail large cap valuation be too high currently extreme do not bode well performance analyst write equity strategy year ahead report estimate be too high need be revise lower reflect slower economy
271,ESRX,third year bear market end small mid cap post high single digit gain same be true year recession analyst write small cap strategy report
272,ESRX,fund category performance fund category rank performance
273,ESRX,double dip fall recession again small cap get more revenue domestically large cap decline analyst add
274,ESRX,deutsche bank also favor investing large cap small year person be underinvested equity overinvest bond favor large cap quality liquidity deutsche say
275,ESRX,quarterly leader lead fund quarter past month
276,ESRX,even gain march low year return remain year low suggest stock be just begin long period strong performance deutsche say
277,ESRX,equity value be also cheap historical basis relative treasury credit deutsche analyst write outlook report price earning growth peg ratio be year low
278,ESRX,goldman sachs project reach open new year see gdp growth accelerate mid
279,ESRX,earning rise share goldman analyst write equity outlook report financial tech energy account half earning forecast
280,ESRX,sector fund return
281,ESRX,december financial service book biggest month gain april basic material commodity be only other post double digit return last month consumer service be laggard
282,ESRX,quarter natural resource basic material lead sector
283,ESRX,rise most year be precious metal consumer service real estate only sector not reach double digit be utility health biotech
284,ESRX,oliver pursche portfolio manager gmg defensive beta say cut back basic material agricultural commodity run buy health care name such abbott lab cvs cvs express script esrx novartis nvs teva pharmaceutical teva
285,ESRX,equity strategy report credit suisse analyst recommend overweighting health care telecom consumer staple market rotate company average dividend yield relatively low imply earning growth rate
286,ESRX,analyst recommend significantly underweight consumer discretionary financial basic material have opposite scenario relatively high earning growth rate average dividend yield
287,ESRX,base study third year previous market cycle believe health care become market leader be consumer discretionary underperform be rare outperform year row
288,ESRX,foreign fund
289,ESRX,december european region lead china lag
290,ESRX,fourth quarter japanese fund be previous quarter loser outpaced foreign fund china return least
291,ESRX,pacific ex japan fund rise outshine world europe trail
292,ESRX,emerge market fund rise december
293,ESRX,contrary popular sentiment gerald jordan manager jordan opportunity fund believe emerge market return fall europe think food inflation prompt government raise interest rate control economy
294,ESRX,historically faster economy grow stock market do say jordan manage asset have growth too fast country have raise rate be negative equity
295,ESRX,more massive inflow emerge market past year mean few bull remain drive price higher
296,ESRX,lynch recommend overweighting germany emerge market especially india taiwan singapore brazil
297,ESRX,lynch see small cap return roughly trail large cap valuation be too high currently extreme do not bode well performance analyst write equity strategy year ahead report estimate be too high need be revise lower reflect slower economy third year bear market end small mid cap post high single digit gain same be true year recession analyst write small cap strategy report
298,ESRX,fund category performance fund category rank performance
299,ESRX,double dip fall recession again small cap get more revenue domestically large cap decline analyst add
300,ESRX,deutsche bank also favor investing large cap small year person be underinvested equity overinvest bond favor large cap quality liquidity deutsche say
301,ESRX,quarterly leader lead fund quarter past month
302,ESRX,even gain march low year return remain year low suggest stock be just begin long period strong performance deutsche say
303,ESRX,equity value be also cheap historical basis relative treasury credit deutsche analyst write outlook report price earning growth peg ratio be year low
304,ESRX,goldman sachs project reach open new year see gdp growth accelerate mid
305,ESRX,earning rise share goldman analyst write equity outlook report financial tech energy account half earning forecast
306,ESRX,sector fund return
307,ESRX,december financial service book biggest month gain april basic material commodity be only other post double digit return last month consumer service be laggard
308,ESRX,quarter natural resource basic material lead sector
309,ESRX,rise most year be precious metal consumer service real estate only sector not reach double digit be utility health biotech
310,ESRX,oliver pursche portfolio manager gmg defensive beta say cut back basic material agricultural commodity run buy health care name such abbott lab cvs cvs express script esrx novartis nvs teva pharmaceutical teva
311,ESRX,equity strategy report credit suisse analyst recommend overweighting health care telecom consumer staple market rotate company average dividend yield relatively low imply earning growth rate
312,ESRX,analyst recommend significantly underweight consumer discretionary financial basic material have opposite scenario relatively high earning growth rate average dividend yield
313,ESRX,base study third year previous market cycle believe health care become market leader be consumer discretionary underperform be rare outperform year row
314,ESRX,foreign fund
315,ESRX,december european region lead china lag
316,ESRX,fourth quarter japanese fund be previous quarter loser outpaced foreign fund china return least
317,ESRX,pacific ex japan fund rise outshine world europe trail
318,ESRX,emerge market fund rise december
319,ESRX,contrary popular sentiment gerald jordan manager jordan opportunity fund believe emerge market return fall europe think food inflation prompt government raise interest rate control economy
320,ESRX,historically faster economy grow stock market do say jordan manage asset have growth too fast country have raise rate be negative equity
321,ESRX,more massive inflow emerge market past year mean few bull remain drive price higher
322,ESRX,lynch recommend overweighting germany emerge market especially india taiwan singapore brazil
323,ESRX,double dip fall recession again small cap get more revenue domestically large cap decline analyst add deutsche bank also favor investing large cap small year person be underinvested equity overinvest bond favor large cap quality liquidity deutsche say
324,ESRX,quarterly leader lead fund quarter past month
325,ESRX,even gain march low year return remain year low suggest stock be just begin long period strong performance deutsche say
326,ESRX,equity value be also cheap historical basis relative treasury credit deutsche analyst write outlook report price earning growth peg ratio be year low
327,ESRX,goldman sachs project reach open new year see gdp growth accelerate mid
328,ESRX,earning rise share goldman analyst write equity outlook report financial tech energy account half earning forecast
329,ESRX,sector fund return
330,ESRX,december financial service book biggest month gain april basic material commodity be only other post double digit return last month consumer service be laggard
331,ESRX,quarter natural resource basic material lead sector
332,ESRX,rise most year be precious metal consumer service real estate only sector not reach double digit be utility health biotech
333,ESRX,oliver pursche portfolio manager gmg defensive beta say cut back basic material agricultural commodity run buy health care name such abbott lab cvs cvs express script esrx novartis nvs teva pharmaceutical teva
334,ESRX,equity strategy report credit suisse analyst recommend overweighting health care telecom consumer staple market rotate company average dividend yield relatively low imply earning growth rate
335,ESRX,analyst recommend significantly underweight consumer discretionary financial basic material have opposite scenario relatively high earning growth rate average dividend yield
336,ESRX,base study third year previous market cycle believe health care become market leader be consumer discretionary underperform be rare outperform year row
337,ESRX,foreign fund
338,ESRX,december european region lead china lag
339,ESRX,fourth quarter japanese fund be previous quarter loser outpaced foreign fund china return least
340,ESRX,pacific ex japan fund rise outshine world europe trail
341,ESRX,emerge market fund rise december
342,ESRX,contrary popular sentiment gerald jordan manager jordan opportunity fund believe emerge market return fall europe think food inflation prompt government raise interest rate control economy
343,ESRX,historically faster economy grow stock market do say jordan manage asset have growth too fast country have raise rate be negative equity
344,ESRX,more massive inflow emerge market past year mean few bull remain drive price higher
345,ESRX,lynch recommend overweighting germany emerge market especially india taiwan singapore brazil even gain march low year return remain year low suggest stock be just begin long period strong performance deutsche say equity value be also cheap historical basis relative treasury credit deutsche analyst write outlook report price earning growth peg ratio be year low goldman sachs project reach open new year see gdp growth accelerate mid earning rise share goldman analyst write equity outlook report financial tech energy account half earning forecast sector fund december financial service book biggest month gain april basic material commodity be only other post double digit return last month consumer service be laggard quarter natural resource basic material lead sector rise most year be precious metal consumer service real estate only sector not reach double digit be utility health biotech oliver pursche portfolio manager gmg defensive beta say cut back basic material agricultural commodity run buy health care name such abbott lab cvs cvs express script esrx novartis nvs teva pharmaceutical teva equity strategy report credit suisse analyst recommend overweighting health care telecom consumer staple market rotate company average dividend yield relatively low imply earning growth rate analyst recommend significantly underweight consumer discretionary financial basic material have opposite scenario relatively high earning growth rate average dividend yield base study third year previous market cycle believe health care become market leader be consumer discretionary underperform be rare outperform year row foreign december european region lead china lag fourth quarter japanese fund be previous quarter loser outpaced foreign fund china return least pacific ex japan fund rise outshine world europe trail emerge market fund rise december contrary popular sentiment gerald jordan manager jordan opportunity fund believe emerge market return fall europe think food inflation prompt government raise interest rate control economy historically faster economy grow stock market do say jordan manage asset have growth too fast country have raise rate be negative equity more massive inflow emerge market past year mean few bull remain drive price higher lynch recommend overweighting germany emerge market especially india taiwan singapore brazil
346,ESRX,slew drug company insurer other medical related stock healthy ibd list be deck report third quarter earning next week first tuesday be impax laboratory ipxl develop drug treat migraine parkinson davita dva provide kidney dialysis service analyst forecast impax morning post earning be
347,ESRX,sector leader end session high reversed lower thursday general market struggle rebound commvault system cvlt rise erase most gain close session low volume tumble average mark lightest session year commvault be still past buy
348,ESRX,sector leader end well session high close slightly lower friday be few exception michael kor kor start strong finished strong gap blast new high stock end smack session high thursday improve guidance give luxury accessory firm
349,ESRX,wag fourth quarter result beat expectation lack progress contract renewal talk express script esrx left more annual revenue jeopardy
350,ESRX,drugstore chain earning rise cent share top analyst view cent revenue climb edge estimate
351,ESRX,share drop broad market rally rival cvs caremark cvs rite aid rad be pharmacy benefit manager express script rise
352,ESRX,same store sale grow gross margin narrow pharmacy margin be flat margin front end store shrank
353,ESRX,pact express script expire jan be already make plan end tie be talk express script client try retain contract end
354,ESRX,talk break june company fought pricing express script manage pharmacy benefit hmo insurer send patient drugstore fill prescription
355,ESRX,sell own pharmacy benefit management unit june have say isn get enough compensation express script
356,ESRX,meantime express script be seek approval buy medco health solution mhs form largest manager drug benefit wag fourth quarter result beat expectation lack progress contract renewal talk express script esrx left more annual revenue jeopardy drugstore chain earning rise cent share top analyst view cent revenue climb edge estimate share drop broad market rally rival cvs caremark cvs rite aid rad be pharmacy benefit manager express script rise same store sale grow gross margin narrow pharmacy margin be flat margin front end store shrank pact express script expire jan be already make plan end tie be talk express script client try retain contract end talk break june company fought pricing express script manage pharmacy benefit hmo insurer send patient drugstore fill prescription sell own pharmacy benefit management unit june have say isn get enough compensation express script meantime express script be seek approval buy medco health solution mhs form largest manager drug benefit
357,ESRX,stock future ease lower ahead friday open dollar gain gdp datum come expectation dow future slip point fair market value future be point nasdaq future shift gain point loss hour start regular trade stock market stock market today start nasdaq steering worst week october thursday open loss week index be testing support day move average tote hefty count distribution day nasdaq be gathering again challenge resistance level maintain support day line be crucial test friday economic commerce department report estimate gdp growth be unchanged prior estimate economist projection upward revision gdp price deflator inflation gauge hold steady line expectation final read march consumer sentiment be expect university michigan et fed chairwoman janet yellen be schedule speak san francisco begin et stocksolin oln rocket higher news dow chemical dow merge chlorine operation olin company expect deal value form industry leader chloralkali process produce vinyl chlorinate organic epoxy dow share rise premarket trade olin have pull back month high briefly clear long term consolidation dow have be consolidate september restoration hardware rh slump more ahead open bell corte madera calif base chain report late thursday narrow earning beat sale line expectation guidance be analyst target stock have be form base base cup end thursday back week line support yahoo yhoo add nearly late thursday announcement share buyback initiative company report new program be addition buyback still active previous plan morgan stanley launch coverage stock overweight rating price target yahoo share have be work retake week move average month consolidation overseaschina market end relatively flat friday week left shanghai composite hong kong hang seng index gain tokyo nikkei dip friday end week little change lead index paris frankfurt be nearly london ftse show loss midday week cac paris frankfurt dax be tracking loss ftse trade last friday close currency dollar gain yen send euro back oil pull back almost benchmark west texas intermediate crude europe brent crude
358,ESRX,investor take more profit wednesday disappointing august new home sale report dour news headline austerity protest street athen madrid major index lead stock also languish just trading day remain third quarter stock exchange level volume be mixed indicate selling institutional
359,ESRX,stock ease moderately midday thursday run optimism euro zone debt crisis upbeat earning report economic datum nyse composite trim gain be nasdaq be much respectively volume be tracking sharply higher
360,ESRX,sector leader mostly moved wednesday impressive volume appear rarely apple aapl be rebound day line apple bounce line tuesday volume climb average stock wednesday add almost investor be prod wednesday report apple have start production smaller version red hot
361,ESRX,dow jone component unitedhealth group unh report first quarter earning open tuesday easily beat wall street expectation first quarter earning rise share revenue grow analyst expect ep revenue accord zack investment research unitedhealth bump full year ep guidance vs range offer january current analyst consensus be get newsletter deliver inbox more info product service privacy policy term useshare jump stock market today hit soon open relative strength line track stock performance vs index be already new high stock have buy point consolidation go back late january rally follow unitedhealth report jan monday unitedhealth rise monday reclaim day move average health care stock especially drugstore operator drug distributor get late day lift monday news amazon amzn be shelving drug wholesale distribution plan meanwhile rival humana hum rise tuesday clear cup handle buy point volume be average suggest modest institutional buy humana pop earlier month report walmart wmt be talk deepen relationship insurer perhaps even takeover ibd take unitedhealth be rate stock ibd medical manage care industry group base composite earning margin relative stock performance unitedhealth be just base stock relative strength alone check ibd stock checkup see other leader pending megamerger cvs health cvs aetna aet cigna ci express script esrx be often say be response loom threat amazon enter shake retail prescription drug broader health industry analyst say company real aim be mirror well adapt unitedhealth model success unitedhealth diversify revenue stream have be envy manage care industry optum unit include health service division grow rapidly acquisition pharmacy benefit management technology outsource health care giant agree december buy medical unit davita unit fourth notable deal also be interested unitedhealth lam research ibm goldman unite airline earning due investing action planmarket uptrend feature leader set upwhat do ibd stock have common netflix nvidia grubhub look best stock buy watch start step routinestock market today track market trend best stock watch
362,ESRX,here investing action plan tuesday need know investor come day health insurance giant unitedhealth unh goldman sachs gs ibm ibm unite airline ual big cap chip gear maker lam research lrcx be big gun report quarterly result earning season heat meanwhile electronic brokerage firm interactive broker ticker
363,ESRX,here weekly investing action plan need know investor come week earning season pick momentum result due netflix nflx goldman sachs gs general electric ge ibm ibm score other airline stock get rattle further unite airline ual report give update expansion plan
364,ESRX,amazon amzn flirtation health care industry have send heart race wall street yet amazon appear be have commitment issue other have leap jeff bezos hesitate now come possible walmart wmt humana hum merger walmart acquisition insurer fundamentally reshape health care delivery way amazon have trouble match walmart humana deal potentially transform health care market senior demographic be critical company walmart already operate store pharmacy vision center humana deal likely accelerate effort develop store clinic clinic haven be knockout success walmart have be learn write tracy watt health reform leader mercer blog post partnership foster new way bring person want need write highlight health care access rural area cvs health cvs be process acquire aetna aet be plan revamp drugstore provide more health service walmart have greater financial wherewithal execute strategy supercenter be more natural fit health service get newsletter deliver inbox more info product service privacy policy term usea walmart humana tie have strategic merit retail giant write stifel analyst mark expect drive greater store traffic produce health care cost saving help discounter keep investing fend amazon saving come closer ty humana largest remain independent pharmacy benefit manager help reduce drug price walmart employee write humana recently purchase major stake home health care business kindred healthcare natural fit walmart home delivery business still be challenge piper jaffray analyst sarah james see hurdle staffing clinic nursing shortage push wage also question attractive merger be humana humana have enviable medicare position walmart have smaller store base compare cvs health walgreen boot alliance wba still humana share rise stock market today even dow jone index nasdaq composite lose more meanwhile share walmart lose amazon skid so far amazon disruptive impact health care have be other be do report last summer amazon enter retail prescription industry shockwave have set motion deal first be cvs buy aetna begin offer same day delivery major market next day nationwide albertson grab rite aid rad store not buy walgreen last month cigna ci announce purchase express script esrx largest pharmacy benefit manager option enter prescription drug business have narrow amazon haven be close entirely potential avenue be acquire walgreen january amazon announce health care venture jpmorgan chase jpm berkshire hathaway brkb health care stock tumble fear amazon use same formula slay book seller department store scariest part company say have intent earn profit effort yet also confess lack coherent plan putt still be form cost save idea work be interested trump tariff china trade war just take surprise turnis fang stock trade dead facebook amazon netflix google lead tech weakness big picture stock do damage repair patience now become best growth stock watch buyhere need know spotify ipo due tuesday
365,ESRX,walgreen boot alliance wba report better expect fiscal second quarter earning revenue wednesday drugstore rival cvs health cvs rite aid rad be midst big merger part wave health care consolidation walgreen also raise full year guidance walgreen earn share vs year earlier revenue grow analyst have expect drugstore chain earn sale accord zack investment research same store sale rise comparable pharmacy sale walgreen now see earning share include trump tax cut benefit be slightly higher cent upper end prior target analyst have expect full year ep share close higher stock market today hit just open stock be not far october year low relative strength line track stock performance vs index be just year low get newsletter deliver inbox more info product service privacy policy term aid be early walgreen spend year try buy rite aid settle purchasing nearly store left rite aid year agree takeover grocery giant albertson have be privately hold year go public result transaction cvs health december agree acquire health insurer aetna aet rally cvs health be drugstore operator also lead pharmacy benefit manager walgreen reportedly have be try take drug distributor abc talk have stall now walgreen already own meanwhile prescription have grow walgreen company december say take stake sinopharm hold guoda drugstore china investment intend expand international reach consolidation have health care industry recent year spur partly affordable care act well amazon amzn pact jpmorgan chase jpm warren buffett berkshire hathaway brkb lower health care cost employee cigna ci recently agree buy pharmacy benefit manager express script esrx threat amazon entry also have help spur more pressure gain size scope cvs walgreen also face competition big retailer walmart wmt target tgt be interested cigna buy express script latest sweeping health care dealstock rise relative price strength humanadrug distributor sink pricing opioid lawsuit concern
366,ESRX,seller be stock market again tuesday dow nasdaq hold stiff loss less hour remain tuesday session dow take biggest hit fall hurt weakness pfizer pfe unitedhealth group unh pfizer earning disappoint fuel loss stock unitedhealth group give back news amazon com amzn berkshire hathway brka jpmorgan chase jpm be collaborate way offer health care employee more transparency lower cost provider pharmacy benefit management service fall hard news express script esrx crater be well session lows touch day move average cvs health cvs slump amazon buck trend rise ahead earning report thursday close leaderboard name have be standout performer buy point lose nasdaq composite ease volume nyse nasdaq be tracking higher monday level stock market today more so nyse nasdaq suffer distribution day monday loss higher volume distribution day be sign institutional selling workday wday be bright spot nasdaq rise nearly weekly chart show conventional entry daily show earlier cup handle entry meanwhile day fed meeting get underway today decision interest rate be due wednesday et market be not expect rate hike time chance march meeting be pretty good accord cme group fedwatch market see chance quarter point hike range march year treasury yield add basis point ahead friday job report economist expect nonfarm payroll rise unemployment rate hold steady ibd align technology algn company invisalign brace re-cover lows quick test day move average share align be still ahead earning report close ibd name grubhub grub gap fall nearly barclay downgrade share equal weight overweight price target stock be flat base clear last week earning be due feb open growth stock be weak again name ibd be more late trading related workday rise veeva upgrade margin hubspot downgrade health care stock tumble amazon berkshire jpmorgan allianceamazon score price target increase ahead fourth quarter reportalibaba likely show strongest revenue growth quarters
367,ESRX,investor be run exit anticipation federal action drug company blame opioid crisis drug distributor include cardinal health cah abc mckesson mck extend loss second day president donald trump pledge lower drug price very substantially not so distant future say justice department be consider major federal litigation company involved crisis trump threaten get tough drug dealer include used death penalty certain case speaking yesterday new hampshire state hardest hit opioid addiction justice department decide early april join local government sue maker opioid painkiller endo international endp share plunge much tuesday be be investigate various state opioid distributor be investigate include cardinal health mckesson much be unclear possible suit distributor however stock clearly seem be trend hyper sensitively evercore analyst ross muken cover drug distributor write note be possible be party proceed join file lawsuit base trump also reiterate promise lower drug price health human service secretary alex azar say agency be roll proposal month plan aim seek discount drug middleman include pharmacy benefit manager such express script esrx cvs health cvs caremark unitedhealth unh optumrx be interested biotech flirt battle opioid makerswal mart offer pill disposal product curb opioid abuseopioid crisis be time larger thought report say
368,ESRX,future index dow jone industrial average nasdaq be modestly higher thursday morning nasdaq continue lead dow jone lag president trump set formally issue steel aluminum tariff afternoon dow jone stock be buy point bullish basis apple aapl microsoft msft visa separately fang stock facebook fb google parent alphabet googl reclaim key support level work basis apple microsoft facebook alphabet be huge weight tech heavy nasdaq major average improve wednesday close white house say trump tariff steel aluminum offer carveout canada mexico trump have tariff signing ceremony et thursday china europe be threaten retaliation trump impose tariff meanwhile health insurer cigna ci buy pharmacy benefit manager express script esrx health care company announce thursday index future rise vs fair value nasdaq future be dow jone future be fair value dow jone component apple microsoft visa have form short new basis brief market correction early february be day move average relative strength line track stock performance vs index have show strength recent week apple share fall wednesday stock market trading stock have messy shape cup handle base buy point microsoft climb approach flat base entry visa advanced advance buy point flat base use ibd marketsmith free march
369,ESRX,see stock buy point get chart pattern recognition run custom screen start nowalphabet facebook manage retake day move average wednesday average volume need few day finish cup basis facebook alphabet have rs line be flat lag recent month several other dow jone stock be basis include goldman sachs gs rs line have be sideway lag goldman longer seem best class wall street peer american express axp caterpillar cat dowdupont dwdp be several blue chip stock consolidation stick day line be interested big picture be real news investorshere be chip stock breaking hit new high set upwhat do facebook grubhub salesforce epam have common stock bounce white house say tariff exempt canada mexicoapple iphone sale bite year dog china
370,ESRX,rise online medical diagnostic tool mobile health apps wearable person be take health own hand perhaps more ever so laboratory corp america lh diagnostic giant be reach past doctor office directly public company be let consumer order test measure cholesterol
371,ESRX,america biggest company still sit more cash apple aapl alone hold pace dividend increase so far be slowest year strong dollar concern economic growth low commodity price firm be dividend increase year
372,ESRX,fda approve amgen amgn cholesterol drug repatha late thursday give similar label recently approve rival regeneron regn sanofi sny slightly lower price agency say have clear repatha new pcsk inhibitor class drug patient heterozygous familial hefh homozygous familial hofh patient heart disease need more cholesterol bust power standard treatment statin be essentially same label give regeneron sanofi praluent be approve last month praluent be not approve hofh company do not seek approval group have hope broader label include patient don yet have heart disease primary prevention praluent be approve wall street generally expect similar label believe fda adopt class labele repatha make primary prevention claim unlikely nomura analyst ian somaiya write july research note however believe label include secondary prevention statin intolerant patient be sufficiently broad support current peak sale estimate estimate pcsk class capture share patient segment fda press release didn specifically mention statin intolerance much dispute condition regeneron sanofi have be hope include praluent label esperion therapeutic espr have also be target group cholesterol lower drug candidate different class lead much stock volatility pcsk drama have unfold amgen press release say drug cost year bit praluent year praluent repatha be basically similar arrival new drug have be widely expect apply pricing pressure wasn clear much pharmacy benefit manager express script esrx have signale intention spark price war keep cost amgen price only modestly undercut real world pricing often involve great deal rebate consensus call repatha bring revenue third quarter accord rbc capital market amgen rise fraction hour trading thursday climb regular trade close regeneron be flat hour trade close fraction esperion dip regular trade bounce hour connect amy reeve ibd_areeve facebook
373,ESRX,stock market recent fit volatility manage care giant unitedhealth group be pretty good run nation biggest health insurer see stock price touch new high aug fall broader market share now trade high unitedhealth unh have deliver straight quarters double digit ep
374,ESRX,drug giant allergan agn apple aapl be top favorite hedge fund express script hold esrx walt disney ibm ibm lead list most short stock accord goldman sachs report
375,ESRX,allergan early august only modestly beat analyst consensus estimate stock fall shortly stock touch time high
376,ESRX,share be midday trading stock market today allergan stock last month hit buy point cup handle base rank wednesday midweek update ibd
377,ESRX,apple have be stock hit concern china slow economy yuan devaluation dollar
378,ESRX,hedge fund have increase long position facebook fb amazon com amzn say goldman sachs report google googl citigroup valeant pharmaceutical vrx be also top goldman rank long favorite number fund have stock top holding
379,ESRX,most short stock base total value short interest include chip leader intel intc caterpillar cat exxon mobil xom qualcomm qcom
380,ESRX,average hedge fund return be again lag say goldman sachs report
381,ESRX,goldman sachs have own method analyze long short hedge fund stock position report analyze hedge fund gross equity position start
382,ESRX,accord morgan stanley report institutional ownership also publish thursday average portfolio allocation large cap tech stock be flat quarter quarter exit june quarter amazon microsoft msft see largest uptick report say
383,ESRX,apple institutional ownership be roughly flat quarter quarter drug giant allergan agn apple aapl be top favorite hedge fund express script hold esrx walt disney ibm ibm lead list most short stock accord goldman sachs report allergan early august only modestly beat analyst consensus estimate stock fall shortly stock touch time high share be midday trading stock market today allergan stock last month hit buy point cup handle base rank wednesday midweek update ibd apple have be stock hit concern china slow economy yuan devaluation dollar hedge fund have increase long position facebook fb amazon com amzn say goldman sachs report google googl citigroup valeant pharmaceutical vrx be also top goldman rank long favorite number fund have stock top holding most short stock base total value short interest include chip leader intel intc caterpillar cat exxon mobil xom qualcomm qcom average hedge fund return be again lag say goldman sachs report goldman sachs have own method analyze long short hedge fund stock position report analyze hedge fund gross equity position start accord morgan stanley report institutional ownership also publish thursday average portfolio allocation large cap tech stock be flat quarter quarter exit june quarter amazon microsoft msft see largest uptick report say apple institutional ownership be roughly flat quarter quarter
384,ESRX,payer be aggressive try drive price new pcsk cholesterol drug accord survey recent comment rbc capital market other hand fear lose money hepatitis drug seem be fading prescription be fall analyst michael yee round comment major health insurer
385,ESRX,second half august be usually desert business news fda schedule be year round several important drug be approval decision month provide upside biotech stock have recently be suffering
386,ESRX,get most attention likely be repatha amgen amgn cholesterol drug expect be approve aug repatha be pcsk inhibitor similar praluent drug regeneron pharmaceutical regn sanofi sny be approve much fanfare last month
387,ESRX,give resemblance drug repatha be widely expect be approve july research note nomura analyst ian somaiya write amgen drug probably also get similar label doesn cover quite many patient have hope be sufficiently broad support peak sale estimate
388,ESRX,be especially interesting investor be pricing dynamic come drug appear market pharmacy benefit manager express script esrx have say hope start price war similar happened abbvie abbv launch rival hepatitis regimen gilead science gild harvoni late last year gilead have maintain dominant market share only rebate half drug list price
389,ESRX,believe rebate drive access sanofi regeneron amgen be directly compete formulary position somaiya write repatha net price month estimate imply discount praluent gross price believe competition result average discounting similar have be see hepatitis
390,ESRX,amgen stock hit new high report have shed larger biotech selloff retain excellent ibd composite rating
391,ESRX,aug fda be due decide label expansion adcetris sole market drug seattle genetic sgen adcetris market partner takeda be already approve patient hodgkin lymphoma ve relapse receive stem cell transplant chemotherapy treatment current filing follow study patient receive transplant hadn relapse find significant improvement progression free survival
392,ESRX,july research note rbc capital market analyst adnan butt write chance approval look good fda didn convene advisory committee approval date normally do have issue drug
393,ESRX,market opportunity post transplant hodgkin lymphoma set take adcetris year higher sale potentially butt write
394,ESRX,get new indication adcetris be key part seattle genetic strategy even drug launch year still hasn make company profitable adcetris be also be test cell lymphoma front line set kind lymphoma january company also announce collaboration bristol myer squibb bmy test bristol hot new cancer drug opdivo adcetris various kind lymphomas
395,ESRX,seattle genetic stock be july high retain good relative strength rating analyst expect turn profitable
396,ESRX,fda have aug deadline decide aristada schizophrenia drug alk create drug take aripiprazole brand name abilify be best seller otsuka bristol myer go patent year add own technology turn dose regimen daily pill monthly injection patient compliance be biggest problem face psychotic medicine generally less frequent dose better
397,ESRX,aristada win be alone long act psychotic market leerink analyst michael schmidt say do nearly well johnson johnson jnj invega sustenna also used technology be therefore provide royalty
398,ESRX,model aristada sale write july research note
399,ESRX,aristada be important component strategy return growth be lead stock last year sacrifice profit growth invest marketing new drug vivitrol most recent quarter revenue also flatlined analyst expect sale growth next year rise profitability be not see return accord thomson reuter
400,ESRX,stock hit high march go form cup handle base fail break slump sector last week be trading fraction wednesday afternoon
401,ESRX,connect amy reeve ibd_areeve facebook second half august be usually desert business news fda schedule be year round several important drug be approval decision month provide upside biotech stock have recently be suffering get most attention likely be repatha amgen amgn cholesterol drug expect be approve aug repatha be pcsk inhibitor similar praluent drug regeneron pharmaceutical regn sanofi sny be approve much fanfare last month give resemblance drug repatha be widely expect be approve july research note nomura analyst ian somaiya write amgen drug probably also get similar label doesn cover quite many patient have hope be sufficiently broad support peak sale estimate be especially interesting investor be pricing dynamic come drug appear market pharmacy benefit manager express script esrx have say hope start price war similar happened abbvie abbv launch rival hepatitis regimen gilead science gild harvoni late last year gilead have maintain dominant market share only rebate half drug list price believe rebate drive access sanofi regeneron amgen be directly compete formulary position somaiya write repatha net price month estimate imply discount praluent gross price believe competition result average discounting similar have be see hepatitis amgen stock hit new high report have shed larger biotech selloff retain excellent ibd composite rating aug fda be due decide label expansion adcetris sole market drug seattle genetic sgen adcetris market partner takeda be already approve patient hodgkin lymphoma ve relapse receive stem cell transplant chemotherapy treatment current filing follow study patient receive transplant hadn relapse find significant improvement progression free survival july research note rbc capital market analyst adnan butt write chance approval look good fda didn convene advisory committee approval date normally do have issue drug market opportunity post transplant hodgkin lymphoma set take adcetris year higher sale potentially butt write get new indication adcetris be key part seattle genetic strategy even drug launch year still hasn make company profitable adcetris be also be test cell lymphoma front line set kind lymphoma january company also announce collaboration bristol myer squibb bmy test bristol hot new cancer drug opdivo adcetris various kind lymphomas seattle genetic stock be july high retain good relative strength rating analyst expect turn profitable fda have aug deadline decide aristada schizophrenia drug alk create drug take aripiprazole brand name abilify be best seller otsuka bristol myer go patent year add own technology turn dose regimen daily pill monthly injection patient compliance be biggest problem face psychotic medicine generally less frequent dose better aristada win be alone long act psychotic market leerink analyst michael schmidt say do nearly well johnson johnson jnj invega sustenna also used technology be therefore provide royalty model aristada sale write july research note aristada be important component strategy return growth be lead stock last year sacrifice profit growth invest marketing new drug vivitrol most recent quarter revenue also flatlined analyst expect sale growth next year rise profitability be not see return accord thomson reuter stock hit high march go form cup handle base fail break slump sector last week be trading fraction wednesday afternoon connect amy reeve ibd_areeve facebook
402,ESRX,gilead science have be winning streak recent year competition price pressure push biotech pace setter go acquisition continue momentum gilead gild revenue climb percent year earlier period company share earning more double foster city calif base gilead annual sale total more past year market value have rise more fivefold reach impressive stock earn best possible ibd composite rating mean stock have outperformed other stock combination factor include earning share relative strength rating gilead have flourished focuse treat hiv hepatitis patient hepatitis drug sovaldi harvoni have chalk more half company product sale backlash have be build sovaldi gilead have price drug pill week life treatment time get major move very hard person completely forget say michael holland head new york money management firm holland co management have task show person biotech boom isn ready end yet gilead continue be major player industry have show world have strong long last growth strategy just case kind bad news surface again consumerism be grow health care gilead surely feel pressure price charge say paul carroll partner devil advocate group consult firm ceo pressure take time build attempt deny use medicine base cost bring person woodwork shout death panel gilead need be prepare doomsday scenario imagine life be world longer charge pill not everyone agree rhetoric surround sovaldi gilead be very strong position strategically say dan mendelson ceo health business advisor avalere health strong position globally hep be big public health issue time dr barnett mennen physician long experience pharmaceutical industry have say sovaldi have change game many patient ve offer cure much be worth someone be suffering gilead be other price put pressure gilead company share plunge percent last dec reach month low fda approve rival abbvie abbv hepatitis product same time abbvie forge agreement express script esrx offer drug lower price become only hepatitis product big pharmacy benefit entity sanction industry observer say gilead handle pressure be look few acquisition target way lock continue solid growth brian skorney analyst baird milwaukee tell ibd jacob plieth senior editorial analyst epvantage also expect gilead pursue acquisition hard know else proceed have competitor come recent earning conference call gilead coo president john milligan say typically acquire company have impact phase drug trial accelerate product approval process integrator indication approval process tend think still re look thing feel catalyze development product have greater utility overall acquisition targetsin early gilead acquire danish drugmaker epitherapeutic other company gilead buy skorney be eyee such potential takeover target south boston mass base vertex pharmaceutical vrtx global biotech entity have draw praise work cystic fibrosis vertex fit nicely gilead skorney say point vertex have put stamp treat cystic fibrosis much gilead have focuse hepatitis also vertex have more dozen continue program target other life threaten disease acquisition be nothing new gilead company announce acquisition pharmasset give further range treat hepatitis sufferer acquisition turn be huge success not acquisition succeed remain dicey be long history bad acquisition pharmaceutical world note carroll devil advocate nevertheless epvantage plieth say gilead be very strong position right now have be most amazing biotech stock look back past year
403,ESRX,fda advisory committee vote late tuesday favor approve cholesterol buster praluent linger question remain just many person treat praluent team regeneron pharmaceutical regn sanofi sny be due final decision approval july analyst expect multibillion dollar annual sale eventually
404,ESRX,unitedhealth beat second quarter forecast up full year guidance thursday build dominant position medical industry remain lock merger melee largest health insurer be mostly mum conference call say earning grow share cent street view revenue notch
405,ESRX,unitedhealth group unh log solid slower growth report earning thursday meanwhile industry watcher wonder nation biggest health insurer be interested enter industry consolidation sweepstake
406,ESRX,reuter cite tweet cnbc report thursday unitedhealth be look bid cigna ci even cigna anthem antm have reportedly rekindle merger talk last month cigna spurn takeover anthem
407,ESRX,mega merger aetna aet humana hum be already work
408,ESRX,unitedhealth stock price rise more afternoon trading friday share set new high june company boast very strong ibd composite rating
409,ESRX,play unitedhealth prepare report earning open thursday analyst poll thomson reuter expect ep previous year revenue be see climb result hold mark third straight quarter double digit earning growth unitedhealth
410,ESRX,first quarter company grow earning revenue be biggest earning gain second quarter biggest top line increase least year
411,ESRX,result featured strong performance unitedhealth optum health service platform deliver year year revenue gain optum include manage care business software consult unit pharmacy benefit management pbm service provider
412,ESRX,pbm unit optumrx get much bigger unitedhealth close acquisition catamaran deal announce march be expect close fourth quarter
413,ESRX,combine entity serve customer give unitedhealth pbm business kind scale bargaining power land better deal drug make more competitive cvs health cvs express script esrx analyst say
414,ESRX,meanwhile unitedhealth other manage care stock appear have get lift last month supreme court decision uphold health care subsidy allow affordable care act obamacare
415,ESRX,research report trefis say decision benefit insurer such unitedhealth partly obamacare customer not be able afford private health insurance subsidy
416,ESRX,maintain subsidy mean private health insurance market be able sustain growth go forward trefis say furthermore unitedhealth be able maintain industry lead market share private health insurance be major business company unitedhealth group unh log solid slower growth report earning thursday meanwhile industry watcher wonder nation biggest health insurer be interested enter industry consolidation sweepstake reuter cite tweet cnbc report thursday unitedhealth be look bid cigna ci even cigna anthem antm have reportedly rekindle merger talk last month cigna spurn takeover anthem mega merger aetna aet humana hum be already work unitedhealth stock price rise more afternoon trading friday share set new high june company boast very strong ibd composite rating play unitedhealth prepare report earning open thursday analyst poll thomson reuter expect ep previous year revenue be see climb result hold mark third straight quarter double digit earning growth unitedhealth first quarter company grow earning revenue be biggest earning gain second quarter biggest top line increase least year result featured strong performance unitedhealth optum health service platform deliver year year revenue gain optum include manage care business software consult unit pharmacy benefit management pbm service provider pbm unit optumrx get much bigger unitedhealth close acquisition catamaran deal announce march be expect close fourth quarter combine entity serve customer give unitedhealth pbm business kind scale bargaining power land better deal drug make more competitive cvs health cvs express script esrx analyst say meanwhile unitedhealth other manage care stock appear have get lift last month supreme court decision uphold health care subsidy allow affordable care act obamacare research report trefis say decision benefit insurer such unitedhealth partly obamacare customer not be able afford private health insurance subsidy maintain subsidy mean private health insurance market be able sustain growth go forward trefis say furthermore unitedhealth be able maintain industry lead market share private health insurance be major business company
417,ESRX,lot be go specialty drugmaker horizon pharma so much almost different company be month last july horizon hznp learn express script esrx cvs cvs caremark be knock flagship drug vimovo duexis prefer formulary list ground drug
418,ESRX,key start point find winning stock be look top rate leader top rank industry group best group score multiple ibd smartselect rating rank biotech industry group gilead science gild fit bill california base firm develop therapy hiv aids liver disease oncology hematology other condition
419,ESRX,team diplomat pharmacy waste time muscle acquisition follow stock market debut oct diplomat dplo be largest independent specialty pharmacy april close purchase rival biorx lift already strong position market diplomat paid cash
420,ESRX,horizon pharma hznp have turn nearly deal year continue hunt drug acquisition ub say friday raise price target horizon pharma stock well revenue estimate research report ub analyst marc goodman ami fadium write track record balance sheet
421,ESRX,straight quarters double digit sale growth straight quarters double digit earning growth prescription drug medical supply distributor mckesson be strongest financial run year
422,ESRX,company continue generate robust sale thank key retail partnership favorable secular trend health care include increase demand medication age baby boomer generation
423,ESRX,mckesson mck biggest trio major distributor dominate market partner pharmacy chain rite aid rad deliver drug manufacturer consumer retail outlet medical center
424,ESRX,last year company announce new year agreement design create drug purchasing distribution efficiency deal run march mckesson assume responsibility sourcing brand generic medication
425,ESRX,top line lift
426,ESRX,agreement help mckesson post biggest revenue gain year fiscal end march company logged little more revenue year fiscal
427,ESRX,mckesson abc cardinal health cah partner walgreen boot alliance wba cvs health cvs respectively control roughly fourth fifth drug distribution market
428,ESRX,rite aid partnership provide mckesson massive scale purchasing power analyst say turn give sale volume pricing advantage enable grow revenue maintain favorable profit margin
429,ESRX,mckesson be best position firm health care industry morningstar analyst vishnu lekraj tell ibd ve be very good performer
430,ESRX,company also have partnership omnicare ocr provide pharmacy service long term care facility however bloomberg news have report omnicare have attract recent buyout interest express script hold esrx cvs health threaten mckesson relationship
431,ESRX,fiscal fourth quarter mckesson wholesale drug distribution business drive sale grow year earlier exclude time item earning continue operation climb share
432,ESRX,analyst poll thomson reuter expect full year earning rise fiscal year fiscal
433,ESRX,mckesson stock price touch high currently trade stock be more
434,ESRX,mckesson spokeswoman say executive be not available comment article conference chief financial officer james beer offer bullish outlook fiscal year ahead
435,ESRX,be call continue growth strength right distribution solution business say
436,ESRX,beer point solid generic drug price increase fiscal say higher price be increasingly important factor positive trend be case again
437,ESRX,too soon gauge current fiscal year be strong front last year say generic price be still expect rise heighten demand drug treat wide array ailment
438,ESRX,brand drug front beer say mckesson anticipate steady pricing volume growth year ahead several drug include treat hepatitis high cure rate be increasingly prescribe
439,ESRX,strong price volume be important drug distributor buy medication manufacturer store then sell retail pharmacy other outlet
440,ESRX,distributor profit spread wholesale price charge manufacturer retail price pharmacy set conjunction insurer
441,ESRX,even drug price taper distributor still generate solid profit margin selling drug other product high volume
442,ESRX,majority mckesson pharmaceutical distribution business be north america be push growth internationally buyout german drug distributor celesio help mckesson grow sale outside north america latest complete quarter
443,ESRX,continue view mckesson best position company pharma supply chain believe generic drug purchasing celesio synergy capital deployment drive upside stock deutsche bank analyst george hill note june research report
444,ESRX,cfo beer say conference more buyout be offing find attractive opportunity sensible price
445,ESRX,june report barclay capital analyst eric percher say base talk mckesson management be clear priority percher suggest mckesson be most likely build celesio deal make europe international priority
446,ESRX,similarly morningstar lekraj say acquisition particularly international one line celesio give mckesson add global purchasing power complement distribution operation
447,ESRX,boomer boost
448,ESRX,sam pappas ceo mystic asset management long time health care industry investor tell ibd population age develop part world include europe demand prescription drug increase
449,ESRX,be particularly evident massive baby boomer generation say couple more american now cover health insurance wake obamacare rollout mean more person not only need medication more american be able afford
450,ESRX,need health care include medication be only go continue increase pappas say
451,ESRX,roughly american baby boomer generation born accord census datum
452,ESRX,many have moved retirement pappas say have show propensity seek medication early often treat ailment cause age do remain active drife overall demand prescription drug
453,ESRX,point sale growth prominent prescription drug distributor such mckesson lekraj say be better beneficiary trend health care overall straight quarters double digit sale growth straight quarters double digit earning growth prescription drug medical supply distributor mckesson be strongest financial run year company continue generate robust sale thank key retail partnership favorable secular trend health care include increase demand medication age baby boomer generation mckesson mck biggest trio major distributor dominate market partner pharmacy chain rite aid rad deliver drug manufacturer consumer retail outlet medical center last year company announce new year agreement design create drug purchasing distribution efficiency deal run march mckesson assume responsibility sourcing brand generic medication top line liftthe agreement help mckesson post biggest revenue gain year fiscal end march company logged little more revenue year fiscal mckesson abc cardinal health cah partner walgreen boot alliance wba cvs health cvs respectively control roughly fourth fifth drug distribution market rite aid partnership provide mckesson massive scale purchasing power analyst say turn give sale volume pricing advantage enable grow revenue maintain favorable profit margin mckesson be best position firm health care industry morningstar analyst vishnu lekraj tell ibd ve be very good performer company also have partnership omnicare ocr provide pharmacy service long term care facility however bloomberg news have report omnicare have attract recent buyout interest express script hold esrx cvs health threaten mckesson relationship fiscal fourth quarter mckesson wholesale drug distribution business drive sale grow year earlier exclude time item earning continue operation climb share analyst poll thomson reuter expect full year earning rise fiscal year fiscal mckesson stock price touch high currently trade stock be more mckesson spokeswoman say executive be not available comment article conference chief financial officer james beer offer bullish outlook fiscal year ahead be call continue growth strength right distribution solution business say beer point solid generic drug price increase fiscal say higher price be increasingly important factor positive trend be case again too soon gauge current fiscal year be strong front last year say generic price be still expect rise heighten demand drug treat wide array ailment brand drug front beer say mckesson anticipate steady pricing volume growth year ahead several drug include treat hepatitis high cure rate be increasingly prescribe strong price volume be important drug distributor buy medication manufacturer store then sell retail pharmacy other outlet distributor profit spread wholesale price charge manufacturer retail price pharmacy set conjunction insurer even drug price taper distributor still generate solid profit margin selling drug other product high volume majority mckesson pharmaceutical distribution business be north america be push growth internationally buyout german drug distributor celesio help mckesson grow sale outside north america latest complete quarter continue view mckesson best position company pharma supply chain believe generic drug purchasing celesio synergy capital deployment drive upside stock deutsche bank analyst george hill note june research report cfo beer say conference more buyout be offing find attractive opportunity sensible price june report barclay capital analyst eric percher say base talk mckesson management be clear priority percher suggest mckesson be most likely build celesio deal make europe international priority similarly morningstar lekraj say acquisition particularly international one line celesio give mckesson add global purchasing power complement distribution operation boomer boostsam pappas ceo mystic asset management long time health care industry investor tell ibd population age develop part world include europe demand prescription drug increase be particularly evident massive baby boomer generation say couple more american now cover health insurance wake obamacare rollout mean more person not only need medication more american be able afford need health care include medication be only go continue increase pappas say roughly american baby boomer generation born accord census datum many have moved retirement pappas say have show propensity seek medication early often treat ailment cause age do remain active drife overall demand prescription drug point sale growth prominent prescription drug distributor such mckesson lekraj say be better beneficiary trend health care overall
454,ESRX,drama surround express script esrx wag help boost cvs caremark cvs bottom line second straight quarter
455,ESRX,stop fill express script prescription end company couldn agree new contract customer jump ship other pharmacy such cvs
456,ESRX,cvs estimate former customer add cent share earning company say earlier expect cent gain share
457,ESRX,analyst be expect pharmacy report jump earning cent share report second quarter result tuesday
458,ESRX,express script reach agreement last month begin fill prescription date be nearly month half away give customer time switch remain loyal cvs
459,ESRX,analyst be anticipate express script report rise ep report market close tuesday sale be see double acquisition medco health solution pharmacy benefit plan operator april
460,ESRX,analyst be worry fall enrollment wellpoint wlp express script largest client
461,ESRX,generic drug also be issue express script pfizer pfe cholesterol fighter lipitor bristol myer squibb bmy blood thinner plavix recently lose patent protection cheaper generic drug offering boost profit margin hurt revenue
462,ESRX,retail drugstore group be rank investor business daily industry group drama surround express script esrx wag help boost cvs caremark cvs bottom line second straight quarter stop fill express script prescription end company couldn agree new contract customer jump ship other pharmacy such cvs cvs estimate former customer add cent share earning company say earlier expect cent gain share analyst be expect pharmacy report jump earning cent share report second quarter result tuesday express script reach agreement last month begin fill prescription date be nearly month half away give customer time switch remain loyal cvs analyst be anticipate express script report rise ep report market close tuesday sale be see double acquisition medco health solution pharmacy benefit plan operator april analyst be worry fall enrollment wellpoint wlp express script largest client generic drug also be issue express script pfizer pfe cholesterol fighter lipitor bristol myer squibb bmy blood thinner plavix recently lose patent protection cheaper generic drug offering boost profit margin hurt revenue retail drugstore group be rank investor business daily industry group
463,ESRX,rite aid rad wag stock be tuesday market close rival drugstore cvs caremark cvs post disappointing second quarter earning morning express script esrx center saga top view cvs share fall rite aid gain lift express script edge pharmacy benefit manager
464,ESRX,lead big cap stock medical sector be still king hill nearly third today member ibd big cap come biggest fastest grow sector economy ibd stock research table medical sector be rank sector monday ibd not great still good growth investor be more likely find outstanding gain homing most dynamic exciting company health care say utility currently rank food beverage alcohol tobacco course defensive sector feature stock muscle produce gain more proper buy point day dividend be loom largely investor mind industry attract buyer pay quarterly dividend few company be able produce blockbuster product way amgen amgn do epogen neupogen treatment anemia other cancer related blood condition today year go public june amgen be mature large cap have share outstanding quadruple number outstanding share alexion pharmaceutical alxn amgen market value be edge closer cisco system csco have largest market value ibd biotech group amgen be still show growth july oak calif firm complete buy kai pharmaceutical be develop treatment secondary patient chronic kidney disease be dialysis june amgen acquire turkish company mustafa nevzat pharmaceutical order provide platform growth turkey surround region amgen ceo bob bradway point july news release result biologic amg be exciting prospect company experimental drug pipeline amgen stock have climb clear flat base base pattern past late june point key patiently secondary buy opportunity elsewhere big cap hiv specialist gilead science gild be recent new close monday past entry celgene celg have be develop cup base peak april stock monday return day long term move average good sign specialist cancer inflammatory disease fight medicine have grow earning share vs year level quarters row express script esrx be build long base base pattern test entry then retreat
465,ESRX,stock continue trade moderately lower early afternoon trading tuesday investor look release fed minute afternoon minute be slate hit wire et market observer be go search hint possible third round quantitative ease central bank shore
466,ESRX,stock stage quiet mixed open wednesday disappointing gain february durable good order pullback oil price nasdaq pull dow jone industrial average slip fraction dip bank america bac lead dow gain nvidia nvda rise top nasdaq
467,ESRX,antitrust regulator be weigh scuttle express script esrx buyout rival pharmacy benefit manager medco health solution mhs opposition mount reuter report monday key official federal trade commission believe deal be stop want ensure have enough evidence stop deal court reuter also report food marketing institute represent biggest grocery chain ask ftc step fear merged company cut payment supermarket pharmacy already operate tight margin ftc spokesman decline comment report status review food marketing institute do not respond request comment decision challenge acquisition be expect end february early march reuter report cite source closely watch deal report send company share lower express script fall more late afternoon trading medco lose have suffer heavier intraday loss update express script close medco lose wag announce friday sharp drop january prescription sale lose business express script start year rise nearly close pharmacy benefit manager be hire insurance company handle prescription drug plan cvs caremark cvs be latest space revenue follow medco express script cvs report wednesday share edge lower medco express script first announce deal july say expect close first half go merger give third market coalition consumer group have be urge regulator block deal group state attorney general have be consider launch own challenge food marketing institute include wal mart wmt safeway swy joined opposition letter ftc earlier month reuter report say letter note largest supermarket chain have meet ftc official ask deal be stop do not identify chain express script say acquisition bring efficiency drug distribution chain serve bulwark rise prescription drug cost lower drug cost be far too high improve health outcome consumer express script ceo george paz say testimony senate subcommittee december big drug company merge large chain drug store buy competition demand higher price become more effective represent interest plan sponsor consumer obama administration have be wary big industry merger justice department objected propose buy deutsche telekom mobile lead bell drop takeover attempt
468,ESRX,market correction have shake ibd send familiar stock pack bring fresher name usually happen list elite stock general downtrend newer entrant be alaska airline alk silica slca alaska have touch multiyear high report increase third quarter earning
469,ESRX,stock pull higher solid trade morning second wave economic datum be encourage more detail euro zone greek debt rescue plan materialize nyse composite lead gain rise nasdaq volume rise modestly nyse be sharply higher nasdaq compare same time yesterday manufacturing mid atlantic region picked july hoisting philadelphia federal reserve manufacturing index vs decline june consumer board lead indicator index gain june downwardly revise number line expectation federal housing finance administration housing price index rise april increase wednesday top perform sector financial get early boost morgan stanley ms jump early trading bank hold company report loss cent share better cent loss analyst expect revenue be expectation lead stock face pressure second straight day several take healthy gain example catalyst health solution chsi pop sympathy move follow express script esrx announce acquisition medco health service mhs catalyst be buy point week cup handle downside tractor supply tsco plow rut company top second quarter earning estimate revenue come just shade short expectation company offer full year revenue guidance low end expectation tractor supply have give most gain breaking flat base past buy point network ffiv drop massive trading maker optimization software application deliver network report late wednesday earning top forecast revenue fall just shy view stock have be consolidate january
470,ESRX,rob bartolo stock not environment manager rowe price growth stock fund invest bottom sector be knock cover ball find attractive stock ll pass likewise ll favor good prospect even re struggle sector least quarters
471,ESRX,lot company talk customer service deliver be matter catalyst health solution chsi offer pharmacy benefit management pbm be prove see thing customer view lead rise revenue growth ironically many firm focus best company rather customer meeting customer need create client benefit
472,ESRX,last month top perform mutual fund have be heavily buy share big name industry leader include bank america bac intel intc boee ba abbott laboratory charle schwab schw investing well period bofa lead group top fund manager scoop more financial giant share boost demand stock be now buy point clear september semiconductor equipment maker apply material amat software analytic leader adobe adbe come just shy mark get investment approximately respectively ibd screen identify top growth stock be strongly display key trait typically share biggest stock market winner name month list new buy top fund be also currently ibd include apply material adobe abiom abmd lam research lrcx global spgi get newsletter deliver inbox more info product service privacy policy term usein addition bofa other bank stock make list joined financial sector company include charle schwab be name best online stock broker lead portfolio manager also continue pick share semiconductor stock include aforementioned intel apply material lam research well microsemi mscc kla tencor klac portfolio manager also show healthy interest medical stock company sector join abiom abbot laboratory list include express script esrx cantel medical cmd just mutual fund manager have be buy stock doesn mean time individual investor pick share especially give overall market have come selling pressure recently be sure run stock idea buy checklist do additional research make investment decision tuesday apply material clear buy point later stage therefore riskier double bottom relative strength line have be trend sharply higher be just shy new high ground lam research be also work late stage double bottom have now climb entry scanning tracking solution leader zebra technology zbra leap past buy point january pull back stock market fall sharply early february feb zebra soar earning report be now initial entry adobe also launch successful january have now climb buy point ibd member svb financial sivb own silicon valley bank be just featured ibd stock analysis break past entry tuesday be now testing support buy point resignation donald trump top economic advisor gary cohn rattle market be top new buy month boee top list stock be sell net seller fund selling buy american express axp be second net seller fund selling buy manage care provider humana hum motorola solution msi also see significant number net seller also be today fastest grow company find track best mutual fundsvideo quickly find top perform mutual fund
473,ESRX,spark therapeutic once glaxosmithkline gsk be pricing world first approve gene therapy figure approach apiece expect even higher charge report say wednesday spark luxturna treat rare eye disease cause blindness price tag eye put total cost eye yet be still many analyst view spark price gene therapy glaxo drug strimveli be approve europe treat disease often refer bubble boy disease child cost wednesday institute recommend strimveli cost effective bloomberg say gene therapy be meant be time treatment make question pricing tricky therapy spark glaxo treat small patient population spark outlined think luxturna pricing email investor business daily price reflect stakeholder consideration have learn past month include access concern patient family health care provider treatment center budgetary concern public private payer need build sustainable company address unmet need patient genetic disease spark say ibd take spark have poor ibd composite rating best possible meaning trail nearly stock term key growth metric head ibd stock checkup look stronger stock contender biotech group addition unveil price luxturna spark also detailed series payer model program help patient access drug include outcome base rebate arrangement harvard pilgrim contract model express script esrx contract model aim reduce cost payer commercial payer pharmacy purchase luxturna rather treatment center agree cover treatment member expedite benefit process cap pocket amount network limit arrangement spark assume drug transit storage handle risk spark be also discussion center medicare medicaid service proposal enable company offer payer option spread payment luxturna multiple year provide flexibility greater outcome base rebate spark also create support system help patient navigate insurance process provide travel accommodation help assist other pocket cost related treatment close bell stock market today spark jump close glaxo slip fractionally related biotech gain first ever approval gene therapy treat eye diseasewhy biotech stock be defy hematology related spark gene therapy also be boon biotechs
474,ESRX,phillip curve theory heart federal reserve approach raise interest rate economic expansion march ahead be lower unemployment give rise faster wage growth fed policymaker figure inflation pressure win follow too far wage pressure business pass portion higher wage bill yet assumption central proactive monetary policy steady diet fed rate hike even inflation remain fed target have take knock lately jobless rate expect sink year fall lower biggest question financial market be much link unemployment wage inflation finally assert soon tax reform pass december dozen major company include walmart wmt cvs health cvs bank america bac starbucks sbux announce wage hike reflection tighten labor market good bet wage growth be head higher much pricing power company really have here be key understand outlook inflation fed rate hike policy understand link wage inflation isn clear once be target tgt be good place start september discount retailer announce big wage hike broad base price cut just week apart price cut thousand item come shortly amazon com amzn celebrate close whole food acquisition cut upscale natural food grocer price much select item avocado kale then bid limit employee turnover attract seasonal worker tight labor market target hike minimum wage hour commit hourly wage end higher wage not feed higher price term few huge company have significant market power incentive put market share profit amazon have be reward massive valuation sale growth grow reach prime membership even profit disappoint internet enabled transparency also keep lid price not just true retail marriott international mar ceo arne sorenson have explain hotel group doesn have much ability raise price have past cycle home sharing airbnb have impact leisure traveler see bigger issue radical transparency pricing ibd take stock market volatility have return so more important ever read big picture column day stay top market direction key indicator let know be aggressive move sideline just few relatively modest trend reversal inflation have be move only direction lower sink more core consumer price inflation exclude sometimes volatile food energy category hasn touch aggressive fed rate hike paul volcker push back inflation early pre emptive fed rate increase mid alan greenspan ushered current low inflation environment technological advance empower consumer globalization manufacturing supply chain part capitalize lower wage labor fed prefer inflation gauge core personal consumption expenditure price index hasn even touch decade sit end even tight labor market gdp growth foster bit more inflation perspective be order neither investor fed policymaker be likely get overly concern guess apple aapl iphone raise eyebrow start price be release november send price index phone equipment surge release be right point labor department adjust price change account technological advance say phone equipment cost fall january vs year earlier be smallest decline combination quality improvement productivity gain manufacturing global competition go long way explain most inflation be service year january service inflation be run good inflation be just exclude food energy good inflation be exception good category be prescription drug price always rise bring political scrutiny prescription drug price rise just january vs year earlier roughly half increase see prior year prescription benefit manager express script esrx say average member prescription cost employer plan serve rise lowest key generic fill rate rise prior year likely reflect part fda new expedite generic approval approach so gain be sustain likewise health care service price rise historically tame january regulate industry health care price be rarely transparent government play especially large role power raise price be limit regulator fed favore pce price index cpi reflect price individual pay directly indirectly such health care be subsidize government employer health care account just pce index vs cpi weight meanwhile housing account similar pce index more cpi shelter cost rise year january difference go long way explain core cpi inflation typically exceed core pce inflation labor market tighten worker have more opportunity quit find greener pasture company pressured raise wage have possibility deal higher compensation cost increase price lower profit offset higher wage bill increase worker output find other efficiency extent earning boost trump tax cut slash corporate tax rate make company more willing swallow higher wage pass cost customer incentive tax bill allow immediate expensing equipment purchase increase investment make worker more productive key question be heighten wage pressure bigger investment incentive combine get productivity rut be much past decade so raise growth ceiling economy stoke inflation be interested shock economic outlook keep stock market edgechart read basic find correct buy point lead stocksbitcoin blockchain private industry ain see nothing yetwhy bull market rally be time review stock selling smartsai news artificial intelligence trend lead stock
475,ESRX,amazon com amzn warren buffett berkshire hathaway brkb jpmorgan chase jpm announce tuesday morning be partner way address healthcare employee aim improve employee satisfaction reduce cost corporate giant create independent company be free profit make incentive accord statement announce alliance tackle enormous challenge healthcare harness full benefit be greatest issue face society today bring together world lead organization new innovative construct group hope draw combine capability resource take fresh approach critical matter health insurer pharmacy benefit manager sell concern corporate america try slash cost reduce price demand service cvs health cvs major pbm well drug store giant tumble soon open stock market today express script esrx lose cvs health be process acquire insurer aetna aet deal compete unitedhealth unh speculation amazon enter prescription drug pharmacy business way aetna report earning tuesday morning share slide dow unitedhealth have pbm retreat new joint venture be lead todd comb investment officer berkshire hathaway marvelle sullivan berchtold manage director jpmorgan chase beth galettus amazon senior vice president be interested amazon score price target hike ahead earningsdow pfizer beat earning view guide higher expect apple amazon other tech titan earning
476,ESRX,invisalign maker align technology algn share pop hour then quickly reversed wall street digest earning result estimate increase share profit cent revenue growth accord zack investment research result diluted ep just cent due negative impact share change tax law adjust align earn share company report sale total case shipment rise quarter case teenage patient record revenue be year year drive increase invisalign volume geography customer channel well record itero scanner revenue say ceo joe hogan statement invisalign volume be year year reflect strong international growth increase utilization expansion customer base include new customer third consecutive quarter stock share maker clear dental aligner device initially sky-rocket late trade then quickly reversed lower trade slide stock market today earlier tuesday share have tumble much briefly sank day move average align intraday breach key level violate previous buy point however stock regain support day intraday show strength wake earning result have potentially translate fresh buy opportunity align have rally more first stage most recent base be third stage carry greater risk failure ibd take buy hold stock be risky head earning report here earning option strategy help cash post earning stock gain minimize risk weak quarter elsewhere health care space amazon amzn berkshire hathaway brkb jpmorgan chase jpm shake sector announce plan improve health care cost service american employee health care pharmacy benefit manager pbm stock sell tuesday cvs health cvs unitedhealth unh express script esrx take big hit be interested abiom arista align yy read stock rebound fast grow sector leader tell different story ahead earningschip stock watch semiconductor industry newsstock buy watch top ipos big small cap growth stockslooking best stock buy watch start here
477,ESRX,index other major average have first week be worst show year apple aapl guide lower many suspect amazon amzn boee ba deliver strong result facebook fb tout strong ad rate alibaba baba miss earning paypal pypl crash former parent ebay ebay moved cut ty move amazon jpmorgan chase jpm berkshire hathaway brkb team tackle health care cost hit insurer pharmacy benefit manager bitcoin meltdown continuedx hot start major average suffer worst weekly loss year dow nasdaq rise bond yield worldwide pressured stock unitedhealth unh cvs health cvs many other insurer fall amazon jpmorgan berkshire health care joint venture amazon boee facebook be earning winner alibaba be notable loser apple aapl do bitcoin plummet loss accelerate facebook joined chorus regulator worldwide crack cryptocurrency apple aapl earning share rise year year sale fiscal first quarter narrowly beat expectation apple sell iphone vs consensus unit average selling price due new iphone iphone model fuel overall result march quarter apple expect sale base midpoint guidance official estimate share fall friday new month low commerce leader report adjust earning share smash consensus big benefit tax cut help revenue rise also beating revenue amazon web service rise sale echo line smart speaker far exceed expectation amazon amzn say share gain hit new high intraday facebook fb report robust earning revenue growth top forecast user growth cool user time spend facebook fall even latest big news feed change executive say conference call ad rate be soar ease analyst revenue fear share hit record high thursday alphabet googl share fall google parent report adjust earning be share year earlier miss view traffic acquisition cost google pay partner website carry ad soar google expect rise tac moderate google rise tac have be link contract renewal apple well internet search shift mobile phone revenue rise top consensus adjust ep exclude impact tax reform result additional expense amazon jeff bezos jpmorgan jamie dimon berkshire warren buffett say new nonprofit company be aim reduce cost employee be successful own firm think be expand service corporate america health insurer pharmacy benefit manager sell unitedhealth largest health insurer also pbm sank drugstore pbm cvs health cvs be buy insurer aetna aet lose pure play pbm express script esrx retreat paypal pypl report strong earning line guidance former parent ebay ebay report line earning stronger expect gross merchandise volume real news be ebay stunned wall street news replace paypal handle payment own site partnership adyen move add revenue stream share ebay soar nearly thursday paypal lose week close buy point day line chinese commerce giant revenue soar best gain least quarters beating view earning share climb slightly miss forecast alibaba buy stake ant financial former unit run payment service alipay replace deal alibaba get ant financial pretax profit alibaba provide intellectual property not cash move clear hurdle possible ant financial ipo alibaba share week tumble recent buy point add job january better expect average hourly wage surge vs year earlier far view best ism manufacturing index continue point raid employment gain fast growth wage gain be good news spur federal reserve raise rate more aggressively year software leader report adjust earning share cent year year sale fiscal second quarter analyst expect cent microsoft get lift cloud compute business include azure office dynamic current quarter microsoft guide earning share cent sale view share hit record high intraday thursday amd amd broadcom avgo qorvo qrvo offer investor positive financial news amd beat wall street target december quarter guide estimate higher current quarter broadcom give preliminary sale earning guidance fiscal first quarter top view qorvo rocket disclose big contract major customer apple aapl next generation iphone qorvo deliver better expect result fiscal guide well wall street target current quarter boee ba report ep share exclude share benefit tax cut way boee beat analyst view revenue climb also top view boee also guide ep revenue forecast higher tax cut spur more investment make case new midmarket jet more compelling boee also get missile defense contract pentagon up up order new jet give venerable jumbo jet new lifeline meanwhile lockheed martin lmt ep jump revenue rise defense giant guide ep view higher boee share rise week lockheed hit new high video game publisher electronic art ea see stock surge record high report big gain online service associate sport game franchise fifa madden nfl boost live service be reveal part ea line december quarter earning report video game hardware software firm nintendo ntdoy post better expect december quarter result thank continue success switch console related software take interactive software announce major delay highly anticipate wild west action game red dead redemption now set release oct instead spring visa mastercard top analyst forecast person break plastic more often spend holiday visa also buyback follow american express axp just suspend buyback visa also hike quarterly cash dividend cent share homebuilder stock continue struggle even big builder report better expect earning prior week surprise miss nvr nvr housing demand price be strong concern be grow rise labor material cost mortgage rate low be rise america largest homebuilder horton dhi beat ep revenue wednesday share meet resistance day line pultegroup phm stock keep fall slide gross margin even earning sale top view smaller meritage home mth also beat smaller home mho holding mdc miss ep slew biotechs drugmaker report earning include pfizer pfe eli lilly lly vertex pharmaceutical vrtx astrazeneca azn merck mrk top wall street fourth quarter earning expectation pfizer come sale adjust profit cent share lilly total sale grow firm bring adjust income share vertex report sale adjust profit cent share astrazeneca report core earning share sale merck result be mixed top line miss view adjust income cent share beat cent amgen amgn report sale adjust earning share lag consensus merger news sanofi sny announce acquire ablynx ablx exxon mobil xom fall well short consensus fellow dow industrial component chevron cvx also miss ep view share plunge day line chevron undercut recent buy point separately crude production continue hit fresh longtime high crude supply rise first time week crude future remain year high ferrari race gap buy zone report strong earning thursday meanwhile auto sale slump january big decline ford fiat chrysler fcau gm gm sale edge higher miss view toyota tm sale sky-rocket strong truck sale
478,ESRX,sell health stock tuesday joint venture amazon com amzn jpmorgan chase jpm berkshire hathaway brkb wring cost saving health care system appear very unlikely impact industry earning next couple year accord analyst figure rein health cost participation big health care player look impossible task needham analyst kevin caliendo say note cost implement system adjudicate patient datum partner hospital doctor pharmacy national basis be onerous caliendo add scale big new partner wouldn be big enough squeeze discount provider steering patient way compare purchasing power unitedhealth unh cvs health cvs aetna aet anthem antm new company have align other provider way provide best care employee caliendo conclude fact caliendo give cvs big vote confidence earlier tuesday say plan combination aetna position create saving government private employer needham raise rating cvs strong buy target caliendo do think profit industry especially underwriting level be excessive be improvement current care delivery model be make see prime reason cvs aetna deal cvs be look shift more health care service lowest cost location store clinic different take unitedhealth playbook expand urgent care other outpatient locale drive saving customer such path forward be evident announcement amazon jpmorgan berkshire plan establish independent company be early plan stage accord statement trio group do not come problem answer acknowledge berkshire ceo warren buffett success be go require talented expert beginner mind long term orientation say amazon jeff bezos yet unclear point talented expert be wall street weigh long term nature effort dearth substantive detail initial shock wave ripple wall street subside share dow jone industrial average component unitedhealth nation largest insurer sank stock market today diving much earlier cvs health be process buy aetna pare loss drop drug distributor cardinal health cah mckesson mck be respectively prescription benefit management firm express script esrx sank have tumble earlier cvs unitedhealth also operate pbms manage prescription side health insurance contract pharmaceutical biotech stock also lose ground hit didn look much broader market downdraft tuesday merck mrk shed allergan agn gilead science gild pfizer pfe lose top earning view offer bullish guidance ibd take unitedhealth be rank ibd medical manage care industry group base earning sale margin stock performance trend visit ibd stock checkup see leader category insurer have be solid performer rank group long current confirm uptrend equivalent green light stay place lead stock lead group break buy point be more likely not have wind back here good place start look stock be poise move higher knee jerk reaction investor be surely reflection unsustainably high cost health care fact amazon have be itch disrupt retail prescription business be attach effort traditionally fear health care investor have be government not private sector impose cost control get handle runaway budget deficit thin industry profit process medicare negotiating drug cost be such fear industry expert say government be unlikely produce much way saving be willing deny patient access certain drug create political backlash amazon jpmorgan berkshire aren first big employer join force attack health cost leerink analyst ana gupte note tuesday health transformation alliance group large self insure employer launch last year also hope find saving improve employee satisfaction work cvs unitedhealth achieve aim initial report indicated alliance member expect save combine prescription cost year amazon jpmorgan berkshire say initial focus be technology solution provide employee family simplified high quality transparent healthcare reasonable cost new corporate entity say be free profit make incentive constraint just form technology solution take be far clear caliendo suppose berkshire bring underwriting skill ve never underwritten healthcare amzn make pharmacy medical procurement contribution provide expertise leerkink gupte say unclear amazon wading deeper solve health care mess accelerate move supply chain prescription industry also be interested trump state union move market downstock fall market show sign be ready breakgrubhub redhat lead ibd stock buy invest stock free new apps aim invest stock market start simple routine
479,ESRX,important metric look stock be higher relative strength rating diplomat pharmacy dplo clear benchmark tuesday jump tuesday exclusive rating investor business daily track market leadership worst best score grade show stock price movement trail week stack other stock database history reveal best stock often have better rs rating begin biggest run look best stock buy watch start herediplomat pharmacy be work consolidation buy point see stock clear price volume least average take look top bottom line number company have post quarters increase earning growth revenue growth have be different story come most recent report diplomat pharmacy earn rank peer medical service industry group express script esrx laboratory corporation america lh be also group highest rate stock related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
480,ESRX,stock market need band aid monday stop bleed need full blow tourniquet tuesday dow take biggest hit fall give back hurt largely weakness commodity stock nasdaq composite lose decline be worst major stock index start
481,ESRX,invest disruptor advice wall street giant biotech company incumbent big pharma be brace get crushed more innovative cheaper new drug start continue analyst say generic drug approval be rise interesting new medicine be start take market share legacy maker medication consumer use frequently include big pharma biotech company blockbuster drug represent estimate annual sale be set lose patent protection next decade analyst say disruption come generic drug innovative new biologic alternative come market be brutal jmp security analyst mike king tell investor business daily be knife fight market cholesterol lower drug king expect amgen amgn regeneron pharmaceutical regn sanofi sny feel heat like esperion therapeutic espr medicine co mdco alnylam pharmaceutical alny meanwhile inflammatory treatment celgene celg otezla gain blockbuster status miss sale forecast wide cut third quarter analyst say newly approve drug treat same condition eli lilly lly novartis nvs be take market share gilead science gild be still feel pain mature hepatitis drug unit europe rapid pace gilead hepatitis sale decline be expect slow somewhat newer medicine abbvie abbv mavyret be likely swipe sale big pharma isn get help regulator food drug administration head scott gottlieb continue increase approval copycat drug stoke competition brand generic drug face new rival firm try undercut price big pharma company pfizer pfe be forefront feel sting generic take sale earlier month teva pharmaceutical teva be allow launch generic copy blockbuster erectile dysfunction drug viagra generic drug tend be cheaper brand counterpart viagra be pricey drug tablet accord accessrx pfizer lose exclusivity viagra canada europe worldwide sale fall today generic europe have slash price drug contain same active ingredient viagra generic version viagra cost third price canada viagra price also fall trend repeat generic market teva meanwhile be struggle debt end third quarter thursday teva announce plan cut workforce more quarter close several manufacturing facility suspend dividend ordinary share firm be also plan review generic drug portfolio most specifically change price discontinue product ibd take see giant biotechs fared vs smaller player third quarter visit industry snapshot hint quarter be classify alarm large cap biotech be trouble see more competition traditional moneymaker board spending prescription drug increase just person accord report express script esrx rise represent drop growth rate trend be likely continue fbb capital partner analyst mike bailey tell ibd credit gottlieb decline generic price gottlieb be run fda business allow cycle more approval more competition lower price center medicare medicaid service use tool influence pricing unlikely president trump use executive power enact sweeping drug pricing reform such allow medicare negotiate price enact pricing control bailey say wouldn expect major change trump administration pricing say think mechanically politically difficult get pricing law system politically more acceptable just get more generic drug approval jmp king count drug treat rheumatoid arthritis psoriatic arthritis crowd area drug class cost average prescription benefit increase utilization unit cost accord express script third quarter thing begin look dour like celgene miss expectation inflammation drug otezla lag be even sharper analyst suggest celgene be force take price concession celgene also cut guidance terminate trial drug treat crohn disease condition result chronic inflammation digestive tract now see inflammation immunology drug bring combine outlook issue biotech company big pharma need get realistic pricing competitive arena king say same be say company make treatment hepatitis multiple sclerosis high cholesterol be highly saturate market latter point expect price drug know pcsk inhibitor repatha amgen praluent regeneron sanofi be microscope drug lower bad ldl cholesterol blood evidence show also have benefit cardiovascular outcome repatha be list year praluent cost rival be close medicine co alnylam be work cholesterol drug know inclisiran meanwhile analyst expect bempedoic acid esperion be cheaper big pharma biotech company be probably go get arm twisted lot king say pricing umbrella have create opportunity new company come scale market share be careful own incumbent invest disruptor other area be seemingly immune pricing pressure analyst say price multiple sclerosis drug rise average continue trend fbb bailey say price increase have be so egregious house democrat launch investigation august note many drug carry price tag north year investigation be launch rep elijah cumming peter welch center bayer bayry biogen biib emd sereno novartis roche rhhby sanofi teva pharmaceutical biotech company teva milligram dose copaxone have increase most rise approval annual price today accord national multiple sclerosis society novartis gilenya approve be highest price investigation be year too late say more difficult push price control specialty market multiple sclerosis be massive market now stakeholder view specialty market rare disease innovative cancer therapy also seem immune pricing control analyst say example earlier year novartis gilead acquisition kite pharma gain approval car drug know kymriah yescarta respectively car drug be develop used patient own immune system cell be trained seek destroy cancer cell kymriah go year yescarta be list ark invest analyst manisha samy write recent post gene therapy be begin cure cancer come price cause sticker stock say say compare traditional therapy suppress do not cure cancer cost benefit analysis gene therapy be compelling pricing shock tend tamp excitement really compelling drug bailey say prime example be biogen ionis pharmaceutical ion spinraza first spinal muscular atrophy drug approve cost first year subsequent year sentiment biotech company share be already say so drug pricing concern shouldn be big stock killer past biotech stock go quickly get new drug person be excited lot time someone throw grenade drug pricing bailey say sentiment be already even concern drug pricing see little less downside ibd company biotech industry group be now rank group track have fall first just month share collectively near year high october have shucked almost point same time amgen celgene biggest biotechs have see share price dive respectively regeneron have take hit gilead have tumble meanwhile alnylam esperion look likely rival psck inhibitor drugmaker amgen regeneron have lift respectively abbvie recently launch rival gilead hepatitis franchise be novartis lilly be compete celgene treat inflammatory condition have see share retreat smaller degree respectively share price be match dip ibd company ethical drug industry group generic drug stock rank group have actually broadly rise mid october respective dip teva mylan myl biggest name related teva restructure plan case be here do generic drug maker face pricing issue other pharmas don ttop biotech company innovation earn recognition new award
482,ESRX,aetna aet easily top wall street third quarter earning estimate tuesday even fall short revenue health insurer say win comment report be talk be acquire cvs health cvs drugstore giant pharmacy benefit manger be mull report try position entry amazon com amzn retail prescription business xmeanwhile rival health insurer wellcare health wcg soar back buy zone blowout earning aetna earning share rise revenue fall analyst have expect ep revenue aetna raise full year ep guidance range offer early august analyst consensus give cent beat imply ep roughly line wellcare health earn share vs year earlier more double expect revenue grow be just consensus aetna share fall stock market today continue slip thursday spike news cvs merger talk hit wellcare share jump hit record high retake buy point meanwhile cvs share rise tumble more prior session lowest level early buzz be offer aetna amazon share surge friday better expect earning edge higher early continue rally surge friday blowout earning aetna highlighted medicare company primary growth driver new member add quarter plan expand geographic footprint aetna end period insure member revenue decline reflect year suspension affordable care act health insurer fee be tack premium pullback obamacare individual market medicaid contract loss management say restoration health insurance fee knock cent ep ibd take dow jone industrial average close friday more point ibd change market trend indicator confirm uptrend uptrend pressure equivalent yellow light turn green make sure read big picture column day stay top market direction key indicator let know be aggressive move sideline analyst have be somewhat divide benefit cvs aetna deal say provide negotiating leverage drug manufacturer other warning other health plan distance cvs antitrust also be issue cvs aetna deal be see challenge dominance unitedhealth group unh spearhead combination manage care prescription benefit management acquisition catamaran now optumrx unitedhealth share slip monday unitedhealth be rank ibd medical manage care industry group base earning revenue margin stock performance trend express script esrx stand alone prescription benefit manager be see increasingly vulnerable potential takeover target share express script dip loss monday related cvs health look buy aetna amazon threat get realamazon blow past earning view beat sale share jump prescription business amazon speculation swirlsamazon new online drug retailer cvs walgreen bewarestock buy watch top ipos big small cap growth daily update stock potential big gain
483,ESRX,cvs health cvs buy aetna aet create health care giant have hand everything insurance corner drugstore cvs pay share aetna share cash rest stock company say statement sunday premium aetna share price oct day company be report be talk deal be biggest health care merger past decade combine largest drugstore chain third biggest health insurer cvs also manage drug benefit plan employer insurer business help steer aetna customer cvs drugstore fill prescription deal give aetna insurance plan closer ground tie customer get care include cvs assumption aetna debt deal be value expect close second half company say joint interview cvs chief executive officer larry merlo aetna ceo mark bertolini say combine company help cvs expand variety retail medical service vision care nutrition advice audiology make basic care more convenient less costly consumer aetna be operated separate business unit new service be design appeal broadly customer other insurance company well executive say immediate financial benefit deal be project be relatively modest company say expect synergy profit improvement low mid single digit second full year merger be complete company be bet longer term profit reshape customer get care create executive be call new front door health care system cvs store clinic think store hub new way access health care service america merlo say joint interview re bring health care person live work cvs drugstore fill prescription cvs drug plan also give aetna insurance plan closer ground tie customer get care deal be finance mix cash debt barclay goldman sachs bank america have commit provide financing person say expect close second half create cost saving say person deal close aetna operate separate unit run member current management aetna chief executive officer mark bertolini join cvs board other aetna director come health sector be look horizon amazon com amzn company shake business buy distribute selling drug medical product get health care retail industry have be batter online giant amazon hasn reveal plan problem health care system be so fragmented so little coordination say steve kraus invest health firm bessemer venture partner better vertically integrate less siloed system be good thing mind also set new round takeover cvs aetna competitor look reshape landscape nov ceo express script esrx say pure play pharmacy benefit manager be open deal right price wasn actively look don need sell be very successful future be always open other sudden conclude want have express script ceo tim wentworth say interview also mentioned possibility partner amazon drug distribution arrangement express script be just company universe independent drug plan insurer supply chain middleman wellcare health plan wcg humana hum centene cnc become merger target cvs aetna deal accord matthew borsch analyst bmo capital market drug distributor cardinal health cah mckesson mck retailer such walgreen boot alliance wba also face pressure find partner cvs operate retail store walk medical clinic have be move drugstore root year buy pharmacy benefit manager caremark rx business make almost half woonsocket rhode island base company operate profit third quarter cvs stop selling cigarette add health name aetna have emphasize desire move care closer consumer brian tanquilut analyst jeffery say oct cvs capability include minute clinic coram home infusion business enable health plan improve health outcome reduce cost trend consolidation be pick health care supplier administrator insurer seek more control consumer get care propose megamerger insurer include deal aetna humana be block year antitrust ground lead company look rival insurer different type health care company potential deal cvs aetna deal antitrust prospect depend regulator be tasked review accord bloomberg intelligence analyst jennifer rie federal trade commission have be less critical consolidation company adjacent business know vertical consolidation justice department other hand last month sue block merger time warner twx vertical deal michael newshel analyst evercore isi say doj effort block time warner deal do raise concern cvs aetna deal do have path forward aetna likely need divest medicare drug plan business say biggest health insurer unitedhealth group unh be also most diversify unite own doctor clinic outpatient surgery chain also have pharmacy benefit management call optumrx build acquisition catamaran corp
484,ESRX,anthem antm second largest health insurer say wednesday launch own pharmacy benefit management business rely heavily cvs health cvs back end process retail distribution year anthem cvs deal take effect anthem current contract express script esrx expire anthem move bring closer resemble model establish unitedhealth group unh buy pharmacy benefit manager catamaran cigna ci also have establish own pharmacy benefit management business amazon com amzn reportedly be close enter prescription dispense field several analyst speculate amazon acquire pbm gain entry business cvs health drugstore operator have serve pbm acquisition caremark share anthem close stock market today rise earlier briefly top buy point cvs health gain express script expressed disappointment lose anthem business open lower reversed higher settle gain reason rebound wasn immediately clear analyst have speculate express script be target amazon cigna rise unitedhealth add hit record high tuesday follow release strong third quarter earning amazon dip back level ibd take share anthem be close buy point point investor have best odd see term gain anthem be rank ibd medical manage care industry group visit ibd stock checkup see leader be find stock rank industry group pbm essentially do prescription benefit manage care company do manage nonprescription health benefit claim pbms seek lower cost pharmacy benefit used expertise buy power direct most appropriate medicine patient lowest cost amazon want get retail prescription business face big challenge deal regulatory compliance claim process aspect business pbm expertise process system come however bernstein analyst lance wilke have say most logical path forward amazon be form partnership unitedhealth nation largest insurer ask unitedhealth earning call tuesday potential amazon enter prescription dispense business management say be willing partner anybody drife value goal meeting consumer want related unitedhealth signal openness amazon partnership earning beatamazon new online drug retailer cvs walgreen bewarestock buy watch top ipos big small cap growth daily update stock potential big gain
485,ESRX,pharmacy benefit manager express script esrx topple monday retailer walgreen boot alliance wba cvs health cvs continue slide potential amazon com amzn disrupt pharma world venture online prescription drug sale prod analyst downgrade express script xon stock market today express script dove touch month low intraday cvs fall month low walgreen sank lowest nearly year friday express script lose cvs walgreen plunge raymond james analyst michael baker downgrade express script underperform market perform rating cite escalate competitive pressure give pure play model pharmacy benefit manager possibility wild card amazon enter market selling season be shape be more competitive baker write note client commentary suggest opportunity be push script play combine competitor prime therapeutic be unlikely contract anthem antm meaning likely go blue cross blue shield contract hold express script totale total drug spending baker say ibd take medtech space have be less affected drug pricing worry pharma biotech space space climb higher still year head industry snapshot closer look group strong performer express script also have blue cross blue shield contract bid worth drug spending estimate add pressure web giant amazon be rumore be consider entrance online prescription drug sale market decision expect thanksgiving email friday amazon decline comment investor business daily see potential route decide enter team distributor target cash pay market make bigger splash go insure market baker say be different way penetrate insure market partner exist pbms purchase pbm baker trim adjust earning share view express script keep estimate issue model latter forecast be cent consensus related amazon new online drug retailer cvs walgreen get free google home smart speaker hit payroll wage hike speed fed rate hike
486,ESRX,even cvs health cvs walgreen boot alliance wba have repeatedly throw cold water idea amazon com amzn take prescription dispense industry idea just win die xon thursday bernstein analyst lance wilke seem ante amazon rumore interest sector say expect happen accord thefly com wilke see amazon buy partner pharmacy benefit management company help drive volume navigate industry regulation wilke have be work cover health care service arena quarter century so perspective amazon be well position disrupt industry carry weight investor note concern amazon entry negative effect pbm industry earning report amazon be likely longer run concern investor so pharmacy focus thursday be weak sale rite aid rad cite challenge reimbursement rate environment new generic hold prescription price report earning amazon share add head back day move average rite aid share tumble hit year low stock market today cvs be drugstore pbm slip walgreen lose walgreen month win ftc approval buy rite aid store long battle buy smaller rival fall apart due regulatory objection dow component unitedhealth group unh operate optumrx pharmacy benefit management company rise lag solid gain see other manage care player express script esrx largest pure play pbm be higher health care group suffering most thursday be drug distributor mckesson mck fall abc cardinal health cah amazon be enter pharmaceutical industry industry watcher have speculate cut distributor deal directly drug manufacturer ibd take ibd premium feature be free oct visit ibd stock checkup see stock portfolio watch list match industry peer base earning sale margin stock performance also read big picture daily update underlie market trend aug ibd shift market trend gauge confirm uptrend uptrend pressure equivalent flash yellow light turn green earning call aug cvs ceo larry merlo discuss host reason industry not play amazon strong suit addition be distribution point pharmacy be also clinical outcome be provide merlo say accord seek alpha transcript environment migration more value base care clinical capability be go continue grow importance merlo say highly regulate industry have high barrier entry note work require pharmacist payer physician add patient put trust retail pharmacist add mail order pharmacy have decline recent year have speculate amazon use whole food location place store pharmacy pickup related market be amazon next casualty notrite aid stock crash same store declinestock buy watch top ipos big small cap growth stock
487,ESRX,gilead science gild report more positive datum hepatitis drug pipeline wednesday send share stock market today datum come phase study used recently approve drug sofosbuvir candidate ledipasvir patient genotype virus most common type sustain response rate be well
488,ESRX,gilead science gild newly approve hepatitis drug sovaldi come fire price pharmacy benefit manager express script esrx tuesday rival abbvie abbv report good datum compete drug candidate gilead stock drop abbvie rise stock market today bloomberg reporter draw say twitter express script chief medical officer
489,ESRX,market fall just short erase big loss earlier thursday again earning news provide most fuel winning lose stock sector leader shadow market most trim loss close session high such celgene celg intuitive surgical isrg priceline pcln still fall small loss express
490,ESRX,action be sleepy sector leader monday volume fall list have anemic look monday edition top sector include utility medium alcohol tobacco build food beverage do not host single leadership quality stock last week stock such energy drink maker monster beverage mnst online travel arranger priceline com pcln fall
491,ESRX,stock future blipped higher ahead thursday open market appear set build wednesday late day rally dow future trade point fair market value have come well earlier high nasdaq future be strong point future show point gain
492,ESRX,stock market today head session nasdaq lower week ibd index be russell open loss rally late wednesday session follow release federal reserve september beige book report left nasdaq top day trading range positive sign little have change regard overall message correct market be send be patient build watch list watch follow day
493,ESRX,investor attention be august nonfarm payroll report due friday thursday preliminary include august job cut report challenger gray christmas show number layoff slow sharply vs july year high compare year figure employer announce plan cut worker retail sector account nearly layoff most tie bankruptcy grocery chain report say
494,ESRX,initial jobless claim rise week end aug labor department say economist consensus have project claim week move average edge
495,ESRX,stock grifol grfs rise sunedison sune jump market continue be hard slip up late season earning report
496,ESRX,be morning weak revenue guidance upended quarterly result verint system vrnt tumble better expect earning revenue do not offset full year earning guidance consensus view
497,ESRX,generic drug maker lannett lci spiked premarket trade philadelphia base company say pay acquire kremer urban pharmaceutical generic drug unit belgium base ucb kremer own portfolio drug strong pipeline pending application candidate effectively double lannett revenue lannett end wednesday april high fall week line support early august
498,ESRX,switzerland base syngenta syt rolled gain announce seek divest vegetable seed business launch share repurchase program syngenta see more revenue herbicide insecticide stock end wednesday june high
499,ESRX,lead stock be unusually flat ahead open refinery operator tesoro tso post largest move ibd stock premarket trade stock have be work fashion bottom week consolidation hover week move average
500,ESRX,overseas china market be close country celebrate anniversary end wwii europe market layer healthy gain lead index more board midday
501,ESRX,dollar trade flat vs euro yen bond slip not much crude oil ease few penny west texas intermediate hold barrel week gold ease ounce less week stock future blipped higher ahead thursday open market appear set build wednesday late day rally dow future trade point fair market value have come well earlier high nasdaq future be strong point future show point gain stock market today head session nasdaq lower week ibd index be russell open loss rally late wednesday session follow release federal reserve september beige book report left nasdaq top day trading range positive sign little have change regard overall message correct market be send be patient build watch list watch follow day investor attention be august nonfarm payroll report due friday thursday preliminary include august job cut report challenger gray christmas show number layoff slow sharply vs july year high compare year figure employer announce plan cut worker retail sector account nearly layoff most tie bankruptcy grocery chain report say initial jobless claim rise week end aug labor department say economist consensus have project claim week move average edge stock grifol grfs rise sunedison sune jump market continue be hard slip up late season earning report be morning weak revenue guidance upended quarterly result verint system vrnt tumble better expect earning revenue do not offset full year earning guidance consensus view generic drug maker lannett lci spiked premarket trade philadelphia base company say pay acquire kremer urban pharmaceutical generic drug unit belgium base ucb kremer own portfolio drug strong pipeline pending application candidate effectively double lannett revenue lannett end wednesday april high fall week line support early august switzerland base syngenta syt rolled gain announce seek divest vegetable seed business launch share repurchase program syngenta see more revenue herbicide insecticide stock end wednesday june high lead stock be unusually flat ahead open refinery operator tesoro tso post largest move ibd stock premarket trade stock have be work fashion bottom week consolidation hover week move average overseas china market be close country celebrate anniversary end wwii europe market layer healthy gain lead index more board midday dollar trade flat vs euro yen bond slip not much crude oil ease few penny west texas intermediate hold barrel week gold ease ounce less week
502,ESRX,most big cap stock be trading new high distinction be say many lead growth stock day
503,ESRX,average stock be just new high comparison ibd stock be average prior high
504,ESRX,stock new high have break basis recently
505,ESRX,latest be seed company hit new high monday stock have make handle june break late month
506,ESRX,many other company tie commodity market earning have be erratic profit performance have go loss cent share august end quarter gain follow quarter
507,ESRX,sale growth have fluctuated too
508,ESRX,abbott laboratory make push new high june share jump volume grow normal pace diversify medical product manufacturer remain buy range buy point
509,ESRX,company earning sale growth traditionally have be modest trend remain even stock continue long upward march
510,ESRX,costco cost make june rise past cup handle nearly double volume get average day trading
511,ESRX,warehouse store chain earning growth be not stellar have be accelerate ep increase most recent period
512,ESRX,breakout big cap have occur light volume disappointing sign reason be skeptical buy
513,ESRX,express script esrx example have top buy point cup handle volume have be pedestrian ecolab ecl be suspicious
514,ESRX,case volume swell day still act confirmation institutional investor be buy share
515,ESRX,happened hsy april trading didn get serious company report earning april send stock sharply higher
516,ESRX,amgen amgn break june be volume surge day later
517,ESRX,wal mart wmt be biggest winner screen have shot more clear resistance be solid rally stock mature wal mart discount retailer have be market leader year
518,ESRX,consumer tilt remain big capitalization leader stock be retail related field comcast cmcsa be major medium company
519,ESRX,health care make big piece new big cap stock not include related company such ecolab most big cap stock be trading new high distinction be say many lead growth stock day average stock be just new high comparison ibd stock be average prior high stock new high have break basis recently latest be seed company hit new high monday stock have make handle june break late month many other company tie commodity market earning have be erratic profit performance have go loss cent share august end quarter gain follow quarter sale growth have fluctuated too abbott laboratory make push new high june share jump volume grow normal pace diversify medical product manufacturer remain buy range buy point company earning sale growth traditionally have be modest trend remain even stock continue long upward march costco cost make june rise past cup handle nearly double volume get average day trading warehouse store chain earning growth be not stellar have be accelerate ep increase most recent period breakout big cap have occur light volume disappointing sign reason be skeptical buy express script esrx example have top buy point cup handle volume have be pedestrian ecolab ecl be suspicious case volume swell day still act confirmation institutional investor be buy share happened hsy april trading didn get serious company report earning april send stock sharply higher amgen amgn break june be volume surge day later wal mart wmt be biggest winner screen have shot more clear resistance be solid rally stock mature wal mart discount retailer have be market leader year consumer tilt remain big capitalization leader stock be retail related field comcast cmcsa be major medium company health care make big piece new big cap stock not include related company such ecolab
520,ESRX,stock notch solid open tuesday tech transportation stock lead energy mining issue bring rear
521,ESRX,nasdaq climb add dow jone industrial average tack gain
522,ESRX,volume be briskly mixed stock market today nasdaq nyse inverse early trading action monday
523,ESRX,air transport issue lead fedex fdx unite parcel service up notch best early gain industry group track ibd gold coal oil group post worst loss list
524,ESRX,commerce department report construction spending surge october reversed revise decline september easily outpaced economist expectation increase
525,ESRX,early stock action showedbiogen biib skip company report positive result phase study alzheimer treatment plan aggressively move phase trial gain lift share back converge week move average left stock still month consolidation
526,ESRX,cypress semiconductor cy power punch month high agree be acquire sunnyvale calif base spansion code stock deal value cypress share have be wallow consolidation mid spansion share fire ahead well new high
527,ESRX,leader ambarella amba celgene celg jump front ibd list
528,ESRX,ambarella pop start trade retake portion tumble take monday video chip maker be trading friday high extend strong october rebound week support
529,ESRX,biotech drug maker celgene climb nearly move new high now buy point double bottom base stock notch solid open tuesday tech transportation stock lead energy mining issue bring rear nasdaq climb add dow jone industrial average tack gain volume be briskly mixed stock market today nasdaq nyse inverse early trading action monday air transport issue lead fedex fdx unite parcel service up notch best early gain industry group track ibd gold coal oil group post worst loss list commerce department report construction spending surge october reversed revise decline september easily outpaced economist expectation increase early stock action showedbiogen biib skip company report positive result phase study alzheimer treatment plan aggressively move phase trial gain lift share back converge week move average left stock still month consolidation cypress semiconductor cy power punch month high agree be acquire sunnyvale calif base spansion code stock deal value cypress share have be wallow consolidation mid spansion share fire ahead well new high leader ambarella amba celgene celg jump front ibd list ambarella pop start trade retake portion tumble take monday video chip maker be trading friday high extend strong october rebound week support biotech drug maker celgene climb nearly move new high now buy point double bottom base
530,ESRX,oppenheimer small mid cap growth fund be do want growth fund be hold ground even broad market struggle market low oct fund total return april be vs fund direct rival track
531,ESRX,stock open quiet mixed trade tuesday investor look release fed minute afternoon nasdaq rise apple aapl climb more dow jone industrial average be effectively flat dip netflix nflx research motion rimm netapp ntap post nasdaq heaviest loss alcoa aa
532,ESRX,many investor last fall write rise star sxc health solution sxci pharmacy benefit management outfit head life support sxc ceo mark thierer tell ibd phone interview momentum investor hedge fund sell share news biggest client healthspr hs be acquire insurer cigna healthcare ci figured sxc
533,ESRX,market slip correction week weigh many lead stock major average be thursday testing week move average most top stock have also pull back volume have mostly be weak many issue remain well buy range ride long market uptrend begin follow day july
534,ESRX,medical cable tv credit card stock dominate week big cap accounting half list most be buy range member highly rate medical biomedical biotech industry group appear lineup include alexion pharmaceutical alxn celgene celg amgen amgn gilead science gild alexion develop drug treat rare disease be
535,ESRX,allergan agn mylan myl teva pharmaceutical teva stock fall wednesday department justice accuse former pharmaceutical executive collude fix generic drug price former heritage pharmaceutical ceo jeffrey glazer jason malek ex president be charge wednesday philadelphia conspire fix price antibiotic diabetes med felony doj say release be fire heritage august accord bloomberg report cite lawsuit file last month new jersey heritage accuse glazer malek steal ten million dollar siphon profit various racketeering scheme fbi be prepared go pharma company violate antitrust law say special agent charge michael harpster statement filing charge drug price collusion skews market flout common decency say sad state affair pharmaceutical executive be determine further pad profit back person health depend company drug say ibd take biotechs have nearly return pre election level recent commentary donald trump work cut drug price wednesday teva stock fall mylan allergan ibd company medical generic drug industry group fall charge be first year investigation generic drugmaker include allergan mylan teva lannett lci impax laboratory ipxl covis pharma sun pharmaceutical mayne pharma taro pharmaceutical taro endo international endp email statement edison base heritage pharma say august follow internal investigation reveal variety serious misconduct individual charge today heritage pharmaceutical terminate be fully cooperate aspect department justice continue investigation recently heritage initiate own legal action same individual seek redress elaborate embezzlement self deal scheme be deeply disappoint misconduct be commit ensure do not happen again last month allergan sun pharma decline comment ibd mylan say have disclose subpoena regard antibiotic doxycycline be subpoena information pricing tactic digoxin blood pressure med ceo drug biotech market have comment rise drug price light recent commentary president elect donald trump go bring drug price hillary clinton be often see tougher drug price earlier wednesday express script esrx ceo timothy wentworth joined fracas say doesn see major impact business affordable care act be repeal say guidance call analyst overarch drug price conversation isn go away be question mind conversation be not go go away need demonstrate used tool client voice well demonstrate say accord marketwatch share pharmacy benefit management company tank much wednesday end day day line express script affirm earning share ex item view deliver line sale view related drugmaker mylan slate growth follow price fix fracasincyte recoup loss price fix fracas strong chemo result
536,ESRX,cvs health cvs tuesday say measure growth pharmacy benefit client prescription drug spending slow last year price inflation specialty brand outweighed other trend driver company say statement specialty drug well new launch rise cost have less impact inflation brand high volume category such drug used treat diabetes announcement follow year price specialty drug have be increase scrutiny double digit drug trend increase be experience result call action client help ensure plan member access medication need stay healthy affordable price cvs health executive vice president robert say cvs share finished lower stock market today rival walgreen boot alliance wba fall rite aid rad walgreen be buy ease price specialty drug exemplify digit treatment price hepatitis drug gilead science gild become lightning rod criticism pharmacy benefit manager such cvs express script esrx have negotiate discount drugmaker exchange coverage lightning rod become practice company include valeant pharmaceutical vrx martin shkreli turing pharmaceutical buy obscure drug cheap hike price cvs have try curb usage valeant jublia toenail fungus drug reportedly have retail price milliliter bottle monday accord bloomberg cvs say launch optional program april intend steer patient cheaper treatment cvs client spending jublia soar last year bloomberg say add express script say also try bring price toenail fungus treatment gilead science share dip express script close valeant climb image provide shutterstock
537,ESRX,pharmacy benefit manager express script esrx tuesday issue earning share guidance solidly view analyst expressed concern company contract health insurer anthem antm express script share settle lower stock market today rise much earlier anthem close conference call discuss outlook express script say be review pricing contract anthem largest client expect company reach mutually beneficial agreement accord reuter be unclear agreement be strike look give absence agreement guidance issue tuesday do not reflect potential change express contract anthem term year agreement begin allow company re evaluate pricing occasionally reuter say question regard long term relationship anthem continue be concern investor fbr say note evercore isi analyst ross muken say review present number variable prevent clarity timing financial ramification contract aside bmo analyst jennifer lynch say note tuesday do not view newly issue guidance game changer story express hold ep guidance year analyst expect company see adjust claim roughly line guidance year still management call say be happy initial result selling season muken say focuse model alignment have position uniquely health care service landscape improve health outcome lower cost client patient ceo george paz say statement most recently express script month say partner imprimis pharmaceutical immy promote call cheaper alternative daraprim toxoplasmosis drug become more expensive year be acquire martin shkreli turing pharmaceutical cvs health cvs buy pharmacy benefit manager caremark finished follow bill peter twitter ibd_bpeter
538,ESRX,unitedhealth group unh signale openness partner amazon amzn be reportedly consider push prescription dispense business beating earning forecast insurer optum business provider health service prescription benefit management technology service have be growth driver help company stand apart rest manage care market ask potential amazon enter prescription dispense business optumrx unit ceo john prince say company be willing partner anybody drife value goal meeting consumer want bernstein analyst lance wilke write earlier october see partnership unitedhealth most logical path forward amazon target prescription business share unitedhealth jump close record high stock market today bounce support day average help dow jone industrial average climb amazon edge pharmacy benefit manager express script esrx rise drug distributor mckesson mck dip cvs health cvs also have phm unit add unitedhealth be rank ibd medical manage care industry group centene cnc cigna ci base earning sale margin stock performance trend centene rise cigna tuesday help bipartisan deal fund obamacare subsidy insurer ibd take get ready earning season day read ibd daily investing action plan highlight stock be buy range close unitedhealth ep surge beating view revenue climb match forecast optum revenue rise company raise guidance full year earning share vs prior range analyst have expect insurer have extricate obamacare exchange gop effort target medicaid have run trouble well position deal shift political wind fact unitedhealth market type short term medical plan trump want make widely available less costly alternative obamacare plan management note earning call ll consult trump administration official rule govern short term plan other area target trump executive order last week related trump executive order hit obamacare insurersamazon new online drug retailer cvs walgreen amazon health care isn sweat trumpstock buy watch top ipos big small cap growth daily update stock potential big gain
539,ESRX,other major index continue climb etching fresh record high wal mart soar investor increasingly see discount giant give amazon amzn run money other retailer falter jpmorgan chase jpm citigroupc charge off other issue stock back delta dal offer solid earning guidance other carrier give upbeat figure crash report more pay tv loss signale wo medium company generally index nasdaq rise dow industrial climb index continue hit record high wal mart boom even retailer continue tumble warning analyst downgrade amazon speculation nvidia make yet advance new move autonomous vehicle delta air line kick airline earning big carrier seem be regain altitude wal mart wmt announce buyback program say see fiscal net sale rise commerce sale soar current fiscal year wal mart see earning share discount giant see ep growth fiscal wal mart also plan add online grocery location current store look take amazon amzn target tgt investor day call wal mart signale wouldn hike wage target wal mart share surge nearly week blast past buy point even many retail stock group struggle related wal mart break buyback bullish online sale chase jpm bank america bac citigroup report better expect earning revenue ongoing trading wo wall street jpmorgan say see trading remain weak fourth quarter jpmorgan bank america citigroup raise reserve credit card have see higher delinquency recent month well fargo wfc report mixed result revenue net interest margin fall short well fargo retreat friday share other big bank pull back somewhat week cable tv company medium stock sell renew worry pay tv cord cut be accelerate preannounce financial number include loss video subscriber actually lose pay tv customer add internet video subscriber partially offset loss ub estimate pay tv industry lose subscriber third quarter compare same quarter last year worry medium company garner subscriber programming fee tumble drop collar propose acquisition medium giant time warner twx stock be share deal close time warner shareholder stand get more stock share company now hold cable internet content giant comcast cmcsa lose thursday month low viacom viab skid year low related fallout pay tv industry lose air line dal kick third quarter earning industry group beating estimate give solid unit revenue guidance earlier week american airline aal unite airline ual raise outlook unit revenue total figure big indicated analyst airfare pricing be improve follow concern recent month impact series hurricane fare war unite spirit airline save southwest luv also say begin service hawaii next year likely meaning more competition hawaiian airline parent hawaiian holding delta share rise week approach buy point related delta air line see turnaround crucial highly competitive marketsay aloha airfare price wargraphic chip maker nvidia nvda tout expertise make brain self drive vehicle conference germany unveil artificial intelligence computer fully autonomous vehicle be already be used more company develop driverless taxi also announce german logistic giant deutsche post dhl group be deploy test fleet self drive delivery truck next year used nvidia technology nvidia stock climb hit new high minute federal reserve september meeting show several policymaker fence raise interest rate december market be now pricing consumer price retail sale datum show post hurricane boost september core inflation remain tame crude future rise barrel stockpile fall third straight week inventory fall barrel accord energy information administration far more barrel decline analyst expect domestic production fall barrel day week prior international energy agency predict opec continue supply cut current deal expire march agency say cartel output rise bpd last month iea keep demand forecast unchanged still see demand growth barrel day year demand growth bpd saudi arabia say export less crude sea next month related oil inventory production drop iea see more opec cutsexpress script esrx announce buy evicore healthcare privately hold medical benefit management service company way pharmacy benefit manager diversify report amazon amzn be reportedly close enter online pharmaceutical sale express script tumble year low lose oct amazon speculation heated cvs health cvs be drugstore operator pbm sank walgreen boot alliance wba skid earning hit share revenue rise better expect same store sale rise also view share fall week ep beat estimate thank accounting change comp wall street consensus be far gain year earlier related domino earning help accounting change flop wall st honeywell confirm spin home adi global distribution business transportation system company worth combine confirm monday report noncore asset spinoff honeywell keep aerospace holding call activist investor third point divest honeywell share dip still buy zone pfizer pfe say tuesday consider selling spin counter business include advil centrum personal care item chapstick anbesol pain relieve gel toothach decision isn expect woman apparel chain jill jill issue big profit warning send share recent ipo crash thursday retailer sell day penney jcp hit time low ulta beauty ulta william sonoma wsm rocked analyst downgrade procter gamble pg narrowly win proxy fight vs activist investor nelson peltz have be fight board seat press strategic shift more innovative brand fewer corporate division trian fund have take stake earlier year anaptysbio anab sky-rocket record high tuesday eczema drug appear outperform regeneron pharmaceutical sanofi potential blockbuster eczema drug dupixent phase trial day patient moderate severe eczema see improvement symptom chip equipment maker ichor holding ichr say have enter substantial agreement produce liquid delivery system key customer do not identify customer ichor stock surge nearly time high apple aapl inked first major internet television deal signing acclaim director producer steven spielberg make new episode anthology show amazing story barracuda network cuda sell post line fiscal earning bear pounce lower customer renewal rate subscription well security software maker reiteration fiscal revenue guidance
540,ESRX,amazon amzn acquisition natural food grocer whole food market wfm friday stunned market clobber grocery stock spur joke jibe twitterverse wag tweet jeffbezos wasn exactly wealth redistribution have mind ask yesterday bezos alexa need grocery alexa buy whole food samppa lahtinen samppasos june so amazon go next here be potential industry commerce giant xamazon already be say be consider entry pharmaceutical market speculation have center online drug delivery amazon also conceivably add pharmacy whole food location several analyst note friday create further synergy food drug online order store purchase amazon enter field send tremor pharmaceutical food chain drugstore chain such walgreen boot alliance wba cvs health cvs pharmacy benefit manager such express script esrx distributor such amerisource bergen abc amazon do have finger pie once backed drugstore com online retail pharmacy be acquire walgreen then shut walgreen share fall cvs health reflect least part immediate investor concern impact food sale express script amerisource bergen also be lower amazon business business business unit launch sell worth lab equipment deep fryer other gear seek business owner first year operation division continue grow such torrid pace eat lunch grainger gww hd supply hds other firm industrial supply sector market be extremely fragmented estimate player value year amazon disrupt streamline marketplace hd supply fall friday grainger rise meanwhile home improvement store home depot hd lowe low floor decor fnd have be amazon proof so far not always stay true amazon have automotive ambition too be be rumore want move aggressively auto part carve slice diy aftermarket part market news be eyee auto part retail sector send brick mortar retailer such autozone azo reilly auto part orly advance auto part aap sharply lower january report time say online juggernaut already have contract dorman product dorm other part maker share auto part retailer be still mired week lows autozone reilly auto advance auto part fall friday messaging service slack technology target corporate chat room be say make silicon valley startup attractive amazon be big player enterprise service market microsoft msft alphabet googl other have messaging service help corporate business amazon web service microsoft google have own cloud compute business have slack messaging feature aw have be key internet giant streak stellar earning fact whole food switch allegiance amazon web service current status microsoft cloud customer give friday news slack be say have value least so be biggest ever acquisition amazon surpass whole food amazon issue small loan past year merchant online platform bloomberg report june issue loan seller unite state unite kingdom japan have plan expand key market such china lend business gain momentum amazon weigh online lender such lend club lc well payment processor such paypal pypl square sq also offer credit user bank lend heavily small business also take hit lend program also keep customer loyal amazon be see rival such ebay ebay wal mart wmt step commerce strategy amazon lend program launch allow profit directly indirectly interest rate more transaction fee merchant grow sale share amazon be rise stock market today whole food rise slightly amazon offer price related amazon whole food deal mean retailamazon whole food merger be category killer food eateriesnew flooring retailer manage sidestep amazon squeeze
541,ESRX,xfuture dow jone industrial average index nasdaq composite signale modest gain early tuesday major market average look set hold extend monday big gain dow component mcdonald mcd caterpillar cat report earning open lockheed martin lmt pulte group phm be buy range monday close caterpillar take big step monday own entry point meanwhile look express script esrx sell tuesday open bad news express script announce be likely lose top customer anthem antm send share pharmacy benefit manager late monday cvs health cvs be major pbm addition drugstore operation be late perhaps hope anthem business monday nasdaq composite soar hit time high dow jone industrial average index rise retake day move average market rally worldwide follow sunday first round france presidential election emmanuel macron pro reform pro eu centrist nationalist marine le pen move runoff poll show macron easily beating immigrant populist le pen dow future be nearly fair value nasdaq future be higher ibd take thank strong gain major market average several new breakout lead stock market be now back confirm uptrend quick thorough analysis market read big picture day stock close session high vast majority monday gain be open push market higher here lead stock buy range be report earning tuesday morning burger giant be currently buy range entry rise past session monday analyst expect sale decline earning share same store sale be watch closely result guidance analyst look mcdonald clue roll mobile order pay system well further talk delivery investor also want know mcdonald big mccafe promotion be work impact starbucks sbux starbucks have break own consolidation ahead earning thursday analyst expect maker heavy construction mining equipment report ep decline cent sale monday caterpillar report equipment sale retailer rise month march vs year earlier first such gain november caterpillar share rise monday retake day line approach flat base buy point defense contractor report revenue rise ep also lockheed martin rise monday still range buy point retake last week defense stock have rally hope higher military spending increase geopolitical tension syrium north korea raytheon rtn northrop grumman noc general dynamic gd well boee ba report later week stock be buy point well homebuilder be expect report ep rise cent revenue rise share be technically buy range only high volume decline row spark concern guidance fellow builder horton dhi japan nikkei rise tuesday intraday trade china shanghai composite climb hong kong hang seng related top stock buy zone ahead result investing action plan defense stock buy range earning come outcaterpillar end month slump stock near buy point earning
542,ESRX,xstock thunder second day strong gain tuesday big name earning report power weighty move market dow jone industrial average bring home gain gain breathe room day move average close march peak nasdaq clear level rise fresh high climb end just march high alcoa aa surge miner freeport mcmoran fcx rattle gain whirlpool whr biogen biib jetblue airway jblu rise apiece caterpillar cat be prime mover power easily lead dow industrial push stock day gain mark best week nov presidential election heavy equipment maker report gain earning rise revenue first revenue advance quarters stock move clear buy point traditional flat base entry more aggressive entry leave share highest level november netflix nflx stream higher top nasdaq news company land agreement iqiyi own internet search giant baidu bidu begin offer content china chinese regulator have bar netflix offer content directly consumer country netflix also announce monday issue bond offer investor outside fund new content strategic acquisition gain send netflix share past buy point week tight pattern baidu share rise tuesday just cup base buy point earning baidu be due thursday close steel alloy specialist allegheny technology atus forge gain report earning growth accelerate revenue pop first quarter share end session so far week begin right side month consolidation downside weak quarterly result send ryder system expressscript esrx loss verizon vz marked dow worst loss news report say verizon offer straight path communication strp outsize earlier offer straight path bolt higher ease earning report schedule close include exxon mobil xom illumina ilmn cree cree macon technology solution mtsi many other related caterpillar break steamroll earning enter china new buy zone
543,ESRX,stock open sharply higher tuesday ride wave early earning news positive sentiment follow monday solid performance dow jone industrial average power nasdaq climb move spur cavalcade early earning report gannett gci surge biogen biib leap express script esrx dive busy morning report dow industrial name include dupont dd rise nearly follow report coca cola ko report mixed first quarter performance caterpillar cat plow early gain double first quarter earning rise revenue company say higher sale especially market part drive beat share break past buy point flat base be view alternative entry adhesive leader mmm be fraction report board beat first quarter share be slightly flat base buy point alcoa aa polish mixed first quarter report monday close result be strong however rise earning revenue gain company report also pricing strength raise forecast growth aluminum demand prior estimate demand growth share be climb bottom month consolidation lockheed martin lmt slump turn mixed first quarter performance earning top view revenue gain stop short expectation management lower full year earning guidance consensus view stock clear buy point flat base monday be also just earlier buy point diversify operator crane cr hoist gain stamford conn base company report first quarter result late monday be forecast earn upgrade outperform market perform william blair tuesday stock break past flat base buy point homebuilder pulte group phm slump nearly report adjust first quarter earning just analyst target weaker forecast revenue growth stock plunge day line erased gain buy point trigger sell signal amazon com amzn be flat start bell downgrade market perform outperform raymond james stock be extend buy point week tight pattern home housing price index be due et federal housing finance agency case shiller et march new home sale datum be expect commerce department conference board release april consumer confidence number europe market remain positive monday rally spur first round presidential election france sunday afternoon trade cac paris be frankfurt dax hold gain london ftse climb asia market picked france fuel rally tuesday hong kong hang seng jump tokyo nikkei logging advance related top stock buy zone ahead result investing action planbull be back leader earning keep stock run
544,ESRX,xa powerful rebound monday left nasdaq new high heft dow industrial back day move average first time april be only start action nasdaq vault dow jone industrial average rise small cap slightly outpaced general action russell notch gain next be hour report session earning report whirlpool whr barrick gold abx range resource rrc set tone week jam economic political news more dozen dow list stock be set report earning alcoa aa be extend trading follow result express script esrx also announce result be unchanged first round presidential vote france sunday set second round far right wing candidate marine le pen centrist challenger emmanuel macron schedule macron victory strength poll ahead second round vote ease investor concern france be head exit european union move threaten union stock also receive boost white house news report say president trump have call tax plan wednesday prioritize trimming corporate tax rate hold deficit treasury secretary steven mnuchin national economic council director gary cohn be schedule meet key gop congressional leader discuss plan tuesday accord wall street journal combine result send steel maker bank miner soar jpmorgan jpm lead dow jone industrial average nearly gain goldman sachs gs jump caterpillar cat climb nearly fiber optic telecom stock also outpaced general market lead infinera infn apply optoelectronic aaoi stock be not valid buy point bard bcr easily top spiking report first quarter earning news break company be acquire becton dickinson bdx deal value becton slump hurt downgrade credit watch negative due financial risk associate bard deal standard poor hasbro have thrash gain follow strong first quarter result seize new high narrowly top buy point flat base share remain buy range dell technology dvmt pop strong trade enough take new high clear flat base buy point ibd leaderboard swing trader stock be cup handle base november oil gold drop almost session miner energy stock fared reasonably well nasdaq stock biomarin pharmaceutical bmrn xylinx xlnx lead more xylinx end just double bottom base buy point micron technology mu take nasdaq hardest hit bit less strong trade memory chip maker end late march high be still hold support week move average related top stock buy zone ahead result investing action planthese stock break nasdaq near new high
545,ESRX,president elect trump want crack drug pricing start pharmacy benefit manager express script esrx short seller citron research suggest thursday twitter twtr citron call express script philidor pharma industry refer specialty pharmacy bloomberg report last year be say have change doctor order boost reimbursement insurer juice sale valeant pharamacuetical vrx last year say be cut ty philidor express script cvs health cvs last year also cut philidor network email ibd spokesman express script point decision response citron comment say re nothing philidor recall remove philidor network more year company add hadn see report citron express script be market force uniquely put medicine reach drive cost care improve health outcome remark citron come time week publish story trump say be go bring drug price add don have happened drug price esrx be philidor pharma industry promise fix drug pricing word express script citron research citronresearch december realdonaldtrump tell esrx re fire head roll culprit pharmaceutical price gouge price target citron research citronresearch december express script plunge stock market today fall sell territory near buy point cvs health cvs be pharmacy benefit manager addition be drug store giant drop ibd take trump tweet have hurt share drug company aerospace giant boee election have cause steel stock surge citron also tweet andrew left citron executive editor appear cnbc fast money afternoon talk more express script related be trump jump come top rate build stock cvs health dife sale miss earning guidance walgreen fallsvaleant takeda salix negotiation bust price report
546,ESRX,talk rebound columbia large cap growth fund slogged tough loss lag peer track morningstar inc
547,ESRX,so far year fund be go wednesday top direct rival
548,ESRX,make difference double high quality company say fund manager
549,ESRX,past year large cap growth average annual return be ranking top category average be averaged
550,ESRX,lead manager john wilson year old manager peter deininger talk shop ibd office boston
551,ESRX,ibd have performance improve so much year
552,ESRX,wilson increase bias quality name come year add weight highest conviction name case have lag earning revenue growth second half reduce lower end large cap spectrum name prune midcap name investment thesis be not crisp
553,ESRX,have not ignore market interest dividend yield exponent total return think market operate uncertain time extent find high quality name nice income component bolster overall return case
554,ESRX,ibd add peter
555,ESRX,deininger thing different year be especially latter part be different efficacy strategy our more focuse stock selection play keep sector weight tight band vs benchmark russell growth index try keep majority risk budget emphasize individual stock selection
556,ESRX,last year especially late year have broader factor drive overall performance have market characterize high correlation year be lower correlation make stock selection more important
557,ESRX,ibd yet risk control be limit bet individual name right
558,ESRX,wilson run diversify portfolio have name re not overly reliant name limit sector bet percentage point index weighting
559,ESRX,ibd take watson pharmaceutical wpi ve build stake straight disclosure period
560,ESRX,wilson launch significant acquisition earlier year actavis together create third largest global generic pharmaceutical company world allow operate more global scale have access new market russia eastern europe
561,ESRX,health care cost containment be powerful theme world not just watson benefit merger provide significant accretion earning next several year expect earning growth be excess annually next couple year
562,ESRX,ibd pharmacy benefit manager express script esrx be cost containment play right
563,ESRX,wilson right merger medco health solution allow additional synergy allow relatively powerful economy purchasing dispense drug cost containment scenario regardless macro economic end white house
564,ESRX,ibd biogen idec biib quarterly earning share rebound grow fall prior quarter view
565,ESRX,wilson local company here boston period maturity past several year re enter new phase growth lead new oral drug bg multiple sclerosis be likely be approve year be powerful engine growth patient compliance oral drug be much stronger injectable
566,ESRX,ibd get back edward lifescience ew disclosure period have exit stock thesis
567,ESRX,wilson be health care company revolutionary product treat heart valve replacement typical heart valve replacement be invasive expensive edward have come product delivery system catheter insert patient thigh avoid crack open patient chest
568,ESRX,be tremendous advance especially older patient product be approve patient not withstand invasive open chest procedure materially expand market europe
569,ESRX,ibd view regeneron pharmaceutical regn be profitable product sale first time open position disclosure
570,ESRX,wilson rapidly grow biotech company lead product be eylea be used treat macular degeneration serious condition increase age age international population be grow
571,ESRX,eylea meet strong consumer acceptance revenue earning growth have be faster initially expect have lot conviction product
572,ESRX,ibd apple aapl have have great run course shareholder expect run continue
573,ESRX,deininger term several major product cycle front case be make momentum company business
574,ESRX,thing play advantage be product be not just shiny new toy come go ve create ecosystem keep customer come back incremental product instead drift glitzier phone product competitor
575,ESRX,go forward be few high volume market left find make new high volume market be greatest challenge
576,ESRX,ibd be drive google goog run quarter
577,ESRX,wilson google still have dominant position search re do better monetize thing youtube be heavily traffic company have not yet deliver lot revenue earning growth product still think be come road valuation be line market ratio standpoint
578,ESRX,ibd peter tech be bailiwick add please
579,ESRX,deininger thing help be google have strategy monetize shift more mobile internet usage have be grow skepticism social medium internet company transition mobile use google have show steep trajectory ability monetize
580,ESRX,ibd drive ebay ebay be also run
581,ESRX,wilson story have be transformation ebay have get stale suffer loss innovation management embarked series change result improve traffic purchase volume
582,ESRX,second powerful point more responsible stock performance be evolution paypal payment ecosystem start ebay have spread broadly online be test couple real world offline opportunity
583,ESRX,growth core ebay operation lead stock performance think continue deliver solid result
584,ESRX,ibd teradata tdc have straight quarters earning share growth mid high percentage play
585,ESRX,deininger be few pure play address increasingly important area spending technology be datum analytic
586,ESRX,have number system range appliance very high power system serve repository analysis tool company datum be datum growth company traditional part business well increase amount internet interaction so grow need manage analyze
587,ESRX,company talk big datum be explosive amount information be come company teradata have best technology deal be grow share
588,ESRX,ibd do double stake technology avgo latest disclosure
589,ESRX,deininger be semiconductor company be part supply chain be enable radio frequency technology handset market be grow portion business have be lever higher end smartphone
590,ESRX,develop phone operate world phone greater geography take advantage new network technology still handle legacy network be grow need radio frequency product produce
591,ESRX,ibd do see alliance datum ad earning share growth have accelerate quarters
592,ESRX,deininger comprise portion be private label credit card be grow business ve gain share acquire attractive portfolio retailer produce tailwind growth
593,ESRX,second part be call epsilon do lot marketing solution
594,ESRX,third part be build loyalty program traditionally base canada be expand brazil large new market
595,ESRX,segment work together now be dynamic have not see number year nature business give visibility so pillar give pipeline business give earning growth expect continue
596,ESRX,ibd be tjx co tjx play sluggish gdp growth
597,ESRX,wilson hit tj maxx appeal value conscious shopper have execute well give slow wage growth high unemployment value ring lot consumer comp store sale overall top line have do well past couple year expect sustain
598,ESRX,ibd do begin stake discovery disc disclosure
599,ESRX,wilson well run cable network global operation execute well several year programming be relatively economical produce don have do lot convert program view format international so marketing be strong most person see cable good entertainment value so world consumer discretionary cable tv represent pretty stable revenue cash flow stream
600,ESRX,ibd bring comcast cmcsa do build stake latest disclosure
601,ESRX,wilson comcast be lead cable programming provider have execute well last several year
602,ESRX,be gain share satellite telephone company ve do nice job layer additional product high speed internet business perform quite well
603,ESRX,company be pretty resilient change macro economic demand
604,ESRX,so profile be consistent growth little potential economic disruption
605,ESRX,be try introduce product service reduce dependence be live room watch comcast
606,ESRX,ibd be anheuser busch inbev play big international beer maker growth emerge market
607,ESRX,wilson pretty much exactly be leadership name be dominant beer franchise world company have be put together series merger last year benefit consolidation geography steady end consumption talk rebound columbia large cap growth fund slogged tough loss lag peer track morningstar inc so far year fund be go wednesday top direct rival make difference double high quality company say fund manager past year large cap growth average annual return be ranking top category average be averaged lead manager john wilson year old manager peter deininger talk shop ibd office boston ibd have performance improve so much year wilson increase bias quality name come year add weight highest conviction name case have lag earning revenue growth second half reduce lower end large cap spectrum name prune midcap name investment thesis be not crisp have not ignore market interest dividend yield exponent total return think market operate uncertain time extent find high quality name nice income component bolster overall return case ibd add peter deininger thing different year be especially latter part be different efficacy strategy our more focuse stock selection play keep sector weight tight band vs benchmark russell growth index try keep majority risk budget emphasize individual stock selection last year especially late year have broader factor drive overall performance have market characterize high correlation year be lower correlation make stock selection more important ibd yet risk control be limit bet individual name right wilson run diversify portfolio have name re not overly reliant name limit sector bet percentage point index weighting ibd take watson pharmaceutical wpi ve build stake straight disclosure period wilson launch significant acquisition earlier year actavis together create third largest global generic pharmaceutical company world allow operate more global scale have access new market russia eastern europe health care cost containment be powerful theme world not just watson benefit merger provide significant accretion earning next several year expect earning growth be excess annually next couple year ibd pharmacy benefit manager express script esrx be cost containment play right wilson right merger medco health solution allow additional synergy allow relatively powerful economy purchasing dispense drug cost containment scenario regardless macro economic end white house ibd biogen idec biib quarterly earning share rebound grow fall prior quarter view wilson local company here boston period maturity past several year re enter new phase growth lead new oral drug bg multiple sclerosis be likely be approve year be powerful engine growth patient compliance oral drug be much stronger injectable ibd get back edward lifescience ew disclosure period have exit stock thesis wilson be health care company revolutionary product treat heart valve replacement typical heart valve replacement be invasive expensive edward have come product delivery system catheter insert patient thigh avoid crack open patient chest be tremendous advance especially older patient product be approve patient not withstand invasive open chest procedure materially expand market europe ibd view regeneron pharmaceutical regn be profitable product sale first time open position disclosure wilson rapidly grow biotech company lead product be eylea be used treat macular degeneration serious condition increase age age international population be grow eylea meet strong consumer acceptance revenue earning growth have be faster initially expect have lot conviction product ibd apple aapl have have great run course shareholder expect run continue deininger term several major product cycle front case be make momentum company business thing play advantage be product be not just shiny new toy come go ve create ecosystem keep customer come back incremental product instead drift glitzier phone product competitor go forward be few high volume market left find make new high volume market be greatest challenge ibd be drive google goog run quarter wilson google still have dominant position search re do better monetize thing youtube be heavily traffic company have not yet deliver lot revenue earning growth product still think be come road valuation be line market ratio standpoint ibd peter tech be bailiwick add please deininger thing help be google have strategy monetize shift more mobile internet usage have be grow skepticism social medium internet company transition mobile use google have show steep trajectory ability monetize ibd drive ebay ebay be also run wilson story have be transformation ebay have get stale suffer loss innovation management embarked series change result improve traffic purchase volume second powerful point more responsible stock performance be evolution paypal payment ecosystem start ebay have spread broadly online be test couple real world offline opportunity growth core ebay operation lead stock performance think continue deliver solid result ibd teradata tdc have straight quarters earning share growth mid high percentage play deininger be few pure play address increasingly important area spending technology be datum analytic have number system range appliance very high power system serve repository analysis tool company datum be datum growth company traditional part business well increase amount internet interaction so grow need manage analyze company talk big datum be explosive amount information be come company teradata have best technology deal be grow share ibd do double stake technology avgo latest disclosure deininger be semiconductor company be part supply chain be enable radio frequency technology handset market be grow portion business have be lever higher end smartphone develop phone operate world phone greater geography take advantage new network technology still handle legacy network be grow need radio frequency product produce ibd do see alliance datum ad earning share growth have accelerate quarters deininger comprise portion be private label credit card be grow business ve gain share acquire attractive portfolio retailer produce tailwind growth second part be call epsilon do lot marketing solution third part be build loyalty program traditionally base canada be expand brazil large new market segment work together now be dynamic have not see number year nature business give visibility so pillar give pipeline business give earning growth expect continue ibd be tjx co tjx play sluggish gdp growth wilson hit tj maxx appeal value conscious shopper have execute well give slow wage growth high unemployment value ring lot consumer comp store sale overall top line have do well past couple year expect sustain ibd do begin stake discovery disc disclosure wilson well run cable network global operation execute well several year programming be relatively economical produce don have do lot convert program view format international so marketing be strong most person see cable good entertainment value so world consumer discretionary cable tv represent pretty stable revenue cash flow stream ibd bring comcast cmcsa do build stake latest disclosure wilson comcast be lead cable programming provider have execute well last several year be gain share satellite telephone company ve do nice job layer additional product high speed internet business perform quite well company be pretty resilient change macro economic demand so profile be consistent growth little potential economic disruption be try introduce product service reduce dependence be live room watch comcast ibd be anheuser busch inbev play big international beer maker growth emerge market wilson pretty much exactly be leadership name be dominant beer franchise world company have be put together series merger last year benefit consolidation geography steady end consumption
608,ESRX,healthcare exchange trade fund defy market weakness monday news health insurance giant wellpoint wlp agree buy amerigroup agp deal value largest player medicaid share amerigroup share shot close ishare dow jone healthcare provider ihf gap etf appear be form cup handle pattern potential buy point have middle road ibd relative strength rating strong accumulation distribution rating mean price performance be outpace market institution be buy more share selling ihf have asset invest wellpoint amerigroup largest holding be unitedhealth group unh accounting asset express script holding esrx deal be estimate save wellpoint amerigroup combine operation buyout be set close first quarter next year pending regulatory approval completion wellp oint be largest medicaid manage care provider subscriber state largest health insurer cover member unicare blue cross blue shield plan unitedhealth largest medicaid provider currently cover person medicaid serve low income family disabled person be jointly cover state federal government buyout expand wellpoint reach fast grow medicaid market analyst say wellpoint have not have much success own past come winning medicaid contract jeffery equity analyst david windley colleague write client note amerigroup experience arena elevate success rate rate wellpoint share hold wellpoint recognize growth opportunity government space state continue face significant budget challenge manage care be still underpenetrated raymond james analyst michael baker cathy chen write client wellpoint expect spending manage care medicaid grow end amerigroup membership grow average annually revenue grow same period other government sponsored healthcare program provider wellcare health plan wcg molina healthcare moh centene cnc jump speculation be next buyout target potential suitor include large diversify provider small reach medicaid such aetna aet cigna ci humana hum say baker chen medicaid manage care provider likely be biggest beneficiary patient protection affordable care act ppaca say david kremp analyst morningstar informally know obama care law pass march require adult not cover employer government sponsored health plan buy insurance pay tax kremp estimate most new medicaid enrollee end private medicaid plan
609,ESRX,bank america bac usually trade high volume lead list top stock trading volume thursday afternoon follow finnish mobile phone maker nokia nok drugstore chain wag financial service company morgan stanley ms chinese provider language training test preparation new oriental education technology edu bofa be trading
610,ESRX,thomas marsico be fund industry marquee manager
611,ESRX,run janus fund march july time fund average annual gain outpaced large cap growth peer accord morningstar inc averaged
612,ESRX,now be chairman ceo marsico capital run co run fund firm subadviser
613,ESRX,columbia marsico focuse equity fund holding aug reflect concentrated portfolio style marsico be well know coralie year old be co manager
614,ESRX,marsico talk shop office
615,ESRX,ibd do concentrated portfolio
616,ESRX,marsico have variety company represent lot industry give lot best breed company
617,ESRX,ibd say best breed do mean
618,ESRX,marsico company have strong market position be not dependent capital market fund growth generate lot free cash have opportunity invest back don see steady growth dividend share repurchase
619,ESRX,ibd be allocate rest world now
620,ESRX,marsico history manage money year ve always own thought be dominant franchise be world ll see number international name portfolio baidu bidu obviously dominant search company china accenture acn headquarter ireland be dominant firm datum service consult anheuser busch inbev bud base belgium be basically big consolidation brewing
621,ESRX,so portfolio be company deem be international aug same weighting now company accenture inbev get lot revenue
622,ESRX,ibd asset consumer cyclical be largest sector july health care weighting have soar past quarters be
623,ESRX,marsico passage health care law ve start increase position health care company change last few year didn know rule regulation be new health care paradigm be
624,ESRX,result supreme court judge obamacare constitutional fee impose individual don buy coverage be more tax day ruling be acquisition bristol myer squibb bmy amylin pharmaceutical amln follow monday hmo wellpoint wlp buy different amerigroup agp so health care provider be wait decision ready make move
625,ESRX,own health care company come new treatment unmet medical need ve take weighting year act pretty defensive group rally see summer now re see strength group give backdrop very difficult economic environment so health care company be defensive now also provide moderate growth pretty good dividend yield share repurchase
626,ESRX,think share repurchase be important seem be unwillingness investor put money stock ve see more money go bond fund surrogate even low interest rate
627,ESRX,ibd ve get biogen idec biib well gather new drug treatment multiple sclerosis look promising
628,ESRX,marsico have tremendous franchise rheumatoid arthritis re develop bg multiple sclerosis be take orally other drug be take infusion patient go facility bg treatment profile be better so outcome profile be better
629,ESRX,ibd open current position express script esrx april thesis
630,ESRX,marsico acquisition medco be dominant player pharmacy benefit management industry now be size scale get significant cost saving also see new opportunity move specialty pharma biologic generate lot cash flow be grow share repurchase program
631,ESRX,ibd begin current stake home depot hd last december have build do housing
632,ESRX,marsico housing be area look homebuilder not industry be great franchise value
633,ESRX,so ve have large position home depot have be successful go change leadership current leadership be strong operate business very high level think be better position lowe low do customer think only small portion business be related new home construction
634,ESRX,ibd be impact rise exist home price
635,ESRX,marsico ve see datum last couple week median price exist home be move so person be see equity return value home so margin person be likely invest home again build new bath remodel kitchen help home depot
636,ESRX,ibd be housing situation ve be generally build stake recent quarters big bank well fargo wfc bancorp usb
637,ESRX,marsico point rise home price also translate banking have position well fargo bancorp largest mortgage origination company
638,ESRX,well fargo be currently originate loan close new home
639,ESRX,be tremendous consolidation mortgage industry result collapse
640,ESRX,ibd fund be sector agnostic have sector weighting want technology be second largest weighting asset not larger weighting sector many manager see mother lode innovation
641,ESRX,marsico general be lightly weight tech few company have proprietary exclusive type product be difficult duplicate lifecycle product be long couple year short maybe month
642,ESRX,so area haven aggressively invest do company used technology improve information customer ability produce logistic company ve invest be well aware customer be spending money
643,ESRX,ibd ve get apple aapl do think still have leg
644,ESRX,marsico largest position ve own long time cost basis be now trading mid position different time ve cut back think leadership tim cook be very strong pipeline new innovative idea be strong have execute very high level also ve implement basically dividend now significant share repurchase expect grow dividend amount stock repurchase
645,ESRX,ibd other holding use technology way
646,ESRX,marsico own equinix eqix be datum center company convert reit status early take advantage tax benefit considerable moat have be location datum center be nexus telephone trunk come together well cable system generally intersection most digital traffic be
647,ESRX,use digital datum continue grow now voice be be converted datum radio voice be be converted datum so be new ip packet especially go lte network be be switch new smartphone product
648,ESRX,so equinix business colocate service close ramp internet telephone network equinix have locate datum center
649,ESRX,ibd be creative user technology
650,ESRX,marsico have proprietary position find hybrid find technology improve yield farmer
651,ESRX,next product be drought tolerant corn severe drought demand be high even normal condition product extend corn farm high plain arid area colorado lot land not lot water
652,ESRX,ve expand business brazil argentina gmo genetically modify organism product become more accept europe farmer be used more be used more eastern europe
653,ESRX,ibd priceline pcln be also innovative tech user rather tech creator right ve be trimming
654,ESRX,marsico announce quarter cut position half be concern travel activity europe
655,ESRX,actually stock have perform well adjustment downward reflect new estimate quarter so be not company want be completely
656,ESRX,cost basis be low stock be trading
657,ESRX,priceline let small hotel add exposure internet give priceline more destination other travel service dominate europe be process dominate asia agoda service
658,ESRX,europe fall recession thing not get significantly saving traveler get book priceline be significant priceline comp vs last year get easier
659,ESRX,ibd chipotle grill cmg earning share growth have accelerate quarters much growth be front
660,ESRX,marsico watch meal prepared front own eye easy model execute focus natural product make unique
661,ESRX,have tremendous opportunity expand number store penetration east coast be low have ability take company international re just start take advantage couple store
662,ESRX,re introduce second concept thai food palate person have get broader
663,ESRX,have proprietary product have good value proposition double size footprint just chipotle more new food concept
664,ESRX,ibd be find so many promising name consumer discretionary have asset house weighting
665,ESRX,marsico don think sell discretionary product
666,ESRX,dollar general gd be dollar chain sell basic good convenience low price
667,ESRX,average ticket dollar general be trip pricing be similar wal mart wmt dollar be more convenient
668,ESRX,also be expand california have only store now see opportunity grow store base dramatically next year
669,ESRX,be well run buy back lot own stock margin profile be improve quarter quarter year year
670,ESRX,ibd tom run janus fund march july be difference fund
671,ESRX,marsico say be difference now be more experience same fundamental research same concentration re benchmark agnostic don need index don follow say change stripe re not organization change stripe
672,ESRX,re fundamental investor look high quality company right price
673,ESRX,large shareholder fund marsico capital eat own cook thomas marsico be fund industry marquee manager run janus fund march july time fund average annual gain outpaced large cap growth peer accord morningstar inc averaged now be chairman ceo marsico capital run co run fund firm subadviser columbia marsico focuse equity fund holding aug reflect concentrated portfolio style marsico be well know coralie year old be co manager marsico talk shop office ibd do concentrated portfolio marsico have variety company represent lot industry give lot best breed company ibd say best breed do mean marsico company have strong market position be not dependent capital market fund growth generate lot free cash have opportunity invest back don see steady growth dividend share repurchase ibd be allocate rest world now marsico history manage money year ve always own thought be dominant franchise be world ll see number international name portfolio baidu bidu obviously dominant search company china accenture acn headquarter ireland be dominant firm datum service consult anheuser busch inbev bud base belgium be basically big consolidation brewing so portfolio be company deem be international aug same weighting now company accenture inbev get lot revenue ibd asset consumer cyclical be largest sector july health care weighting have soar past quarters be marsico passage health care law ve start increase position health care company change last few year didn know rule regulation be new health care paradigm be result supreme court judge obamacare constitutional fee impose individual don buy coverage be more tax day ruling be acquisition bristol myer squibb bmy amylin pharmaceutical amln follow monday hmo wellpoint wlp buy different amerigroup agp so health care provider be wait decision ready make move own health care company come new treatment unmet medical need ve take weighting year act pretty defensive group rally see summer now re see strength group give backdrop very difficult economic environment so health care company be defensive now also provide moderate growth pretty good dividend yield share repurchase think share repurchase be important seem be unwillingness investor put money stock ve see more money go bond fund surrogate even low interest rate ibd ve get biogen idec biib well gather new drug treatment multiple sclerosis look promising marsico have tremendous franchise rheumatoid arthritis re develop bg multiple sclerosis be take orally other drug be take infusion patient go facility bg treatment profile be better so outcome profile be better ibd open current position express script esrx april thesis marsico acquisition medco be dominant player pharmacy benefit management industry now be size scale get significant cost saving also see new opportunity move specialty pharma biologic generate lot cash flow be grow share repurchase program ibd begin current stake home depot hd last december have build do housing marsico housing be area look homebuilder not industry be great franchise value so ve have large position home depot have be successful go change leadership current leadership be strong operate business very high level think be better position lowe low do customer think only small portion business be related new home construction ibd be impact rise exist home price marsico ve see datum last couple week median price exist home be move so person be see equity return value home so margin person be likely invest home again build new bath remodel kitchen help home depot ibd be housing situation ve be generally build stake recent quarters big bank well fargo wfc bancorp usb marsico point rise home price also translate banking have position well fargo bancorp largest mortgage origination company well fargo be currently originate loan close new home be tremendous consolidation mortgage industry result collapse ibd fund be sector agnostic have sector weighting want technology be second largest weighting asset not larger weighting sector many manager see mother lode innovation marsico general be lightly weight tech few company have proprietary exclusive type product be difficult duplicate lifecycle product be long couple year short maybe month so area haven aggressively invest do company used technology improve information customer ability produce logistic company ve invest be well aware customer be spending money ibd ve get apple aapl do think still have leg marsico largest position ve own long time cost basis be now trading mid position different time ve cut back think leadership tim cook be very strong pipeline new innovative idea be strong have execute very high level also ve implement basically dividend now significant share repurchase expect grow dividend amount stock repurchase ibd other holding use technology way marsico own equinix eqix be datum center company convert reit status early take advantage tax benefit considerable moat have be location datum center be nexus telephone trunk come together well cable system generally intersection most digital traffic be use digital datum continue grow now voice be be converted datum radio voice be be converted datum so be new ip packet especially go lte network be be switch new smartphone product so equinix business colocate service close ramp internet telephone network equinix have locate datum center ibd be creative user technology marsico have proprietary position find hybrid find technology improve yield farmer next product be drought tolerant corn severe drought demand be high even normal condition product extend corn farm high plain arid area colorado lot land not lot water ve expand business brazil argentina gmo genetically modify organism product become more accept europe farmer be used more be used more eastern europe ibd priceline pcln be also innovative tech user rather tech creator right ve be trimming marsico announce quarter cut position half be concern travel activity europe actually stock have perform well adjustment downward reflect new estimate quarter so be not company want be completely cost basis be low stock be trading priceline let small hotel add exposure internet give priceline more destination other travel service dominate europe be process dominate asia agoda service europe fall recession thing not get significantly saving traveler get book priceline be significant priceline comp vs last year get easier ibd chipotle grill cmg earning share growth have accelerate quarters much growth be front marsico watch meal prepared front own eye easy model execute focus natural product make unique have tremendous opportunity expand number store penetration east coast be low have ability take company international re just start take advantage couple store re introduce second concept thai food palate person have get broader have proprietary product have good value proposition double size footprint just chipotle more new food concept ibd be find so many promising name consumer discretionary have asset house weighting marsico don think sell discretionary product dollar general gd be dollar chain sell basic good convenience low price average ticket dollar general be trip pricing be similar wal mart wmt dollar be more convenient also be expand california have only store now see opportunity grow store base dramatically next year be well run buy back lot own stock margin profile be improve quarter quarter year year ibd tom run janus fund march july be difference fund marsico say be difference now be more experience same fundamental research same concentration re benchmark agnostic don need index don follow say change stripe re not organization change stripe re fundamental investor look high quality company right price large shareholder fund marsico capital eat own cook
674,ESRX,watersh moment drug benefit management trade come april federal trade commission wave express script esrx acquisition medco health solution merger hotly contest many consumer industry advocate quickly close same day collapse industry big big cvs caremark cvs moved
675,ESRX,pharmacy benefit management firm express script esrx say acquisition rival medco health solution deliver saving faster expect help drive better expect result
676,ESRX,company say impasse drugstore chain wag settle last month didn hurt much
677,ESRX,news help boost express script share more week help elevate elite ibd list
678,ESRX,be firm promote list publish monday investor business daily
679,ESRX,consult market research firm gartner joined profit university grand canyon education lope joined
680,ESRX,danish drugmaker nordisk nvo be fertilizer maker agrium agu moved business intelligence firm ihs ihs moved
681,ESRX,network testing equipment maker ixia xxia be disk drive maker seagate technology stx moved fertilizer maker rentech nitrogen partner rnf moved
682,ESRX,other fall make room
683,ESRX,be monster beverage mnst energy drink maker disclose late thursday be be investigate state attorney general ingredient advertising other issue
684,ESRX,online travel agency priceline com pcln also slip share tumble week give weak guidance economic head wind europe currency effect
685,ESRX,other list be cosmetic retailer ulta beauty ulta farm supplier tractor supply tsco bakery cafe chain panera bread pnra freight hauler union pacific unp discount flier spirit airline save oil mover storer plain american pipeline paa network security firm fortinet ftnt pharmacy benefit management firm express script esrx say acquisition rival medco health solution deliver saving faster expect help drive better expect result company say impasse drugstore chain wag settle last month didn hurt much news help boost express script share more week help elevate elite ibd list be firm promote list publish monday investor business daily consult market research firm gartner joined profit university grand canyon education lope joined danish drugmaker nordisk nvo be fertilizer maker agrium agu moved business intelligence firm ihs ihs moved network testing equipment maker ixia xxia be disk drive maker seagate technology stx moved fertilizer maker rentech nitrogen partner rnf moved other fall make room be monster beverage mnst energy drink maker disclose late thursday be be investigate state attorney general ingredient advertising other issue online travel agency priceline com pcln also slip share tumble week give weak guidance economic head wind europe currency effect other list be cosmetic retailer ulta beauty ulta farm supplier tractor supply tsco bakery cafe chain panera bread pnra freight hauler union pacific unp discount flier spirit airline save oil mover storer plain american pipeline paa network security firm fortinet ftnt
686,ESRX,new weight loss drug belviq officially set sail market friday investor analyst alike hope time believe hype belviq be first commercial product biotech arena pharmaceutical arna win approval food drug administration nearly year arena then have sit drug enforcement
687,ESRX,want see business equivalent python swallow boar try catalyst health solution chsi buyout pharmacy benefit unit wag deal close june drive membership catalyst service just catalyst estimate volume prescription filled likewise more
688,ESRX,stock groan lower hectic early trade wednesday follow lead global market china continue let currency fall line currency market influence
689,ESRX,nasdaq dow jone industrial average slump drop
690,ESRX,volume rise nasdaq higher nyse compare volume level same time tuesday
691,ESRX,stock market today launch tear hole support day move average level index take quick breath air day line monday tuesday drop back repeat pattern day test begin june time index have finished session line support july nasdaq be trading just day move average
692,ESRX,economic news be relatively minor labor department june job opening labor turnover survey narrowing unfilled position vs open job
693,ESRX,new york federal reserve chief william dudley speaking rochester say be early judge be go china country currency have be appreciate dollar need adjustment
694,ESRX,obviously chinese economy be weaker maybe chinese authority anticipate probably not inappropriate currency adjust consequence weakness say
695,ESRX,energy information administration report weekly oil inventory et treasury department report july budget
696,ESRX,dow open almost unanimously lower only chevron cvx rise aid rebound oil price apple aapl nike nke jpmorgan jpm boee ba fall more
697,ESRX,fossil fosl yahoo yhoo be worst hit fossil report weaker expect revenue growth guidance yahoo drop be likely attributable share stake alibaba have say spin point separately trade entity
698,ESRX,top banking payment software technology firm fidelity national information service fis jump nearly announce pay acquire sungard datum system privately hold sungard have register initial public offer june company report debt june national report cash stock deal create company combine revenue wednesday gain hoist share just buy point shallow month cup base
699,ESRX,china base retail giant alibaba baba retreat open trade second quarter earning narrowly top expectation revenue jump stop short projection growth total gross volume slow management launch year share buyback initiative loss put share november high september ipo price
700,ESRX,leader ambarella amba lead developer video process chip skid lower bottom ibd list key client gopro gpro be also lower early trade ambarella be struggle hold day line support second time month stock groan lower hectic early trade wednesday follow lead global market china continue let currency fall line currency market influence nasdaq dow jone industrial average slump drop volume rise nasdaq higher nyse compare volume level same time tuesday stock market today launch tear hole support day move average level index take quick breath air day line monday tuesday drop back repeat pattern day test begin june time index have finished session line support july nasdaq be trading just day move average economic news be relatively minor labor department june job opening labor turnover survey narrowing unfilled position vs open job new york federal reserve chief william dudley speaking rochester say be early judge be go china country currency have be appreciate dollar need adjustment obviously chinese economy be weaker maybe chinese authority anticipate probably not inappropriate currency adjust consequence weakness say energy information administration report weekly oil inventory et treasury department report july budget dow open almost unanimously lower only chevron cvx rise aid rebound oil price apple aapl nike nke jpmorgan jpm boee ba fall more fossil fosl yahoo yhoo be worst hit fossil report weaker expect revenue growth guidance yahoo drop be likely attributable share stake alibaba have say spin point separately trade entity top banking payment software technology firm fidelity national information service fis jump nearly announce pay acquire sungard datum system privately hold sungard have register initial public offer june company report debt june national report cash stock deal create company combine revenue wednesday gain hoist share just buy point shallow month cup base china base retail giant alibaba baba retreat open trade second quarter earning narrowly top expectation revenue jump stop short projection growth total gross volume slow management launch year share buyback initiative loss put share november high september ipo price leader ambarella amba lead developer video process chip skid lower bottom ibd list key client gopro gpro be also lower early trade ambarella be struggle hold day line support second time month
701,ESRX,payer anthem antm humana hum unite healthcare unh be broadly deny unh case restrict coverage sarepta therapy srpt fda approve duchenne muscular dystrophy drug jeffery analyst gena wang say wednesday wang slash price target sarepta therapy stock have hold rating sarepta stock crash close wednesday share be year have trade day move average late october food drug administration grant accelerate approval sarepta exondys september drug target dmd population confirm mutation gene amenable exon skip drug be costly sarepta estimate average annual cost patient majority patient be cover medicaid benefit discount private plan likely get same discount wang say appear be legal consequence accord kol key opinion leader payer medicaid private restrict deny coverage cite clinical benefit criterium coverage decision fda approval status secondary write research report ibd take sarepta be diving fellow biotech regeneron have bright future ahead eczema drug dupilumab analyst say tuesday takeaway be broader biotech sector head ibd industry theme bigger picture outside medicaid private arena wang say national regional manage care organization mco have say largely deny coverage exondys anthem deny coverage exondys say drug fail show improve health outcome humana have say cover exondys ambulatory patient provide remain able walk drug be approve month determine clinical review wang note largely unprecendented fda approve drug be deny restrict aetna aet require drug be initiate age patient be able average minute walking distance unite healthcare be mostly unrestricted only cover drug initial week likely require monitoring first month wang say only certain cigna ci plan cover exondys write cvs health cvs caremark cover drug month then look improvement level minute walking distance renewal express script esrx hasn disclose plan exondys most pediatric hospital clinic administer exondys be eligible discount drug pricing program wang say home infusion potentially cut cost wang see long shot outside private insurance plan editor note clarify first paragraph note unite healthcare restrict do not deny coverage sarepta dmd drug sixth last graph correct show anthem do not cover exondys explain clarify humana coverage exondys related sarepta muscular dystrophy drug interrupt day biotech slump blockbuster franchise spark fever sarepta ariad biotechs
702,ESRX,teva pharmaceutical teva mylan myl endo pharmaceutical endp lannett lci other generic drug maker tumble thursday afternoon bloomberg report justice department be investigate possible price collusion charge likely year end doj be probe more dozen generic drug maker collude pricing accord bloomberg mylan issue follow statement mylan be have always be commit cooperate antitrust division investigation date know evidence mylan participate price fix teva pharmaceutical have disclose subpoena be cooperate bloomberg add lannett also have receive subpoena wall street journal say antitrust probe be year old cover dozen drug bloomberg say cite source grand jury be examine executive agree raise price teva share plunge stock market today fall lowest level november mylan lose lannett crash endo pharmaceutical akorn akrx taro pharmaceutical taro fall doj collusion probe news be latest sign drug industry face increase regulatory political pressure price hillary clinton have vow crack drug price former democratic rival bernie sander have hit specific drug stock negative tweet latest report hit more just drugmaker cvs health cvs drug store giant pharmacy benefit manager lose pure play pbm express script esrx sank drug distributor abc mckesson mck cardinal health cah fall nearly follow huge loss oct mckesson miss warn cite competitive pressure price mckesson lose nearly day cardinal nearly diplomat pharmacy dplo crash huge miss late wednesday price concession lower demand hepatitis drug
703,ESRX,share generic drug giant mylan myl rebound early trading thursday then lose steam company say expand patient assistance controversially price drug epipen move hit share pharmacy benefit manager pbm express script esrx pharmacy chain cvs health cvs mylan stock have be fall week member congress call investigation pricing emergency allergy drug have go last few year wednesday presidential candidate hillary clinton also criticize company promise act high drug price president statement demolish drug stock rally last few day thursday mylan issue press release say be double eligibility patient assistance program epipen poverty level meaning family make year pay nothing also offer saving card defray pocket cost frugal insurance plan ibd take mylan trouble be foresee industry not alone see june article drugmaker be next price war casualty evercore isi analyst umer raffat roughly estimate new program have most annual impact mylan epipen sale earlier week note be evidence heavy rebate already go epipen provide mylan revenue notice net sale increase vs be roughly volume price year year raffat write email client speak contractual arrangement epipen mylan ceo heather bresch make similar point interview cnbc late wednesday say middleman mylan have go strip large chunk price leerink analyst david larsen write research note be likely express script cvs health be selling thursday obviously imply cvs express script pbms be reap significant profit epipen larsen write therefore reduction epipen price presumably be feel well say express script stock fall thursday hit month low intraday cvs stock be larsen also note fellow generic drugmaker teva pharmaceutical industry teva have epipen competitor hit market generic launch be pending believe mylan have be get slightly more aggressive pricing write mylan rise much early trading stock market today have lose more previous day stock close related astrazeneca sell antibiotic business mallinckrodt shed imaging unit
704,ESRX,federal reserve chief janet yellen say case rate hike be stronger now investor weren sure make pfizer pfe paid drug biotech share drug pharma supply chain company sell mylan myl epipen price hike draw outrage best buy bby earning surprised investor dollar store come pressure week nasdaq fall dow major average be still sideway action drug stock be big mover pfizer medivation mdvn deal mylan epipen furor dollar store suffer heavy loss competition wal mart wmt be heating fed chair janet yellen say friday long await speech case interest rate hike have strengthen recent month follow other modestly hawkish statement fellow fed policymaker however vice chairman stanley fischer say yellen comment be consistent september rate increase see possibility rate hike year market have already price fed move perhaps december don expect quick follow upnew home sale soar annual rate july far highest october commerce department report rise june surprised economist look slight dip luxury homebuilder toll bro tol confirm high end market be prosper report jump third quarter earning share rise revenue strong backlog order exist home sale fall more expect july be june cycle high application loan buy home fall month low toll share soar month high move day move average generic drugmaker mylan sell week member senate other politician start inquiring price increase emergency allergy drug device epipen fuel selling drug biotech stock mylan ceo heather bresch daughter sen joe machin say only fraction list price make back mylan due middleman lead share express script esrx cvs health cvs abc fall well big pharma pfizer agree buy medivation cash snatch cancer drug specialist sanofi sny have be try month acquire medivation biotechs rally monday news biomarin pharmaceutical bmrn jump rumor be sanofi second choice target wednesday pfizer agree buy antibiotic business astrazeneca azn possible future milestone sale payment royalty amount oil price be settle trading range mid high range opec member give conflict signal support production freeze goldman sachs say such move not be sufficient support price much further meanwhile energy information administration say crude inventory rise barrel vs expectation small drop domestic production fall slightly road self drive car get little more crowd mobileye mbly announce partner general motor gm supplier delphi automotive dlph jointly develop shelf autonomous drive technology automaker company co develop market first turnkey level automate drive solution mobileye already have deal bmw bmwyy intel intc bring autonomous vehicle market mobileye share spiked tuesday delphi news briefly top buy point share rise week tesla motor tsla be end business relationship mobileye introduce new version model boost speed drive range power update battery technology tesla say upgrade model be now fastest accelerate car commercial production tesla share fall close day line just day line tesla partner nvidia nvda unveil new processor autonomous drive say more powerful other mobile processor beauty product retailer report better expect earning sale yet quarter double digit same store growth ulta beauty ulta also raise full year ep guidance profit range be little cautious ulta share have be strong run so have be price perfection ulta share tumble friday undercut day move average workday wday report wider expect adjust loss top key metric include revenue rise share cloud base human resource software maker rise hit high thursday july ipo talend tlnd lose adjust share accord late thursday release french big datum firm later clarify bottom line actually meet estimate loss cent share adjust share count follow initial offer revenue rise just beating talend see loss line view guide revenue slightly higher share fall much bigger intraday loss best buy bby stock jump week month high better expect sale earning fiscal second quarter include surprise increase same store sale consumer electronic retailer credit rise demand wearable technology appliance home theater system increase video game electronic retailer gamestop gme disappoint investor line ep forecast sale discount retailer dollar general dg dollar tree dltr suffer double digit share price loss report second quarter result come short wall street expectation fall grocery price tougher competition hurt sale result come wal mart be wage own campaign cut price move draw more customer have become more cautious spending meanwhile jeweler tif hold full year outlook ep beat view help boost share however signet jeweler sig parent mall jeweler kay jared zale slash fiscal year outlook partly due difficulty energy dependent region region economy have be hurt cheap oil other commodity hp inc hpq report fiscal earning share time item jump fiscal cent decline sale better view current quarter printer pc maker see gaap ep cent vs consensus cent hp be reduce printing supply inventory be deeply discounting printer expand install base share close little change brief thursday morning sell
705,ESRX,pharmacy benefit manager express script esrx boost full year adjust profit guidance share prior outlook share well current wall street view share share earning grow match analyst forecast revenue dip miss consensus estimate express script expect share midpoint be line present forecast share share fall late close regular session longtime espn air talent monday night football play play commentator mike tirico be leave walt disney sport cable network comcast cmcsa own nbc accord cite source outlet say tirico have be espn be expect become nbc thursday night football lead play play announcer walt disney comcast share be little change late boyd gaming byd agree buy cannery casino resort boyd gaming second la vegas acquisition week announce ll buy aliante casino hotel spa last week boyd gaming release earning tuesday market close share rise fractionally late close boyd gaming hit record high april say still consolidation go back early november pioneer natural resource pxd continue report improve not yet strong result irve texas base oil gas company record cent loss vs cent loss better expect cent loss be fourth quarter row pioneer natural resource have top earning estimate revenue fall continue oil industry slump analyst expect notably pioneer natural resource be produce barrel oil equivalent day be oil production grow barrel day compare prior quarter be significantly pioneer guidance barrel share climb late close stock rise month cup handle base buy point april rise just week canadian national railway cni say diluted earning local canadian currency rise fiscal second quarter revenue decline dollar share profit come cent top view cent revenue fall short view company cut ep guidance flat prior year vs current view cite weaker expect freight demand certain market strengthen canadian dollar relative dollar share fall extend trading close stock market today snack food jjsf maker soft pretzel churro frozen beverage report better expect fiscal profit net earning rise cent share beating analyst consensus cent revenue edge lighter expect share be halter extend trading close stock rise high oct drift be trading point well week day average
706,ESRX,behavior be directly connect thought spark ideal action check current human mind process bit information second amount similar throughput original ethernet cable conscious thought re deliberately mull run only bit second so considerable cerebral resource
707,ESRX,stock future pull back sharply early high ahead tuesday open commerce department trim view gdp growth third quarter
708,ESRX,dow future remain point fair market value point gain hour earlier nasdaq future narrow early point advance point future be point point
709,ESRX,small cap take early heat russell future reversed narrow early gain point loss
710,ESRX,stock market today be again poise early gain monday early rally peter flash late day buy hoisting nasdaq healthy finish
711,ESRX,tuesday start early dose economic news commerce department revise estimate gdp growth third quarter lower change be line consensus projection slowdown reflect primarily slowdown private inventory investment slowdown export department say
712,ESRX,department price estimate hold steady gdp price index also line expectation
713,ESRX,federal housing finance agency report october housing price index et national association realtor deliver november exist home sale number richmond federal reserve bank release fifth district survey manufacturing activity
714,ESRX,overseas market be mixed moderate asia europe dollar backed bit bond inched oil price rise not much west texas intermediate dime just barrel brent crude penny just most metal trade lower only fraction
715,ESRX,stock verizon vz lead premarket dow apple aapl be only decliner slip
716,ESRX,stock pharmacy benefit manager express script esrx grab gain management offer full year earning guidance line estimate raise guidance consensus stock have build week flat base deeper consolidation
717,ESRX,spirit airline save whip gain upgrade buy hold stifel spirit share have gain altitude follow mid november low remain deep month consolidation
718,ESRX,netapp ntap drop more ahead open announce have agree buy flash storage gear maker solidfire cash netapp share have be deepen correction month
719,ESRX,leader be generally quiet premarket action most ibd stock hold gain loss less nike nke rise positive mode ahead fiscal earning report due today close stock future pull back sharply early high ahead tuesday open commerce department trim view gdp growth third quarter dow future remain point fair market value point gain hour earlier nasdaq future narrow early point advance point future be point point small cap take early heat russell future reversed narrow early gain point loss stock market today be again poise early gain monday early rally peter flash late day buy hoisting nasdaq healthy finish tuesday start early dose economic news commerce department revise estimate gdp growth third quarter lower change be line consensus projection slowdown reflect primarily slowdown private inventory investment slowdown export department say department price estimate hold steady gdp price index also line expectation federal housing finance agency report october housing price index et national association realtor deliver november exist home sale number richmond federal reserve bank release fifth district survey manufacturing activity overseas market be mixed moderate asia europe dollar backed bit bond inched oil price rise not much west texas intermediate dime just barrel brent crude penny just most metal trade lower only fraction stock verizon vz lead premarket dow apple aapl be only decliner slip stock pharmacy benefit manager express script esrx grab gain management offer full year earning guidance line estimate raise guidance consensus stock have build week flat base deeper consolidation spirit airline save whip gain upgrade buy hold stifel spirit share have gain altitude follow mid november low remain deep month consolidation netapp ntap drop more ahead open announce have agree buy flash storage gear maker solidfire cash netapp share have be deepen correction month leader be generally quiet premarket action most ibd stock hold gain loss less nike nke rise positive mode ahead fiscal earning report due today close
720,ESRX,specialty drugmaker horizon pharma hznp rise much early friday leerink launch coverage outperform rating
721,ESRX,analyst jason gerberry write horizon legacy brand arthritis medicine vimovo duexis have prove surprisingly resilient be remove prefer formulary express script esrx cvs health cvs year cash flow brand help company build portfolio write expect serious acquisition year end
722,ESRX,potential target list pernix therapeutic ptx supernus pharmaceutical supn vanda pharmaceutical vnda
723,ESRX,gerberry also write actimmune rare disease drug horizon acquire last year be asset
724,ESRX,recent phase datum friedreich ataxia have generate significant excitement physician manage fa include several medacorp specialist speak prior report gerberry write fa indication likely triple actimmune target market assign odd phase success top line expect temper high placebo effect fa
725,ESRX,horizon pharma stock fall earlier month earning report miss analyst expectation bottom line even revenue be strong horizon stock have re-cover then however midmorning stock market today be trading more april time high
726,ESRX,horizon pharma stock rank wednesday midweek update ibd list top perform stock
727,ESRX,follow amy reeve twitter ibd_areeve specialty drugmaker horizon pharma hznp rise much early friday leerink launch coverage outperform rating analyst jason gerberry write horizon legacy brand arthritis medicine vimovo duexis have prove surprisingly resilient be remove prefer formulary express script esrx cvs health cvs year cash flow brand help company build portfolio write expect serious acquisition year end potential target list pernix therapeutic ptx supernus pharmaceutical supn vanda pharmaceutical vnda gerberry also write actimmune rare disease drug horizon acquire last year be asset recent phase datum friedreich ataxia have generate significant excitement physician manage fa include several medacorp specialist speak prior report gerberry write fa indication likely triple actimmune target market assign odd phase success top line expect temper high placebo effect fa horizon pharma stock fall earlier month earning report miss analyst expectation bottom line even revenue be strong horizon stock have re-cover then however midmorning stock market today be trading more april time high horizon pharma stock rank wednesday midweek update ibd list top perform stock follow amy reeve twitter ibd_areeve
728,ESRX,cvs health cvs confirm thursday buy omnicare ocr pharmacy benefit provider senior deal value
729,ESRX,cvs health pay share cash omnicare close price wednesday take omnicare debt deal be expect close end year cvs expect deal add cent share earning
730,ESRX,acquisition omnicare significantly expand business provide cvs health access new pharmacy dispense channel cvs ceo larry merlo say release also create new opportunity extend high quality innovative pharmacy program broader population senior chronic care patient
731,ESRX,cvs stock rise stock market today cvs hit intraday close march peak
732,ESRX,omnicare share climb share spiked late wednesday bloomberg report company be advanced talk omnicare stock have rise april buyout speculation
733,ESRX,cvs pharmacy benefit management unit revenue rise pbm revenue account majority cvs sale be grow faster cvs retail sale
734,ESRX,omnicare sale be company be focuse long term care age customer
735,ESRX,cvs say long term care be growth segment health care system more person be expect use assist live facility independent live community come decade
736,ESRX,deal come pharmacy benefit manager be merge pharmacy health insurance provider get better deal medication also follow cvs acquisition caremark rx pbm
737,ESRX,past february rite aid rad say acquire pharmacy benefit manager envisionrx march unitedhealth unh announce plan buy pharmacy benefit firm catamaran ctrx
738,ESRX,express script esrx rise breaking flat base new high express script be largest independent pbm
739,ESRX,follow gillian rich twitter ibd_grich cvs health cvs confirm thursday buy omnicare ocr pharmacy benefit provider senior deal value cvs health pay share cash omnicare close price wednesday take omnicare debt deal be expect close end year cvs expect deal add cent share earning acquisition omnicare significantly expand business provide cvs health access new pharmacy dispense channel cvs ceo larry merlo say release also create new opportunity extend high quality innovative pharmacy program broader population senior chronic care patient cvs stock rise stock market today cvs hit intraday close march peak omnicare share climb share spiked late wednesday bloomberg report company be advanced talk omnicare stock have rise april buyout speculation cvs pharmacy benefit management unit revenue rise pbm revenue account majority cvs sale be grow faster cvs retail sale omnicare sale be company be focuse long term care age customer cvs say long term care be growth segment health care system more person be expect use assist live facility independent live community come decade deal come pharmacy benefit manager be merge pharmacy health insurance provider get better deal medication also follow cvs acquisition caremark rx pbm past february rite aid rad say acquire pharmacy benefit manager envisionrx march unitedhealth unh announce plan buy pharmacy benefit firm catamaran ctrx express script esrx rise breaking flat base new high express script be largest independent pbm follow gillian rich twitter ibd_grich
740,ESRX,rise biotech star medivation start lose altitude hour trading thursday report miss estimate day several high rate drug stock report medivation mdvn earning exclude time item totale cent share reverse year earlier loss miss analyst consensus cent accord thomson reuter revenue climb short consensus nonetheless company affirm full year guidance revenue do not offer ep guidance forecast expense remain same conference call discuss result analyst cfo rick bierly say company have warn call quarter be likely be slow cite buildup inventory company sole market drug xtandi have now return normal well unusually high refund rate due reset medicare part donut hole start year also anticipate return normal year go stock take hit hour trading rise regular trade close also fall late trading be specialty drugmaker jazz pharmaceutical jazz also affirm guidance report mixed quarter jazz revenue rise previous year hair short wall street estimate profit also increase share miss consensus cent jazz also announce have decide not move forward clinical trial jzp product develop partnership concert pharmaceutical cnce possible successor jazz bestselling narcolepsy drug xyrem company say underwhelm result phase study lead decision continue evaluate possible used drug earlier day big cap biotech regeneron pharmaceutical regn report more positive quarter raise guidance stock still close fraction regeneron earning rise year earlier quarter share beating analyst consensus cent sale climb consensus beat come sale regeneron flagship eye drug eylea jump street expect accord rbc capital market firm now expect eylea sale rise year previous guidance company do not provide overall revenue guidance foreign eylea sale be handled bayer bayry other sale come collaboration milestone payment regeneron executive stress importance protocol study compare eylea head head chief competitor roche rhhby lucentis avastin patient diabetic macular edema dme type vision loss associate diabetes commercial head robert terifay tell analyst company earning conference call regeneron market research indicated study publish february be drive uptake drug take share competitor ceo len schleifer add anecdotal account indicated also be help sale eylea original target wet age related macular degeneration specialist have only have avastin stock now have eylea available used have previously thought eylea lucentis share least equilibrate now believe eylea overtake lucentis maybe even grow market share away avastin least dme write rbc capital market analyst adnan butt research note thursday regn also have power post surprise pipeline pipeline product draw most discussion call be praluent cholesterol fighter be fda review expect be approve july call terifay remain bullish drug blockbuster potential acknowledge negotiation payer slow launch express script esrx have make clear praluent drug class be next target price war be work player involved market access decision make process focus patient good terifay say say likely take several month commercial government payer take formulary reviews make reimbursement coverage decision
741,ESRX,corner stand dodge cox stock fund top rank heavyweight outperformed large cap stock fund least asset month end feb accord morningstar inc portfolio be morningstar category top large cap value peer be
742,ESRX,retailer wag have shuffle deck get new card go forward year old company have make move past couple year first most recently company announce march year agreement medical distributor abc analyst say pooled purchasing power make company world largest buyer
743,ESRX,sector leadership appear need drink smoke get tuesday election alcohol tobacco be add leadership mix stock wednesday continue sell begin mid september wednesday ibd alcohol tobacco sector moved position add recent steep advance oct alcohol tobacco be laggard
744,ESRX,cvs caremark cvs dominant drugstore chain pharmacy benefit partner express script esrx report third quarter profit top wall street outlook
745,ESRX,share company fall early tuesday express script plunge much early say late monday analyst forecast current quarter be overly aggressive cast cloud pharmacy sector
746,ESRX,cvs revenue climb better last year analyst estimate
747,ESRX,sale rise part cvs hold customer gain long express script dispute end september
748,ESRX,didn fill express script prescription start year dispute fee cvs say expect retain least customer prior projection fall more monday weaker expect october same store sale stock dip nearly tuesday morning pierce day move average intraday
749,ESRX,cvs earn cent share quarter cent last year penny better expect
750,ESRX,cvs share rise initially quickly reversed tuesday morning trading
751,ESRX,elsewhere retail drug store group wag slide rite aid rad be unchanged
752,ESRX,express script late monday report ep well last year cent share beating analyst forecast cent
753,ESRX,sale more double lighter wall street be look
754,ESRX,conference call express script say company believe outlook also be influenced current weak business climate unemployment outlook factor likely result significant group member attrition continue low utilization rate increase client demand expectation
755,ESRX,analyst have different take say comment cast doubt company ability complete integrate medco health solution buy july
756,ESRX,express script share be late morning trade tuesday
757,ESRX,other large company medical service group catamaran ctrx fall catamaran report profit drop earlier month deal cost
758,ESRX,cvs say east coast store be damage hurricane sandy expect see slight impact ep associate cost
759,ESRX,still cvs raise forecast due higher customer count rise flu related shot prescription
760,ESRX,see full year ep earlier analyst expect cvs caremark cvs dominant drugstore chain pharmacy benefit partner express script esrx report third quarter profit top wall street outlook share company fall early tuesday express script plunge much early say late monday analyst forecast current quarter be overly aggressive cast cloud pharmacy sector cvs revenue climb better last year analyst estimate sale rise part cvs hold customer gain long express script dispute end september didn fill express script prescription start year dispute fee cvs say expect retain least customer prior projection fall more monday weaker expect october same store sale stock dip nearly tuesday morning pierce day move average intraday cvs earn cent share quarter cent last year penny better expect cvs share rise initially quickly reversed tuesday morning trading elsewhere retail drug store group wag slide rite aid rad be unchanged express script late monday report ep well last year cent share beating analyst forecast cent sale more double lighter wall street be look conference call express script say company believe outlook also be influenced current weak business climate unemployment outlook factor likely result significant group member attrition continue low utilization rate increase client demand expectation analyst have different take say comment cast doubt company ability complete integrate medco health solution buy july express script share be late morning trade tuesday other large company medical service group catamaran ctrx fall catamaran report profit drop earlier month deal cost cvs say east coast store be damage hurricane sandy expect see slight impact ep associate cost still cvs raise forecast due higher customer count rise flu related shot prescription see full year ep earlier analyst expect
761,ESRX,big cap company market capitalization more offer investor stability stability doesn have mean sacrifice growth ibd big cap leader screen day sift large cap find best return sort composite rating proprietary ibd rating combine rating include earning
762,ESRX,investor early friday be look see walgreen wag earning fared nation drugstore chain finally put dispute key partner express script quarter company end bitter year long dispute express script esrx nation largest pharmacy benefit management company quarterly report also come recent report
763,ESRX,consumer worry job rein spending last month most large retailer report disappointing result expectation more margin erode discount ahead
764,ESRX,sale store open least year climb smallest annual gain august accord retail metric shy slim gain expect luxury bargain hunter chain shine retailer miss expectation
765,ESRX,warehouse store costco cost say same store sale rise view part fall gas price stronger dollar share fall fractionally
766,ESRX,target tgt comp grow little forecast big discounter reaffirm earning guidance share fall
767,ESRX,retailer face tough comparison vs june meanwhile consumer sentiment have soured anemic job growth overseas economy be sputtering violent storm part country likely crimped sale end already slow month say ken perkin president retail metric
768,ESRX,expectation july be typically muted major catalyst such august back school push perkin predict more summer weakness job datum other economic indicator don turn upbeat soon
769,ESRX,softness continue really go pressure retailer be aggressive promotion say
770,ESRX,macy comp rise half be expect ceo terry lundgren statement blame macroeconomic environment be stagnant best lower spending tourist city such new york also cite ongoing renovation flagship new york store macy share rise
771,ESRX,price brand good retailer ross store rost tjx tjx enjoy same store gain ross share rise tjx new high
772,ESRX,wealthier shopper continue shrug economic worry same store sale jwn sak sk climb respectively beating forecast sak share climb rise nearly
773,ESRX,limit brand ltd deliver largest surprise same store gain fuel rise victorium secret lingerie chain share leap
774,ESRX,generally low expectation june result be generally better absolute basis be strong nomura analyst paul lejuez write
775,ESRX,wag comp dive reflect lose express script esrx business exclude drugstore total comp rise
776,ESRX,datum exclude world largest retailer wal mart wmt doesn report monthly figure release second quarter result next month
777,ESRX,sluggish retail sale follow automaker report tuesday strong june sale pent demand replace old car
778,ESRX,june job datum be due friday analyst expect unchanged unemployment rate consumer worry job rein spending last month most large retailer report disappointing result expectation more margin erode discount ahead sale store open least year climb smallest annual gain august accord retail metric shy slim gain expect luxury bargain hunter chain shine retailer miss expectation warehouse store costco cost say same store sale rise view part fall gas price stronger dollar share fall fractionally target tgt comp grow little forecast big discounter reaffirm earning guidance share fall retailer face tough comparison vs june meanwhile consumer sentiment have soured anemic job growth overseas economy be sputtering violent storm part country likely crimped sale end already slow month say ken perkin president retail metric expectation july be typically muted major catalyst such august back school push perkin predict more summer weakness job datum other economic indicator don turn upbeat soon softness continue really go pressure retailer be aggressive promotion say macy comp rise half be expect ceo terry lundgren statement blame macroeconomic environment be stagnant best lower spending tourist city such new york also cite ongoing renovation flagship new york store macy share rise price brand good retailer ross store rost tjx tjx enjoy same store gain ross share rise tjx new high wealthier shopper continue shrug economic worry same store sale jwn sak sk climb respectively beating forecast sak share climb rise nearly limit brand ltd deliver largest surprise same store gain fuel rise victorium secret lingerie chain share leap generally low expectation june result be generally better absolute basis be strong nomura analyst paul lejuez write wag comp dive reflect lose express script esrx business exclude drugstore total comp rise datum exclude world largest retailer wal mart wmt doesn report monthly figure release second quarter result next month sluggish retail sale follow automaker report tuesday strong june sale pent demand replace old car june job datum be due friday analyst expect unchanged unemployment rate
779,ESRX,cvs caremark cvs buy back share have fall more value early july add repurchase authorize last year drugstore chain pharmacy benefit manager say complete previous buyback end year time expect buy
780,ESRX,omnicare ocr pharmaceutical service provider be offer share cash pharmerica pmc left open possibility press bid objection management omnicare say be approach smaller rival april pharmerica have decline engage talk larger company say still prefer reach
781,ESRX,stock be mixed midday thursday sign economy remain resilient continue financial turmoil europe slowdown china dow jone industrial average rise pare earlier gain nasdaq be reverse earlier gain volume be fractionally lower nasdaq be
782,ESRX,stock lose ground close session lows tuesday latest fed minute disappoint investor look additional economic stimulus measure dow jone industrial average retreat nasdaq volume increase board accord preliminary datum market drop session lows minute march
783,ESRX,stock be lower midday wednesday durable good order rise less expect february suggest weaker expect first quarter economic growth nasdaq pull be reverse earlier gain dow jone industrial average slip dip volume nasdaq nyse be slightly higher compare same time tuesday durable good order rise february wall street have expect gain follow january decline apple aapl lead ibd climb much record high strong volume give back advance now past buy point invensense invn be lower strong trade compound monday drop move put maker motion process chip software used primarily video game console smartphone back former high prior sharp pullback stock week move average elsewhere amylin pharmaceutical amln soar bloomberg report company last month reject unsolicited takeover bid bristol myer squibb bmy bristol myer have not try follow share bid report say amylin be discuss possible partnership several large drug company overseas drug bloomberg say medco health mhs gap express script esrx rise earlier gapping gain pharmacy benefit manager say close merger early next week express script announce july acquire medco medco be make new high clear cup handle base january express script be climb right side month consolidation commodity crude oil slip just barrel
784,ESRX,stock show modest loss tuesday wake minute latest meeting federal reserve policymaker many market leader brave storm push higher
785,ESRX,dow jone industrial average fall nasdaq final hour trade see average pare slightly deeper loss dow nasdaq
786,ESRX,volume rise board accord early reading
787,ESRX,minute march meeting federal open market committee show policymaker want see inflation dip add accommodation measure sense urgency fomc member add liquidity seem be fading
788,ESRX,apple aapl continue steep climb gain average volume make new high market leader
789,ESRX,sxc health solution sxci bolt heavy volume putt pharmacy benefit manager buy point week tight pattern analyst speculate federal trade commission approval monday takeover medco health solution express script esrx make sxc lead takeover candidate
790,ESRX,gun maker sturm ruger rgr climb new high double average daily trade thinly trade stock be past buy point square box base company say last week have receive order gun first quarter exceed production capacity analyst say firearm business be boom fear president obama restrict gun ownership re elect fall
791,ESRX,gnc holding gnc lurch ahead fast trade notch new high gain gnc stand buy point week tight pattern
792,ESRX,recent ipo michael kor kor climb still trading relatively tight band month run see stock more double ipo price
793,ESRX,name price travel site priceline com pcln have be tear add hit new high fast trade yoga apparel retailer lululemon athletica lulu also climb volume come just slightly average stock show modest loss tuesday wake minute latest meeting federal reserve policymaker many market leader brave storm push higher dow jone industrial average fall nasdaq final hour trade see average pare slightly deeper loss dow nasdaq volume rise board accord early reading minute march meeting federal open market committee show policymaker want see inflation dip add accommodation measure sense urgency fomc member add liquidity seem be fading apple aapl continue steep climb gain average volume make new high market leader sxc health solution sxci bolt heavy volume putt pharmacy benefit manager buy point week tight pattern analyst speculate federal trade commission approval monday takeover medco health solution express script esrx make sxc lead takeover candidate gun maker sturm ruger rgr climb new high double average daily trade thinly trade stock be past buy point square box base company say last week have receive order gun first quarter exceed production capacity analyst say firearm business be boom fear president obama restrict gun ownership re elect fall gnc holding gnc lurch ahead fast trade notch new high gain gnc stand buy point week tight pattern recent ipo michael kor kor climb still trading relatively tight band month run see stock more double ipo price name price travel site priceline com pcln have be tear add hit new high fast trade yoga apparel retailer lululemon athletica lulu also climb volume come just slightly average
794,ESRX,stock stretched loss midday wednesday durable good order rise less expect february suggest weaker expect first quarter economic growth
795,ESRX,nasdaq be rise earlier dow jone industrial average slip dip volume nasdaq nyse grow compare same time tuesday
796,ESRX,durable good order rise february wall street have expect gain follow january decline
797,ESRX,ibd stock be lower invensense invn sank strong trade compound monday drop move put maker motion process chip software used primarily video game console smartphone back high prior sharp pullback week move average
798,ESRX,stock accumulation distribution rating have fall past day sell
799,ESRX,drugmaker alexion pharmaceutical alxn network management software developer solarwind swi also fall heavy volume
800,ESRX,alexion be slightly buy point week tight pattern solarwind sank second straight high volume decline erase monday hefty gain solarwind be now back entry square box base
801,ESRX,upside apple aapl be fractionally climb much record high strong volume now past buy point
802,ESRX,elsewhere amylin pharmaceutical amln soar bloomberg report company last month reject unsolicited takeover bid bristol myer squibb bmy bristol myer have not try follow share bid report say amylin be discuss possible partnership several large drug company overseas drug bloomberg say
803,ESRX,medco health mhs ease bit gap express script esrx rise earlier gapping gain pharmacy benefit manager say close merger early next week express script announce july acquire medco
804,ESRX,medco be make new high clear cup handle base january express script be climb right side month consolidation
805,ESRX,commodity crude oil slip just barrel stock stretched loss midday wednesday durable good order rise less expect february suggest weaker expect first quarter economic growth nasdaq be rise earlier dow jone industrial average slip dip volume nasdaq nyse grow compare same time tuesday durable good order rise february wall street have expect gain follow january decline ibd stock be lower invensense invn sank strong trade compound monday drop move put maker motion process chip software used primarily video game console smartphone back high prior sharp pullback week move average stock accumulation distribution rating have fall past day sell drugmaker alexion pharmaceutical alxn network management software developer solarwind swi also fall heavy volume alexion be slightly buy point week tight pattern solarwind sank second straight high volume decline erase monday hefty gain solarwind be now back entry square box base upside apple aapl be fractionally climb much record high strong volume now past buy point elsewhere amylin pharmaceutical amln soar bloomberg report company last month reject unsolicited takeover bid bristol myer squibb bmy bristol myer have not try follow share bid report say amylin be discuss possible partnership several large drug company overseas drug bloomberg say medco health mhs ease bit gap express script esrx rise earlier gapping gain pharmacy benefit manager say close merger early next week express script announce july acquire medco medco be make new high clear cup handle base january express script be climb right side month consolidation commodity crude oil slip just barrel
806,ESRX,stock finished wednesday mild gain volume lower previous day accord preliminary datum nasdaq rise dow jone industrial average climb stock market today bond yield have be rise sharply recent day anticipation federal reserve raise interest rate fall sharply
807,ESRX,casino operator isle capri isle rise seventh straight day be report earning tuesday same day be discuss ibd stock spotlight column week emerge flat base buy point stock rise more first week be hold least week
808,ESRX,ibd stock be higher be lower worst performer be french ad agency criteo crto finished middle daily range buy point cup base be report apple aapl let iphone user block online ad safari
809,ESRX,krispy kreme doughnut kkd rise gapping upbeat earning report stock have be underperformer past couple year
810,ESRX,man mw beat estimate earning report close wednesday rise heavy volume stock finished wednesday mild gain volume lower previous day accord preliminary datum nasdaq rise dow jone industrial average climb stock market today bond yield have be rise sharply recent day anticipation federal reserve raise interest rate fall sharply casino operator isle capri isle rise seventh straight day be report earning tuesday same day be discuss ibd stock spotlight column week emerge flat base buy point stock rise more first week be hold least week ibd stock be higher be lower worst performer be french ad agency criteo crto finished middle daily range buy point cup base be report apple aapl let iphone user block online ad safari krispy kreme doughnut kkd rise gapping upbeat earning report stock have be underperformer past couple year man mw beat estimate earning report close wednesday rise heavy volume
811,ESRX,get feel michael have spend lot time try clear misconception drug alcohol addiction be ceo co founder aac holding aac parent american addiction center provide inpatient substance abuse treatment service person drug alcohol other addiction aac therapy service include everything motivational interview cognitive behavioral therapy family intervention service also provide personal training yoga session massage therapy other amenity end first quarter aac operated substance abuse treatment facility mental health facility specialize binge eating disorder also make series acquisition quarter expand operation aren lot company do large scale acadium healthcare achc best know psychiatric service treatment facility also offer treatment addiction chemical dependency other lead player include element behavioral health foundation recovery network estimate be treatment provider vast majority be small mom pop operation ipo serve expansionaac currently have facility operation texas nevada florida california intend become national brand reason initial public offer october expand nationally need capital so go public raise capital tell ibd suggest doesn seem be much model operate large national brand addiction treatment center quickly strike notion american society addiction medicine have be build model last year regard clinical science treat drug alcohol addiction different level care tell ibd lot datum just diabetes treat very scientifically problem say be too many person equate alcoholism drug addiction treatment alcoholic anonymous aa be nonprofessional organization step program incorporate fellowship spiritual element more post treatment say person say not model clinical approach be not look science research addiction disease be same anywhere go say science diagnosis care treatment be different maine be oregon so develop national model addiction treatment be different develop national model hospital diabetes center say diabetes industry have aggregate last year alcohol drug addiction treatment industry be very unaggregated unite state say think ripe consolidator see diabetes space psychiatric hospital space addressable marketryan daniel analyst william blair co note research report aac have plenty room grow substance abuse treatment industry estimate bring year company have active pipeline organic growth opportunity well ample opportunity facility marketing vehicle say believe aac be faster grow health care service company public market come year aac have make numerous move year expand footprint february buy former convent total acre ringwood cash be converted future site bed residential treatment facility renovation exist structure ground begin summer month later aac agree buy operate asset sunrise house foundation nonprofit network provider substance abuse treatment new jersey april aac close acquisition bed hospital laguna beach calif be renovate chemical dependency recovery hospital bed renovation construction work be do first half meanwhile company expect complete construction bed residential facility tampa fla second half most aac acquisition be consider meaning company buy property convert facility rather buy facility be already open produce revenue however aac occasionally acquire facility be already run february complete buyout recovery first operator inpatient substance abuse treatment facility greater fort lauderdale fla area facility be undergo expansion be complete fourth quarter last month aac complete purchase clinical service rhode island operator outpatient treatment facility state aac expansion strategy be not different other type business eye market be sufficient population density support treatment facility region country have huge population addict influx note due partly obamacare mental health parity addiction equity act make easier addict get insurance coverage condition lot more person have access treatment say insurance company deny not offer coverage substance abuse say now be deny coverage disease be huge uplift term person access care revenue aac see revenue balloon less year earlier april company post first quarter revenue previous year earning come cent share magic formula aac financial growth say long facility be filled provide great clinical care financial part take care analyst poll thomson reuter expect aac post full year ep cent company stock price trade high set feb more march aac have best possible ibd composite rating belong ibd medical service group rank industry track group feature pretty diverse range stock include pharmacy benefit manager express script holding esrx pharmacy distribution consult firm omnicare ocr clinical testing service provider laboratory corp america lh
812,ESRX,big cap biotech regeneron pharmaceutical regn beat wall street estimate raise guidance thursday send stock more early trading
813,ESRX,regeneron earning rise year earlier quarter share beating analyst consensus cent accord thomson reuter revenue climb consensus
814,ESRX,beat come sale regeneron flagship eye drug eylea jump street expect accord rbc capital market company say now expect eylea sale rise year previous guidance company do not provide overall revenue guidance foreign eylea sale be handled bayer bayry other sale come collaboration milestone payment
815,ESRX,regeneron executive stress importance protocol study compare eylea head head chief competitor roche rhhby lucentis avastin patient diabetic macular edema dme type vision loss associate diabetes commercial head robert terifay tell analyst company earning conference call regeneron market research indicated study publish february be drive uptake drug take share competitor
816,ESRX,see open vs avastin
817,ESRX,ceo len schleifer add anecdotal account indicated also be help sale eylea original target wet age related macular degeneration specialist have previously only have avastin stock now have eylea available used
818,ESRX,have previously thought eylea lucentis share least equilibrate now believe eylea overtake lucentis maybe even grow market share away avastin least dme write rbc capital market analyst adnan butt research note thursday regn also have power post surprise pipeline
819,ESRX,pipeline product draw most discussion call be praluent cholesterol fighter fda review be expect be approve july call terifay remain bullish drug blockbuster potential acknowledge negotiation payer slow launch express script esrx have make clear praluent drug class be next target price war
820,ESRX,be work player involved market access decision make process focus patient good say terifay say likely take several month commercial government payer take formulary reviews make reimbursement coverage decision begin process patient claim give reason expect initial gradual uptake launch
821,ESRX,terifay say expect most patient begin lower mg dose praluent then move mg dose need regeneron executive see potential approval dosage important difference praluent amgen amgn repatha similar drug approval deadline be only month later
822,ESRX,regeneron stock rise much early trading stock market today morning trading be fraction regeneron stock touch time high march
823,ESRX,follow amy reeve twitter ibd_areeve big cap biotech regeneron pharmaceutical regn beat wall street estimate raise guidance thursday send stock more early trading regeneron earning rise year earlier quarter share beating analyst consensus cent accord thomson reuter revenue climb consensus beat come sale regeneron flagship eye drug eylea jump street expect accord rbc capital market company say now expect eylea sale rise year previous guidance company do not provide overall revenue guidance foreign eylea sale be handled bayer bayry other sale come collaboration milestone payment regeneron executive stress importance protocol study compare eylea head head chief competitor roche rhhby lucentis avastin patient diabetic macular edema dme type vision loss associate diabetes commercial head robert terifay tell analyst company earning conference call regeneron market research indicated study publish february be drive uptake drug take share competitor see open vs avastinceo len schleifer add anecdotal account indicated also be help sale eylea original target wet age related macular degeneration specialist have previously only have avastin stock now have eylea available used have previously thought eylea lucentis share least equilibrate now believe eylea overtake lucentis maybe even grow market share away avastin least dme write rbc capital market analyst adnan butt research note thursday regn also have power post surprise pipeline pipeline product draw most discussion call be praluent cholesterol fighter fda review be expect be approve july call terifay remain bullish drug blockbuster potential acknowledge negotiation payer slow launch express script esrx have make clear praluent drug class be next target price war be work player involved market access decision make process focus patient good say terifay say likely take several month commercial government payer take formulary reviews make reimbursement coverage decision begin process patient claim give reason expect initial gradual uptake launch terifay say expect most patient begin lower mg dose praluent then move mg dose need regeneron executive see potential approval dosage important difference praluent amgen amgn repatha similar drug approval deadline be only month later regeneron stock rise much early trading stock market today morning trading be fraction regeneron stock touch time high march follow amy reeve twitter ibd_areeve
824,ESRX,march datum point strong month prescription drug sell stock supply chain be single thursday top idea drug supply chain report evercore isi single cvs health cvs drug distribution giant mckesson mck have buy rating attractive upside next month see numerous
825,ESRX,express script esrx break base thursday solid volume rise close earning growth have be run single digit have picked recent quarters earning grow last report bit estimate revenue rise straight quarters decline company be pharmacy benefit
826,ESRX,walgreen boot alliance wba rite aid rad pharmacy chain be see make advance report quarterly result week earning growth be expect decelerate rite aid fiscal share earning be expect rise cent penny last year result report
827,ESRX,walgreen boot alliance expand cost cut plan thursday indicated be look more takeover fully acquire alliance boot last year drugstore giant now see saving end fiscal prior target feel more cost pressure government such reimbursement cut government
828,ESRX,stock toggle mixed terrain early go thursday
829,ESRX,half hour open dow jone industrial average be fraction nasdaq be equal amount
830,ESRX,volume start mixed nasdaq nyse compare action same time wednesday
831,ESRX,stock market today open grope direction overseas market be generally positive oil price trim early advance benchmark west texas intermediate europe brent crude stock exchange begin trading
832,ESRX,business report february wholesale inventory rise accord commerce department fourth gain month gain be equal january better expansion project economist
833,ESRX,stock mist buyout rumor hung thursday early action
834,ESRX,express script esrx rocked ahead open only remain stand alone pharmacy benefit manager have be object much speculation manage care provider unitedhealth group unh announce march buy catamaran ctrx pbm expressscript gain lift just buy point flat base
835,ESRX,chip designer altera altr topple trip news report intel intc have abandon talk acquire company stock have pull back jump march follow report talk company altera be now trading march high
836,ESRX,akorn akrx jump lead ibd list early trade then trim gain illinois base drugmaker be mid march low work climb right side possible base
837,ESRX,bottom list china base athm fall give back small portion gain week wednesday
838,ESRX,china noah holding noah slip more trimming advance so far week stock toggle mixed terrain early go thursday half hour open dow jone industrial average be fraction nasdaq be equal amount volume start mixed nasdaq nyse compare action same time wednesday stock market today open grope direction overseas market be generally positive oil price trim early advance benchmark west texas intermediate europe brent crude stock exchange begin trading business report february wholesale inventory rise accord commerce department fourth gain month gain be equal january better expansion project economist stock mist buyout rumor hung thursday early action express script esrx rocked ahead open only remain stand alone pharmacy benefit manager have be object much speculation manage care provider unitedhealth group unh announce march buy catamaran ctrx pbm expressscript gain lift just buy point flat base chip designer altera altr topple trip news report intel intc have abandon talk acquire company stock have pull back jump march follow report talk company altera be now trading march high akorn akrx jump lead ibd list early trade then trim gain illinois base drugmaker be mid march low work climb right side possible base bottom list china base athm fall give back small portion gain week wednesday china noah holding noah slip more trimming advance so far week
839,ESRX,stock rolled choppy open tuesday start mixed then slip moderate loss
840,ESRX,nasdaq open higher then drop dow jone industrial average be
841,ESRX,volume be mixed trade nyse nasdaq compare action same time monday
842,ESRX,stock market today receive mixed economic news case shiller city composite home price index rise february be increase january well consensus projection gain
843,ESRX,consumer confidence ease bit april conference board report consumer confidence index slip march far forecast uptick
844,ESRX,stock energy play include bp bp valero energy vlo be industrial such cummin cmi ford be quarterly report
845,ESRX,apple aapl shed premarket gain slip fraction early trade iphone imac apple watch maker report sale earning well analyst consensus view heavy volume gain monday left share just flat base buy point
846,ESRX,appliance maker whirlpool whr dive more early action first quarter sale earning stop short consensus estimate company say currency issue weaken demand brazil be key factor stock have be deepen consolidation february
847,ESRX,ibd list ipg photonic ipgp spark more first quarter earning beat revenue miss analyst forecast gain lift share buy point flat base
848,ESRX,downside china base asset manager noah holding noah drop almost heavy trade stock have reversed sharply high monday week hold rule remain effect big buy point early month
849,ESRX,heavy roster quarterly report be schedule today close lead twitter twtr gopro gpro buffalo wild wing bwld akamai technology akam kraft food krft express script hold esrx stock rolled choppy open tuesday start mixed then slip moderate loss nasdaq open higher then drop dow jone industrial average be volume be mixed trade nyse nasdaq compare action same time monday stock market today receive mixed economic news case shiller city composite home price index rise february be increase january well consensus projection gain consumer confidence ease bit april conference board report consumer confidence index slip march far forecast uptick stock energy play include bp bp valero energy vlo be industrial such cummin cmi ford be quarterly report apple aapl shed premarket gain slip fraction early trade iphone imac apple watch maker report sale earning well analyst consensus view heavy volume gain monday left share just flat base buy point appliance maker whirlpool whr dive more early action first quarter sale earning stop short consensus estimate company say currency issue weaken demand brazil be key factor stock have be deepen consolidation february ibd list ipg photonic ipgp spark more first quarter earning beat revenue miss analyst forecast gain lift share buy point flat base downside china base asset manager noah holding noah drop almost heavy trade stock have reversed sharply high monday week hold rule remain effect big buy point early month heavy roster quarterly report be schedule today close lead twitter twtr gopro gpro buffalo wild wing bwld akamai technology akam kraft food krft express script hold esrx
850,ESRX,earning season be high gear company announce earning late tuesday include buffalo wild wing bwld wynn resort wynn see wild price swing report buffalo wild wing be extend trading sport bar chain report rise first quarter earning share
851,ESRX,maybe bigger be better pharmacy benefit manager pbms unitedhealth group unh think catamaran ctrx be worth increase leverage bargaining pricey medicine pbms client include health insurer employer labor union health plan handle process medical prescription negotiate price drug company analyst say grow size benefit more
852,ESRX,pharmacy benefit manager express script esrx say prescription drug spending rise more last year have accord annual review accord drug trend report spending drug commercially insure rise member last year medicare spending rise member medicaid spending climb
853,ESRX,report say spending hepatitis drug account more half increase be not big surprise disease be still treat mainly generic drug gilead science gild premium price sovaldi often prescribe tandem johnson johnson jnj also pricey olysio take market october gilead launch harvoni render olysio obsolete cost more sovaldi
854,ESRX,express script pharmacy benefit management leader be earliest loudest critic sovaldi price amount standard week treatment press release accompany report pbm brag have take bite gilead make exclusive deal abbvie abbv come gilead first serious competitor form viekira pak year end express claim save client year
855,ESRX,not clear however well be work abbvie analyst tracking prescription datum estimate only have market share datum be incomplete win be fully know abbvie report caveat be express price datum do not include rebate be significant part picture especially hepatitis market lately
856,ESRX,gilead report last month investor have minor freak company executive guide gross net adjustment rebate level hepatitis franchise
857,ESRX,express script release also echo comment make ceo january jpmorgan healthcare conference indicated next price war target be pcsk inhibitor new class cholesterol drug expect come market year offering amgen amgn team regeneron pharmaceutical regn sanofi sny
858,ESRX,drug trend report didn specifically mention do drug end cost year
859,ESRX,follow amy reeve twitter ibd_areeve pharmacy benefit manager express script esrx say prescription drug spending rise more last year have accord annual review accord drug trend report spending drug commercially insure rise member last year medicare spending rise member medicaid spending climb report say spending hepatitis drug account more half increase be not big surprise disease be still treat mainly generic drug gilead science gild premium price sovaldi often prescribe tandem johnson johnson jnj also pricey olysio take market october gilead launch harvoni render olysio obsolete cost more sovaldi express script pharmacy benefit management leader be earliest loudest critic sovaldi price amount standard week treatment press release accompany report pbm brag have take bite gilead make exclusive deal abbvie abbv come gilead first serious competitor form viekira pak year end express claim save client year not clear however well be work abbvie analyst tracking prescription datum estimate only have market share datum be incomplete win be fully know abbvie report caveat be express price datum do not include rebate be significant part picture especially hepatitis market lately gilead report last month investor have minor freak company executive guide gross net adjustment rebate level hepatitis franchise express script release also echo comment make ceo january jpmorgan healthcare conference indicated next price war target be pcsk inhibitor new class cholesterol drug expect come market year offering amgen amgn team regeneron pharmaceutical regn sanofi sny drug trend report didn specifically mention do drug end cost year follow amy reeve twitter ibd_areeve
860,ESRX,flu season get weak start largest drugstore chain rally anyway earning season get underway week
861,ESRX,wag largest retail drug chain report result fiscal first quarter friday day rite aid rad weigh
862,ESRX,analyst expect earning shoot last year cent share settle contract dispute vs express script esrx last year earning have grow double digit february end quarter easy comparison prior year help
863,ESRX,also presumably save money global generic drug sourcing venture swiss base alliance boot drug distributor abc joined march
864,ESRX,rite aid have be turnaround mode buy most brand drug generic distributor mckesson mck be process acquire german drug wholesaler celesio also move meant keep cost
865,ESRX,last week drug wholesaler cardinal health cah announce be form generic drug buy venture cvs caremark cvs drugstore chain pharmacy benefit manager
866,ESRX,cost saving be work pharmacy side account more drugstore overall revenue retail environment front store have be tough chain have be try drive traffic sale heavy promotion analyst say
867,ESRX,sale have grow slower pace earning even stake take alliance boot august
868,ESRX,chain pre report revenue be same store increase largely due gain pharmacy side
869,ESRX,prescription filled store open least month increase pharmacy sale grow slow start flu season negatively impact pharmacy sale percentage point number flu shot have administer date be vs last year
870,ESRX,front end comparable sale grow only november sale be consensus heavy discounting environment
871,ESRX,promotional tone sale report write credit suisse analyst edward kelly research note seem telegraph more difficult gross margin
872,ESRX,rite aid say earlier total sale rise same store sale be front end same store sale fall pharmacy same store sale rise
873,ESRX,rite aid post first profit year february end fiscal year have see gain then profit be see dip cent
874,ESRX,term be somewhat more bumpy rite aid recent quarters write jpmorgan analyst lisa gill cite economy reimbursement pressure ongoing work execute turnaround plan
875,ESRX,early november cvs report gain earning september end share be third straight quarter double digit profit growth revenue grow nearly flu season get weak start largest drugstore chain rally anyway earning season get underway week wag largest retail drug chain report result fiscal first quarter friday day rite aid rad weigh analyst expect earning shoot last year cent share settle contract dispute vs express script esrx last year earning have grow double digit february end quarter easy comparison prior year help also presumably save money global generic drug sourcing venture swiss base alliance boot drug distributor abc joined march rite aid have be turnaround mode buy most brand drug generic distributor mckesson mck be process acquire german drug wholesaler celesio also move meant keep cost last week drug wholesaler cardinal health cah announce be form generic drug buy venture cvs caremark cvs drugstore chain pharmacy benefit manager cost saving be work pharmacy side account more drugstore overall revenue retail environment front store have be tough chain have be try drive traffic sale heavy promotion analyst say sale have grow slower pace earning even stake take alliance boot august chain pre report revenue be same store increase largely due gain pharmacy side prescription filled store open least month increase pharmacy sale grow slow start flu season negatively impact pharmacy sale percentage point number flu shot have administer date be vs last year front end comparable sale grow only november sale be consensus heavy discounting environment promotional tone sale report write credit suisse analyst edward kelly research note seem telegraph more difficult gross margin rite aid say earlier total sale rise same store sale be front end same store sale fall pharmacy same store sale rise rite aid post first profit year february end fiscal year have see gain then profit be see dip cent term be somewhat more bumpy rite aid recent quarters write jpmorgan analyst lisa gill cite economy reimbursement pressure ongoing work execute turnaround plan early november cvs report gain earning september end share be third straight quarter double digit profit growth revenue grow nearly
876,ESRX,analyst be singing praise life science giant gilead science gild illumina ilmn wednesday morning surge estimate late tuesday share company be stock market today
877,ESRX,gilead sale new hepatitis drug sovaldi be call most impressive beat biopharma history piper jaffray joshua schimmer increase price target only dollar gilead be morning trading wednesday
878,ESRX,rbc capital market analyst michael yee lift sale estimate previous add full year ep estimate now expect sovaldi sale hit next year ep reach
879,ESRX,nomura ian somaiya lift price target write gilead position hcv market be sustainable say sovaldi new sovaldi base combo pill expect launch later year be superior compete product abbvie abbv merck mrk
880,ESRX,cowen phil nadeau be also impressed note lengthy discussion payor pushback tuesday earning call provide probably not nearly enough resolution satisfy investor pharmacy benefit manager express script esrx insurer unite health unh have criticize sovaldi price
881,ESRX,gilead do discuss argument support price sovaldi such value cure health care system cost treat patient end stage liver disease yr nadeau write find gilead discussion datapoint encourage suspect investor concern payor ability limit access sovaldi shuttle patient compete regimen linger abbv pricing strategy be know presumably approval payor strategy be defined early
882,ESRX,meanwhile gene testing company illumina be wednesday morning beat estimate raise guidance sale rise year earlier quarter nearly consensus earning climb cent share top estimate cent
883,ESRX,company now expect full year sale growth ep range be consensus
884,ESRX,leerink analyst dan leonard write note tuesday report exceed even have consider best case scenario face multiple new instrument launch lift price target write launch new hiseq miseq gene sequence system do not appear be cannibalize older version add order hiseq system illumina announce january fanfare due claim sequence genome apiece be double initial target
885,ESRX,isi group ross muken note demand be illumina entire sequence portfolio raise price target reflect increase ep forecast however maintain neutral rating stock say current price already reflect annual revenue growth
886,ESRX,follow amy reeve twitter be singing praise life science giant gilead science gild illumina ilmn wednesday morning surge estimate late tuesday share company be stock market today gilead sale new hepatitis drug sovaldi be call most impressive beat biopharma history piper jaffray joshua schimmer increase price target only dollar gilead be morning trading wednesday rbc capital market analyst michael yee lift sale estimate previous add full year ep estimate now expect sovaldi sale hit next year ep reach nomura ian somaiya lift price target write gilead position hcv market be sustainable say sovaldi new sovaldi base combo pill expect launch later year be superior compete product abbvie abbv merck mrk cowen phil nadeau be also impressed note lengthy discussion payor pushback tuesday earning call provide probably not nearly enough resolution satisfy investor pharmacy benefit manager express script esrx insurer unite health unh have criticize sovaldi price gilead do discuss argument support price sovaldi such value cure health care system cost treat patient end stage liver disease yr nadeau write find gilead discussion datapoint encourage suspect investor concern payor ability limit access sovaldi shuttle patient compete regimen linger abbv pricing strategy be know presumably approval payor strategy be defined early meanwhile gene testing company illumina be wednesday morning beat estimate raise guidance sale rise year earlier quarter nearly consensus earning climb cent share top estimate cent company now expect full year sale growth ep range be consensus leerink analyst dan leonard write note tuesday report exceed even have consider best case scenario face multiple new instrument launch lift price target write launch new hiseq miseq gene sequence system do not appear be cannibalize older version add order hiseq system illumina announce january fanfare due claim sequence genome apiece be double initial target isi group ross muken note demand be illumina entire sequence portfolio raise price target reflect increase ep forecast however maintain neutral rating stock say current price already reflect annual revenue growth follow amy reeve twitter ibd_areeve
887,ESRX,biotech stock bounce back recently last month medical biom biotech group be rank ibd industry be dead last last week plunge partly reflect growth stock overall fall hard current market correction specific concern sky high drug price notably gilead science blockbuster hepatitis
888,ESRX,big pharma merck mrk report stellar result phase hepatitis hcv drug trial thursday spark debate analyst potential take market share leader gilead science
889,ESRX,international liver congress london merck report cure rate patient hepatitis genotype take combination drug candidate mk mk
890,ESRX,potentially combine pill take once day pairing rival convenience effectiveness gilead gild combo sofosbuvir ledipasvir be currently await fda approval expect october
891,ESRX,gilead launch sofosbuvir alone sovaldi december be still recommend be combine interferon genotype account hcv infection be already enjoy biggest launch drug history
892,ESRX,now however wall street attention be turn rival
893,ESRX,face competiton
894,ESRX,isi group analyst mark schoenebaum write email client consensus peak sale estimate merck regimen almost certainly go current nonetheless write rise present real danger gilead
895,ESRX,most analyst include have assume gild capture perhaps genotype share peak write open question however have be company grab other market propose perhaps mrk be now lead contender position
896,ESRX,merck still have way go clinical trial file approval win have first compete regimen expect be abbvie abbv enanta enta cocktail also expect launch late year
897,ESRX,however research note thursday nomura analyst ian somaiya write symposium hepatologist stefan zeuzam bring gilead higher efficacy abbvie certain patient well risk drug interaction patient also have hiv
898,ESRX,zeuzam also raise issue higher alanine level small percentage patient merck regimen point acute liver injury motivate many physician avoid regimen somaiya raise estimate gilead total hcv franchise year next year
899,ESRX,defense
900,ESRX,well fargo financial adviser brian abraham rise abbvie defense
901,ESRX,thesis regard hep competitive dynamic be abbvie regimen be competitor gild give efficacy multiple patient type clean safety still have disadvantage versus gild merck regimen be hyped potential competitive threat write research note thursday
902,ESRX,gilead share tumble more thursday lowest close mid october biotechs other growth stock lead sharp market sell abbvie lose even merck initially rise year intraday high close
903,ESRX,gilead worry express script esrx officer say pharmacy benefit manager try drive sovaldi price goldman sachs analyst terence flynn wednesday trim gilead price target physician survey imply hcv market be price sensitive big pharma merck mrk report stellar result phase hepatitis hcv drug trial thursday spark debate analyst potential take market share leader gilead science international liver congress london merck report cure rate patient hepatitis genotype take combination drug candidate mk mk potentially combine pill take once day pairing rival convenience effectiveness gilead gild combo sofosbuvir ledipasvir be currently await fda approval expect october gilead launch sofosbuvir alone sovaldi december be still recommend be combine interferon genotype account hcv infection be already enjoy biggest launch drug history now however wall street attention be turn rival face competitonisi group analyst mark schoenebaum write email client consensus peak sale estimate merck regimen almost certainly go current nonetheless write rise present real danger gilead most analyst include have assume gild capture perhaps genotype share peak write open question however have be company grab other market propose perhaps mrk be now lead contender position merck still have way go clinical trial file approval win have first compete regimen expect be abbvie abbv enanta enta cocktail also expect launch late year however research note thursday nomura analyst ian somaiya write symposium hepatologist stefan zeuzam bring gilead higher efficacy abbvie certain patient well risk drug interaction patient also have hiv zeuzam also raise issue higher alanine level small percentage patient merck regimen point acute liver injury motivate many physician avoid regimen somaiya raise estimate gilead total hcv franchise year next year defensewell fargo financial adviser brian abraham rise abbvie defense thesis regard hep competitive dynamic be abbvie regimen be competitor gild give efficacy multiple patient type clean safety still have disadvantage versus gild merck regimen be hyped potential competitive threat write research note thursday gilead share tumble more thursday lowest close mid october biotechs other growth stock lead sharp market sell abbvie lose even merck initially rise year intraday high close gilead worry express script esrx officer say pharmacy benefit manager try drive sovaldi price goldman sachs analyst terence flynn wednesday trim gilead price target physician survey imply hcv market be price sensitive
904,ESRX,wag report first quarter sale friday just miss earning only meet view fewer new generic drug continue soft economy share rise drugstore giant see better time ahead fiscal earning rise cent share expect include defer tax benefit cent partnership
905,ESRX,investor be warn avoid buy stock market downturn such begin market pulse indicated correction have begin yet temptation lurk week big cap top rank company market value more be buy area other be just entry point stock pop market turn biotech stock amgen amgn be just buy point flat base profit first quarter rise compare year earlier period biggest increase year revenue rise most least year oak calif base company be highly rank medical biom biotech industry group boast strong annual pretax margin return equity also accumulation distribution rating indicate share be demand stock clear buy point april strong volume have struggle climb much higher highlight risk buy market downturn american tower reit amt operate cellular tower used broadcaster wireless service provider be past buy point flat base putt limit define buy area amgen american tower clear entry point april however volume be weak stock have struggle gain traction week company have composite rating putt top member telecom service wireless industry group be rank weak group track ibd earning share rating be best possible however reflect jump past quarters also several stock big cap american tower relative strength line be time high bullish sign meanwhile whole food market wfm be flat base buy point clear huge volume stock whole food be just few percentage point record high sign hold well turmoil clean product marketer ecolab ecl be big cap stock still buy area entry cup handle base however profit growth have decelerate straight quarters other stock watch include hcp hcp operator health care facility be just buy point cup handle base express script holding esrx provider pharmacy benefit management service employer insurer manage care organization be buy point
906,ESRX,stock turn higher early thursday afternoon sign economy remain resilient continue financial turmoil europe slowdown china be dow jone industrial average nasdaq rise volume be fractionally higher nasdaq almost nyse compare same time
907,ESRX,stock hold gain late thursday afternoon sign economy remain resilient continue financial turmoil europe slowdown china be dow jone industrial average climb blue chip index try snap day lose streak nasdaq have fall
908,ESRX,major stock index seesaw back mixed territory midday monday euro pare loss volume be again tracking lower board
909,ESRX,nyse composite rise dow tick fraction nasdaq fall hampered loss research motion rimm first solar fslr
910,ESRX,gold bolt new session high gain ounce hit time high price euro metal hit record high
911,ESRX,veeco instrument veco erased morning gain drop fast trade stock breach day move average have be trading long term support line year veeco isn top rate stock composite rating be
912,ESRX,coinstar cstr reversed open gain fall brisk turnover stock have already trade more half average daily volume coinstar touch new record high thursday
913,ESRX,iii apparel group giii also reversed lower fall heavy trading earlier clothing manufacture report narrower expect quarterly loss give upbeat full year outlook
914,ESRX,upside express script esrx rise regain day move average stock climb news wag end pharmacy benefit business cvs caremark cvs major stock index seesaw back mixed territory midday monday euro pare loss volume be again tracking lower board nyse composite rise dow tick fraction nasdaq fall hampered loss research motion rimm first solar fslr gold bolt new session high gain ounce hit time high price euro metal hit record high veeco instrument veco erased morning gain drop fast trade stock breach day move average have be trading long term support line year veeco isn top rate stock composite rating be coinstar cstr reversed open gain fall brisk turnover stock have already trade more half average daily volume coinstar touch new record high thursday iii apparel group giii also reversed lower fall heavy trading earlier clothing manufacture report narrower expect quarterly loss give upbeat full year outlook upside express script esrx rise regain day move average stock climb news wag end pharmacy benefit business cvs caremark cvs
915,ESRX,stock trade peak session early afternoon action tuesday hold firmly positive territory dow jone industrial average be nasdaq advanced turnover still be tracking monday level major exchange just modestly higher top rate stock bj restaurant bjri jump heavy volume
916,ESRX,ibd market outlook improve confirm uptrend past week stock stage broad rally tuesday quite few lead stock be behave well other have break recent session
917,ESRX,catalyst health solution chsi bolt ahead thursday move past buy point cup handle base pharmacy benefit manager get lift merger news industry express script esrx agree buy medco health service mhs
918,ESRX,ag related leader sociedad quimica minera sqm have form week tight pattern buy point chilean fertilizer producer last base be cup high handle pattern entry clear
919,ESRX,armour ua break cup high handle trigger tuesday daily turnover wasn strong see trade come average more level prefer day apparel maker close thursday
920,ESRX,longtime leader priceline pcln be offer chance get board online travel agency have etch cup handle base buy point note thursday stock spotlight column chief drawback priceline stock chart be latest base be riskier later stage structure
921,ESRX,accretive health suffer ugly negative reversal july try top buy point stock be now recover ipo produce base accretive provide financial service hospital such benefit verification collection
922,ESRX,jewelry name fossil fosl tif continue show strength headline weekly review lineup yet again stock be well extend proper buy range ibd market outlook improve confirm uptrend past week stock stage broad rally tuesday quite few lead stock be behave well other have break recent session catalyst health solution chsi bolt ahead thursday move past buy point cup handle base pharmacy benefit manager get lift merger news industry express script esrx agree buy medco health service mhs ag related leader sociedad quimica minera sqm have form week tight pattern buy point chilean fertilizer producer last base be cup high handle pattern entry clear armour ua break cup high handle trigger tuesday daily turnover wasn strong see trade come average more level prefer day apparel maker close thursday longtime leader priceline pcln be offer chance get board online travel agency have etch cup handle base buy point note thursday stock spotlight column chief drawback priceline stock chart be latest base be riskier later stage structure accretive health suffer ugly negative reversal july try top buy point stock be now recover ipo produce base accretive provide financial service hospital such benefit verification collection jewelry name fossil fosl tif continue show strength headline weekly review lineup yet again stock be well extend proper buy range
923,ESRX,wall street extend solid gain afternoon monday erase tiny open loss strong chinese manufacturing datum outweighed report suggest europe have fall recession
924,ESRX,nasdaq climb dow jone industrial average rise volume rise nasdaq be mildly higher nyse compare same time friday
925,ESRX,institute supply management manufacturing index rise point march top expectation reading indicate expansion manufacturing activity china hit month high activity member euro zone shrank eighth straight month unemployment bloc tick year high
926,ESRX,meanwhile construction spending unexpectedly slip february accord census bureau hit homebuilder stock kb home kbh lose initially rebound break even continue long slide have take stock well day move average lennar len be luxury homebuilder toll bro tol also fall find support day line
927,ESRX,most ibd stock be higher however
928,ESRX,apple aapl monday ibd jump more recoup friday drop climb back mark volume be run usual level tech giant have gain jan yet valuation be not much higher overall market click here story apple valuation
929,ESRX,chipmaker invensense invn be more bounce day line strong volume rebound day line usually provide opportunity buy additional share stock have make high volume plunge key support level give investor pause
930,ESRX,tibco software tibx also recoup part friday loss climb strong volume stock be find support day line be now buy point
931,ESRX,meanwhile casino game maker shuffle master shfl jump close new high follow low volume pullback
932,ESRX,express script esrx climb federal trade commission approve company purchase medco health solution mhs company say monday vote be final step month process complete deal announce july combine company reportedly handle prescription third population expect annual cost saving merger
933,ESRX,monday gain put express script just buy point month cup handle base buy point exist
934,ESRX,downside buffalo wild wing bwld lose double average daily volume raymond james downgrade stock underperform market perform sport bar chain hold week move average be still buy point clear cup handle base february
935,ESRX,liquidity service lqdt slip pare earlier loss see stock pull back test support week move average be online inventory auctioneer third visit week line clear buy point december buy point emerge later wall street extend solid gain afternoon monday erase tiny open loss strong chinese manufacturing datum outweighed report suggest europe have fall recession nasdaq climb dow jone industrial average rise volume rise nasdaq be mildly higher nyse compare same time friday institute supply management manufacturing index rise point march top expectation reading indicate expansion manufacturing activity china hit month high activity member euro zone shrank eighth straight month unemployment bloc tick year high meanwhile construction spending unexpectedly slip february accord census bureau hit homebuilder stock kb home kbh lose initially rebound break even continue long slide have take stock well day move average lennar len be luxury homebuilder toll bro tol also fall find support day line most ibd stock be higher however apple aapl monday ibd jump more recoup friday drop climb back mark volume be run usual level tech giant have gain jan yet valuation be not much higher overall market click here story apple valuation chipmaker invensense invn be more bounce day line strong volume rebound day line usually provide opportunity buy additional share stock have make high volume plunge key support level give investor pause tibco software tibx also recoup part friday loss climb strong volume stock be find support day line be now buy point meanwhile casino game maker shuffle master shfl jump close new high follow low volume pullback express script esrx climb federal trade commission approve company purchase medco health solution mhs company say monday vote be final step month process complete deal announce july combine company reportedly handle prescription third population expect annual cost saving merger monday gain put express script just buy point month cup handle base buy point exist downside buffalo wild wing bwld lose double average daily volume raymond james downgrade stock underperform market perform sport bar chain hold week move average be still buy point clear cup handle base february liquidity service lqdt slip pare earlier loss see stock pull back test support week move average be online inventory auctioneer third visit week line clear buy point december buy point emerge later
936,ESRX,stock stretched loss late wednesday durable good order rise less expect february suggest weaker expect first quarter economic growth nasdaq be rise earlier dow jone industrial average also slip be volume nasdaq nyse grow compare same time tuesday durable good
937,ESRX,stock show small gain so so show weekly unemployment claim mixed september retail number
938,ESRX,nasdaq rise add dow jone industrial average be flat volume be moderately lower exchange compare same time yesterday
939,ESRX,yahoo yhoo slip heavy volume give back portion wednesday gain stock be still so far week follow strategic alliance abc news report possible takeover interest china base alibaba report late wednesday say microsoft msft not bid yahoo
940,ESRX,express script esrx scorched ahead huge trade post strongest gain pharmacy benefit manager lower profit outlook due economic condition reduce demand medicine cut be reportedly less expect
941,ESRX,retailer be take gain loss september sale result rolled ross store rost jump powerful trade cent store ndn soar fast action
942,ESRX,tjx company tjx owner tjmaxx marshall chain drop more company say sale store open least year rise september better gain expect analyst company reaffirm earning guidance share vs consensus estimate
943,ESRX,stock have thread way higher support week line have pull back mixed trade test support line follow high stock show small gain so so show weekly unemployment claim mixed september retail number nasdaq rise add dow jone industrial average be flat volume be moderately lower exchange compare same time yesterday yahoo yhoo slip heavy volume give back portion wednesday gain stock be still so far week follow strategic alliance abc news report possible takeover interest china base alibaba report late wednesday say microsoft msft not bid yahoo express script esrx scorched ahead huge trade post strongest gain pharmacy benefit manager lower profit outlook due economic condition reduce demand medicine cut be reportedly less expect retailer be take gain loss september sale result rolled ross store rost jump powerful trade cent store ndn soar fast action tjx company tjx owner tjmaxx marshall chain drop more company say sale store open least year rise september better gain expect analyst company reaffirm earning guidance share vs consensus estimate stock have thread way higher support week line have pull back mixed trade test support line follow high
944,ESRX,wall street extend solid gain late monday afternoon lead apple aapl strong chinese manufacturing datum outweighed report suggest europe have fall recession nasdaq climb dow jone industrial average rise major index reversed early loss volume rise nasdaq
945,ESRX,stock cut more loss late trading wednesday dollar trim gain nyse composite fall dow be session low nasdaq slip volume be again tracking higher exchange hms holding hmsy fall fast trade be nearly trim loss find support day move average provider cost containment revenue recovery service report earning friday open analyst see profit rise cent share cavium network cavm erased earlier loss climb month high heavy trading stock clear buy point cup handle base cavium report result close analyst see chipmaker earning bolt cent share sale be slate surge akamai technology akam pull back be still ahead own quarterly result close analyst be expect cent share sale akamai break double bottom base aug be form base base pattern illumina ilmn be also session peak still heavy volume stock gap buy point week tight pattern late tuesday maker genetic analysis instrument smash view pop earning gain sale agnico eagle mine aem express script esrx irobot irbt la vegas sand lvs reilly automotive orly solutia soa sourcefire fire release earning close
946,ESRX,unitedhealth group deliver best quarter year thursday benefit new obamacare customer strong optum platform show tame medical expense nation health insurer also raise full year sale earning guidance unitedhealth unh logged first quarter earning share vs year earlier estimate revenue
947,ESRX,share unitedhealth group unh moved higher thursday nation biggest health insurer top first quarter earning revenue view raise forecast boost strong performance optum health service platform report open unitedhealth logged ep prior year consensus estimate revenue gain
948,ESRX,specialty drugmaker horizon pharma hznp beat analyst expectation raise guidance friday send stock new high horizon revenue quarter more triple analyst consensus accord thomson reuter exclude time item firm make cent share reverse year earlier loss
949,ESRX,unitedhealth group unh be expect produce best performance year report first quarter result thursday stock price continue trade record high follow major acquisition end march analyst poll thomson reuter expect nation health insurer post earning share prior year hold be biggest gain third quarter revenue be see rise be biggest top line increase september quarter unitedhealth top sale earning view optum health service platform deliver revenue gain optum include manage care business software consult unit pharmacy benefit management pbm provider pbm unit optumrx get lot bigger unitedhealth close acquisition catamaran ctrx be announce march deal be expect close fourth quarter merged entity serve customer nearly twice catamaran currently serve give unitedhealth pbm business kind scale bargaining power land better deal drug analyst say combination entity take total annual prescription filled nearly make third largest player industry market share trefis analyst note recent report comparison report say cvs health cvs express script esrx together control more pbm market filled prescription trefis say optumrx be fastest grow business entire optum division optumrx revenue have almost double be improvement bottom line well be exhibit fact ebitda margin improve unitedhealth have ibd composite rating belong ibd medical manage care group rank industry track ibd aetna aet be schedule report april anthem antm humana hum be due april cigna ci april
950,ESRX,catamaran ctrx surpass fourth quarter earning sale estimate thursday share sank weak full year ep outlook provider pharmacy benefit management service see adjust earning climb cent share mark second straight quarter accelerate growth analyst poll thomson reuter expect cent revenue jump
951,ESRX,special report best mutual fund february performance report stock mutual fund manager andrew acheson paul cloonan have be kick higher gear pioneer fundamental growth fund average annual return fund rank top large cap growth rival track morningstar inc year end
952,ESRX,stock market close mixed friday index bounce back early slump nasdaq rise thank strength biotechs security software solar stock fall dow jone industrial average lag drop close session lows small cap pace market small cap russell climb volume rise nyse edge lower nasdaq accord early figure serious decline prior day friday price reversal be encourage yet market remain lock long sideway trend stock sank open better expect job report trigger slide bond price energy stock rise opec left output target unchanged expect solar share jump china base ja solar jaso chief executive offer buy company take private financial also help lead stock market today bank america bac rise more close back buy point jpmorgan jpm rise hit new high thinly trade bofi holding bofi rise top buy point long cup handle base be strong day ibd average component volume be just average light most stock
953,ESRX,drugstore operator seek new way boost revenue have be enter pharmacy benefit manage field rite aid rad become latest do so announce wednesday buy envisionrx pharmacy benefit manager own private equity firm tpg cash stock acquisition let rite aid run prescription drug plan
954,ESRX,drugmaker show appetite orphan disease drug dollar deal send stock soar monday israeli drug giant teva pharmaceutical industry teva agree pay share cash auspex pharmaceutical aspx have drug market plan apply approval huntington disease treatment sd next few month auspex be
955,ESRX,gilead science beat analyst fourth quarter expectation tuesday give weak sale guidance biotech suffer pricing pressure blockbuster hepatitis drug earning leap share cent consensus revenue jump more wall street view however gilead gild see full year net product sale
956,ESRX,sector leader finished mostly little change thursday market waver narrowly mixed finish bulk moved less issue have outsized move realpage rp lose ground third straight session lose breach day move average volume rise
957,ESRX,bigger isn always better year gobble largest prey ever express script esrx have show bigger indeed be better most account express script be stronger pharmacy benefit management pbm firm wellpoint health network wlp nextrx business belt express script acquire health plan
958,ESRX,nothing competition help lower price market abbvie abbv enter hepatitis arena december gilead science gild have be discounting price sovaldi harvoni drug foster city calif base biotech jan sign health insurer aetna aet provider sovaldi cost week
959,ESRX,price war new hepatitis drug heat consensus estimate be too high accord deutsche bank separate note tuesday wednesday analyst robyn karnauskas calculate prospect abbvie abbv viekira pak gilead science gild harvoni sovaldi company announce series exclusive agreement payer pharmacy benefit manager abbv have so far nail life express script esrx national formulary gild have be choose prefer life cvs cvs anthem antm write be assume market share abbv exclusive prefer life see overall share abbv sale add revenue europe drug viekira pak be expect launch year set separate product karnauskas arrived total hcv sale vs consensus however also expect gilead be go low ball consensus due price discount have negotiate compete abbvie worst case expect discount commercial channel be harvoni sovaldi couple government discount harvoni sovaldi calculate overall discount hcv franchise write explain result revenue guidance lower present consensus guidance come lower validate pbms pharmacy benefit manager be telegraph regard discount abbvie be due report guidance jan gilead hasn yet set date report lower estimate karnauskas maintain buy rating stock due pipeline full other promising drug candidate stock didn react much stock market today afternoon trading gilead be abbvie be gilead moved back day move average tuesday abbvie continue slide key level follow amy reeve twitter ibd_areeve related aetna side gilead hepatitis drug battle
960,ESRX,abbvie be make major oncology push agree late wednesday pay acquire pharmacyclic pcyc maker blockbuster blood cancer drug imbruvica abbvie pay share cash stock pharmacyclic close price wednesday biotech close record high wednesday buyout buzz
961,ESRX,monday bring surprising turn twist story hepatitis treatment pharmacy giant cvs health say offer exclusive coverage gilead science hep drug
962,ESRX,key issue price remain unanswered deal seem counterattack cut week pharmacy benefit manager express script esrx abbvie abbv day fda abbvie drug viekira pak genotype hepatitis virus hcv express script say start cover only viekira pak genotype patient already start course drug firm be tight lip detail cvs cvs deal appear mirror express script start wednesday cvs also operate pharmacy benefit manager cover gilead gild sovaldi harvoni exclusively cvs caremark standard commercial exchange marketplace medicare part medicaid formulary viekira pak be cover only patient get exception prior approval didn say be much cvs pay drug price be big motive express script deal have objected cost new hepatitis drug ever sovaldi launch december week round therapy harvoni most patient eliminate need companion drug launch october week however wasn much anyone do long be competitor equal quality market viekira pak be approve dec price war seem have be avert treatment price modest discount harvoni week most analyst thought account fact more complicate take pill day harvoni equally effective price subject hagglingas evercore isi analyst mark schoenebaum have observed official list price drug be lot sticker price car just start point haggle abbvie acknowledge express get viekira pak discount decline reveal much analyst think have be gilead stock fall more day express disclose deal analyst cut rating lower target monday news help gilead stock rally abbvie fall gilead be not biotech start maxim group analyst jason kolbert say monday be savvy marketing drive company understand launch manage product life cycle don underestimate gilead ability manage competitive environment own research note monday rbc capital market analyst michael yee point most street have already assume gilead price cut once viekira pak come already have steep gross net move follow few quarters yee write so not think average price cvs be go be drastically different discount
963,ESRX,cvs health cvs monday say select gilead science gild sovaldi harvoni exclusive treatment hepatitis patient use benefit plan latest development become price war hepatitis drugmaker decision take hold wednesday come express script esrx move last month dump gilead drug prefer formulary list genotype hepatitis patient favor abbvie abbv rival drug viekira pak abbvie agree discount drug get list concern hep drug abbvie gilead be too expensive many low income patient harvoni cost week treatment compare viekira pak sovaldi cost week treatment goal be create lowest net cost solution entire population patient genotype hepatitis cvs say accord bloomberg be unclear gilead cvs agree kind discount express script announce decision add abbvie drug prefer list cite concern lack sufficient price competition hepatitis drug space company client have also warn cost specialty drug trend continue increase double digit percentage payer be force implement even more narrow management tool thus limit number patient afford receive drug therapy paula jakub ceo american foreign service protective association say last month only make sense manufacturer work payer pricing decision gilead share tumble dec day express script announcement be stock market today abbvie share fall day line first time october cvs say sovaldi harvoni be exclusive treatment list standard commercial drug well medicaid medicare part health exchange formulary wall street journal report patient get abbvie viekira pak only obtain approval medical exception advance rbc capital market react favorably cvs decision analyst note view positive remove term uncertainty many investor fear cvs also strike deal abbv further put more pressure gild rbc say
964,ESRX,gilead science gild picked provider hepatitis drug friday ongoing battle market share disease giant health insurer aetna announce harvoni sovaldi now be prefer therapy aetna commercial customer company negotiate unspecified discount drug price officially sovaldi be
965,ESRX,share big pharma abbvie abbv drop more friday morning company issue ep guidance get downgrade bank america abbvie say expect full year earning midpoint just average estimate analyst poll thomson reuter company say further refine guidance
966,ESRX,stock end solid gain friday battle back weakness spur disappointing job report nasdaq end respectively be friday low dow jone industrial average climb accord preliminary datum volume end higher board stock market today lead stock dave buster entertainment play reversed higher gain stock have already rise thursday follow pricing share offer dave buster be recently featured stock spotlight verisk analytic vrsk stretched streak straight session rebound loss rise stock nearly reach buy point flat base verisk provide datum insurance underwriter bank be add wednesday close tyler technology tyl add second straight new high now past buy point flat base clear thursday company announce buy privately hold new world system cash stock domino pizza dpz climb buck morning weakness fail retake day move average domino report earning thursday analyst poll thomson reuter see pizza chain profit rise cent share
967,ESRX,investor turn bit skittish medical stock monday gilead science gild plunge express script esrx announce support hepatitis drug abbvie abbv rather gilead sovaldi ibd stock spotlight pharmaceutical actavis act valeant pharmaceutical vrx take comparatively mild hit ireland base actavis ease weak trade stock be look
968,ESRX,pharmacy benefit manager express script announce monday putt abbvie newly approve hepatitis treatment prefer formulary list knock rival treatment gilead science gilead gild stock plunge abbvie abbv fall late friday food drug administration approve abbvie viekira pak combination novel drug older
969,ESRX,regeneron pharmaceutical report solid sale big cap biotech stock reversed lower tuesday potentially huge new cholesterol fighter be crosshair lead pharmacy benefit manager pbm
970,ESRX,jpmorgan healthcare conference san francisco express script esrx ceo george paz chat session company recent success drive discount pricey new hepatitis drug exclude gilead science gild sovaldi harvoni national prefer formulary favor abbvie abbv viekira pak pbm drug store giant cvs health cvs have opted sovaldi harvoni viekira pak
971,ESRX,ask sort drug be next list sort action paz say big course be cholesterol lower drug be come market
972,ESRX,pre emptive drug price war
973,ESRX,everyone take be refer pcsk inhibitor new class ldl lower drug first be expect launch third quarter year regeneron regn praluent alirocumab develop partnership sanofi sny amgen amgn evolocumab be expect bring multibillion dollar annual sale eventually pfizer pfe also have farther pipeline
974,ESRX,be powerful drug re also very expensive paz say be several chain re talk drugmaker see show promise re talk market share position pricing more be too more need understand competitive nature re enter
975,ESRX,paz comment seem allude widespread perception street pcsk be basically similar
976,ESRX,regeneron ceo len schleifer dispute session own presentation same conference later tuesday point praluent likely be approve different dose evolocumab be set be available just
977,ESRX,schleifer be diplomatic express say have exact same goal downplay impact market share end day not sure turn much differently be exclusive formulary negotiation not
978,ESRX,regeneron eylea sale bright
979,ESRX,presentation schleifer give preliminary sale figure regeneron lead product eye drug eylea be high side firm prior guidance factset consensus
980,ESRX,also guide expense item tend do lieu earning be heavily affected option expense
981,ESRX,range be set sg capital spending tax rate figure be gaap analyst estimate available ibd used gaap so wasn clear compare expectation
982,ESRX,regeneron stock rise nearly intraday reversed overall market close day move average
983,ESRX,separately conference robotic surgery system maker former star stock intuitive surgical isrg release preliminary sale year earlier more consensus firm also see procedure growth rbc capital market analyst brandon henry write be line expectation
984,ESRX,expect isrg share move higher morning continue believe worst be isrg henry write note market open
985,ESRX,be right first part intuitive surgical rise intraday stock retreat afternoon close regeneron pharmaceutical report solid sale big cap biotech stock reversed lower tuesday potentially huge new cholesterol fighter be crosshair lead pharmacy benefit manager pbm jpmorgan healthcare conference san francisco express script esrx ceo george paz chat session company recent success drive discount pricey new hepatitis drug exclude gilead science gild sovaldi harvoni national prefer formulary favor abbvie abbv viekira pak pbm drug store giant cvs health cvs have opted sovaldi harvoni viekira pak ask sort drug be next list sort action paz say big course be cholesterol lower drug be come market pre emptive drug price wareveryone take be refer pcsk inhibitor new class ldl lower drug first be expect launch third quarter year regeneron regn praluent alirocumab develop partnership sanofi sny amgen amgn evolocumab be expect bring multibillion dollar annual sale eventually pfizer pfe also have farther pipeline be powerful drug re also very expensive paz say be several chain re talk drugmaker see show promise re talk market share position pricing more be too more need understand competitive nature re enter paz comment seem allude widespread perception street pcsk be basically similar regeneron ceo len schleifer dispute session own presentation same conference later tuesday point praluent likely be approve different dose evolocumab be set be available just schleifer be diplomatic express say have exact same goal downplay impact market share end day not sure turn much differently be exclusive formulary negotiation not regeneron eylea sale brightat presentation schleifer give preliminary sale figure regeneron lead product eye drug eylea be high side firm prior guidance factset consensus also guide expense item tend do lieu earning be heavily affected option expense range be set sg capital spending tax rate figure be gaap analyst estimate available ibd used gaap so wasn clear compare expectation regeneron stock rise nearly intraday reversed overall market close day move average separately conference robotic surgery system maker former star stock intuitive surgical isrg release preliminary sale year earlier more consensus firm also see procedure growth rbc capital market analyst brandon henry write be line expectation expect isrg share move higher morning continue believe worst be isrg henry write note market open be right first part intuitive surgical rise intraday stock retreat afternoon close
986,ESRX,today continue review second quarter result company featured column pepsico pep featured here ibd june edition gap lower open thursday fall much end volume jump time average stock drop back day move average beverage snack food
987,ESRX,major index turn lower thursday wide swath lead stock suffer heavy loss nasdaq drop dow nyse composite dip lift part firmer energy sector volume fall nasdaq nyse compare wednesday level broad market have suffer
988,ESRX,stock take whiffle ball bounce wednesday rise light trade fed chief ben bernanke reiterate pledge keep interest rate low nasdaq lead dow take gain nyse composite climb volume remain soft major exchange market bounce look good term
989,ESRX,image burn bank greece do little soothe world market wednesday lead stock more loss weaker trading nyse composite fall nasdaq dow end day nyse rest april high nasdaq nasdaq dow
990,ESRX,stock climb second straight session wednesday market shake big jump energy price volume rise nyse dip nasdaq nyse index fared best dow industrial jump nyse composite vault nasdaq settle gain september crude rally much
991,ESRX,stock tumble monday tough trading day make way asia europe want hear ibd analysis today market emerge stock click here watch latest market wrap video nasdaq slide nyse dow trading be light however spare market
992,ESRX,update surprising drop march retail sale bank worry drop stock tuesday
993,ESRX,nyse composite fall dow nasdaq lose apiece
994,ESRX,turnover climb sharply exchange
995,ESRX,close intel intc report lower earning sale top view bellwether didn give specific sale outlook only say revenue be flat compare first quarter share fall hour trading
996,ESRX,regular session goldman sachs gs tumble nearly more double average trade close just day move average bank better expect earning report be offset news stock offer
997,ESRX,jpmorgan chase jpm drop breach day line report earning thursday
998,ESRX,bank america bac well fargo wfc drop respectively
999,ESRX,meanwhile shanda interactive entertainment snda swoon more twice average volume downturn erased monday advance then hit chinese online gaming firm still sit past buy point
1000,ESRX,american public education apei give double average trade school operator come pressure barrington research say stock be most expensive peer
1001,ESRX,medassest mda reversed early gain slip provider software health care sector enter ibd week
1002,ESRX,upside express script esrx rally heavy trading news agree buy wellpoint wlp pharmacy benefit unit
1003,ESRX,open text otex rise nearly twice average normal trade put content software firm past buy point cup handle pattern
1004,ESRX,tap wednesday be earning abbott laboratory charle schwab schw infosys infy peabody energy btu march consumer price empire state manufacturing survey fed beige book also be
1005,ESRX,update stock retreat heavier volume
1006,ESRX,vincent mao
1007,ESRX,stock sell tuesday finishing worst level session
1008,ESRX,accord preliminary datum nyse composite shed nasdaq lose meanwhile dow also lose fall back mark
1009,ESRX,volume jump board hand market distribution day
1010,ESRX,decliner beat advancer exchange
1011,ESRX,financial be biggest decliner medical energy issue buck trend
1012,ESRX,update stock trim loss late trade
1013,ESRX,vincent mao
1014,ESRX,stock remain lower session lows late trading tuesday still major index be pace log distribution day
1015,ESRX,trim earlier loss nyse composite slip dow nasdaq lose
1016,ESRX,volume be run higher board
1017,ESRX,federal reserve chairman ben bernanke see sign economic contraction be slow echo earlier remark president obama
1018,ESRX,recently have see tentative sign sharp decline economic activity be slow example datum home sale homebuilding consumer spending include sale new motor vehicle bernanke say speech morehouse college atlanta
1019,ESRX,rail operator csx csx slip ahead earning report close analyst see profit fall cent share
1020,ESRX,upside dress barn dbrn jump month high heavy trading morning suntrust robinson humphrey raise clothing retailer fiscal earning estimate range cent cent share well ahead cent expect thomson reuter broker also lift dress barn full year projection
1021,ESRX,dress barn report earning
1022,ESRX,intel intc edge fraction ahead first quarter number due close world largest chipmaker be expect earn cent share sale
1023,ESRX,update more red stock
1024,ESRX,vincent mao
1025,ESRX,major stock index slump new intraday lows afternoon trading tuesday
1026,ESRX,shed nasdaq nyse composite drop dow lose component red citigroup general motor gm johnson johnson jnj be only gainer
1027,ESRX,turnover be again tracking vastly higher board point distribution day make decliner beat advancer better exchange
1028,ESRX,goldman sachs gs widen loss late monday bank deliver earning smash view plan sell share proceed repay tarp fund
1029,ESRX,fellow bank well fargo wfc jpmorgan chase jpm shed respectively
1030,ESRX,elsewhere recent ipo chang com lose chinese provider online gaming service be spun sohu com sohu earlier month
1031,ESRX,update stock lows comeback fade
1032,ESRX,vincent mao
1033,ESRX,stock hover session lows morning rebound effort wane
1034,ESRX,nasdaq lose dow fall nyse composite give
1035,ESRX,volume be tracking sharply higher exchange
1036,ESRX,speech georgetown university president obama say economy be recover also stress mean be wood
1037,ESRX,buckle bke drop fast trade continue pull back score straight weekly gain heavy volume apparel retailer be work handle buckle report earning analyst see profit rise cent share
1038,ESRX,shanda interactive entertainment snda extend loss follow morning downgrade downturn stock still sit past buy point cup handle pattern
1039,ESRX,fastenal fast shed heavy trading miss view open construction supply store operator say earning fall cent share penny consensus estimate sale drop also view
1040,ESRX,upside longtop financial technology lft rise highest level december chinese firm make software provide service financial service industry
1041,ESRX,update nasdaq expand loss midday
1042,ESRX,jonah keri
1043,ESRX,tech stock picked pace loss midday tuesday market continue trade lower higher volume
1044,ESRX,nasdaq slide dow industrial nyse composite slip small cap fall hardest drop
1045,ESRX,volume jump board soar nasdaq nyse compare same period monday
1046,ESRX,american public education apei appear track fifth straight day fall nearly time usual volume profit education firm slice day move average monday
1047,ESRX,upside open text otex rise nearly time normal trade last week content management software developer acquire vizible expand open text digital medium reach
1048,ESRX,cree cree bounce brisk turnover daily chart maker led power switch other device appear break april base date back mid september stock face possible overhead resistance
1049,ESRX,commodity news crude price tick cent barrel weekly supply report energy information administration be due wednesday energy research firm platt predict crude oil stockpile have increase barrel last week
1050,ESRX,update stock cut early loss
1051,ESRX,update surprising drop march retail sale bank worry drop stock tuesday nyse composite fall dow nasdaq lose apiece turnover climb sharply exchange close intel intc report lower earning sale top view bellwether didn give specific sale outlook only say revenue be flat compare first quarter share fall hour trading regular session goldman sachs gs tumble nearly more double average trade close just day move average bank better expect earning report be offset news stock offer jpmorgan chase jpm drop breach day line report earning thursday bank america bac well fargo wfc drop respectively meanwhile shanda interactive entertainment snda swoon more twice average volume downturn erased monday advance then hit chinese online gaming firm still sit past buy point american public education apei give double average trade school operator come pressure barrington research say stock be most expensive peer medassest mda reversed early gain slip provider software health care sector enter ibd week upside express script esrx rally heavy trading news agree buy wellpoint wlp pharmacy benefit unit open text otex rise nearly twice average normal trade put content software firm past buy point cup handle pattern tap wednesday be earning abbott laboratory charle schwab schw infosys infy peabody energy btu march consumer price empire state manufacturing survey fed beige book also be update stock retreat heavier volumeby vincent maostock sell tuesday finishing worst level session accord preliminary datum nyse composite shed nasdaq lose meanwhile dow also lose fall back mark volume jump board hand market distribution day decliner beat advancer exchange financial be biggest decliner medical energy issue buck trend update stock trim loss late tradeby vincent maostock remain lower session lows late trading tuesday still major index be pace log distribution day trim earlier loss nyse composite slip dow nasdaq lose volume be run higher board federal reserve chairman ben bernanke see sign economic contraction be slow echo earlier remark president obama recently have see tentative sign sharp decline economic activity be slow example datum home sale homebuilding consumer spending include sale new motor vehicle bernanke say speech morehouse college atlanta rail operator csx csx slip ahead earning report close analyst see profit fall cent share upside dress barn dbrn jump month high heavy trading morning suntrust robinson humphrey raise clothing retailer fiscal earning estimate range cent cent share well ahead cent expect thomson reuter broker also lift dress barn full year projection dress barn report earning intel intc edge fraction ahead first quarter number due close world largest chipmaker be expect earn cent share sale update more red stocksby vincent maomajor stock index slump new intraday lows afternoon trading tuesday shed nasdaq nyse composite drop dow lose component red citigroup general motor gm johnson johnson jnj be only gainer turnover be again tracking vastly higher board point distribution day make decliner beat advancer better exchange goldman sachs gs widen loss late monday bank deliver earning smash view plan sell share proceed repay tarp fund fellow bank well fargo wfc jpmorgan chase jpm shed respectively elsewhere recent ipo chang com lose chinese provider online gaming service be spun sohu com sohu earlier month update stock lows comeback fadesby vincent maostock hover session lows morning rebound effort wane nasdaq lose dow fall nyse composite give volume be tracking sharply higher exchange speech georgetown university president obama say economy be recover also stress mean be wood buckle bke drop fast trade continue pull back score straight weekly gain heavy volume apparel retailer be work handle buckle report earning analyst see profit rise cent share shanda interactive entertainment snda extend loss follow morning downgrade downturn stock still sit past buy point cup handle pattern fastenal fast shed heavy trading miss view open construction supply store operator say earning fall cent share penny consensus estimate sale drop also view upside longtop financial technology lft rise highest level december chinese firm make software provide service financial service industry update nasdaq expand loss middayby jonah keritech stock picked pace loss midday tuesday market continue trade lower higher volume nasdaq slide dow industrial nyse composite slip small cap fall hardest drop volume jump board soar nasdaq nyse compare same period monday american public education apei appear track fifth straight day fall nearly time usual volume profit education firm slice day move average monday upside open text otex rise nearly time normal trade last week content management software developer acquire vizible expand open text digital medium reach cree cree bounce brisk turnover daily chart maker led power switch other device appear break april base date back mid september stock face possible overhead resistance commodity news crude price tick cent barrel weekly supply report energy information administration be due wednesday energy research firm platt predict crude oil stockpile have increase barrel last week update stock cut early loss
1052,ESRX,update stock finished lower second straight session tuesday more case swine flu bank worry offset spike consumer confidence trading be choppy bulk session
1053,ESRX,nyse composite lose nasdaq slip dow fall milder thank ibm ibm raise dividend approve additional stock buyback big blue rise
1054,ESRX,volume drop exchange good sign professional didn dump share
1055,ESRX,brink home security cfl fall heavy trading snap session advance be biggest percentage decliner ibd downturn left stock slightly buy point cup handle pattern
1056,ESRX,longtop financial technology lft fall double average trade be much session low chinese financial software firm late monday announce acquisition file sell share
1057,ESRX,upside aaron aan gap surge huge volume late monday rental firm easily beat view jump earning also raise full year profit outlook
1058,ESRX,green mountain coffee roaster gmcr reversed loss rally nearly record high stock clear buy point week tight pattern
1059,ESRX,elsewhere gdp number fed decision interest rate be wednesday
1060,ESRX,earning due aetna aet arcelormittal mt burger king bkc citrix system ctxs express script esrx fti consult fcn general dynamic gd medasset mda medco health solution mhs moody mco reilly automotive orly sap sap visa
1061,ESRX,update index seesaw lower close
1062,ESRX,vincent mao
1063,ESRX,major index finished lower seesaw session tuesday more case swine flu bank fear trump jump consumer confidence
1064,ESRX,nyse composite fall dow nasdaq lose
1065,ESRX,accord preliminary datum volume fall board advancer edge decliner exchange
1066,ESRX,financial steel metal stock be biggest decliner home furnishing apparel maker buck trend
1067,ESRX,update stock find direction late trade
1068,ESRX,vincent mao
1069,ESRX,struggle direction most session major index push new session high late trade tuesday
1070,ESRX,dow rally lead gain ibm ibm exxon mobil xom chevron cvx nyse composite climb respectively meanwhile nasdaq rise didn hit new session high
1071,ESRX,volume be slightly lower board
1072,ESRX,buffalo wild wing bwld rise month high brisk trade sport bar grill chain report result close analyst be expect earning cent share sale
1073,ESRX,downside dendreon dndn plunge have huge change heart biotech be earlier session datum study show provenge prostate drug extend survival rate vs placebo share have be halter edt
1074,ESRX,advent software advs slip ahead earning report be expect close
1075,ESRX,update stock trim gain lackluster trading
1076,ESRX,vincent mao
1077,ESRX,major stock index pare gain turn narrowly mixed afternoon trading tuesday market action continue be choppy
1078,ESRX,dow rise thank largely jump ibm ibm edge nasdaq nyse composite be flat
1079,ESRX,turnover be tracking lower exchange
1080,ESRX,green mountain coffee roaster gmcr reversed loss perked fresh time high stock clear buy point week tight pattern green mountain report earning wednesday close analyst see profit rise cent share
1081,ESRX,downside brink home security holding cfl fall pull back session nice gain drop left stock just buy point cup handle pattern
1082,ESRX,baidu com bidu reversed shed heavy trading chinese internet search firm be more follow strong result late monday earlier tuesday needham upgrade stock underperform hold pali research upgrade sell neutral
1083,ESRX,update stock rebound choppy trading
1084,ESRX,vincent mao
1085,ESRX,stock bounce back early afternoon trading brief dip red still action have be choppy
1086,ESRX,nasdaq lead pack rise dow rise meanwhile nyse composite be flat loss metal steel financial weigh index
1087,ESRX,turnover be tracking slightly lower board advancer beat decliner exchange
1088,ESRX,com ramp time high recent ipo report earning analyst see online gaming firm profit double cent share com be spun sohu com sohu earlier month
1089,ESRX,steven madden shoo add year high footwear accessory maker report earning preannounce strong result last week
1090,ESRX,downside rent center rcii gap tumble deliver lower expect sale give weak outlook late monday electronic furniture rental chain say first quarter revenue fall vs view guide second quarter earning line analyst estimate sale forecast fall short view earlier tuesday sterne agee cut share neutral buy
1091,ESRX,starent network star fall downgrade cite valuation cantor fitzgerald cut maker infrastructure product hold buy downturn erased monday gain stock didn undercut buy point
1092,ESRX,update major index pull back again midday
1093,ESRX,jonah keri
1094,ESRX,stock fade midday tuesday morning left market mixed result
1095,ESRX,nasdaq climb less dow industrial fall meanwhile nyse composite drop small cap gain
1096,ESRX,volume ease board sank nyse nasdaq compare same period monday
1097,ESRX,edward lifescience ew jump nearly time normal trade maker product used treat cardiovascular disorder report first quarter earning top wall street estimate raise full year profit forecast stock be approach potential buy point base base pattern
1098,ESRX,casual restaurant chain buffalo wild wing bwld extend early gain climb brisk turnover
1099,ESRX,green mountain coffee roaster gmcr add average volume coffee distributor have post straight tight weekly close breaking base march
1100,ESRX,tyler technology tyl leap time typical turnover provider management service beat earning view tyler stock have surge week high
1101,ESRX,update stock turn higher
1102,ESRX,jonah keri
1103,ESRX,major market index turn early loss gain tuesday
1104,ESRX,nasdaq climb dow industrial advanced add meanwhile nyse composite rise small cap bounce
1105,ESRX,volume ease board sank nyse nasdaq compare same period monday
1106,ESRX,rock tenn rkt jump volume tracking time monday level maker packaging merchandising display smash fiscal second quarter earning view monday close rock tenn be build right side deep base now sit week high
1107,ESRX,family dollar store fdo rise average trade deep discount chain stage breakaway gap march trade tight range past month
1108,ESRX,express script esrx picked rapid turnover provider pharmacy benefit management service have vault day move average work right side base
1109,ESRX,downside longtop financial technology lft slide massive trade china base financial software maker be pace third big drop heavy volume past session stock have find support day line
1110,ESRX,update market pare loss early trade
1111,ESRX,update stock finished lower second straight session tuesday more case swine flu bank worry offset spike consumer confidence trading be choppy bulk session nyse composite lose nasdaq slip dow fall milder thank ibm ibm raise dividend approve additional stock buyback big blue rise volume drop exchange good sign professional didn dump share brink home security cfl fall heavy trading snap session advance be biggest percentage decliner ibd downturn left stock slightly buy point cup handle pattern longtop financial technology lft fall double average trade be much session low chinese financial software firm late monday announce acquisition file sell share upside aaron aan gap surge huge volume late monday rental firm easily beat view jump earning also raise full year profit outlook green mountain coffee roaster gmcr reversed loss rally nearly record high stock clear buy point week tight pattern elsewhere gdp number fed decision interest rate be wednesday earning due aetna aet arcelormittal mt burger king bkc citrix system ctxs express script esrx fti consult fcn general dynamic gd medasset mda medco health solution mhs moody mco reilly automotive orly sap sap visa update index seesaw lower closeby vincent maomajor index finished lower seesaw session tuesday more case swine flu bank fear trump jump consumer confidence nyse composite fall dow nasdaq lose accord preliminary datum volume fall board advancer edge decliner exchange financial steel metal stock be biggest decliner home furnishing apparel maker buck trend update stock find direction late tradeby vincent maoafter struggle direction most session major index push new session high late trade tuesday dow rally lead gain ibm ibm exxon mobil xom chevron cvx nyse composite climb respectively meanwhile nasdaq rise didn hit new session high volume be slightly lower board buffalo wild wing bwld rise month high brisk trade sport bar grill chain report result close analyst be expect earning cent share sale downside dendreon dndn plunge have huge change heart biotech be earlier session datum study show provenge prostate drug extend survival rate vs placebo share have be halter edt advent software advs slip ahead earning report be expect close update stock trim gain lackluster tradingby vincent maomajor stock index pare gain turn narrowly mixed afternoon trading tuesday market action continue be choppy dow rise thank largely jump ibm ibm edge nasdaq nyse composite be flat turnover be tracking lower exchange green mountain coffee roaster gmcr reversed loss perked fresh time high stock clear buy point week tight pattern green mountain report earning wednesday close analyst see profit rise cent share downside brink home security holding cfl fall pull back session nice gain drop left stock just buy point cup handle pattern baidu com bidu reversed shed heavy trading chinese internet search firm be more follow strong result late monday earlier tuesday needham upgrade stock underperform hold pali research upgrade sell neutral update stock rebound choppy tradingby vincent maostock bounce back early afternoon trading brief dip red still action have be choppy nasdaq lead pack rise dow rise meanwhile nyse composite be flat loss metal steel financial weigh index turnover be tracking slightly lower board advancer beat decliner exchange com ramp time high recent ipo report earning analyst see online gaming firm profit double cent share com be spun sohu com sohu earlier month steven madden shoo add year high footwear accessory maker report earning preannounce strong result last week downside rent center rcii gap tumble deliver lower expect sale give weak outlook late monday electronic furniture rental chain say first quarter revenue fall vs view guide second quarter earning line analyst estimate sale forecast fall short view earlier tuesday sterne agee cut share neutral buy starent network star fall downgrade cite valuation cantor fitzgerald cut maker infrastructure product hold buy downturn erased monday gain stock didn undercut buy point update major index pull back again middayby jonah keristock fade midday tuesday morning left market mixed result nasdaq climb less dow industrial fall meanwhile nyse composite drop small cap gain volume ease board sank nyse nasdaq compare same period monday edward lifescience ew jump nearly time normal trade maker product used treat cardiovascular disorder report first quarter earning top wall street estimate raise full year profit forecast stock be approach potential buy point base base pattern casual restaurant chain buffalo wild wing bwld extend early gain climb brisk turnover green mountain coffee roaster gmcr add average volume coffee distributor have post straight tight weekly close breaking base march tyler technology tyl leap time typical turnover provider management service beat earning view tyler stock have surge week high update stock turn higherby jonah major market index turn early loss gain tuesday nasdaq climb dow industrial advanced add meanwhile nyse composite rise small cap bounce volume ease board sank nyse nasdaq compare same period monday rock tenn rkt jump volume tracking time monday level maker packaging merchandising display smash fiscal second quarter earning view monday close rock tenn be build right side deep base now sit week high family dollar store fdo rise average trade deep discount chain stage breakaway gap march trade tight range past month express script esrx picked rapid turnover provider pharmacy benefit management service have vault day move average work right side base downside longtop financial technology lft slide massive trade china base financial software maker be pace third big drop heavy volume past session stock have find support day line update market pare loss early trade
1112,ESRX,update stock slide close
1113,ESRX,vincent mao
1114,ESRX,stock wosen late trading tuesday major index now negative territory dow turn triple digit gain triple digit loss
1115,ESRX,edt nasdaq take biggest hit dow drop nyse composite
1116,ESRX,volume be again tracking higher exchange
1117,ESRX,number nasdaq heavyweight get hit
1118,ESRX,amazon com amzn tumble heavy trading web retailer take monday high low
1119,ESRX,apple aapl reversed drop active trading just ahead holiday season company unveil several new laptop computer lowest price model macbook now start currently
1120,ESRX,intel intc also reversed ahead report bell fall fast trade analyst expect chip giant post earning cent share sale chipmaker result outlook give insight technology spending environment
1121,ESRX,meanwhile csx csx reversed early gain dump ahead earning close turn tail intraday high rail operator be expect earn cent share
1122,ESRX,upside grainger gww gap dash beat view raise guidance maintenance product distributor report earning share cent view be best performance many quarters
1123,ESRX,sale grow also view company raise full year profit outlook range share share analyst expect
1124,ESRX,update most index improve midday trading
1125,ESRX,vincent mao
1126,ESRX,major stock index exception nasdaq return positive ground midday tuesday dip red be still well morning high
1127,ESRX,edt nyse composite be
1128,ESRX,dow climb nasdaq fall
1129,ESRX,turnover be again tracking higher board
1130,ESRX,market retreat bank be still mostly higher morgan stanley ms surge citigroup state street stt goldman sachs gs
1131,ESRX,intuitive surgical isrg gap gain fast trade robotic surgical system maker report earning thursday profit be expect rise share
1132,ESRX,amedisys am gap day move average rally session high home nursing care provider sale growth have accelerate straight quarters
1133,ESRX,abbott laboratory rise brisk volume
1134,ESRX,earlier medical product maker hit session high regain day line news stock buyback
1135,ESRX,downside adtran adtn slump report profit line view open telecom equipment maker deliver earning cent share year sale rise view company also declare quarterly dividend cent share
1136,ESRX,charle schwab schw erased early gain tumble brokerage erased nearly monday advance
1137,ESRX,update early gain fade index more deeply mixed
1138,ESRX,alan elliott
1139,ESRX,stock backtrack slip more seriously mixed territory
1140,ESRX,financial continue work gain ground techs energy stock crank drag
1141,ESRX,nasdaq composite have surrender reversed spark early trade nyse composite give dow keep finger positive territory hold
1142,ESRX,tech international energy stock be pull nyse
1143,ESRX,amazon amzn microsoft msft appear be primary hold back nasdaq lodging strong volume loss
1144,ESRX,volume show firmly higher exchange nyse higher nasdaq
1145,ESRX,crude oil hold steady barrel dollar slip monday run natural gas metal grain rise gold backed ounce
1146,ESRX,stock advancer lead decliner nyse nasdaq decliner lead narrow margin
1147,ESRX,express script esrx vault third day gain pharmacy benefit manager be just face resistance day move average sharp week sell
1148,ESRX,almost family afam also enter third day gain gap add put home nursing service provider back week move average eighth week possible base
1149,ESRX,downside pnc financial service group pnc shed move kill eastern seaboard super regional bank attempt beat resistance day move average tamp back day line
1150,ESRX,china shanghai composite backed sign weaker earning primarily brokerage steel maker give back large share monday surge hong kong hang seng index bolt higher
1151,ESRX,japan tokyo nikkei sprung optimism congeal global financial strategy record day gain retook half ground lose index last week
1152,ESRX,stock europe backed early high spur develop financial rescue london ftse have add more midday pull back gain late afternoon trade frankfurt dax add cac paris hold gain bank oil related issue lead gain
1153,ESRX,south america brazil bovespa hurl ahead more early trade have backed gain midday
1154,ESRX,update stock spike then retreat
1155,ESRX,vincent mao
1156,ESRX,stock charge gate tuesday have pull back
1157,ESRX,nasdaq surge open minute have reversed negative territory
1158,ESRX,edt jump dow nyse composite gain meanwhile nasdaq fall volume be tracking vastly higher board
1159,ESRX,bond sell investor rushed back stock push yield year note basis point
1160,ESRX,bank be biggest winner follow government capital plan morgan stanley ms surge citigroup report earning thursday jump bank america bac rally
1161,ESRX,sovereign bancorp sov gap gain
1162,ESRX,spain banco santander std buy remain share sovereign doesn already own stock
1163,ESRX,elsewhere ingersoll rand ir gain lower guidance cite weakness north america western europe well strong dollar diversify manufacturer now see earning range cent share prior outlook share analyst expect company see full year profit share vs view
1164,ESRX,update stock set strong open
1165,ESRX,vincent mao
1166,ESRX,stock future point big open tuesday government unveil additional measure counter financial crisis
1167,ESRX,nasdaq future jump point vs fair value future rally point dow future tack point
1168,ESRX,government spend rescue plan buy equity stake bank confirm report late monday go prefer share largest bank include bank america bac citigroup well fargo wfc goldman sachs gs morgan stanley ms bank new york bk state street stt bofa well fargo get additional fund respective purchase lynch fore mentioned bank be pre market
1169,ESRX,be essential short term measure assure viability america banking system say president bush measure be not design take free market preserve add
1170,ESRX,also fdic provide temporary insurance loan bank fdic remove deposit insurance cap interest bearing account
1171,ESRX,meanwhile johnson johnson jnj jump pre open beating view health care product giant earn third quarter cent view sale rise also view also raise full year ep outlook share vs consensus estimate
1172,ESRX,pepsico pep fall pre market miss view announce round layoff beverage giant report flat earning cent share cent shy view pepsi also slash job world seek save next year
1173,ESRX,crude oil continue bounce back friday month low november contract gain barrel hope policymaker ease credit crisis limit damage global economy be spur expectation stronger demand commodity update stock slide closeby vincent maostock wosen late trading tuesday major index now negative territory dow turn triple digit gain triple digit loss edt nasdaq take biggest hit dow drop nyse composite volume be again tracking higher exchange number nasdaq heavyweight get hit amazon com amzn tumble heavy trading web retailer take monday high low apple aapl reversed drop active trading just ahead holiday season company unveil several new laptop computer lowest price model macbook now start currently intel intc also reversed ahead report bell fall fast trade analyst expect chip giant post earning cent share sale chipmaker result outlook give insight technology spending environment meanwhile csx csx reversed early gain dump ahead earning close turn tail intraday high rail operator be expect earn cent share upside grainger gww gap dash beat view raise guidance maintenance product distributor report earning share cent view be best performance many quarters sale grow also view company raise full year profit outlook range share share analyst expect update most index improve midday tradingby vincent maothe major stock index exception nasdaq return positive ground midday tuesday dip red be still well morning high edt nyse composite be dow climb nasdaq fall turnover be again tracking higher board market retreat bank be still mostly higher morgan stanley ms surge citigroup state street stt goldman sachs gs intuitive surgical isrg gap gain fast trade robotic surgical system maker report earning thursday profit be expect rise share amedisys am gap day move average rally session high home nursing care provider sale growth have accelerate straight quarters abbott laboratory rise brisk volume earlier medical product maker hit session high regain day line news stock buyback downside adtran adtn slump report profit line view open telecom equipment maker deliver earning cent share year sale rise view company also declare quarterly dividend cent share charle schwab schw erased early gain tumble brokerage erased nearly monday advance update early gain fade index more deeply mixedby alan elliottstock backtrack slip more seriously mixed territory financial continue work gain ground techs energy stock crank drag nasdaq composite have surrender reversed spark early trade nyse composite give dow keep finger positive territory hold tech international energy stock be pull nyse amazon amzn microsoft msft appear be primary hold back nasdaq lodging strong volume loss volume show firmly higher exchange nyse higher nasdaq crude oil hold steady barrel dollar slip monday run natural gas metal grain rise gold backed ounce stock advancer lead decliner nyse nasdaq decliner lead narrow margin express script esrx vault third day gain pharmacy benefit manager be just face resistance day move average sharp week sell almost family afam also enter third day gain gap add put home nursing service provider back week move average eighth week possible base downside pnc financial service group pnc shed move kill eastern seaboard super regional bank attempt beat resistance day move average tamp back day line china shanghai composite backed sign weaker earning primarily brokerage steel maker give back large share monday surge hong kong hang seng index bolt higher japan tokyo nikkei sprung optimism congeal global financial strategy record day gain retook half ground lose index last week stock europe backed early high spur develop financial rescue london ftse have add more midday pull back gain late afternoon trade frankfurt dax add cac paris hold gain bank oil related issue lead gain south america brazil bovespa hurl ahead more early trade have backed gain midday update stock spike then retreatby vincent maostock charge gate tuesday have pull back nasdaq surge open minute have reversed negative territory edt jump dow nyse composite gain meanwhile nasdaq fall volume be tracking vastly higher board bond sell investor rushed back stock push yield year note basis point bank be biggest winner follow government capital plan morgan stanley ms surge citigroup report earning thursday jump bank america bac rally sovereign bancorp sov gap gain spain banco santander std buy remain share sovereign doesn already own stock elsewhere ingersoll rand ir gain lower guidance cite weakness north america western europe well strong dollar diversify manufacturer now see earning range cent share prior outlook share analyst expect company see full year profit share vs view update stock set strong openby vincent maostock future point big open tuesday government unveil additional measure counter financial crisis nasdaq future jump point vs fair value future rally point dow future tack point government spend rescue plan buy equity stake bank confirm report late monday go prefer share largest bank include bank america bac citigroup well fargo wfc goldman sachs gs morgan stanley ms bank new york bk state street stt bofa well fargo get additional fund respective purchase lynch fore mentioned bank be pre market be essential short term measure assure viability america banking system say president bush measure be not design take free market preserve add also fdic provide temporary insurance loan bank fdic remove deposit insurance cap interest bearing account meanwhile johnson johnson jnj jump pre open beating view health care product giant earn third quarter cent view sale rise also view also raise full year ep outlook share vs consensus estimate pepsico pep fall pre market miss view announce round layoff beverage giant report flat earning cent share cent shy view pepsi also slash job world seek save next year crude oil continue bounce back friday month low november contract gain barrel hope policymaker ease credit crisis limit damage global economy be spur expectation stronger demand commodity
1174,ESRX,update stock continue march higher late thursday near session high
1175,ESRX,edt nyse composite nasdaq climb respectively be poise lock third straight day gain rally dow
1176,ESRX,volume be tracking lower exchange
1177,ESRX,new oriental education technology group edu rally third straight day gain stock be form double bottom base larger consolidation
1178,ESRX,express script esrx jump ahead earning close provider pharmacy benefit management service be slate earn cent share mutual fund ownership stock have rise straight quarters
1179,ESRX,downside mcafee mfe reversed early gain drop maker web security product report result bell expect earn cent share sale
1180,ESRX,rival symantec symc slump report light sale give dim outlook late wednesday
1181,ESRX,life partner holding lphi also reversed shed heavy trading broker life settlement contract reversed record high
1182,ESRX,crude oil settle barrel
1183,ESRX,update stock rebound midday trade
1184,ESRX,vincent mao
1185,ESRX,major stock index bounce back midday thursday most dip briefly red
1186,ESRX,edt nyse composite be session high gain nasdaq dow
1187,ESRX,turnover be again mixed nasdaq be vastly higher nyse slightly lower
1188,ESRX,crude oil reversed lower trading barrel december contract be
1189,ESRX,spartan store sptn charge push grocery store operator back day move average stock be work new base fail double bottom early month
1190,ESRX,clean harbor clhb jump fast trade environmental service provider be recently add midcap pace finish higher heavy volume third straight week
1191,ESRX,avon product avp gap dump miss estimate caution tough time ahead exclude item cosmetic firm earn cent share third quarter cent view sale grow beating street
1192,ESRX,statement company warn negative consumer environment north america continue weigh avon performance region company expect trend further deteriorate fourth quarter additionally recent significant movement foreign exchange rate maintain current level negatively impact fourth quarter full year growth rate operate margin
1193,ESRX,earlier week rival estee lauder el lower full year outlook
1194,ESRX,sonosite sono slump heavy trading goldman sachs cut ultrasound system maker sell hold sonosite also report earning close analyst expect cent share year result
1195,ESRX,update stock retreat morning high
1196,ESRX,alan elliott
1197,ESRX,market launch day volatile action spring higher gate ease morning trade gdp decline slightly not much expect first time third quarter measure inflation buck higher
1198,ESRX,world largest company exxon mobil xom report earning far analyst estimate american express axp announce heavy cost cut measure
1199,ESRX,financial energy stock hold nyse composite edt nasdaq composite remain dow cling gain exxon pull hard downside
1200,ESRX,volume be tracking mixed nasdaq slightly higher nyse lower
1201,ESRX,natural gas gold silver moved higher logging big gain yesterday gasoline price continue fall dollar lose ground vs european currency overseas market soar overnight pare loss thursday morning
1202,ESRX,stock credit card bellwether american express add cent announce cut job worldwide effort cut cost next year company also say suspend salary increase management expect take pretax charge
1203,ESRX,strayer education stra blast fifth straight session gain gapping add private college operator ep cent top estimate cent revenue fall just shy analyst view company offer ep guidance vs consensus estimate
1204,ESRX,surgical infection control product maker steris ste gap add mentor ohio base company neatly top ep consensus guide full year result expectation move lift share back day move average first time september
1205,ESRX,almost family afam also gap punch gain stock be ninth week cup shape base
1206,ESRX,downside life insurer hartford financial hig stumble company report loss fox pitt kelton downgrade stock inline outperform cite possibility rating agency downgrade company uncertain capital condition hartford also cut full year outlook
1207,ESRX,overseas market europe hold early gain frankfurt dax clock advance cac paris click london ftse hold gain
1208,ESRX,federal reserve addition announce half point rate cut wednesday say provide swap line foreign central bank help improve monetary liquidity economy include brazil mexico south korea south korea market subsequently vault largest day gain record international monetary fund also make available ailing central bank
1209,ESRX,update stock big mixed volume
1210,ESRX,vincent mao
1211,ESRX,stock charge gate thursday news economy shrank third quarter
1212,ESRX,edt major average be early high still comfortably black nyse composite rise nasdaq dow
1213,ESRX,volume be mixed nasdaq tracking higher nyse slight lower
1214,ESRX,mantech international mant gap climb fast trade stock regain day move average late wednesday provider service beat view rise earning jump sale
1215,ESRX,foundry network fdry gap day line gain agree lower buyout offer brocade communication brcd now buy foundry cash
1216,ESRX,la vegas sand lvs gap fly heavy trading casino operator say plan open marina bay sand resort end report say be month schedule
1217,ESRX,downside biogen idec biib gap drop late wednesday biotech report third case brain disease stem patient used tysabri multiple sclerosis drug partner drug elan eln fall
1218,ESRX,update gdp global market fuel stock future
1219,ESRX,vincent mao
1220,ESRX,surge global stock market better expect gdp datum fuel stock future thursday signale sharply higher open nasdaq future jump point vs fair value future rally point dow future charge point
1221,ESRX,day federal reserve cut fed fund rate stock market world rally hong kong hang seng leap japan nikkei jump european market be less enthusiastic germany dax climb london ftse rise
1222,ESRX,other central bank be expect follow fed footstep bank japan meet friday bank england european central bank meet next week
1223,ESRX,economic news third quarter gdp fall annual rate third quarter weakest year gain second quarter be less economist expectation drop consumer spending account third economic growth drop worst year
1224,ESRX,initial jobless claim week end oct be unchanged vs expectation drop
1225,ESRX,exxon mobil xom gain pre market follow latest quarterly result oil titan earn third quarter largest profit ever public firm exclude item earn share cent view sale climb
1226,ESRX,first solar fslr surge pre open strong earning late wednesday maker solar module trounce view jump profit rise sale company also boost full year sale outlook morning merriman ford upgrade share buy neutral
1227,ESRX,crude oil continue rebound month low december contract rise barrel
1228,ESRX,update stock continue march higher late thursday near session high edt nyse composite nasdaq climb respectively be poise lock third straight day gain rally dow volume be tracking lower exchange new oriental education technology group edu rally third straight day gain stock be form double bottom base larger consolidation express script esrx jump ahead earning close provider pharmacy benefit management service be slate earn cent share mutual fund ownership stock have rise straight quarters downside mcafee mfe reversed early gain drop maker web security product report result bell expect earn cent share sale rival symantec symc slump report light sale give dim outlook late wednesday life partner holding lphi also reversed shed heavy trading broker life settlement contract reversed record high crude oil settle barrel update stock rebound midday tradeby vincent maothe major stock index bounce back midday thursday most dip briefly red edt nyse composite be session high gain nasdaq dow turnover be again mixed nasdaq be vastly higher nyse slightly lower crude oil reversed lower trading barrel december contract be spartan store sptn charge push grocery store operator back day move average stock be work new base fail double bottom early month clean harbor clhb jump fast trade environmental service provider be recently add midcap pace finish higher heavy volume third straight week avon product avp gap dump miss estimate caution tough time ahead exclude item cosmetic firm earn cent share third quarter cent view sale grow beating street statement company warn negative consumer environment north america continue weigh avon performance region company expect trend further deteriorate fourth quarter additionally recent significant movement foreign exchange rate maintain current level negatively impact fourth quarter full year growth rate operate margin earlier week rival estee lauder el lower full year outlook sonosite sono slump heavy trading goldman sachs cut ultrasound system maker sell hold sonosite also report earning close analyst expect cent share year result update stock retreat morning high
1229,ESRX,alan elliott
1230,ESRX,market launch day volatile action spring higher gate ease morning trade gdp decline slightly not much expect first time third quarter measure inflation buck higher
1231,ESRX,world largest company exxon mobil xom report earning far analyst estimate american express axp announce heavy cost cut measure
1232,ESRX,financial energy stock hold nyse composite edt nasdaq composite remain dow cling gain exxon pull hard downside
1233,ESRX,volume be tracking mixed nasdaq slightly higher nyse lower
1234,ESRX,natural gas gold silver moved higher logging big gain yesterday gasoline price continue fall dollar lose ground vs european currency overseas market soar overnight pare loss thursday morning
1235,ESRX,stock credit card bellwether american express add cent announce cut job worldwide effort cut cost next year company also say suspend salary increase management expect take pretax charge
1236,ESRX,strayer education stra blast fifth straight session gain gapping add private college operator ep cent top estimate cent revenue fall just shy analyst view company offer ep guidance vs consensus estimate
1237,ESRX,surgical infection control product maker steris ste gap add mentor ohio base company neatly top ep consensus guide full year result expectation move lift share back day move average first time september
1238,ESRX,almost family afam also gap punch gain stock be ninth week cup shape base
1239,ESRX,downside life insurer hartford financial hig stumble company report loss fox pitt kelton downgrade stock inline outperform cite possibility rating agency downgrade company uncertain capital condition hartford also cut full year outlook
1240,ESRX,overseas market europe hold early gain frankfurt dax clock advance cac paris click london ftse hold gain
1241,ESRX,federal reserve addition announce half point rate cut wednesday say provide swap line foreign central bank help improve monetary liquidity economy include brazil mexico south korea south korea market subsequently vault largest day gain record international monetary fund also make available ailing central bank
1242,ESRX,update stock big mixed volume
1243,ESRX,vincent mao
1244,ESRX,stock charge gate thursday news economy shrank third quarter
1245,ESRX,edt major average be early high still comfortably black nyse composite rise nasdaq dow
1246,ESRX,volume be mixed nasdaq tracking higher nyse slight lower
1247,ESRX,mantech international mant gap climb fast trade stock regain day move average late wednesday provider service beat view rise earning jump sale
1248,ESRX,foundry network fdry gap day line gain agree lower buyout offer brocade communication brcd now buy foundry cash
1249,ESRX,la vegas sand lvs gap fly heavy trading casino operator say plan open marina bay sand resort end report say be month schedule
1250,ESRX,downside biogen idec biib gap drop late wednesday biotech report third case brain disease stem patient used tysabri multiple sclerosis drug partner drug elan eln fall
1251,ESRX,update gdp global market fuel stock future
1252,ESRX,vincent mao
1253,ESRX,surge global stock market better expect gdp datum fuel stock future thursday signale sharply higher open nasdaq future jump point vs fair value future rally point dow future charge point
1254,ESRX,day federal reserve cut fed fund rate stock market world rally hong kong hang seng leap japan nikkei jump european market be less enthusiastic germany dax climb london ftse rise
1255,ESRX,other central bank be expect follow fed footstep bank japan meet friday bank england european central bank meet next week
1256,ESRX,economic news third quarter gdp fall annual rate third quarter weakest year gain second quarter be less economist expectation drop consumer spending account third economic growth drop worst year
1257,ESRX,initial jobless claim week end oct be unchanged vs expectation drop
1258,ESRX,exxon mobil xom gain pre market follow latest quarterly result oil titan earn third quarter largest profit ever public firm exclude item earn share cent view sale climb
1259,ESRX,first solar fslr surge pre open strong earning late wednesday maker solar module trounce view jump profit rise sale company also boost full year sale outlook morning merriman ford upgrade share buy neutral
1260,ESRX,crude oil continue rebound month low december contract rise barrel alan elliottmarket launch day volatile action spring higher gate ease morning trade gdp decline slightly not much expect first time third quarter measure inflation buck higher world largest company exxon mobil xom report earning far analyst estimate american express axp announce heavy cost cut measure financial energy stock hold nyse composite edt nasdaq composite remain dow cling gain exxon pull hard downside volume be tracking mixed nasdaq slightly higher nyse lower natural gas gold silver moved higher logging big gain yesterday gasoline price continue fall dollar lose ground vs european currency overseas market soar overnight pare loss thursday morning stock credit card bellwether american express add cent announce cut job worldwide effort cut cost next year company also say suspend salary increase management expect take pretax charge strayer education stra blast fifth straight session gain gapping add private college operator ep cent top estimate cent revenue fall just shy analyst view company offer ep guidance vs consensus estimate surgical infection control product maker steris ste gap add mentor ohio base company neatly top ep consensus guide full year result expectation move lift share back day move average first time september almost family afam also gap punch gain stock be ninth week cup shape base downside life insurer hartford financial hig stumble company report loss fox pitt kelton downgrade stock inline outperform cite possibility rating agency downgrade company uncertain capital condition hartford also cut full year outlook overseas market europe hold early gain frankfurt dax clock advance cac paris click london ftse hold gain federal reserve addition announce half point rate cut wednesday say provide swap line foreign central bank help improve monetary liquidity economy include brazil mexico south korea south korea market subsequently vault largest day gain record international monetary fund also make available ailing central bank update stock big mixed volumeby vincent maostock charge gate thursday news economy shrank third quarter edt major average be early high still comfortably black nyse composite rise nasdaq dow volume be mixed nasdaq tracking higher nyse slight lower mantech international mant gap climb fast trade stock regain day move average late wednesday provider service beat view rise earning jump sale foundry network fdry gap day line gain agree lower buyout offer brocade communication brcd now buy foundry cash la vegas sand lvs gap fly heavy trading casino operator say plan open marina bay sand resort end report say be month schedule downside biogen idec biib gap drop late wednesday biotech report third case brain disease stem patient used tysabri multiple sclerosis drug partner drug elan eln fall update gdp global market fuel stock futuresby vincent maosurge global stock market better expect gdp datum fuel stock future thursday signale sharply higher open nasdaq future jump point vs fair value future rally point dow future charge point day federal reserve cut fed fund rate stock market world rally hong kong hang seng leap japan nikkei jump european market be less enthusiastic germany dax climb london ftse rise other central bank be expect follow fed footstep bank japan meet friday bank england european central bank meet next week economic news third quarter gdp fall annual rate third quarter weakest year gain second quarter be less economist expectation drop consumer spending account third economic growth drop worst year initial jobless claim week end oct be unchanged vs expectation drop exxon mobil xom gain pre market follow latest quarterly result oil titan earn third quarter largest profit ever public firm exclude item earn share cent view sale climb first solar fslr surge pre open strong earning late wednesday maker solar module trounce view jump profit rise sale company also boost full year sale outlook morning merriman ford upgrade share buy neutral crude oil continue rebound month low december contract rise barrel
1261,ESRX,stock finished vastly lower tuesday morning rally fizzle reversal come news european union send greece keep default positive earning report also fuel gain early news germany propose ban naked short selling hurt equity
1262,ESRX,want hear ibd analysis today market emerge stock
1263,ESRX,click here watch latest market wrap video
1264,ESRX,nasdaq shed nyse composite dow volume rise exchange
1265,ESRX,euro also turn lower top hit fresh year low dollar oil gold also finished lower
1266,ESRX,veeco instrument veco erased open gain tumble month low stock also close line first time feb veeco have drop april peak
1267,ESRX,volterra semiconductor vltr lose reverse early gain stock once again near day move average
1268,ESRX,skywork solution swks turn lower drop nearly twice average volume stock accumulation distribution rating have drop worst possible late april
1269,ESRX,elsewhere dick sporting good dks turn gain loss open retailer beat view earning double give lukewarm profit outlook current quarter guide full year earning ahead analyst expectation
1270,ESRX,close hewlett packard hpq rise deliver fiscal result ahead view dow component also raise full year profit outlook share vs view
1271,ESRX,earning wednesday citi trend ctrn limit group ltd target tgt
1272,ESRX,datum april consumer price also be wednesday
1273,ESRX,stock hard intraday reversal
1274,ESRX,vincent mao
1275,ESRX,stock close sharply lower give early gain tuesday major index manage trim loss thank last minute buy
1276,ESRX,nasdaq drop fall much nyse composite fall dow accord preliminary datum volume rise exchange decliner beat advancer more nyse nearly nasdaq
1277,ESRX,bank be hardest hit financial reform loom techs also get hurt chip stock fare worst
1278,ESRX,stock hit session lows nasdaq fare worst
1279,ESRX,jonah keri
1280,ESRX,sharp decline chip stock other techs send nasdaq session lows tuesday highlight rough day market
1281,ESRX,nasdaq fall nyse composite dow volume turn mixed rise nyse fall nasdaq compare same period monday
1282,ESRX,credit card company be pressure mastercard visa sank heavy volume
1283,ESRX,profit education stock also slump capella education cpla shed itt educational service esi apollo group apol rapid turnover
1284,ESRX,elsewhere home depot hd shed more twice normal trade home improvement chain report first quarter profit cent share top view nickel revenue result also beat estimate
1285,ESRX,stock loss accelerate
1286,ESRX,stock finished vastly lower tuesday morning rally fizzle reversal come news european union send greece keep default positive earning report also fuel gain early news germany propose ban naked short selling hurt equity want hear ibd analysis today market emerge stock
1287,ESRX,click here watch latest market wrap video
1288,ESRX,nasdaq shed nyse composite dow volume rise exchange euro also turn lower top hit fresh year low dollar oil gold also finished lower veeco instrument veco erased open gain tumble month low stock also close line first time feb veeco have drop april peak volterra semiconductor vltr lose reverse early gain stock once again near day move average skywork solution swks turn lower drop nearly twice average volume stock accumulation distribution rating have drop worst possible late april elsewhere dick sporting good dks turn gain loss open retailer beat view earning double give lukewarm profit outlook current quarter guide full year earning ahead analyst expectation close hewlett packard hpq rise deliver fiscal result ahead view dow component also raise full year profit outlook share vs view earning wednesday citi trend ctrn limit group ltd target tgt datum april consumer price also be wednesday stock hard intraday reversalby vincent maostock close sharply lower give early gain tuesday major index manage trim loss thank last minute buy nasdaq drop fall much nyse composite fall dow accord preliminary datum volume rise exchange decliner beat advancer more nyse nearly nasdaq bank be hardest hit financial reform loom techs also get hurt chip stock fare worst stock hit session lows nasdaq fare worstby jonah kerium sharp decline chip stock other techs send nasdaq session lows tuesday highlight rough day market nasdaq fall nyse composite dow volume turn mixed rise nyse fall nasdaq compare same period monday credit card company be pressure mastercard visa sank heavy volume profit education stock also slump capella education cpla shed itt educational service esi apollo group apol rapid turnover elsewhere home depot hd shed more twice normal trade home improvement chain report first quarter profit cent share top view nickel revenue result also beat estimate stock loss accelerate
1289,ESRX,stock open higher quickly begin trim gain friday dollar edge higher oil price hold steady dow jone industrial average add apiece nasdaq hold advance
1290,ESRX,volume be soft nasdaq lower nyse compare trade same time thursday
1291,ESRX,stock market today be rebound still correct nasdaq deep hole week market receive early assist today china rule change federally engineer buy help lift market first healthy close week
1292,ESRX,december hire be also factor labor department report payroll jump month far expectation
1293,ESRX,wholesale inventory drop november commerce department say be even october slip expectation change
1294,ESRX,market have ear post payroll comment san francisco federal reserve bank president john william speak et richmond federal reserve bank president jeffrey lacker docket speech
1295,ESRX,apple aapl dupont dd race head dow nearly wynn resort wynn head gain
1296,ESRX,gap gps crater announce late thursday december same store sale slip vs consensus view decline
1297,ESRX,chipmaker apple supplier qorvo qrvo drop greensboro company late thursday lower revenue guidance well consensus expectation company also say repurchase share quarter leave share repurchase program cash balance more share trade week june high
1298,ESRX,ibd list universal display oled flash ahead nearly open maker organic light emit diode chip used high definition tv computer screen be trading buy point cup base trigger automatic sell signal diving more mark
1299,ESRX,hawaiian jump more report total number passenger rise load factor fourth quarter stock remain well day move average be attempt build right side deep consolidation
1300,ESRX,aircraft carrier mechanic huntington ingall industry hii sail ahead nearly cowen co upgrade stock outperform market perform huntington be trading buy point long cup handle base stock open higher quickly begin trim gain friday dollar edge higher oil price hold steady dow jone industrial average add apiece nasdaq hold advance volume be soft nasdaq lower nyse compare trade same time thursday stock market today be rebound still correct nasdaq deep hole week market receive early assist today china rule change federally engineer buy help lift market first healthy close week december hire be also factor labor department report payroll jump month far expectation wholesale inventory drop november commerce department say be even october slip expectation change market have ear post payroll comment san francisco federal reserve bank president john william speak et richmond federal reserve bank president jeffrey lacker docket speech apple aapl dupont dd race head dow nearly wynn resort wynn head gain gap gps crater announce late thursday december same store sale slip vs consensus view decline chipmaker apple supplier qorvo qrvo drop greensboro company late thursday lower revenue guidance well consensus expectation company also say repurchase share quarter leave share repurchase program cash balance more share trade week june high ibd list universal display oled flash ahead nearly open maker organic light emit diode chip used high definition tv computer screen be trading buy point cup base trigger automatic sell signal diving more mark hawaiian jump more report total number passenger rise load factor fourth quarter stock remain well day move average be attempt build right side deep consolidation aircraft carrier mechanic huntington ingall industry hii sail ahead nearly cowen co upgrade stock outperform market perform huntington be trading buy point long cup handle base
1301,ESRX,wag shift private health insurance exchange employee isn necessarily harbinger doom pharmacy benefit manager pbms catamaran ctrx express script esrx
1302,ESRX,fact pbms pick business private exchange grow bmo capital market analyst jennifer lynch suggest research note thursday
1303,ESRX,announcement wednesday plan send employee private health insurance exchange rather provide coverage option serve catalyst wednesday plunge catamaran share
1304,ESRX,lynch estimate catamaran lose annual prescription provide drug coverage employee
1305,ESRX,small part overall customer base next year estimate more prescription be likely low profitability business company say
1306,ESRX,reaction news be overblown add reiterate outperform rating price target catamaran be trading early afternoon trading stock market today
1307,ESRX,express script edge be nearly flat
1308,ESRX,rival rite aid rad gap soar year high heavy volume drugstore chain earn cent share fiscal second quarter reverse last year cent loss top view cent deficit revenue grow also beating forecast
1309,ESRX,same store sale also rise increase pharmacy sale offset dip front end sale
1310,ESRX,rite aid guide higher fiscal expect ep cent share sale analyst see cent revenue wag shift private health insurance exchange employee isn necessarily harbinger doom pharmacy benefit manager pbms catamaran ctrx express script esrx fact pbms pick business private exchange grow bmo capital market analyst jennifer lynch suggest research note thursday announcement wednesday plan send employee private health insurance exchange rather provide coverage option serve catalyst wednesday plunge catamaran share lynch estimate catamaran lose annual prescription provide drug coverage employee small part overall customer base next year estimate more prescription be likely low profitability business company say reaction news be overblown add reiterate outperform rating price target catamaran be trading early afternoon trading stock market today express script edge be nearly flat rival rite aid rad gap soar year high heavy volume drugstore chain earn cent share fiscal second quarter reverse last year cent loss top view cent deficit revenue grow also beating forecast same store sale also rise increase pharmacy sale offset dip front end sale rite aid guide higher fiscal expect ep cent share sale analyst see cent revenue
1311,ESRX,biotech stock sell hard friday wall street blame letter several house democrat ask gilead science justify price hepatitis blockbuster sovaldi
1312,ESRX,letter date thursday be sign rep henry waxman frank pallone diana degete ranking member committee energy commerce call sovaldi breakthrough hcv treatment expressed concern treatment not cure patient afford
1313,ESRX,due sovaldi price tag letter go say colorado pennsylvania medicaid program have already announce re funding sovaldi only sickest patient california be still figure reimbursement policy letter also note pharmacy benefit manager express script esrx be encourage doctor network delay prescribe sovaldi
1314,ESRX,meanwhile hepatitis be disease find poor result lawmaker tell gilead provide explanation pricing april
1315,ESRX,health insurer wellpoint wlp chime friday concern new hepatitis drug cost say executive ken goulet
1316,ESRX,biotech stock cheaper
1317,ESRX,gilead gild fall nearly month close low biotechs selling expensive drug fall even harder perhaps fear larger change national mood drug pricing
1318,ESRX,alexion pharmaceutical alxn sole drug soliris go upward year tumble vertex pharmaceutical vrtx also sell expensive hepatitis drug call incivek retreat
1319,ESRX,biogen idec biib have costly multiple sclerosis treatment tecfidera lose
1320,ESRX,ibd top rate medical biom biotech group fall
1321,ESRX,abbvie abbv likely come rival possibly cheaper rival sovaldi later year initially rally friday close fraction
1322,ESRX,gilead catch cold rest market catch pneumonia say tom vandeventer portfolio manager tocqueville opportunity fund
1323,ESRX,sovaldi bargain
1324,ESRX,analyst most part advise stay calm michael yee rbc capital market write email client friday pricing discussion generate headline concern view underscore drug be go be huge re cure patient improve society hcv be important public health issue hiv be validate significance market
1325,ESRX,deutsche bank analyst robyn karnauskas write client note speak gilead official be already make case sovaldi be actually bargain
1326,ESRX,liver transplant related hcv cost year med so person do not reject liver write gilead have co pay program place pocket cost be low
1327,ESRX,isi group analyst mark schoenebaum point sovaldi compare favorably older hepatitis drug especially vertex incivek go year sovaldi cure rate be also much higher incivek so cost cure be even better say webinar friday
1328,ESRX,dem seek public shaming
1329,ESRX,schoenebaum also query terry haine longtime washington lawyer lobbyist once serve senior republican counsel same congre sional committee send letter haine respond government actually have little power address drug price view waxman et al hope accomplish be public shaming not waxman deliver tobacco industry year
1330,ESRX,letter be bank shot get thing go goal get gilead significantly lower price sovaldi haine write
1331,ESRX,such move be politically popular add discontent high price sovaldi new drug general have be swell payer general public time now aids healthcare foundation large nonprofit history criticize gilead hiv drug pricing recently turn fire sovaldi
1332,ESRX,gilead latest display touch greed come heel company january pricing new hepatitis treatment sovaldi sofosbuvir pill more gilead most expensive aids drug stribild ahf say feb press release
1333,ESRX,have play biotech stock have hit lull last few week bull run not see lead fear party be vandeventer say biotechs be high beta group be probably just correction point drug price have be political football early
1334,ESRX,shouldn be completely unexpected kind issue come fore periodically say just part investing health care biotech stock sell hard friday wall street blame letter several house democrat ask gilead science justify price hepatitis blockbuster sovaldi letter date thursday be sign rep henry waxman frank pallone diana degete ranking member committee energy commerce call sovaldi breakthrough hcv treatment expressed concern treatment not cure patient afford due sovaldi price tag letter go say colorado pennsylvania medicaid program have already announce re funding sovaldi only sickest patient california be still figure reimbursement policy letter also note pharmacy benefit manager express script esrx be encourage doctor network delay prescribe sovaldi meanwhile hepatitis be disease find poor result lawmaker tell gilead provide explanation pricing april health insurer wellpoint wlp chime friday concern new hepatitis drug cost say executive ken goulet biotech stock cheapergilead gild fall nearly month close low biotechs selling expensive drug fall even harder perhaps fear larger change national mood drug pricing alexion pharmaceutical alxn sole drug soliris go upward year tumble vertex pharmaceutical vrtx also sell expensive hepatitis drug call incivek retreat biogen idec biib have costly multiple sclerosis treatment tecfidera lose ibd top rate medical biom biotech group fall abbvie abbv likely come rival possibly cheaper rival sovaldi later year initially rally friday close fraction gilead catch cold rest market catch pneumonia say tom vandeventer portfolio manager tocqueville opportunity fund sovaldi bargain analyst most part advise stay calm michael yee rbc capital market write email client friday pricing discussion generate headline concern view underscore drug be go be huge re cure patient improve society hcv be important public health issue hiv be validate significance market deutsche bank analyst robyn karnauskas write client note speak gilead official be already make case sovaldi be actually bargain liver transplant related hcv cost year med so person do not reject liver write gilead have co pay program place pocket cost be low isi group analyst mark schoenebaum point sovaldi compare favorably older hepatitis drug especially vertex incivek go year sovaldi cure rate be also much higher incivek so cost cure be even better say webinar friday dem seek public shaming schoenebaum also query terry haine longtime washington lawyer lobbyist once serve senior republican counsel same congre sional committee send letter haine respond government actually have little power address drug price view waxman et al hope accomplish be public shaming not waxman deliver tobacco industry year letter be bank shot get thing go goal get gilead significantly lower price sovaldi haine write such move be politically popular add discontent high price sovaldi new drug general have be swell payer general public time now aids healthcare foundation large nonprofit history criticize gilead hiv drug pricing recently turn fire sovaldi gilead latest display touch greed come heel company january pricing new hepatitis treatment sovaldi sofosbuvir pill more gilead most expensive aids drug stribild ahf say feb press release have play biotech stock have hit lull last few week bull run not see lead fear party be vandeventer say biotechs be high beta group be probably just correction point drug price have be political football early shouldn be completely unexpected kind issue come fore periodically say just part investing health care
1335,ESRX,share catamaran ctrx express script esrx have get hit concern affordable care act hurt pharmacy benefit manager fact provide lift
1336,ESRX,research note jeffery analyst say obamacare actually be net positive catamaran reiterate buy rating price target
1337,ESRX,share insurer unitedhealth unh wellpoint wlp aetna aet have also rally recently hope obamacare drive enrollment young person well demand pharmacy medical service
1338,ESRX,worry private exchange hurt pharmacy benefit manager be also overblown jeffery add pbms sell hard last month wag say ll shift employee private health insurance
1339,ESRX,catamaran serve drugstore chain worker share fall bmo capital market say soon announcement be small likely low profitability part business reiterate outperform rating catamaran
1340,ESRX,thursday jpmorgan analyst also say don see private exchange major threat catamaran express script think pullback pharmacy benefit manager offer buy opportunity
1341,ESRX,catamaran share gap be higher early afternoon trading stock market today express script rise catamaran be week high express script be week high share catamaran ctrx express script esrx have get hit concern affordable care act hurt pharmacy benefit manager fact provide lift research note jeffery analyst say obamacare actually be net positive catamaran reiterate buy rating price target share insurer unitedhealth unh wellpoint wlp aetna aet have also rally recently hope obamacare drive enrollment young person well demand pharmacy medical service worry private exchange hurt pharmacy benefit manager be also overblown jeffery add pbms sell hard last month wag say ll shift employee private health insurance catamaran serve drugstore chain worker share fall bmo capital market say soon announcement be small likely low profitability part business reiterate outperform rating catamaran thursday jpmorgan analyst also say don see private exchange major threat catamaran express script think pullback pharmacy benefit manager offer buy opportunity catamaran share gap be higher early afternoon trading stock market today express script rise catamaran be week high express script be week high
1342,ESRX,rally tuesday nation drugstore operator beat wall street quarterly profit forecast give bullish commentary boot alliance obamacare impact company earn cent august end fiscal fourth quarter beating analyst forecast penny revenue rise just miss view accord thomson reuter
1343,ESRX,drugstore chain wag be expect continue recent run strong earning gain report fiscal fourth quarter result next week company focus major expansion plan
1344,ESRX,deerfield ill base be schedule report result open oct analyst expect earning cent share quarter end august prior year mark third straight quarter double digit ep growth follow string decline
1345,ESRX,have already release sale report year year gain comparable store sale rise front end comp climb sequentially also post gain prescription comparable store increase comparable pharmacy sale
1346,ESRX,company see sale earning decline fiscal dispute pharmacy benefit manager express script esrx lead big dip number express script prescription filled store dispute be resolve year however lead better result past few quarters
1347,ESRX,company report earning time rapid change expansion
1348,ESRX,earlier month announce plan buy privately hold kerr drug regional pharmacy chain north carolina fiscal revenue revenue deal bring kerr retail drugstore specialty pharmacy business financial term weren disclose
1349,ESRX,rival cvs caremark cvs wal mart wmt rite aid rad also look expand primary care service offer open retail health clinic store enter partnership big medical group
1350,ESRX,recently announce deal palo alto calif base therano bring lab testing store accord press release consumer be able access less invasive more affordable clinician direct lab testing blood sample small few drop
1351,ESRX,such move be design take advantage project increase demand health care service affordable care act otherwise know obamacare expectation be million new patient enter market
1352,ESRX,share touch record high currently trade drugstore chain wag be expect continue recent run strong earning gain report fiscal fourth quarter result next week company focus major expansion plan deerfield ill base be schedule report result open oct analyst expect earning cent share quarter end august prior year mark third straight quarter double digit ep growth follow string decline have already release sale report year year gain comparable store sale rise front end comp climb sequentially also post gain prescription comparable store increase comparable pharmacy sale company see sale earning decline fiscal dispute pharmacy benefit manager express script esrx lead big dip number express script prescription filled store dispute be resolve year however lead better result past few quarters company report earning time rapid change expansion earlier month announce plan buy privately hold kerr drug regional pharmacy chain north carolina fiscal revenue revenue deal bring kerr retail drugstore specialty pharmacy business financial term weren disclose rival cvs caremark cvs wal mart wmt rite aid rad also look expand primary care service offer open retail health clinic store enter partnership big medical group recently announce deal palo alto calif base therano bring lab testing store accord press release consumer be able access less invasive more affordable clinician direct lab testing blood sample small few drop such move be design take advantage project increase demand health care service affordable care act otherwise know obamacare expectation be million new patient enter market share touch record high currently trade
1353,ESRX,stock market close lower monday retailer have bumpy session nasdaq dow jone industrial average fall slip volume rise be surprise friday half session decline stock lead advancer nyse nasdaq stock market today transportation medical retail industry group be weakest monday energy mining stock be strongest lululemon athletica lulu gap loss sink right back day move average analyst fbr capital market downgrade lululemon underperform market perform cut price target investor grow pessimistic early holiday shopping indication other retailer sell heavy trading include ulta beauty ulta urban outfitter urbn regeneron pharmaceutical regn have worst loss ibd bid past buy point have unraveled close unitedhealth group unh say be back forecast earning share revenue be project be health insurer warn nov earning hit obamacare exchange related business cite higher medical cost individual market customer soft enrollment outlook unitedhealth share rise slightly extend trading several economic report be due tuesday manufacturing report purchasing manager institute supply management be due morning automaker report november sale earning report tuesday include fifth street finance fsc guidewire software gwre follow juan carlos arancibia twitter ibd_jarancibia
1354,ESRX,share drug benefit management giant express script esrx jump mid day trading company give better expect earning guidance management say expect adjust earning share higher wall street consensus be accord thomson reuter be revise downward early november
1355,ESRX,express script esrx have be work hard expand lead position pharmacy benefit management pbm industry reap reward st loui base express script be track integration recent acquisition top pbm firm medco analyst expect company realize even more synergy originally announce
1356,ESRX,wag report higher quarterly sale profit share gap hard massive volume early tuesday miss analyst view count nation largest drugstore chain say fiscal third quarter earning share rise cent lighter cent wall street be look revenue grow
1357,ESRX,stock ibd sector leader screen moved thursday main index advanced first time week recoup recent loss screen also featured new name thursday edition financial engine fngn investment adviser asset manager ipo strength include double digit percentage gain quarterly ep
1358,ESRX,mark thierer doesn count luck play high stake merger acquisition game ceo pharmacy benefit manager catamaran ctrx come table arm sharp strategy assure beat odd way thierer feel confident bet game change buy be especially apparent orchestrated merger sxc health solution
1359,ESRX,stock market hold sharp gain early afternoon trading nasdaq surge nyse composite volume be tracking higher fairly easy goal give yesterday light trading winner lead lose stock nyse nasdaq ulta salon fragrance ulta climb
1360,ESRX,sector leader be not immune market dip friday pare morning gain other end loss big volume be largely absent web com group wwww add weak volume provider publish management software service be build pattern run deep base so far run week long
1361,ESRX,cvs caremark cvs report higher fourth quarter revenue early wednesday top wall street expectation global expansion move profit rise well help growth pharmacy service business cvs drugstore outlet nation largest drugstore chain open net store quarter bring total location state
1362,ESRX,be trading session market make follow july judge today weekly review list lead stock be act healthy fashion be extend be proper buy range be perhaps prime future lululemon athletica lulu big winner first half
1363,ESRX,leader advanced wednesday market resume uptrend broad gain higher volume baidu bidu ebix ebix aruba network arun be still lock base build mode have already build several basis big climb baidu be just high ebix be peak watch
1364,ESRX,many customer brace change obamacare drug wholesaler be expansion mode head overseas form purchasing co op see fit massive piece healthcare puzzle be home huge competitor mckesson mck largest abc be expand heavily europe mainly
1365,ESRX,weak open almost turn positive point tuesday session seller come late major average end session lows investor get spook bank japan left interest rate asset buy program unchanged perception more easy money japan be not friendly headline
1366,ESRX,massive health care overall drive more business cvs caremark cvs company say thursday give guidance analyst forecast drugstore chain pharmacy benefit manager say first quarter revenue likely decline due rise generic drug sell discount brand counterpart cvs also announce increase
1367,ESRX,stock advanced rise volume tuesday most leader notch gain decline volume biggest splash day however come negative side medical sector express script esrx gap volume be average pharmacy benefit management company report quarterly result monday close earning edge
1368,ESRX,pharmacy benefit manager catamaran ctrx earning sank acquisition cost earning back cost beat analyst forecast investor push stock higher midday brighter outlook share surge nearly midday trading thursday catamaran change name last summer sxc health solution say adjust earning share climb
1369,ESRX,sector lead stock end mixed thursday mostly lower volume major average eke small gain alexion pharmaceutical alxn rise strong volume try bounce day line end day slide see stock slice major support line high turnover way alexion
1370,ESRX,sector lead stock ibd close mixed friday major average end mixed web com wwww plunge high volume slice day line briefly trading day marker pare loss publish service company dive report close thursday third quarter profit rise better expect
1371,ESRX,apple aapl still have plenty runway growth say michael orndorff fund manager american century cap growth
1372,ESRX,cupertino calif base colossus have dominate holding fund help gain year monday best gain large cap growth peer track morningstar
1373,ESRX,orndorff co manager david hollond marcus scott continue believe apple make portfolio latest report date iphone business account apple revenue quarter end june have room grow orndorff say
1374,ESRX,room exist carrier room add new carrier say
1375,ESRX,see big opportunity china mobile chl apple hasn inked big deal chinese wireless carrier certainly think largest carrier world apple be have discussion point future sign customer orndorff say
1376,ESRX,note china mobile have subscriber many afford iphone still do give significant opportunity sell additional phone say
1377,ESRX,orndorff also see more runway business customer many be still used blackberrys runway overall global market say cell phone be sell year only be iphone
1378,ESRX,fund manager view apple have ability keep grow sustainable growth be key quality want see holding first screen firm show accelerate growth profit revenue orndorff say then study quality growth well sustainability
1379,ESRX,example prefer company expand thank new product market rather currency benefit
1380,ESRX,accelerate fundamental manager look stock price outperformance relative russell orndorff say view technical analysis tool tool set
1381,ESRX,relative strength confirm positive change fundamental also indicate deterioration fundamental say let say relative strength be breaking ll try go back review something fundamental change
1382,ESRX,say american century approach ibd slim strategy be similar focus accelerate fundamental relative strength
1383,ESRX,ibd stock catamaran ctrx be recent top hold orndorff note catamaran start selling service pharmacy benefit manager then become pbm now industry express script esrx fund also own cvs caremark cvs
1384,ESRX,see catamaran take market share say beauty be express cv give little share win matter much be meaningful catamaran give smaller size orndorff say like pbms overall gain employer try cut health care cost
1385,ESRX,fund have trim cyclical play such national oilwell varco nov cut energy material industrial weight economy show sign slow apple aapl still have plenty runway growth say michael orndorff fund manager american century cap growth cupertino calif base colossus have dominate holding fund help gain year monday best gain large cap growth peer track morningstar orndorff co manager david hollond marcus scott continue believe apple make portfolio latest report date iphone business account apple revenue quarter end june have room grow orndorff say room exist carrier room add new carrier say see big opportunity china mobile chl apple hasn inked big deal chinese wireless carrier certainly think largest carrier world apple be have discussion point future sign customer orndorff say note china mobile have subscriber many afford iphone still do give significant opportunity sell additional phone say orndorff also see more runway business customer many be still used blackberrys runway overall global market say cell phone be sell year only be iphone fund manager view apple have ability keep grow sustainable growth be key quality want see holding first screen firm show accelerate growth profit revenue orndorff say then study quality growth well sustainability example prefer company expand thank new product market rather currency benefit accelerate fundamental manager look stock price outperformance relative russell orndorff say view technical analysis tool tool set relative strength confirm positive change fundamental also indicate deterioration fundamental say let say relative strength be breaking ll try go back review something fundamental change say american century approach ibd slim strategy be similar focus accelerate fundamental relative strength ibd stock catamaran ctrx be recent top hold orndorff note catamaran start selling service pharmacy benefit manager then become pbm now industry express script esrx fund also own cvs caremark cvs see catamaran take market share say beauty be express cv give little share win matter much be meaningful catamaran give smaller size orndorff say like pbms overall gain employer try cut health care cost fund have trim cyclical play such national oilwell varco nov cut energy material industrial weight economy show sign slow
1386,ESRX,busiest most important year history catamaran ctrx now tackle major project hold largest customer
1387,ESRX,catamaran formerly know sxc health solution provide pharmacy benefit service health care information technology system corporate client manage care organization government entity other customer
1388,ESRX,pbm company handle drug benefit health plan employer other health care payer work reduce drug cost help client member get deeper discount retail pharmacy manufacturer
1389,ESRX,catamaran pbm business get big boost last year company acquire rival catalyst health solution cash stock deal value
1390,ESRX,deal close july be expect make catamaran more competitive nation other major pbms express script esrx cvs caremark cvs
1391,ESRX,other thing catamaran have design landing more contract kind fortune company be previously dominate other pbms
1392,ESRX,business model catamaran bring party be highly transparent customer friendly flexible be attractive fortune company say brook neill analyst dougherty co estimate fortune employee market be big overall market catamaran have traditionally target
1393,ESRX,catamaran chase more business fortune firm also focus keep biggest customer healthspr medicare carrier account catamaran business third quarter
1394,ESRX,catamaran contract healthspr be set expire end year decision renew now rest manage care firm cigna ci acquire healthspr
1395,ESRX,big customer obviously important contract neill say
1396,ESRX,cigna be expect make decision midyear company have not tip hand neill other sound confident cigna renew healthspr contract catamaran
1397,ESRX,speculation be catamaran be likely retain relationship healthspr possibly even expand business cigna neill say recent commentary catamaran executive have be positive have be neutral
1398,ESRX,feb report jpmorgan analyst lisa gill offer similar view note catamaran remain well position larger outsource deal cigna
1399,ESRX,meanwhile catamaran have score couple impressive win other high profile client
1400,ESRX,early november sign year contract provide pbm service target tgt country largest employer deal cover retail giant worker nationwide contract be previously hold express script
1401,ESRX,target support thesis larger entity catamaran be much better position larger employer contract have historically be sweet spot larger pbms note gabriel leung analyst paradigm capital
1402,ESRX,earlier last year catamaran sign year contract provide pbm service blue cross blue shield rhode island bcbsri contract go effect jan
1403,ESRX,bcbsri health insurer base providence be state lead health insurer cover more member half state population previous pmb provider bcbsri be cvs be base rhode island
1404,ESRX,be note cvs be sixth largest employer rhode island largest private sector employer note tom liston analyst cantor fitzgerald canada bcbsri contract underscore competitive advantage catamaran have situation complex requirement
1405,ESRX,advantage include catamaran transparent pricing technology leadership say
1406,ESRX,advantage be efficient operation let catamaran be competitive price analyst neill say believe catamaran ebitda script be lower competitor so be successful charge customer less money
1407,ESRX,financially catamaran have build reputation deliver consistently strong growth company have increase annual earning double triple digit year quarterly profit have rise double digit past quarters
1408,ESRX,earning third quarter come cent share exclude buyout related expense be cent prior year penny wall street view even include acquisition cost catamaran earn profit cent share
1409,ESRX,revenue quarter more double be fifth time past quarters catamaran top line rise triple digit
1410,ESRX,company be slate report fourth quarter result feb analyst poll thomson reuter expect ep cent share cent year earlier see full year profit rise
1411,ESRX,catamaran stock price hit record high feb busiest most important year history catamaran ctrx now tackle major project hold largest customer catamaran formerly know sxc health solution provide pharmacy benefit service health care information technology system corporate client manage care organization government entity other customer pbm company handle drug benefit health plan employer other health care payer work reduce drug cost help client member get deeper discount retail pharmacy manufacturer catamaran pbm business get big boost last year company acquire rival catalyst health solution cash stock deal value deal close july be expect make catamaran more competitive nation other major pbms express script esrx cvs caremark cvs other thing catamaran have design landing more contract kind fortune company be previously dominate other pbms business model catamaran bring party be highly transparent customer friendly flexible be attractive fortune company say brook neill analyst dougherty co estimate fortune employee market be big overall market catamaran have traditionally target catamaran chase more business fortune firm also focus keep biggest customer healthspr medicare carrier account catamaran business third quarter catamaran contract healthspr be set expire end year decision renew now rest manage care firm cigna ci acquire healthspr big customer obviously important contract neill say cigna be expect make decision midyear company have not tip hand neill other sound confident cigna renew healthspr contract catamaran speculation be catamaran be likely retain relationship healthspr possibly even expand business cigna neill say recent commentary catamaran executive have be positive have be neutral feb report jpmorgan analyst lisa gill offer similar view note catamaran remain well position larger outsource deal cigna meanwhile catamaran have score couple impressive win other high profile client early november sign year contract provide pbm service target tgt country largest employer deal cover retail giant worker nationwide contract be previously hold express script target support thesis larger entity catamaran be much better position larger employer contract have historically be sweet spot larger pbms note gabriel leung analyst paradigm capital earlier last year catamaran sign year contract provide pbm service blue cross blue shield rhode island bcbsri contract go effect jan bcbsri health insurer base providence be state lead health insurer cover more member half state population previous pmb provider bcbsri be cvs be base rhode island be note cvs be sixth largest employer rhode island largest private sector employer note tom liston analyst cantor fitzgerald canada bcbsri contract underscore competitive advantage catamaran have situation complex requirement advantage include catamaran transparent pricing technology leadership say advantage be efficient operation let catamaran be competitive price analyst neill say believe catamaran ebitda script be lower competitor so be successful charge customer less money financially catamaran have build reputation deliver consistently strong growth company have increase annual earning double triple digit year quarterly profit have rise double digit past quarters earning third quarter come cent share exclude buyout related expense be cent prior year penny wall street view even include acquisition cost catamaran earn profit cent share revenue quarter more double be fifth time past quarters catamaran top line rise triple digit company be slate report fourth quarter result feb analyst poll thomson reuter expect ep cent share cent year earlier see full year profit rise catamaran stock price hit record high feb
1412,ESRX,market confirm uptrend be middle month big cap be act well be build basis other be new buy point still other continue sculpt beautiful uptrend leader be build base strong uptrend investor afford time learn more company
1413,ESRX,medical sector have truly be bastion strength so far tuesday action be exception nasdaq composite lose biggest decline july alexion pharmaceutical alxn edge point ahead volume be day average share biotech have rally past flat base
1414,ESRX,regular reader ibd big cap use list barometer not only health large cap sector also industry sector be head class day health care sector be get grade today big cap show company roughly third entire list be health care related come surprise health care be big chunk american economy regardless november presidential election result bound grow year ahead also area continuous innovation development monday daily ibd industry group table show today top group be medical related medical rank just ibd stock table also sport leader have attribute big market winner hca holding hca ignore market decline monday third straight strong advance past base buy point have boost hospital giant week high now stock have wrestle upside resistance price level nashville tenn base firm suffer severe drop earning share hca have get act together earning have climb year then earning grow past quarters revenue growth have be limit same time slim paradigm number be deficient once company relatively mature industry still emerge big stock winner institutional demand be long term overwhelmingly strong hca latest week base only week price show heavy trade relative week move average yet week end july hca close upper weekly price range such action take place base left side actually count week accumulation not distribution express script esrx continue show good action rally past buy point cup handle handle begin july stock reach high retreat decline week handle be normal stock have gain much then trading well day move average be rise be monday close elsewhere ross store rost be verge build new base fall week row decline have be light manner
1415,ESRX,sector leader be rise broad market strike higher ground leave fewer great stock buy zone aerospace company transdigm group tdg climb volume swell norm third straight gain latest strong volume stock now be reach flat base buy point transdigm
1416,ESRX,drugstore chain wag post slumping august sale pressure cheaper generic soon expire impasse prescription benefit manager express script esrx sale pressure continue even begin fill prescription again express script patient defection major customer tricare health care program provide benefit
1417,ESRX,wag fourth quarter earning revenue remain weak struggle regain customer lose due contract dispute express script esrx
1418,ESRX,drugstore operator say ep fall cent beat view penny revenue fall estimate
1419,ESRX,share dip intraday trading
1420,ESRX,be challenge very important year walgreen finished tough quarter say ceo greg wasson controlled cost generate strong cash flow fourth quarter performance also reflect strategic shift promotional spending continue economically challenged consumer impact express script
1421,ESRX,same store sale front end doesn include prescription decrease basket size typical consumer purchase increase total same store sale fall
1422,ESRX,prescription sale make total sale quarter fall filled prescription decline last year fourth quarter
1423,ESRX,stop fill express script prescription begin year firm reach new deal july effective
1424,ESRX,now hammer new contract express need find way get express script customer back rival cvs caremark cvs rite aid rad
1425,ESRX,enter new fiscal year believe be position growth benefit launch balance reward loyalty program re entry express script pharmacy provider network execution alliance boot strategic partnership wasson say
1426,ESRX,retail drugstore group be rank investor business daily industry group wag fourth quarter earning revenue remain weak struggle regain customer lose due contract dispute express script esrx drugstore operator say ep fall cent beat view penny revenue fall estimate share dip intraday trading be challenge very important year walgreen finished tough quarter say ceo greg wasson controlled cost generate strong cash flow fourth quarter performance also reflect strategic shift promotional spending continue economically challenged consumer impact express script same store sale front end doesn include prescription decrease basket size typical consumer purchase increase total same store sale fall prescription sale make total sale quarter fall filled prescription decline last year fourth quarter stop fill express script prescription begin year firm reach new deal july effective now hammer new contract express need find way get express script customer back rival cvs caremark cvs rite aid rad enter new fiscal year believe be position growth benefit launch balance reward loyalty program re entry express script pharmacy provider network execution alliance boot strategic partnership wasson say retail drugstore group be rank investor business daily industry group
1427,ESRX,tuesday marked dull day market few sector leader have more notable move lululemon athletica lulu reversed early loss hit month high rise tuesday marked stock fourth gain past session tuesday turnover drop average stock recently regain week line
1428,ESRX,share biotech vivus vvus jump early trading monday month high company report latest monthly shipment new obesity drug qsymia
1429,ESRX,company disclose sec filing ship qsymia prescription period end dec more previous week period drug be launch september ramp be bit slow be first available only mail order cvs cvs wag then prospect have be boost new insurance coverage aetna aet addition express script esrx provider arena pharmaceutical arna sell obesity drug belviq be unchanged morning trading share biotech vivus vvus jump early trading monday month high company report latest monthly shipment new obesity drug qsymia company disclose sec filing ship qsymia prescription period end dec more previous week period drug be launch september ramp be bit slow be first available only mail order cvs cvs wag then prospect have be boost new insurance coverage aetna aet addition express script esrx provider arena pharmaceutical arna sell obesity drug belviq be unchanged morning trading
1430,ESRX,sector leader manage mixed end tuesday even market reversed lower francesca holding fran bounce back monday high volume downside reversal climb back forth session stock close past buy point cup handle base francesca base be sloppy be flaw generally tighter pattern be more
1431,ESRX,express script esrx have reach agreement provide pharmacy network benefit wag customer walgreen begin fill express script prescription express script share gain afternoon trading hit week high intraday share shot stock have be yearlong downtrend company
1432,ESRX,wag tuesday say buy stake alliance boot switzerland base health beauty retailer cash stock deal create world largest buyer prescription drug
1433,ESRX,investor react negatively costly deal share fall afternoon trading
1434,ESRX,have be shedding market share competitor cvs caremark cvs lose deal pharmacy benefit manager express script esrx end
1435,ESRX,alliance boot operate boot largest drugstore chain also have store norway ireland netherlands thailand lithuania deal open global market pave way expansion develop nation china egypt
1436,ESRX,also begin selling boot product store include popular brand skin care brand
1437,ESRX,be look forward work alliance boot leverage combine strength provide even broader range innovative cost effective product service patient customer health care landscape say ceo gregory wasson together be ideally position expand customer offering exist market become health well be partner choice emerge market
1438,ESRX,open europe be problem chain investor worry volatile debt situation greece spain italy
1439,ESRX,part deal have option buy rest alliance boot year current exchange rate accord ap
1440,ESRX,estimate deal add cent share transaction cost earning year initial stage deal be complete
1441,ESRX,company continue do business brand name job cut be expect term
1442,ESRX,deal be expect be complete september
1443,ESRX,also announce cent increase quarterly dividend cent share
1444,ESRX,competitor cvs present jeffery global consumer conference tuesday say business unit be poise healthy growth
1445,ESRX,cvs be plan increase current minuteclinic full time clinic company also want expand offering coverage medicare medicaid patient
1446,ESRX,be reinvent pharmacy better health better shareholder value say executive vice president mark cosby best class business be position healthy growth year come
1447,ESRX,pharmacy market share fill prescription have be grow past few year total prescription cvs say split express script be opportunity continue grow market share
1448,ESRX,share rise wag tuesday say buy stake alliance boot switzerland base health beauty retailer cash stock deal create world largest buyer prescription drug investor react negatively costly deal share fall afternoon trading have be shedding market share competitor cvs caremark cvs lose deal pharmacy benefit manager express script esrx end alliance boot operate boot largest drugstore chain also have store norway ireland netherlands thailand lithuania deal open global market pave way expansion develop nation china egypt also begin selling boot product store include popular brand skin care brand be look forward work alliance boot leverage combine strength provide even broader range innovative cost effective product service patient customer health care landscape say ceo gregory wasson together be ideally position expand customer offering exist market become health well be partner choice emerge market open europe be problem chain investor worry volatile debt situation greece spain italy part deal have option buy rest alliance boot year current exchange rate accord ap estimate deal add cent share transaction cost earning year initial stage deal be complete company continue do business brand name job cut be expect term deal be expect be complete september also announce cent increase quarterly dividend cent share competitor cvs present jeffery global consumer conference tuesday say business unit be poise healthy growth cvs be plan increase current minuteclinic full time clinic company also want expand offering coverage medicare medicaid patient be reinvent pharmacy better health better shareholder value say executive vice president mark cosby best class business be position healthy growth year come pharmacy market share fill prescription have be grow past few year total prescription cvs say split express script be opportunity continue grow market share share rise
1449,ESRX,stock close narrowly mixed thursday give gain end session nasdaq lose less rise dow jone industrial average also rise snap session lose streak volume decrease wednesday level main exchange accord early datum hour express script esrx be
1450,ESRX,express script esrx finalize purchase medco health solution mhs early next week pharmacy benefit manager say wednesday
1451,ESRX,deal be announce july concern merger not pass antitrust regulator keep medco share lower offer price
1452,ESRX,wednesday news send medco share more early afternoon trading wednesday hit new high express script rise
1453,ESRX,previously company have say deal wouldn be finalize second quarter earliest
1454,ESRX,express script medco say couldn guarantee deal be finalize investor be see new timeline announcement good sign
1455,ESRX,even re not guarantee go close next week quite sign confidence say analyst gabelli co reuter article
1456,ESRX,deal come investigation federal trade commission merger create largest pharmacy benefit manager bigger second place manager cvs caremark cvs
1457,ESRX,company argue merger be good customer help lower drug price not raise
1458,ESRX,earlier year wag end contract express script hurt pharmacy second quarter earning
1459,ESRX,march report drop second quarter profit cent share still beating view penny sale rise vs prior year beating view
1460,ESRX,say expect breakup express script affect earning cent share
1461,ESRX,share edge higher
1462,ESRX,decide end contract express script fill many customer prescription be unprofitable
1463,ESRX,ceo greg wasson affirm decision end contract express script recent earning report
1464,ESRX,medco express deal further impact still fill medco prescription express script esrx finalize purchase medco health solution mhs early next week pharmacy benefit manager say wednesday deal be announce july concern merger not pass antitrust regulator keep medco share lower offer price wednesday news send medco share more early afternoon trading wednesday hit new high express script rise previously company have say deal wouldn be finalize second quarter earliest express script medco say couldn guarantee deal be finalize investor be see new timeline announcement good sign even re not guarantee go close next week quite sign confidence say analyst gabelli co reuter article deal come investigation federal trade commission merger create largest pharmacy benefit manager bigger second place manager cvs caremark cvs company argue merger be good customer help lower drug price not raise earlier year wag end contract express script hurt pharmacy second quarter earning march report drop second quarter profit cent share still beating view penny sale rise vs prior year beating view say expect breakup express script affect earning cent share share edge higher decide end contract express script fill many customer prescription be unprofitable ceo greg wasson affirm decision end contract express script recent earning report medco express deal further impact still fill medco prescription
1465,ESRX,cvs caremark cvs top wall street estimate wednesday express script esrx user flocked drugstore once wag stop deal pharmacy benefit provider
1466,ESRX,cvs report rise first quarter earning share cent beating forecast cent revenue grow estimate
1467,ESRX,share rise early wednesday afternoon share fall
1468,ESRX,cvs raise ep guidance vs analyst expectation company see shift express script customer walgreen cvs long last see ep cent wall street estimate cent
1469,ESRX,longer impasse last stickier customer be go be larry merlo ceo cvs tell reuter re go have opportunity visit cvs multiple time begin establish relationship cvs pharmacist
1470,ESRX,stop fill prescription express script patient end
1471,ESRX,cvs same store sale sale drugstore open least year rise fuel more business medicare recipient well former customer
1472,ESRX,revenue retail pharmacy segment increase mild flu season debut new generic drug weigh slightly revenue sale pharmacy service segment company caremark pharmacy benefit manager rise be mainly acquisition universal american corp medicare prescription drug plan cvs caremark cvs top wall street estimate wednesday express script esrx user flocked drugstore once wag stop deal pharmacy benefit provider cvs report rise first quarter earning share cent beating forecast cent revenue grow estimate share rise early wednesday afternoon share fall cvs raise ep guidance vs analyst expectation company see shift express script customer walgreen cvs long last see ep cent wall street estimate cent longer impasse last stickier customer be go be larry merlo ceo cvs tell reuter re go have opportunity visit cvs multiple time begin establish relationship cvs pharmacist stop fill prescription express script patient end cvs same store sale sale drugstore open least year rise fuel more business medicare recipient well former customer revenue retail pharmacy segment increase mild flu season debut new generic drug weigh slightly revenue sale pharmacy service segment company caremark pharmacy benefit manager rise be mainly acquisition universal american corp medicare prescription drug plan
1473,ESRX,wag share gap week high more twice usual volume wednesday morning ub upgrade nation pharmacy chain neutral buy raise price target ub cite long term growth prospect include higher sale obamacare kick high gear rise profit margin resolution last
1474,ESRX,stock open narrowly mixed higher trade monday echo action overseas market little affected gain manufacturing activity march
1475,ESRX,warm nasdaq dow jone industrial average ease volume rise nasdaq trading express script esrx be run more time average nyse volume rise compare same time friday
1476,ESRX,institute supply management march index tick february level better read expect reading indicate expansion manufacturing ism say index have show expansion consecutive month
1477,ESRX,construction spending slip february accord census bureau decline follow slowdown january straight month gain fall short expectation advance
1478,ESRX,express script jump federal trade commission approve company medco health solution mhs company say monday vote be final step month process complete deal announce july combine company reportedly handle prescription third population expect annual cost saving merger
1479,ESRX,monday gap put express script just buy point month cup handle base buy point exist
1480,ESRX,buffalo wild wing bwld fold raymond james downgrade stock sport bar chain hold week move average be still buy point clear cup handle base february
1481,ESRX,liquidity service lqdt slip pull back test support week move average online inventory auctioneer third visit week line clear buy point december buy point emerge later stock open narrowly mixed higher trade monday echo action overseas market little affected gain manufacturing activity march warm nasdaq dow jone industrial average ease volume rise nasdaq trading express script esrx be run more time average nyse volume rise compare same time friday institute supply management march index tick february level better read expect reading indicate expansion manufacturing ism say index have show expansion consecutive month construction spending slip february accord census bureau decline follow slowdown january straight month gain fall short expectation advance express script jump federal trade commission approve company medco health solution mhs company say monday vote be final step month process complete deal announce july combine company reportedly handle prescription third population expect annual cost saving merger monday gap put express script just buy point month cup handle base buy point exist buffalo wild wing bwld fold raymond james downgrade stock sport bar chain hold week move average be still buy point clear cup handle base february liquidity service lqdt slip pull back test support week move average online inventory auctioneer third visit week line clear buy point december buy point emerge later
1482,ESRX,express script esrx win approval federal trade commission purchase rival medco health solution arduous month review
1483,ESRX,ftc vote clear way merger condition asset sale impose company company release statement say have complete merger
1484,ESRX,combination largest pharmacy benefit manager create largest pbm far
1485,ESRX,pbms administer drug benefit employer health plan run mail order pharmacy
1486,ESRX,express script share jump more midday trading prior monday trading session medco share be converted express script share cash pbm cvs caremark cvs rise less
1487,ESRX,term share medco common stock be converted cash share new express script
1488,ESRX,express script say company be operated separate unit expect achieve synergy once re fully integrate
1489,ESRX,george paz express script ceo say statement merger represent next chapter mission lower cost drive waste health care improve patient health
1490,ESRX,express script medco have argue regulator combine benefit consumer drive prescription cost critic assert megasize pbm lead higher price possibly service
1491,ESRX,last week group drugstore chain community pharmacist file federal lawsuit bid stop merger express medco expressed confidence deal go future
1492,ESRX,express script have make news start year public split former partner wag nation largest drugstore chain
1493,ESRX,contract expire stop fill prescription express script forfeit revenue rather fill say be unprofitable prescription say march see steeper expect decline february sale pact end
1494,ESRX,share climb nearly express script esrx win approval federal trade commission purchase rival medco health solution arduous month review ftc vote clear way merger condition asset sale impose company company release statement say have complete merger combination largest pharmacy benefit manager create largest pbm far pbms administer drug benefit employer health plan run mail order pharmacy express script share jump more midday trading prior monday trading session medco share be converted express script share cash pbm cvs caremark cvs rise less term share medco common stock be converted cash share new express script express script say company be operated separate unit expect achieve synergy once re fully integrate george paz express script ceo say statement merger represent next chapter mission lower cost drive waste health care improve patient health express script medco have argue regulator combine benefit consumer drive prescription cost critic assert megasize pbm lead higher price possibly service last week group drugstore chain community pharmacist file federal lawsuit bid stop merger express medco expressed confidence deal go future express script have make news start year public split former partner wag nation largest drugstore chain contract expire stop fill prescription express script forfeit revenue rather fill say be unprofitable prescription say march see steeper expect decline february sale pact end share climb nearly
1495,ESRX,stock score moderate election day gain tuesday earn day winning streak nyse composite rise respectively finishing not far session high nasdaq tack end middle trading range day volume increase board monday level market rally modestly american
1496,ESRX,cvs caremark cvs expect first quarter sale be boost express script esrx user switch pharmacy company report first quarter result market open wednesday
1497,ESRX,top drugstore chain sale be expect report rise profit share cent sale likely rise
1498,ESRX,cvs issue ep guidance cent february predict many express script customer transfer prescription cvs co wag pharmacy benefit manager couldn reach contract agreement stop fill express script prescription january
1499,ESRX,cvs share rise late afternoon trade tuesday express script climb dip cent
1500,ESRX,wave low cost generic drug hit market boost profit caremark benefit management business brand drug accounting nearly annual sale be expect open generic competition next several year company say earlier
1501,ESRX,cvs report rise ep cent meeting view sale climb forecast
1502,ESRX,end cvs operated drugstore caremark be largest pharmacy benefit manager
1503,ESRX,cvs have composite rating relative strength rating
1504,ESRX,retail drugstore group be rank investor business daily industry group cvs caremark cvs expect first quarter sale be boost express script esrx user switch pharmacy company report first quarter result market open wednesday top drugstore chain sale be expect report rise profit share cent sale likely rise cvs issue ep guidance cent february predict many express script customer transfer prescription cvs co wag pharmacy benefit manager couldn reach contract agreement stop fill express script prescription january cvs share rise late afternoon trade tuesday express script climb dip cent wave low cost generic drug hit market boost profit caremark benefit management business brand drug accounting nearly annual sale be expect open generic competition next several year company say earlier cvs report rise ep cent meeting view sale climb forecast end cvs operated drugstore caremark be largest pharmacy benefit manager cvs have composite rating relative strength rating retail drugstore group be rank investor business daily industry group
1505,ESRX,pharmacy benefit management firm express script esrx have be standoff drug chain wag start year investor analyst look guidance impact current year report fourth quarter earning wednesday market close analyst expect earning climb cent
1506,ESRX,stock touch fresh session lows midafternoon wednesday investor digest release minute federal reserve last policy meeting president obama news conference
1507,ESRX,dow jone industrial average be fall nasdaq drop index have touch fresh low current market correction slump further day move average volume be tracking ahead tuesday level board
1508,ESRX,fed minute indicated official see need additional quantitative ease next year minute also suggest central bank be move closer provide better guidance make first rate hike
1509,ESRX,meanwhile president call congress extend middle class tax break say least do agree say washington then move negotiating handle taxe wealthy work avoid fiscal cliff still market sell have picked midafternoon
1510,ESRX,ibd stock be mostly lower catamaran ctrx slide strong volume pharmacy benefit manager service provider wednesday ibd slice day move average consolidate level last few week rival pharmacy benefit manager express script esrx be also heavy volume slide
1511,ESRX,michael kor kor wednesday ibd fall active turnover clothing accessory maker december ipo have undercut support prior buy point
1512,ESRX,upside cisco system csco jump strong turnover power better expect earning report late tuesday stock remain day day move average well april high cisco have weak ibd composite rating remain tech sector bellwether
1513,ESRX,facebook fb gain big volume big lock expiration day ipo social network remain peak still have poor ibd composite rating stock touch fresh session lows midafternoon wednesday investor digest release minute federal reserve last policy meeting president obama news conference dow jone industrial average be fall nasdaq drop index have touch fresh low current market correction slump further day move average volume be tracking ahead tuesday level board fed minute indicated official see need additional quantitative ease next year minute also suggest central bank be move closer provide better guidance make first rate hike meanwhile president call congress extend middle class tax break say least do agree say washington then move negotiating handle taxe wealthy work avoid fiscal cliff still market sell have picked midafternoon ibd stock be mostly lower catamaran ctrx slide strong volume pharmacy benefit manager service provider wednesday ibd slice day move average consolidate level last few week rival pharmacy benefit manager express script esrx be also heavy volume slide michael kor kor wednesday ibd fall active turnover clothing accessory maker december ipo have undercut support prior buy point upside cisco system csco jump strong turnover power better expect earning report late tuesday stock remain day day move average well april high cisco have weak ibd composite rating remain tech sector bellwether facebook fb gain big volume big lock expiration day ipo social network remain peak still have poor ibd composite rating
1514,ESRX,cvs caremark cvs likely have healthy end turbulence competitor provide beneficial tail wind start year drugstore chain pharmacy benefit management firm report fourth quarter result market open wednesday analyst forecast hike earning cent share high end
1515,ESRX,catamaran ctrx sail higher fourth quarter profit pharmacy benefit manager earning jump new contract see revenue increase big acquisition last year share company formerly name sxc health solution fall early thursday revenue just meet estimate guidance be lighter expect catamaran earning share rise
1516,ESRX,wag january same store sale plummet lower prescription forecast first report leave express script esrx pharmacy network same store sale metric focuse comparable sale store open least year be see good indicator future sale growth share nation largest drugstore chain be
1517,ESRX,falloff prescription send earning lower wag impasse express script esrx continue result still beat analyst forecast
1518,ESRX,nation largest chain drugstore post fiscal second quarter earning cent cent year analyst have forecast cent
1519,ESRX,net sale climb almost also slightly consensus estimate
1520,ESRX,share rise nearly hit month high early
1521,ESRX,front end sale store open least year climb quarter measure exclude prescription total same store sale include prescription fall
1522,ESRX,total prescription account sale quarter decrease
1523,ESRX,filled prescription second quarter
1524,ESRX,mild start flu season also cut seasonal flu shot
1525,ESRX,front end store continue perform strongly attract customer health daily live need ceo greg wasson say statement expect convenience customer focuse selection front end health daily live product service lead higher comparable store front end sale quarter reduce pharmacy volume
1526,ESRX,cease fill prescription patient express script pharmacy benefit management network dec fail agree new contract
1527,ESRX,drugstore chain cvs caremark cvs smaller rival include rite aid rad have be beneficiary contract impasse court winning customer
1528,ESRX,cvs share edge fractionally late morning trade tuesday rite aid rise nearly express script fall falloff prescription send earning lower wag impasse express script esrx continue result still beat analyst forecast nation largest chain drugstore post fiscal second quarter earning cent cent year analyst have forecast cent net sale climb almost also slightly consensus estimate share rise nearly hit month high early front end sale store open least year climb quarter measure exclude prescription total same store sale include prescription fall total prescription account sale quarter decrease filled prescription second quarter mild start flu season also cut seasonal flu shot front end store continue perform strongly attract customer health daily live need ceo greg wasson say statement expect convenience customer focuse selection front end health daily live product service lead higher comparable store front end sale quarter reduce pharmacy volume cease fill prescription patient express script pharmacy benefit management network dec fail agree new contract drugstore chain cvs caremark cvs smaller rival include rite aid rad have be beneficiary contract impasse court winning customer cvs share edge fractionally late morning trade tuesday rite aid rise nearly express script fall
1529,ESRX,medical stock dominate list lead stock be top loser wednesday alexion pharmaceutical alxn fall heavy trade pierce day move average alexion have break past couple week long uptrend begin now recent high yet company
1530,ESRX,call earning surprise fact top drugstore chain beat analyst consensus earning forecast first quarter room spare shock group stock performance other hand have catch industry onlooker guard group drugstore be year date better double
1531,ESRX,pick phone call top executive country learn harlan steinbaum have successful career business do just interview person include leader verizon vz chrysler espn career define choice make write new
1532,ESRX,institution key driver market big name plenty liquidity top tier fundamental ibd big cap leader screen day filter weaker name present best biggy top list be fashion house michael kor kor seller lux purse scarves clothing report boost
1533,ESRX,call earning surprise fact top drugstore chain beat analyst consensus earning forecast first quarter room spare shock group stock performance other hand have catch industry onlooker guard group drugstore be year date better double
1534,ESRX,sector lead stock fall tuesday market uptrend come pressure many appear head test support week move average alexion pharmaceutical alxn be biggest decliner sink more now just flat base buy point be much volume
1535,ESRX,market best rate stock have retreat past week so few be damage process other be build opportunity buy apple aapl fall last week brisk trade fall volume climb moderately average pace be apple first close week
1536,ESRX,stock future pressed higher thursday rise weekly jobless datum dollar skitter lower dow future climb point ahead bell nasdaq future reversed early loss be point future gain point initial jobless claim week end july rise be prior week upwardly
1537,ESRX,most sector lead stock fall monday major average sell commvault system cvlt alexion pharmaceutical alxn slide back buy range yoga style apparel retailer lululemon athletica lulu buck trend end flat average volume stock be shape deep cup handle base lululemon accumulation distribution rating have climb past couple
1538,ESRX,optimism greek confidence vote boost stock future tuesday nasdaq future climb point vs fair value future rally point dow future rise point
1539,ESRX,greek prime minister george papandreou face parliamentary vote confidence later tuesday parliamentary approval help pave way debt ride country pass new austerity measure be need get next installment bailout fund vote take place edt
1540,ESRX,rating agency fitch warn downgrade greece credit rating event voluntary rollover country debt moody standard poor have downgrade greece credit rating recent month
1541,ESRX,fitch also threaten put credit rating negative watch agreement debt ceiling wasn reach aug
1542,ESRX,meanwhile world market moved higher france cac jump afternoon trade london ftse germany dax gain asia hang seng climb shanghai composite rise
1543,ESRX,corporate news wag fall pre open trading top earning view nation biggest drugstore operator say profit climb cent share cent estimate company say fail renew agreement express script esrx longer be part network start next year express script share lose pre market
1544,ESRX,biogen idec biib rise pre open trading upgrade deutsche bank raise biotech buy hold raise price target stock also win upgrade monday
1545,ESRX,datum exist home sale be edt economist see sale decline annualize rate unit unit april
1546,ESRX,fed begin day meeting today decision interest rate come wednesday investor pay attention sign third round quantitative ease optimism greek confidence vote boost stock future tuesday nasdaq future climb point vs fair value future rally point dow future rise point greek prime minister george papandreou face parliamentary vote confidence later tuesday parliamentary approval help pave way debt ride country pass new austerity measure be need get next installment bailout fund vote take place edt rating agency fitch warn downgrade greece credit rating event voluntary rollover country debt moody standard poor have downgrade greece credit rating recent month fitch also threaten put credit rating negative watch agreement debt ceiling wasn reach aug meanwhile world market moved higher france cac jump afternoon trade london ftse germany dax gain asia hang seng climb shanghai composite rise corporate news wag fall pre open trading top earning view nation biggest drugstore operator say profit climb cent share cent estimate company say fail renew agreement express script esrx longer be part network start next year express script share lose pre market biogen idec biib rise pre open trading upgrade deutsche bank raise biotech buy hold raise price target stock also win upgrade monday datum exist home sale be edt economist see sale decline annualize rate unit unit april fed begin day meeting today decision interest rate come wednesday investor pay attention sign third round quantitative ease
1547,ESRX,even market put more loss wednesday sector leader deliver mixed finish few issue manage stage meager upside reversal alexion pharmaceutical alxn tick seesaw session volume cool spiking average tuesday intraday stock test buy point flat base alexion gain be big
1548,ESRX,stock inched higher soft trade friday open market watch sign progress washington dow jone industrial average climb nasdaq drift higher volume be sharply lower stock market today nasdaq lower nyse compare same time
1549,ESRX,sector lead stock end mixed weak volume friday monster beverage mnst plunge second day realpage rp climb seventh straight session meanwhile express script esrx mellanox technology mlnx dip time high several other stock find support day average line monster maker energy drink lose
1550,ESRX,lead stock mostly fared well past week market uptrend continue couple big exception huge dife monster beverage mnst priceline com pcln weigh ibd index lose nearly week meanwhile nasdaq rise nyse composite monster priceline tumble
1551,ESRX,majority sector leader end volatile market session higher friday most issue score modest gain alexion pharmaceutical alxn finished higher first time day rise back forth session turnover climb past session end average stock have form square box base
1552,ESRX,apart few rare exception point buy stock weak industry group uptrend be choppy enough add head wind laggard group so let look stock accord preliminary list be strongest group thing stand first many stock be extend
1553,ESRX,nearly stock sector leader screen lose ground monday major stock average pull back polaris industry pii be only sector leader advanced rise nearly maker atvs snowmobile motorcycle moved further past buy point cup handle pattern polaris previously sketch earlier
1554,ESRX,sometimes opportunity nearly knock door strong rapping other time light tap follow day july many investor thought occasionally hear faint knock only find nothing be now knock form breakout attractive chart be get more frequent louder
1555,ESRX,healthy market be high quality stock buy judge action week ibd big cap bull market be improve health quite few stock be still buy range recently rise past proper buy point come wide range industry mid july agrium agu moved past cup handle entry fast turnover investor not buy stock more past proper price upper limit be agrium monday finished very thin trade worth note agrium handle high exceed cup left side peak be unusual do not negate authenticity pattern bill neil commentary past great winner redman industry last week also point base show handle high be greater price cup high agrium be calgary base producer fertilizer most sale come severe drought year have create fast shrink supply corn analyst reason farmer buy more fertilizer capture more profit high commodity price agrium have respectable earning share rating bottom line be volatile earning have balloon share year consensus wall street forecast see growth cool agrium top line growth appear little more steady still swing sale jump biggest bulge least year economy begin steady horrific agrium sale wilted health care arena express script esrx close monday past cup handle entry mark second straight decline nature pullback be positive last wednesday gap more triple normal volume be kind action want see stock take breather decline be mild weak trade exactly happened express script monday stock also have be buy pharmacy benefit manager have get lot bigger year due merger rival medco health solution be spun merck mrk express script help insurance company negotiate lower drug cost average year year ep increase past quarters be technology space ebay ebay lie extend base buy point commerce powerhouse be close entry square box celgene celg be now cup peak base midpoint
1556,ESRX,stock continue trade narrowly mixed territory late thursday
1557,ESRX,nasdaq rise eke gain meanwhile dow jone industrial average be fractionally lower volume be again tracking lower board
1558,ESRX,fleetcor technology flt be session high still top view raise guidance late wednesday company earn cent share second quarter year beat view cent sale climb fleetcor now see full year profit come share vs view share stock be cup base buy point
1559,ESRX,express script esrx rise new high heavy trading now past buy point cup handle base clear july however move lack big volume investor regard left side high cent more valid entry stock clear buy point strong volume wednesday be past entry
1560,ESRX,late tuesday pharmacy benefit manager beat analyst expectation rise earning pop sale revenue surge be largely due buyout medco health solution complete april management raise full year ep guidance consensus view
1561,ESRX,valspar val push gain heavy trading climb further north day move average barely regain wednesday stock have fall more buy month earlier month have be rebound valspar report fiscal result aug analyst see paint company earning rise cent share sale be slate rise
1562,ESRX,downside monster beverage mnst be session low report disappointing result late wednesday energy drink maker second quarter earning come cent share cent view sale miss expectation company cite higher expect cost international expansion effort gross margin slip year stock be now april peak
1563,ESRX,sodastream international soda trim loss look be pace third straight loss stock have turn tail past session wednesday maker home carbonation system beat view jump earning gain sale sodastream also raise full year growth forecast profit revenue yet sodastream turn gain loss stock continue trade narrowly mixed territory late thursday nasdaq rise eke gain meanwhile dow jone industrial average be fractionally lower volume be again tracking lower board fleetcor technology flt be session high still top view raise guidance late wednesday company earn cent share second quarter year beat view cent sale climb fleetcor now see full year profit come share vs view share stock be cup base buy point express script esrx rise new high heavy trading now past buy point cup handle base clear july however move lack big volume investor regard left side high cent more valid entry stock clear buy point strong volume wednesday be past entry late tuesday pharmacy benefit manager beat analyst expectation rise earning pop sale revenue surge be largely due buyout medco health solution complete april management raise full year ep guidance consensus view valspar val push gain heavy trading climb further north day move average barely regain wednesday stock have fall more buy month earlier month have be rebound valspar report fiscal result aug analyst see paint company earning rise cent share sale be slate rise downside monster beverage mnst be session low report disappointing result late wednesday energy drink maker second quarter earning come cent share cent view sale miss expectation company cite higher expect cost international expansion effort gross margin slip year stock be now april peak sodastream international soda trim loss look be pace third straight loss stock have turn tail past session wednesday maker home carbonation system beat view jump earning gain sale sodastream also raise full year growth forecast profit revenue yet sodastream turn gain loss
1564,ESRX,market confirm uptrend list stock breaking new high be expand wider range sector global jcom advanced clear flat base buy point average volume stock gap rise monday internet service provider say complete acquisition
1565,ESRX,major stock average end mostly dull summer session only minor move lower volume high profile name stage big move
1566,ESRX,nasdaq weigh priceline com pcln plunge fall dip dow jone industrial average add fraction dow extend winning streak day nasdaq snap
1567,ESRX,volume decline nasdaq nyse accord preliminary datum
1568,ESRX,priceline com plunge report late tuesday online travel service firm ep rise share vs view revenue climb just shy street projection priceline earning sale guidance be big disappointment send stock tumble lowest nearly month
1569,ESRX,rival expedia expe tripadvisor trip slump sympathy
1570,ESRX,warner chilcott wcrx dive announce have end talk sell company news report say maker drug related primarily woman health have receive takeover offer target valuation company approve debt offer pledge pay shareholder dividend share payout estimate stock have fall nearly april peak
1571,ESRX,pharmacy benefit manager express script esrx surge heavy trade company report late tuesday earning rise gain sale better forecast revenue jump owe largely company acquisition medco health solution complete april management raise full year ep guidance consensus view
1572,ESRX,stock have pull back test cup handle buy point clear mark moderate volume july be buy point
1573,ESRX,tech sector hewlett packard hpq climb raise third quarter earning guidance make hp dow biggest winner computer maker lift ep outlook prior guidance cent cent management also say company book restructure charge quarter
1574,ESRX,nuance communication nuan maker voice recognition software jump heavy trade jump ep easily clear consensus estimate revenue rise just short expectation adjust recent acquisition revenue top expectation stock have be consolidate mark high feb
1575,ESRX,hms holding hmsy rise soft trade push further north buy point cup handle base clear july stock struggle close back buy trigger tuesday hms help insurer examine medical claim determine pay detect error fraud payment major stock average end mostly dull summer session only minor move lower volume high profile name stage big move nasdaq weigh priceline com pcln plunge fall dip dow jone industrial average add fraction dow extend winning streak day nasdaq snap volume decline nasdaq nyse accord preliminary datum priceline com plunge report late tuesday online travel service firm ep rise share vs view revenue climb just shy street projection priceline earning sale guidance be big disappointment send stock tumble lowest nearly month rival expedia expe tripadvisor trip slump sympathy warner chilcott wcrx dive announce have end talk sell company news report say maker drug related primarily woman health have receive takeover offer target valuation company approve debt offer pledge pay shareholder dividend share payout estimate stock have fall nearly april peak pharmacy benefit manager express script esrx surge heavy trade company report late tuesday earning rise gain sale better forecast revenue jump owe largely company acquisition medco health solution complete april management raise full year ep guidance consensus view stock have pull back test cup handle buy point clear mark moderate volume july be buy point tech sector hewlett packard hpq climb raise third quarter earning guidance make hp dow biggest winner computer maker lift ep outlook prior guidance cent cent management also say company book restructure charge quarter nuance communication nuan maker voice recognition software jump heavy trade jump ep easily clear consensus estimate revenue rise just short expectation adjust recent acquisition revenue top expectation stock have be consolidate mark high feb hms holding hmsy rise soft trade push further north buy point cup handle base clear july stock struggle close back buy trigger tuesday hms help insurer examine medical claim determine pay detect error fraud payment
1576,ESRX,stock slip soft trade early wednesday earning news firm dollar pressured general market nasdaq slip weigh priceline com pcln plunge follow sale miss weak outlook dow jone industrial average dwindle trading be slower nyse nasdaq vs
1577,ESRX,most top stock rise thursday pharmacy benefit manager express script esrx jump new high strong volume big cap stock newcomer list sector leader rise be third straight high volume gain stock be cup handle entry put just
1578,ESRX,nothing prospect winning corporate marriage rev investor enthusiasm consider wall street reaction sxc health solution sxci announce buy fellow midsize pharmacy benefit manager catalyst health solution chsi cash stock deal value share company soar follow news april sxc surge
1579,ESRX,stock hold small gain midday monday shake dalla fed manufacturing datum badly miss expectation
1580,ESRX,nasdaq add be dow inched fraction volume stock market today be tracking significantly higher friday exchange
1581,ESRX,chipotle grill cmg add nearly heavy trading be approach time high stock recently clear buy point shallow consolidation earning sale growth have accelerate last quarters huge same store sale growth burrito chain
1582,ESRX,identity theft protection firm lifelock lock rise heavy volume clear buy point flat base pattern stock be show sign institutional accumulation have highest possible composite rating
1583,ESRX,gilead science gild climb active trading continue bounce support day move average stock come heavy selling pressure last week news express script esrx shun gilead sovaldi drug lower cost alternative abbvie abbv stock hold small gain midday monday shake dalla fed manufacturing datum badly miss expectation nasdaq add be dow inched fraction volume stock market today be tracking significantly higher friday exchange chipotle grill cmg add nearly heavy trading be approach time high stock recently clear buy point shallow consolidation earning sale growth have accelerate last quarters huge same store sale growth burrito chain identity theft protection firm lifelock lock rise heavy volume clear buy point flat base pattern stock be show sign institutional accumulation have highest possible composite rating gilead science gild climb active trading continue bounce support day move average stock come heavy selling pressure last week news express script esrx shun gilead sovaldi drug lower cost alternative abbvie abbv
1584,ESRX,stock slide fresh session lows late monday oil price continue weigh west texas intermediate close barrel
1585,ESRX,dow jone industrial average slump respectively nasdaq drop volume spiked higher major exchange stock market today
1586,ESRX,lead stock virgin america va stretched loss more airline stock be weak monday plunge oil price alaska air group alk delta air line dal southwest airline luv fall delta even boost margin outlook again
1587,ESRX,elsewhere unite rental uri tumble be cut sell buy evercore
1588,ESRX,upside gilead science gild rise reverse high cvs caremark cvs announce cover gilead solvaldi harvoni hepatitis drug several plan gilead tumble last month news express script esrx drop coverage hepatitis treatment favor abbvie abbv
1589,ESRX,fellow biotech akorn akrx be session high still nearly stock slide fresh session lows late monday oil price continue weigh west texas intermediate close barrel dow jone industrial average slump respectively nasdaq drop volume spiked higher major exchange stock market today lead stock virgin america va stretched loss more airline stock be weak monday plunge oil price alaska air group alk delta air line dal southwest airline luv fall delta even boost margin outlook again elsewhere unite rental uri tumble be cut sell buy evercore upside gilead science gild rise reverse high cvs caremark cvs announce cover gilead solvaldi harvoni hepatitis drug several plan gilead tumble last month news express script esrx drop coverage hepatitis treatment favor abbvie abbv fellow biotech akorn akrx be session high still nearly
1590,ESRX,massive ep gain year mean company top next ibd stock today screen be set show ep growth leave dust year not be bountiful share gilead science gild have launch upward hepatitis drug sovaldi debut last year company full year ep be expect grow year year partly sovaldi harvoni combine sovaldi interferon treatment harvoni win fda approval october however drug have face headwind year effectiveness concern government patient advocacy group drug steep cost have persist many have argue drug be far too costly low income hepatitis patient more express script esrx cite concern cost hep drug say monday dump sovaldi harvoni prefer formulary list favor abbvie abbv viekira pak treatment genotype hepatitis gilead stock plunge day fall entire week gilead share have rise begin year have struggle find support day line october relative strength measure have fall well massive ep growth be expect analyst project growth shrivel low double single digit year follow stock close stock market today generic drug maker akorn akrx maintain top shelf ibd composite relative strength rating company be poise see ep gain year however price hike drug clobetasol topical rash treatment weigh result report november gilead analyst forecast akorn earning growth slow dramatically next few year share drop earning result continue consolidation stock begin october have remain facebook fb full year ep be expect grow share drive facebook still cool teen instagram photo sharing app social medium site have snap variety company year attempt anticipate shift online social landscape many forecast company gain big online mobile advertising part effort strengthen position online advertising facebook recently announce deal show nfl video clip verizon vz ad site facebook have warn cost rise step spending analyst currently expect facebook full year ep growth dip then reaccelerate year share hit time intraday high dec clear cup base day earlier share close cent friday bitauto bita auto information advertising base china have benefit be world largest auto market china expand car culture analyst expect company grow ep year november company beat view strength ad gain ever crucial mobile space best ibd fundamental stock have dip day line month cool rise company report result still share close friday more double value begin year analyst expect company ep growth decelerate remain solidly double digit finally alexion pharmaceutical alxn be forecast full year ep growth strength only market drug soliris treat rare blood disease company have year double digit quarterly sale ep growth belt share clear month consolidation october jump strong report stock have see more seller enter picture bring accumulation distribution rating analyst expect only ep growth stronger growth stock have rattle day line past week close friday just line potential sign support come
1591,ESRX,brutal correction several lead biotech member ibd find support day move average correction kick monday express script esrx nation largest health benefit manager announce exclusively use abbvie abbv hepatitis drug left gilead science gild recent growth have be fuel hepatitis
1592,ESRX,pharmacy benefit manager express script announce monday putt abbvie newly approve hepatitis treatment prefer formulary list knock rival treatment gilead science gilead gild stock plunge abbvie abbv fall late friday food drug administration approve abbvie viekira pak combination novel drug older
1593,ESRX,abbvie hepatitis regimen win fda approval friday become second entrant be already huge market interferon free hcv treatment viekira pak cost week line forecast undercut gilead science gild same treatment length abbvie abbv regimen consist drug ombitasvir paritaprevir first develop
1594,ESRX,subject drug pricing keep get hotter most person mysterious process
1595,ESRX,nov pharmacy benefit manager express script esrx say rein cost up number drug exclude formulary new target include amgen amgn popular blood booster epogen aranesp express say intend provoke price war once competitor gilead science gild hepatitis drug sovaldi start come hope bring treatment price tag work mean drugmaker investor explore question ibd speak ed schoonveld manage principal consult firm zs associate author price global health now launch second edition ibd biggest misconception person have drug pricing work schoonveld very complex environment reason be so many be buy process be so different call dinner imagine go restaurant person be order meal person be eating meal other person be pay imagine conversation take place pay say well not sure caviar be necessary then again payer be little too demand well say think hot dog be good enough patient course be interested health be pay only indirectly physician want make sure patient be do well payer be overly concern cost be lot person be say market mechanism be not feel need interfere many case be interfere reason different be such capital intensive industry require lot investment so cost structure be quite different sometimes hard explain patient need pay something person just want cure disease even more important context be change so much combination rise cost health care economy not do too great be putt lot pressure government cut cost reform system then same time have thing ebola pop so do need strong development arm disease be actually very scary technology be advance well be probably lead more expensive solution come together perfect storm payer be face tough decision ibd sovaldi come seem lot insurer be unprepared wound pay more expect do industry learn anything schoonveld obviously raise lot debate interestingly not be lot debate value drug honestly wish have more problem sovaldi problem have cure disease big challenge case be time horizon difficult insurance company fund be tremendous cost offset be go take place number year line doesn tend help short term perspective addition many health care plan be still pharmacy only plan really be not get benefit reduction occurrence liver disease cancer everything else make little harder make decision particularly impact budget case more matter make sure find appropriate way treat patient make sure additional budget available example germany ve do be temporary budget increase curative treatment ibd be pharmacy benefit manager express script get more powerful schoonveld example plan only see cost drug treatment doesn get reward benefit limitation used pbms manage formulary don see much value treatment more intergrate health care system see take step back do be require drug industry engage make sure know value proposition be seem have societal objective bring treatment patient so clear hurdle financing mainly be make sure find solution ibd sort alternative be think schoonveld be not easy be cost offset long term so find way make sure cost offset be be recognize even make sure drugmaker payer pbms government agency talk other rather medium be helpful sovaldi be very specific case be many other drug insurance company physician be look judge value be used appropriately see lot medical society asco american society clinical oncology have be pretty vocal re go take cost more consideration clinical guideline put pharmaceutical industry position even more have make sure realize provide evidence new treatment be provide value patient physician payer make sure be guidance best be used treatment sometimes hard do launch lead
1596,ESRX,biotech stock take bath holiday shorten week catalyst be announcement express script esrx nation largest benefit manager use abbvie abbv hepatitis drug exclusively hurt gilead science gild stock have soar sale own ground breaking hepatitis treatment gilead be hammer loss week so far
1597,ESRX,stock future hold early gain global market spark optimistically higher caution eurozone official bailout agreement greece be not likely today
1598,ESRX,dow future be point fair market value only slightly earlier high nasdaq future be also high still strong point future hung strong point gain small cap be less enthusiastic russell future ahead point
1599,ESRX,rundown stock market today begin overseas market monday give sense pressure place global stock eurozone greek financial crisis
1600,ESRX,lead index paris frankfurt have jump nearly midday tokyo hong kong gain more apiece shanghai exchange be close day holiday
1601,ESRX,greek prime minister alexis tsipra early monday proffer new plan resolve budget problem news report quote finance official say plan first time concede country tightly protected pension arrangement move least crack door hope agreement
1602,ESRX,eurozone official exit summit aim work greece related issue announce caution agreement
1603,ESRX,support extend weekend european central bank prop greece bank depositor confidence monday stall last week run saving withdrawal athen exchange bank stock lead index
1604,ESRX,week steady economic calendar begin exist home sale national association realtor et run university michigan final read june consumer sentiment friday durable good order final read gdp personal income spending way
1605,ESRX,stock thwart merger activity weigh early trade
1606,ESRX,natural gas process transport giant william co wmb spiked open tulsa okla base firm reject unsolicited bid energy transfer equity ete dalla base master limit partnership stock deal be value william be process re absorb master limit partnership william partner wpz say share bid undervalue company william co share have be correct september william partner share fall premarket trade
1607,ESRX,manage care provider cigna ci spiked reject inadequate bid anthem antm value share offer be premium cigna close price friday stock punch new high last week anthem share be fraction higher pre open trade monday
1608,ESRX,stock be generally flat higher ibd list biggest gain go vasco datum security vdsi nearly stock end friday buy point cup handle base
1609,ESRX,currency market dollar be euro yen commodity be mixed oil gold less stock future hold early gain global market spark optimistically higher caution eurozone official bailout agreement greece be not likely today dow future be point fair market value only slightly earlier high nasdaq future be also high still strong point future hung strong point gain small cap be less enthusiastic russell future ahead point rundown stock market today begin overseas market monday give sense pressure place global stock eurozone greek financial crisis lead index paris frankfurt have jump nearly midday tokyo hong kong gain more apiece shanghai exchange be close day holiday greek prime minister alexis tsipra early monday proffer new plan resolve budget problem news report quote finance official say plan first time concede country tightly protected pension arrangement move least crack door hope agreement eurozone official exit summit aim work greece related issue announce caution agreement support extend weekend european central bank prop greece bank depositor confidence monday stall last week run saving withdrawal athen exchange bank stock lead index week steady economic calendar begin exist home sale national association realtor et run university michigan final read june consumer sentiment friday durable good order final read gdp personal income spending way stock thwart merger activity weigh early trade natural gas process transport giant william co wmb spiked open tulsa okla base firm reject unsolicited bid energy transfer equity ete dalla base master limit partnership stock deal be value william be process re absorb master limit partnership william partner wpz say share bid undervalue company william co share have be correct september william partner share fall premarket trade manage care provider cigna ci spiked reject inadequate bid anthem antm value share offer be premium cigna close price friday stock punch new high last week anthem share be fraction higher pre open trade monday stock be generally flat higher ibd list biggest gain go vasco datum security vdsi nearly stock end friday buy point cup handle base currency market dollar be euro yen commodity be mixed oil gold less
1610,ESRX,wednesday report fastest quarterly earning growth more year revenue gain continue slow
1611,ESRX,drug health supply distributor fiscal earning share leap fourth straight quarter accelerate growth beating view cent
1612,ESRX,revenue rise help boot alliance wba contract inked last year provide pharmaceutical product top view sale growth slow more prior quarters
1613,ESRX,abc stock end have rise intraday record high
1614,ESRX,re cycling onboard expect revenue growth come evercore isi analyst ross muken tell ibd growth come be still medical distributor market overall
1615,ESRX,be impressive quarter board notably revenue side think have solid result overall say
1616,ESRX,also lift earning outlook share prior view
1617,ESRX,midpoint be roughly line consensus revision be help cent ep beat acquisition mwi veterinary supply company expect add cent ep latter half year
1618,ESRX,only thing investor question be magnitude earning guidance muken say give be not surprised magnitude earning guidance revision
1619,ESRX,company expect revenue wall street consensus
1620,ESRX,fiscal drug unit sale rise specialty sale jump say drug sale gain be due largely pact demand hepatitis drug
1621,ESRX,market hep drug be increasingly competitive gilead gild sovaldi debut december rival treatment johnson johnson jnj abbvie abbv have launch
1622,ESRX,cvs health cvs month say select gilead sovaldi harvoni exclusive hepatitis treatment express script esrx picked abbvie viekira december wednesday report fastest quarterly earning growth more year revenue gain continue slow drug health supply distributor fiscal earning share leap fourth straight quarter accelerate growth beating view cent revenue rise help boot alliance wba contract inked last year provide pharmaceutical product top view sale growth slow more prior quarters abc stock end have rise intraday record high re cycling onboard expect revenue growth come evercore isi analyst ross muken tell ibd growth come be still medical distributor market overall be impressive quarter board notably revenue side think have solid result overall say also lift earning outlook share prior view midpoint be roughly line consensus revision be help cent ep beat acquisition mwi veterinary supply company expect add cent ep latter half year only thing investor question be magnitude earning guidance muken say give be not surprised magnitude earning guidance revision company expect revenue wall street consensus fiscal drug unit sale rise specialty sale jump say drug sale gain be due largely pact demand hepatitis drug market hep drug be increasingly competitive gilead gild sovaldi debut december rival treatment johnson johnson jnj abbvie abbv have launch cvs health cvs month say select gilead sovaldi harvoni exclusive hepatitis treatment express script esrx picked abbvie viekira december
1623,ESRX,stock be filled christmas cheer little more hour remain wednesday shorten session dow jone industrial average be trading time high
1624,ESRX,nasdaq lead charge dow jone industrial average gain stock market today not surprisingly volume be light
1625,ESRX,best worst industry group swap place day biotechs weak tuesday be best wednesday oil stock strongest prior day be weakest oil price drop again
1626,ESRX,fall oil price help airline become top perform group day new issue virgin america va be top stock group be poise clear first stage ipo base
1627,ESRX,gilead science gild pummeled earlier week express script esrx announcement exclusively use competitor abbvie abbv hepatitis drug rise more try retake day move average celgene celg rise nearly
1628,ESRX,time leader sanchez energy sn fall report first earning decline more year november stock have relative price strength rating meaning be be outperformed stock market
1629,ESRX,dow component financial giant visa bank america bac rise stock be filled christmas cheer little more hour remain wednesday shorten session dow jone industrial average be trading time high nasdaq lead charge dow jone industrial average gain stock market today not surprisingly volume be light best worst industry group swap place day biotechs weak tuesday be best wednesday oil stock strongest prior day be weakest oil price drop again fall oil price help airline become top perform group day new issue virgin america va be top stock group be poise clear first stage ipo base gilead science gild pummeled earlier week express script esrx announcement exclusively use competitor abbvie abbv hepatitis drug rise more try retake day move average celgene celg rise nearly time leader sanchez energy sn fall report first earning decline more year november stock have relative price strength rating meaning be be outperformed stock market dow component financial giant visa bank america bac rise
1630,ESRX,early gain stock market today nearly evaporate midday monday general lack interest go christmas week
1631,ESRX,dow jone industrial average outperformed gain nasdaq add be mostly flat volume be significantly lighter shorten week trading swollen volume friday option expiration
1632,ESRX,dow be hold aloft part tech giant intel intc cisco system csco bank america bac be nearly
1633,ESRX,ibd stock be higher be lower ambarella amba be best performer worst performer be gilead science gild nearly
1634,ESRX,express script esrx largest manager prescription drug benefit say abbvie abbv drug be exclusive option treatment hepatitis instead gilead drug have be gilead growth engine recent quarters
1635,ESRX,abbvie abbv be less express script rise
1636,ESRX,oil resume plunge barrel go noon hour trading
1637,ESRX,energy issue be generally weak exploration production firm chesapeake energy chk crumble early gain stock market today nearly evaporate midday monday general lack interest go christmas week dow jone industrial average outperformed gain nasdaq add be mostly flat volume be significantly lighter shorten week trading swollen volume friday option expiration dow be hold aloft part tech giant intel intc cisco system csco bank america bac be nearly ibd stock be higher be lower ambarella amba be best performer worst performer be gilead science gild nearly express script esrx largest manager prescription drug benefit say abbvie abbv drug be exclusive option treatment hepatitis instead gilead drug have be gilead growth engine recent quarters abbvie abbv be less express script rise oil resume plunge barrel go noon hour trading energy issue be generally weak exploration production firm chesapeake energy chk crumble
1638,ESRX,euphoria third quarter gdp growth evaporate tuesday morning leave stock trading mixed midday nasdaq lead other index best level
1639,ESRX,nasdaq be rise dow jone industrial average gain volume be trend lower exchange
1640,ESRX,befit holiday spirit best perform industry group be leisure toy department store worst perform group be health care field biotech stock show biggest loss morning
1641,ESRX,department store operator dd trouble jcpenney jcp rise macy gain mattel mat hasbro have rise stock market today
1642,ESRX,biotechs have be lead bull market show age tuesday morning celgene celg shed be try find support day move average recent biogen biib fizzle share lose
1643,ESRX,gilead science gild fall punch day move average week monday pharmacy benefit manager express script esrx picked abbvie abbv hepatitis drug gilead sovaldi
1644,ESRX,alexion pharmaceutical alxn fall also fall day line
1645,ESRX,ibd stock be be worst performer be biotech pharmacyclic pcyc fall day line buy point cup base euphoria third quarter gdp growth evaporate tuesday morning leave stock trading mixed midday nasdaq lead other index best level nasdaq be rise dow jone industrial average gain volume be trend lower exchange befit holiday spirit best perform industry group be leisure toy department store worst perform group be health care field biotech stock show biggest loss morning department store operator dd trouble jcpenney jcp rise macy gain mattel mat hasbro have rise stock market today biotechs have be lead bull market show age tuesday morning celgene celg shed be try find support day move average recent biogen biib fizzle share lose gilead science gild fall punch day move average week monday pharmacy benefit manager express script esrx picked abbvie abbv hepatitis drug gilead sovaldi alexion pharmaceutical alxn fall also fall day line ibd stock be be worst performer be biotech pharmacyclic pcyc fall day line buy point cup base
1646,ESRX,institutional sponsorship be key factor check research stock buy
1647,ESRX,demand mutual fund hedge fund other big investor account most market daily activity stock keep advance institution be slim
1648,ESRX,even stock boast strong fundamental show solid price volume action chart big money have presence
1649,ESRX,stock have professional sponsorship chance be performance be more run mill mean least more institutional investor have look stock pass ibd founder chairman william neil write make money stock
1650,ESRX,fund manager get paid select stock devote much time research company run growth fund tend favor stock be leader field too
1651,ESRX,come be stock re eyee leader laggard savvy investor favor best stock strong industry group often have strong growth potential
1652,ESRX,manager also look new factor be new product new management new industry condition new high change spark big run lead stock
1653,ESRX,also get depth look stock sector top perform fund manager favor select holding mutual fund monthly quarterly special section see latest nov ibd
1654,ESRX,special report section ll also find table stock top perform mutual fund have be buy selling datum include number lead fund buy much re putt work
1655,ESRX,look stock fund have be snap potential watch list candidate pro re probably worth closer look
1656,ESRX,likewise fund manager be dump share particular company red flag aggressive selling big money push stock price so helpful pay attention stock fund be unload too
1657,ESRX,find datum mutual fund special section table mentioned too instance top fund latest sell be publish page october special run nov issue mastercard weyerhaeuser wy express script esrx show top list
1658,ESRX,don sell stock just show list conduct due diligence first fund be selling share simply reduce exposure certain sector stock not concern slow earning sale other potential drag
1659,ESRX,top buy last month special section gopro gpro be major purchase top fund third quarter fund invest total action camera maker stock go public june break past ipo base buy point aug trigger week hold rule way gain institutional sponsorship be key factor check research stock buy demand mutual fund hedge fund other big investor account most market daily activity stock keep advance institution be slim even stock boast strong fundamental show solid price volume action chart big money have presence stock have professional sponsorship chance be performance be more run mill mean least more institutional investor have look stock pass ibd founder chairman william neil write make money stock fund manager get paid select stock devote much time research company run growth fund tend favor stock be leader field too come be stock re eyee leader laggard savvy investor favor best stock strong industry group often have strong growth potential manager also look new factor be new product new management new industry condition new high change spark big run lead stock also get depth look stock sector top perform fund manager favor select holding mutual fund monthly quarterly special section see latest nov ibd special report section ll also find table stock top perform mutual fund have be buy selling datum include number lead fund buy much re putt work look stock fund have be snap potential watch list candidate pro re probably worth closer look likewise fund manager be dump share particular company red flag aggressive selling big money push stock price so helpful pay attention stock fund be unload too find datum mutual fund special section table mentioned too instance top fund latest sell be publish page october special run nov issue mastercard weyerhaeuser wy express script esrx show top list don sell stock just show list conduct due diligence first fund be selling share simply reduce exposure certain sector stock not concern slow earning sale other potential drag top buy last month special section gopro gpro be major purchase top fund third quarter fund invest total action camera maker stock go public june break past ipo base buy point aug trigger week hold rule way gain
1660,ESRX,biotech industry be set hit ground run january alone bring passel potentially stock move event biggest player second full week month bring annual jpmorgan healthcare conference san francisco many company release product financial news first thing morning
1661,ESRX,broader index be mostly tread water monday afternoon blue chip continue outshine
1662,ESRX,lift intel intc boee ba ibm ibm dow jone industrial average rally nasdaq edge be fractionally higher volume be tracking sharply lower board stock market today friday turnover be boost expiration option future contract
1663,ESRX,lead stock facebook fb rise time high fast trade ibd stock clear buy point first stage flat base facebook reset base count october breach low prior base
1664,ESRX,wagework wage be still more pare gain earlier stock clear buy point flat base also be view giant cup handle pattern same buy point last month provider health other employee benefit report jump earning gain sale be best several quarters
1665,ESRX,downside gilead science gild come slightly session low be still share slump monday low news express script esrx drop coverage hepatitis drug favor new treatment abbvie abbv share abbvie be reverse early gain
1666,ESRX,other biotechs celgene celg biogen idec biib be session lows still broader index be mostly tread water monday afternoon blue chip continue outshine lift intel intc boee ba ibm ibm dow jone industrial average rally nasdaq edge be fractionally higher volume be tracking sharply lower board stock market today friday turnover be boost expiration option future contract lead stock facebook fb rise time high fast trade ibd stock clear buy point first stage flat base facebook reset base count october breach low prior base wagework wage be still more pare gain earlier stock clear buy point flat base also be view giant cup handle pattern same buy point last month provider health other employee benefit report jump earning gain sale be best several quarters downside gilead science gild come slightly session low be still share slump monday low news express script esrx drop coverage hepatitis drug favor new treatment abbvie abbv share abbvie be reverse early gain other biotechs celgene celg biogen idec biib be session lows still
1667,ESRX,stock edge higher fourth straight session monday bring positive start holiday shorten trading week rise new close high just point away dec time high help strength chip stock nasdaq climb philadelphia semiconductor index rally dow jone industrial
1668,ESRX,biotechs monday sector leader screen have rough go early session most re-cover well session lows overall ibd biotech group hold relatively well consider fall nearly early end loss soundest biotech sector leader point be biogen idec biib
1669,ESRX,stock get mixed start quickly turn positive shorten holiday week drugmaker show particular weakness monday open
1670,ESRX,dow jone industrial average lead nasdaq backed early loss gain struggle hold fractional gain
1671,ESRX,volume be sharply lower nasdaq nyse contrast friday heavy option expiration trading
1672,ESRX,start last week stock market today feel little pressure overseas market oil price reversed early gain oil sector stock put damper early market action
1673,ESRX,drugmaker be be hit hard market merck mrk post heaviest loss dow gilead science gild biogen idec biib regeneron pharmaceutical regn celgene celg hold low ground nasdaq stock energy issue hold worst loss
1674,ESRX,leader leane generally higher gain be limit
1675,ESRX,airline buck head list spirit airline save alaska air group alk ahead more spirit be recover harsh sell week end dec alaska have pull back test week support breaking double bottom base october
1676,ESRX,drugmaker post list worst decline early trade
1677,ESRX,gilead topple prescription benefit manager express script esrx announce support drug combination market abbvie abbv gilead sovaldi prefer treatment patient hepatitis express script rise abbvie share gain fraction
1678,ESRX,celgene biogen also ibd list drop amgen amgn slip lower
1679,ESRX,economic news exist home sale slip november annualize rate accord national association realtor be pace slight downward revision original estimate economist have forecast more moderate slowdown sale stock get mixed start quickly turn positive shorten holiday week drugmaker show particular weakness monday open dow jone industrial average lead nasdaq backed early loss gain struggle hold fractional gain volume be sharply lower nasdaq nyse contrast friday heavy option expiration trading start last week stock market today feel little pressure overseas market oil price reversed early gain oil sector stock put damper early market action drugmaker be be hit hard market merck mrk post heaviest loss dow gilead science gild biogen idec biib regeneron pharmaceutical regn celgene celg hold low ground nasdaq stock energy issue hold worst loss leader leane generally higher gain be limit airline buck head list spirit airline save alaska air group alk ahead more spirit be recover harsh sell week end dec alaska have pull back test week support breaking double bottom base october drugmaker post list worst decline early trade gilead topple prescription benefit manager express script esrx announce support drug combination market abbvie abbv gilead sovaldi prefer treatment patient hepatitis express script rise abbvie share gain fraction celgene biogen also ibd list drop amgen amgn slip lower economic news exist home sale slip november annualize rate accord national association realtor be pace slight downward revision original estimate economist have forecast more moderate slowdown sale
1680,ESRX,be nothing earth shake drug distributor decision change business strategy couple year simply decide go few big client rather pursue bunch smaller one today decision abc be poise post best annual financial performance year company distribute brand
1681,ESRX,hubspot provider cloud base marketing sale software platform raise propose ipo price suggest strong interest institutional investor hubspot hub increase propose price range offer share midpoint hubspot raise more previously expect initial public offer be expect price late wednesday begin trading nyse thursday ticker hub month end june hubspot revenue rise year earlier period report net loss company continue invest heavily sale marketing comparable ipo potential competitor be marketo mkto provide cloud base marketing software platform marketo price ipo now trade investor interest be also climb ipo dave buster entertainment play accord ipo research firm ipo boutique channel check reveal ipo be consider well subscribe tuesday ipo boutique raise rating dave buster moderate buy neutral dave buster operate casual dine restaurant large arcade state plan plan raise offer share expect price late thursday trade friday nasdaq ticker play week end aug company report revenue net loss demand be also reportedly strong diplomat pharmacy dplo largest independent specialty pharmacy company such pharmacy focus improve life patient complex chronic disease ipo boutique say channel check reveal ipo be well oversubscribed rate ipo moderate buy diplomat pharmacy plan raise offer share month end june diplomat pharmacy report revenue net income be schedule price late thursday begin trading nyse friday ticker dplo related publicy trade pharmacy company include wag cvs caremark cvs express script esrx related ipo calendar hubspot dave buster ipos
1682,ESRX,ipos slate week be mix tech health care finance consumer offering combine plan raise follow initial public offering last week ipos raise most proceed quarter accord ipo investment research firm renaissance capital
1683,ESRX,december be usually quiet month medical tech news year bring few potentially stock move event worth keep eye digest thanksgiving turkey here be top chronological order dec biotech incyte incy be look get important expansion label sole market drug jakafi explain recent incyte profile new america incyte partner novartis nvs have be pull respectable income jakafi treatment rare bone marrow cancer call myelofibrosis fda be ponder add indication polycythemia vera milder more common condition uptake condition be expect be fairly slow expect help push incyte more consistently profitable territory next year day later hot medical device company edward lifescience ew hold annual investor day be expect give guidance first time company impressed street last month strong report guidance strong launch latest sapien artificial heart valve currently analyst be forecasting sale year estimate earning share be expect rise then sometime dec likely mean dec fda be due issue verdict abbvie abbv hepatitis combo viekirax exviera clinical trial datum be so good street probably be less surprised meteor hit manhattan fda reject drug have analyst pin needle be price be price significantly lower gilead science gild recently launch harvoni cost week treatment help abbvie gain market share certainly please pharmacy benefit manager express script esrx have be hope start price war drive suddenly high cost hepatitis treatment however most analyst be expect abbvie price only little bit lower also affected be enanta pharmaceutical enta license component viekirax abbvie speaking hepatitis sometime end year street be expect hear phase clinical trial datum achillion pharmaceutical achn drug belong coveted nucleoside inhibitor class gilead mega blockbuster sovaldi also component harvoni belong have otherwise show enough safety issue be few left development especially merck mrk acquire idenix pharmaceutical nuc speculation achillion be next target have drive stock price street have see little real datum safety effectiveness datum help analyst determine just much company be worth speculation exist abort takeover attempt earlier year be re up street seem have mostly give possibility pfizer pfe make bid astrazeneca azn month cool period mandate takeover rule expire wednesday astra ceo pascal soriot throw more cold water appear cnbc thursday say deal have fall apart even have be make propose restriction tax inversion deal however rbc capital market analyst glenn novarro be still hold hope union orthopedic firm stryker syk nephew snn stryker didn bid company news report leak be work get slap month cool period anyway expire nov believe syk snn deal provide more recon reconstructive surgery scale particularly international market expand syk presence trauma sport medicine bring cost synergy novarro write note friday
1684,ESRX,big part business depend unpredictable force weather many emergency happen medical bill get paid expect little earning volatility
1685,ESRX,experience earning volatility expect see stock price bungee time time
1686,ESRX,air method airm have see happen more few time include twice past month
1687,ESRX,company provide air medical transport other service fleet own lease helicopter fix wing aircraft
1688,ESRX,end fleet consist company own aircraft lease aircraft
1689,ESRX,air medical service division largest air medical transport provider america generate lion share revenue
1690,ESRX,air method also have tourism division provide helicopter tour charter flight la vegas grand canyon region hawaii unit unite rotorcraft specialize design manufacture aeromedical aerospace technology
1691,ESRX,air medical unit drife air method financial performance business be hard predict
1692,ESRX,plan emergency
1693,ESRX,air method medical business be divide basic service area hospital base community base
1694,ESRX,hospital base division provide medical helicopter airplane service primarily fix contract paid hospital
1695,ESRX,business air method typically provide only aircraft pilot
1696,ESRX,main challenge hospital base business be foul weather hamper air method ability transport patient
1697,ESRX,lot depend weather actually go respond say richard close analyst avondale partner someone call helicopter visibility be really low go get doesn fly doesn get paid
1698,ESRX,community base service unit be design serve whole community operate independently hospital air method not only provide aircraft crew also critical care medical staff trained area such burn cardiac pediatrics respiratory trauma help specialty team transport
1699,ESRX,side business carry higher margin hospital base division even more volatile addition have deal weather air method handle issue medical care bill
1700,ESRX,anyone health care business know bill medical service doesn necessarily mean get money
1701,ESRX,big variance net revenue base payer mix have commercial insurance depend medicare have insurance close tell ibd not everyone pay time even dynamic have really big impact
1702,ESRX,air method see good bad first quarters
1703,ESRX,aug company post better expect revenue profit second quarter next day stock pop more record close high share currently trade
1704,ESRX,less month earlier stock price sank nearly day air method fall short earning view
1705,ESRX,result quarters weren surprising close say
1706,ESRX,traditionally be little more challenge respect weather so more volatility say
1707,ESRX,trend lend lift
1708,ESRX,good news air method be second quarter result reflect positive trend company say ceo aaron todd
1709,ESRX,include more hospital outsource transport service third party ve see acceleration activity great majority case hospital partner have choose air method outsource todd tell ibd second quarter earning reflect underlie quality be drive positive trend top line expansion more patient be transport
1710,ESRX,air method report earning cent share prior year cent analyst consensus estimate revenue gain also beating view
1711,ESRX,revenue air medical service division rise tourism revenue nearly double revenue unite rotorcraft unit climb
1712,ESRX,second quarter total patient transport rise just less net revenue patient transport also improve
1713,ESRX,much company growth be trace move more hospital community base model save cost close say
1714,ESRX,community base contract cost clinician other expense get shift air method have hire nurse paramedic say advantage hospital also have positive financial impact air method
1715,ESRX,meanwhile company tourism business continue contribute bigger portion revenue business include sundance helicopter air method acquire blue hawaiian buy last year
1716,ESRX,sundance operate helicopter tour la vegas grand canyon blue hawaiian offer tour hawaii tourist island
1717,ESRX,expect side business keep grow
1718,ESRX,look expand tourism business additional acquisition organic growth ceo todd say
1719,ESRX,analyst poll thomson reuter expect air method boost full year earning additional
1720,ESRX,firm be part ibd medical service industry group include name such express script esrx provider pharmacy benefit management service laboratory corp america lh provide clinical testing service quest diagnostic dgx testing service provider air method hold top composite rating group possible big part business depend unpredictable force weather many emergency happen medical bill get paid expect little earning volatility experience earning volatility expect see stock price bungee time time air method airm have see happen more few time include twice past month company provide air medical transport other service fleet own lease helicopter fix wing aircraft end fleet consist company own aircraft lease aircraft air medical service division largest air medical transport provider america generate lion share revenue air method also have tourism division provide helicopter tour charter flight la vegas grand canyon region hawaii unit unite rotorcraft specialize design manufacture aeromedical aerospace technology air medical unit drife air method financial performance business be hard predict plan emergenciesair method medical business be divide basic service area hospital base community base hospital base division provide medical helicopter airplane service primarily fix contract paid hospital business air method typically provide only aircraft pilot main challenge hospital base business be foul weather hamper air method ability transport patient lot depend weather actually go respond say richard close analyst avondale partner someone call helicopter visibility be really low go get doesn fly doesn get paid community base service unit be design serve whole community operate independently hospital air method not only provide aircraft crew also critical care medical staff trained area such burn cardiac pediatrics respiratory trauma help specialty team transport side business carry higher margin hospital base division even more volatile addition have deal weather air method handle issue medical care bill anyone health care business know bill medical service doesn necessarily mean get money big variance net revenue base payer mix have commercial insurance depend medicare have insurance close tell ibd not everyone pay time even dynamic have really big impact air method see good bad first quarters aug company post better expect revenue profit second quarter next day stock pop more record close high share currently trade less month earlier stock price sank nearly day air method fall short earning view result quarters weren surprising close say traditionally be little more challenge respect weather so more volatility say trend lend liftthe good news air method be second quarter result reflect positive trend company say ceo aaron todd include more hospital outsource transport service third party ve see acceleration activity great majority case hospital partner have choose air method outsource todd tell ibd second quarter earning reflect underlie quality be drive positive trend top line expansion more patient be transport air method report earning cent share prior year cent analyst consensus estimate revenue gain also beating view revenue air medical service division rise tourism revenue nearly double revenue unite rotorcraft unit climb second quarter total patient transport rise just less net revenue patient transport also improve much company growth be trace move more hospital community base model save cost close say community base contract cost clinician other expense get shift air method have hire nurse paramedic say advantage hospital also have positive financial impact air method meanwhile company tourism business continue contribute bigger portion revenue business include sundance helicopter air method acquire blue hawaiian buy last year sundance operate helicopter tour la vegas grand canyon blue hawaiian offer tour hawaii tourist island expect side business keep grow look expand tourism business additional acquisition organic growth ceo todd say analyst poll thomson reuter expect air method boost full year earning additional firm be part ibd medical service industry group include name such express script esrx provider pharmacy benefit management service laboratory corp america lh provide clinical testing service quest diagnostic dgx testing service provider air method hold top composite rating group possible
1721,ESRX,stock hit fresh session high late thursday be track fourth straight gain
1722,ESRX,help internet computer hardware stock nasdaq rally dow jone industrial average be volume be tracking modestly higher major exchange stock market today
1723,ESRX,tata motor ttm stretched gain earlier stock clear buy point double bottom base heavy trading indian carmaker have composite rating highest auto manufacturer group tata be mentioned international leader earlier month
1724,ESRX,armour ua rally regain day line fast trade stock be flat base larger pattern telsey advisory group upgrade share outperform market perform wednesday
1725,ESRX,downside microsemi mscc reversed fall ahead fiscal earning close chipmaker be expect earn cent share year mark second straight quarter accelerate growth microsemi be work potential base
1726,ESRX,intuitive surgical isrg kla tencor klac skywork solution swks starbucks sbux also be report earning close stock hit fresh session high late thursday be track fourth straight gain help internet computer hardware stock nasdaq rally dow jone industrial average be volume be tracking modestly higher major exchange stock market todaytata motor ttm stretched gain earlier stock clear buy point double bottom base heavy trading indian carmaker have composite rating highest auto manufacturer group tata be mentioned international leader earlier month armour ua rally regain day line fast trade stock be flat base larger pattern telsey advisory group upgrade share outperform market perform wednesday downside microsemi mscc reversed fall ahead fiscal earning close chipmaker be expect earn cent share year mark second straight quarter accelerate growth microsemi be work potential base intuitive surgical isrg kla tencor klac skywork solution swks starbucks sbux also be report earning close
1727,ESRX,share specialty drugmaker horizon pharma hznp be stock market today major pharmacy benefit manager remove drug formulary horizon disclose sec filing express script esrx caremark cvs cvs pbm division be remove drug duexis vimovo formulary august place
1728,ESRX,drugstore be clearance mode get merchandise shelve back school season start strong pharmacy sale help wag rite aid rad beat june sale estimate
1729,ESRX,same store sale climb top consensus forecast increase lead jump pharmacy side total june sale rise
1730,ESRX,prescription be help extra monday fewer saturday june compare same month last year
1731,ESRX,same store basket size rise june offset dip customer foot traffic comparable front end sale increase miss expectation rise
1732,ESRX,june july be typically clearance period most retailer be work move summer related apparel seasonal merchandise make way key back school floor set end july early august say ken perkin president retail metric report
1733,ESRX,clearance activity picked month progressed retailer be work clear early summer merchandise
1734,ESRX,share rise stock market today
1735,ESRX,rite aid same store sale rise june beating view gain front end comp pharmacy same store number prescription rise total sale edge share jump
1736,ESRX,week pharmacy benefit manager express script esrx decide drop coverage ingredient used compound process mix alter drug create tailor medication target painkil cream ointment
1737,ESRX,company say cost involved be wasteful other cheaper fda approve medication be available accord ap be not clear affect customer express script say consumer still obtain need compound medication
1738,ESRX,express script be partner again company clash contract dispute drugstore be clearance mode get merchandise shelve back school season start strong pharmacy sale help wag rite aid rad beat june sale estimate same store sale climb top consensus forecast increase lead jump pharmacy side total june sale rise prescription be help extra monday fewer saturday june compare same month last year same store basket size rise june offset dip customer foot traffic comparable front end sale increase miss expectation rise june july be typically clearance period most retailer be work move summer related apparel seasonal merchandise make way key back school floor set end july early august say ken perkin president retail metric report clearance activity picked month progressed retailer be work clear early summer merchandise share rise stock market today rite aid same store sale rise june beating view gain front end comp pharmacy same store number prescription rise total sale edge share jump week pharmacy benefit manager express script esrx decide drop coverage ingredient used compound process mix alter drug create tailor medication target painkil cream ointment company say cost involved be wasteful other cheaper fda approve medication be available accord ap be not clear affect customer express script say consumer still obtain need compound medication express script be partner again company clash contract dispute
1739,ESRX,foot traffic have be bigger basket pharmacy revenue help step wag sale send share new high nationwide drugstore comparable store sale increase analyst estimate accord retail metric total front end revenue rise pharmacy sale increase
1740,ESRX,fuel obesity epidemic age population diabetes have become global problem
1741,ESRX,affect estimate person worldwide drug company opportunity
1742,ESRX,denmark nordisk nvo be lead player market chief rival eli lilly lly sanofi sny target many other disease nordisk focus mostly diabetes therapy
1743,ESRX,sharp focus be competitive advantage say ronny gal analyst sanford bernstein co
1744,ESRX,have very good technical skill spend lot money sale marketing say
1745,ESRX,karen andersen analyst morningstar call nordisk most innovative player diabetes
1746,ESRX,nordisk get slow start year first quarter sale be hurt pharmacy benefit manager express script esrx remove company top drug prefer provider list favor drug lower price eli lilly astrazeneca azn
1747,ESRX,analyst expect look healthier nordisk benefit price hike new drug launch raise price insulin drug
1748,ESRX,growth estimate
1749,ESRX,have grow market take pricing typically have good business gal say
1750,ESRX,morningstar estimate global diabetes market grow year next year
1751,ESRX,even pricing power weaken nordisk see strong growth long run andersen say
1752,ESRX,say growth be drive increase diagnosis rate patient move newer pricier therapy emerge market such china mexico growth potential be root more richer diet less exercise person move rural urban area obesity be biggest risk factor develop diabetes
1753,ESRX,andersen expect impact express script decision linger year
1754,ESRX,drug cut prefer list be novolog firm best selling insulin drug novolog mix insulin drug victoza
1755,ESRX,sale victoza class know glp have be grow double digit rate first quarter sale slow fourth quarter be still higher year earlier
1756,ESRX,foreign exchange head wind didn help do industrywide inventory cut wholesaler also company face generic competition prandin blood sugar lower oral drug
1757,ESRX,not only do nordisk miss sale forecast lower forecast full year first time decade
1758,ESRX,revenue quarter grow just danish kroner equivalent local currency
1759,ESRX,new forecast call growth vs previously
1760,ESRX,quarter sale result break streak straight quarters double digit top line growth say kasper poulsen head investor relation
1761,ESRX,know be head wind say say company be surprised fast express script implement prefer provider change go effect jan take just month rather typical say
1762,ESRX,bottom line fared better nordisk earn cent share first quarter penny view earlier year
1763,ESRX,gross margin operate profit be respectively
1764,ESRX,still analyst expect share profit growth american depositary receipt slow year last year revenue be see climb
1765,ESRX,effort cut health cost continue big risk be person begin push back price gal say
1766,ESRX,poulsen say increase pressure contain cost result higher rebate make more important come differentiate product
1767,ESRX,company new generation insulin drug tresiba have be launch country outside include germany japan approval depend result new clinical trial
1768,ESRX,food drug administration ask more datum heart risk long act insulin product
1769,ESRX,nordisk say trial be progress ahead plan expect have enough datum mid support interim analysis
1770,ESRX,launch
1771,ESRX,tresiba show positive datum trial analyst widely expect bode well launch early
1772,ESRX,tresiba help extend growth renew insulin portfolio say andersen expect drug generate
1773,ESRX,tresiba be improve version levemir have better pricing power andersen say
1774,ESRX,tresiba have patent protection vs levemir
1775,ESRX,levemir compete sanofi lantus modern insulin drug be grow robust clip be different enough other maintain pricing power say
1776,ESRX,lantus likely see competition biosimilar drug
1777,ESRX,tresiba launch leave levemir lantus older generation product more likely do better emerge market andersen say
1778,ESRX,nordisk pipeline include combination drug tresiba victoza call xultophy launch europe new year pending regulatory approval drug treat obesity be review fda official europe
1779,ESRX,datum other trial be due next year include faster act version novolog oral glp class drug be also development
1780,ESRX,expect be low event believe be likely bring most important event nordisk analyst peter hugreffe stockholm base seb equity research say recent research report fuel obesity epidemic age population diabetes have become global problem affect estimate person worldwide drug company opportunity denmark nordisk nvo be lead player market chief rival eli lilly lly sanofi sny target many other disease nordisk focus mostly diabetes therapy sharp focus be competitive advantage say ronny gal analyst sanford bernstein co have very good technical skill spend lot money sale marketing say karen andersen analyst morningstar call nordisk most innovative player diabetes nordisk get slow start year first quarter sale be hurt pharmacy benefit manager express script esrx remove company top drug prefer provider list favor drug lower price eli lilly astrazeneca azn analyst expect look healthier nordisk benefit price hike new drug launch raise price insulin drug growth estimate have grow market take pricing typically have good business gal say morningstar estimate global diabetes market grow year next year even pricing power weaken nordisk see strong growth long run andersen say say growth be drive increase diagnosis rate patient move newer pricier therapy emerge market such china mexico growth potential be root more richer diet less exercise person move rural urban area obesity be biggest risk factor develop diabetes andersen expect impact express script decision linger year drug cut prefer list be novolog firm best selling insulin drug novolog mix insulin drug victoza sale victoza class know glp have be grow double digit rate first quarter sale slow fourth quarter be still higher year earlier foreign exchange head wind didn help do industrywide inventory cut wholesaler also company face generic competition prandin blood sugar lower oral drug not only do nordisk miss sale forecast lower forecast full year first time decade revenue quarter grow just danish kroner equivalent local currency new forecast call growth vs previously quarter sale result break streak straight quarters double digit top line growth say kasper poulsen head investor relation know be head wind say say company be surprised fast express script implement prefer provider change go effect jan take just month rather typical say bottom line fared better nordisk earn cent share first quarter penny view earlier year gross margin operate profit be respectively still analyst expect share profit growth american depositary receipt slow year last year revenue be see climb effort cut health cost continue big risk be person begin push back price gal say poulsen say increase pressure contain cost result higher rebate make more important come differentiate product company new generation insulin drug tresiba have be launch country outside include germany japan approval depend result new clinical trial food drug administration ask more datum heart risk long act insulin product nordisk say trial be progress ahead plan expect have enough datum mid support interim analysis launchif tresiba show positive datum trial analyst widely expect bode well launch early tresiba help extend growth renew insulin portfolio say andersen expect drug generate tresiba be improve version levemir have better pricing power andersen say tresiba have patent protection vs levemir levemir compete sanofi lantus modern insulin drug be grow robust clip be different enough other maintain pricing power say lantus likely see competition biosimilar drug tresiba launch leave levemir lantus older generation product more likely do better emerge market andersen say nordisk pipeline include combination drug tresiba victoza call xultophy launch europe new year pending regulatory approval drug treat obesity be review fda official europe datum other trial be due next year include faster act version novolog oral glp class drug be also development expect be low event believe be likely bring most important event nordisk analyst peter hugreffe stockholm base seb equity research say recent research report
1781,ESRX,even re not biotech pharma investor ve probably catch earful news lately virus call hepatitis last december record breaking launch gilead science gild wonder drug sovaldi controversy price tag merck mrk recent buyout formerly neglected biotech idenix pharmaceutical idix
1782,ESRX,rite aid rad lower fiscal outlook blame higher drug cost result delay meeting expect lower price generic medication cause share tumble nearly
1783,ESRX,camp hill pa base pharmacy chain nation third largest reduce full year earning share outlook range cent cent earlier guidance cent cent
1784,ESRX,company also issue preliminary result first quarter end ep cent cent less forecast analyst poll thomson reuter
1785,ESRX,same store quarterly sale rise year year higher prescription sale offset flat front end sale
1786,ESRX,week end same store sale rise pharmacy operation grow front end sale be fraction overall sale rise week
1787,ESRX,rite aid say finalize report back june share fall more stock market today find support day move average rite aid stock be so far year hit long time high wednesday rite aid rad lower fiscal outlook blame higher drug cost result delay meeting expect lower price generic medication cause share tumble nearly camp hill pa base pharmacy chain nation third largest reduce full year earning share outlook range cent cent earlier guidance cent cent company also issue preliminary result first quarter end ep cent cent less forecast analyst poll thomson reuter same store quarterly sale rise year year higher prescription sale offset flat front end sale week end same store sale rise pharmacy operation grow front end sale be fraction overall sale rise week rite aid say finalize report back june share fall more stock market today find support day move average rite aid stock be so far year hit long time high wednesday larger rival wag wednesday report strong sale continue bounce back contract dispute pharmacy benefit management giant express script esrx
1788,ESRX,share rise cvs caremark cvs rise less
1789,ESRX,rite aid february agree mckesson mck expand distribution deal generic drug larger rival wag wednesday report strong sale continue bounce back contract dispute pharmacy benefit management giant express script esrx share rise cvs caremark cvs rise less rite aid february agree mckesson mck expand distribution deal generic drug
1790,ESRX,wag sale climb april more customer visit store spend more visit result also get lift later easter holiday year last drug store operator say share rise record close stock set intraday peak
1791,ESRX,danish drug giant nordisk miss sale estimate lower full year revenue forecast thursday loss support payer hurt stock fall nordisk nvo make cent share quarter year earlier quarter danish kroner penny analyst consensus sale increase
1792,ESRX,grow specialty pharmacy unit get credit cvs caremark cvs help retail health care company notch fifth straight quarter double digit earning growth miss earning estimate woonsocket base company earn share year earlier miss cent estimate analyst poll thomson reuter revenue rise
1793,ESRX,big pharma abbvie abbv beat estimate friday get street talk company executive imply win discount new hepatitis regimen stock be morning trading stock market today
1794,ESRX,abbvie earning rise year earlier quarter cent share beating analyst consensus cent sale rise estimate
1795,ESRX,company do not raise full year guidance however still expect ep vs last year sale fraction exclude impact company new hepatitis regimen await fda approval
1796,ESRX,analyst have many question regimen hepatitis particularly abbvie pricing strategy compete gilead science gild recently launch blockbuster sovaldi pharmacy benefit manager express script esrx have be say hope reduce sovaldi price play competitor other ask abbvie plan compete price ceo richard gonzalez say not strategy go forward
1797,ESRX,sound abbvie wouldn engage significant price war gain share hep morningstar analyst damien conover write email ibd abbvie hold very strong treatment hep think compete efficacy relatively good side effect profile treatment
1798,ESRX,research note friday rbc capital market analyst michael yee agree abbvie executive sound very bullish competitive potential
1799,ESRX,consistently comment allude drug be competitive stand nicely market profile be strong convenience be lower totem pole patient need think long large market never suggest pricing be key lever share write further support gild long term view hcv market be billlion global market gild earn share least mean gild stock be reasonably cheap
1800,ESRX,gilead investor didn seem entirely assuage gilead stock be flat late morning trading
1801,ESRX,yee also note abbvie candidate chronic lymphocytic leukemia cll be move nicely late stage testing potentially create more competition pharmacyclic pcyc recently launch imbruvica however model be likely best sicker patient probably not optimal community docs want less aggressive tolerable pcyc regimen
1802,ESRX,pharmacyclic stock be nearly morning trading
1803,ESRX,follow amy reeve twitter ibd_areeve
1804,ESRX,related gilead illumina earning wall street lovebig pharma abbvie abbv beat estimate friday get street talk company executive imply win discount new hepatitis regimen stock be morning trading stock market today abbvie earning rise year earlier quarter cent share beating analyst consensus cent sale rise estimate company do not raise full year guidance however still expect ep vs last year sale fraction exclude impact company new hepatitis regimen await fda approval analyst have many question regimen hepatitis particularly abbvie pricing strategy compete gilead science gild recently launch blockbuster sovaldi pharmacy benefit manager express script esrx have be say hope reduce sovaldi price play competitor other ask abbvie plan compete price ceo richard gonzalez say not strategy go forward sound abbvie wouldn engage significant price war gain share hep morningstar analyst damien conover write email ibd abbvie hold very strong treatment hep think compete efficacy relatively good side effect profile treatment research note friday rbc capital market analyst michael yee agree abbvie executive sound very bullish competitive potential consistently comment allude drug be competitive stand nicely market profile be strong convenience be lower totem pole patient need think long large market never suggest pricing be key lever share write further support gild long term view hcv market be billlion global market gild earn share least mean gild stock be reasonably cheap gilead investor didn seem entirely assuage gilead stock be flat late morning trading yee also note abbvie candidate chronic lymphocytic leukemia cll be move nicely late stage testing potentially create more competition pharmacyclic pcyc recently launch imbruvica however model be likely best sicker patient probably not optimal community docs want less aggressive tolerable pcyc regimen pharmacyclic stock be nearly morning trading follow amy reeve twitter gilead illumina earning wall street love
1805,ESRX,stock future shed thursday premarket gain reversed moderate loss mixed report unemployment claim gdp growth
1806,ESRX,dow future drop point fair market value point advance hour earlier nasdaq future shed point gain drop point future also reversed trading point
1807,ESRX,stock market today receive boost federal reserve wednesday left nasdaq so far week show gain index be work be fifth straight weekly advance
1808,ESRX,more important growth investor small cap be have strong week russell surge wednesday strongest session dec lift small cap gauge clear day move average put ahead week even so index remain well next test resistance day line
1809,ESRX,ibd index pop wednesday be easily outpace market gain week
1810,ESRX,big day economic news be mixed start preliminary estimate commerce department putt gdp growth less half jump just forecast increase price inflation also softened gdp price index rise shade view advance
1811,ESRX,unemployment claim inched fractionally higher week end oct labor department report be better uptick claim forecast economist prior week tally be claim week move average dip sixth straight decline
1812,ESRX,atlanta federal reserve bank president dennis lockhart be schedule speak washington et national association realtor report september pending home sale datum
1813,ESRX,big oil company get earning ball roll royal dutch shell rdsa total tot conocophillip cop report result oil price backed west texas intermediate barrel surge more wednesday
1814,ESRX,drug maker pfizer pfe climb allergan agn soar news report company be explore possible merger wall street journal quote unnamed source say talk be early stage detail be unclear pfizer end wednesday week less buy point cup handle base
1815,ESRX,premarket session move identity security firm lifelock lock soar healthy result report late wednesday news have settle federal trade commission lawsuit digital video camera maker gopro gpro dive weaker forecast sale earning also report wednesday close
1816,ESRX,lead stock reilly automotive orly jump tesoro tso rise ellie mae elli be flat report reilly end wednesday session buy range less buy point tesoro be buy point cup handle base
1817,ESRX,nxp semiconductor nxpi dive netherlands base chip maker report earning stronger expect revenue rise less weaker estimate management expand stock buyback initiative share nxp finished wednesday just week move average have be work climb right side month consolidation
1818,ESRX,cavium cavm take hit report line earning revenue late wednesday chip maker have be chop uneven consolidation fight hold support june
1819,ESRX,follow alan elliott twitter ibd_aelliott facebook stock future shed thursday premarket gain reversed moderate loss mixed report unemployment claim gdp growth dow future drop point fair market value point advance hour earlier nasdaq future shed point gain drop point future also reversed trading point stock market today receive boost federal reserve wednesday left nasdaq so far week show gain index be work be fifth straight weekly advance more important growth investor small cap be have strong week russell surge wednesday strongest session dec lift small cap gauge clear day move average put ahead week even so index remain well next test resistance day line ibd index pop wednesday be easily outpace market gain week big day economic news be mixed start preliminary estimate commerce department putt gdp growth less half jump just forecast increase price inflation also softened gdp price index rise shade view advance unemployment claim inched fractionally higher week end oct labor department report be better uptick claim forecast economist prior week tally be claim week move average dip sixth straight decline atlanta federal reserve bank president dennis lockhart be schedule speak washington et national association realtor report september pending home sale datum big oil company get earning ball roll royal dutch shell rdsa total tot conocophillip cop report result oil price backed west texas intermediate barrel surge more wednesday drug maker pfizer pfe climb allergan agn soar news report company be explore possible merger wall street journal quote unnamed source say talk be early stage detail be unclear pfizer end wednesday week less buy point cup handle base premarket session move identity security firm lifelock lock soar healthy result report late wednesday news have settle federal trade commission lawsuit digital video camera maker gopro gpro dive weaker forecast sale earning also report wednesday close lead stock reilly automotive orly jump tesoro tso rise ellie mae elli be flat report reilly end wednesday session buy range less buy point tesoro be buy point cup handle base nxp semiconductor nxpi dive netherlands base chip maker report earning stronger expect revenue rise less weaker estimate management expand stock buyback initiative share nxp finished wednesday just week move average have be work climb right side month consolidation cavium cavm take hit report line earning revenue late wednesday chip maker have be chop uneven consolidation fight hold support june follow alan elliott twitter ibd_aelliott facebook
1820,ESRX,index chalk biggest day gain so far year news european union dollar bailout proposal greece trigger boisterous rebound
1821,ESRX,nyse composite head session leap nasdaq composite soar dow
1822,ESRX,midcaps outpaced session lift
1823,ESRX,volume surge open push major index day high mark volume backed remainder session end friday level
1824,ESRX,boston beer sam pop gain rebound week move average heavy trading
1825,ESRX,kansa city southern ksu bounce big volume dahlman rise analyst raise full year earning projection company cite expand market mexico company entrepreneurial nature
1826,ESRX,downside priceline com pcln topple hour cede regular session gain online travel bargain heavyweight report earning top census estimate revenue fall short consensus management also provide sale earning guidance current expectation
1827,ESRX,stock hold session high
1828,ESRX,index chalk biggest day gain so far year news european union dollar bailout proposal greece trigger boisterous rebound nyse composite head session leap nasdaq composite soar dow midcaps outpaced session lift volume surge open push major index day high mark volume backed remainder session end friday level boston beer sam pop gain rebound week move average heavy trading kansa city southern ksu bounce big volume dahlman rise analyst raise full year earning projection company cite expand market mexico company entrepreneurial nature downside priceline com pcln topple hour cede regular session gain online travel bargain heavyweight report earning top census estimate revenue fall short consensus management also provide sale earning guidance current expectation stock hold session high
1829,ESRX,update barrage economic datum intel cloudy outlook downbeat comment wal mart ceo hit market wednesday major average end higher
1830,ESRX,nyse composite climb dow nasdaq edge open lower stay red final minute session
1831,ESRX,volume fall board mitigate gain
1832,ESRX,leader fared well
1833,ESRX,shanda interactive entertainment snda jump nearly twice average trade chinese online gaming firm regain good chunk tuesday loss
1834,ESRX,group mate netease com nte rise more triple average volume today marked heaviest volume day feb chinese internet portal be nearly session lows
1835,ESRX,chipotle grill cmg reversed early loss rise heavy trading stock shrug downgrade jeffery co cite pricing issue prospect soft traffic broker cut chipotle underperform hold
1836,ESRX,tap thursday be build permit housing start initial jobless claim philly fed index
1837,ESRX,earning calendar company due report include baxter international bax biogen idec biib blackrock blk google goog intuitive surgical isrg jpmorgan chase jpm
1838,ESRX,update late rally send stock higher
1839,ESRX,vincent mao
1840,ESRX,stock finished higher rocky session wednesday final hour comeback seal day fate even nasdaq turn final minute trading lower bulk session
1841,ESRX,accord preliminary datum nyse composite climb dow gain close mark
1842,ESRX,meanwhile nasdaq turn loss gain advancer beat decliner more nyse slightly less nasdaq
1843,ESRX,volume fall exchange
1844,ESRX,update beige book fail inspire
1845,ESRX,vincent mao
1846,ESRX,stock weaken further fed release beige book economic condition
1847,ESRX,dow nyse composite remain only index black be gain more slip nasdaq slump new session low
1848,ESRX,volume be again tracking vastly lower board
1849,ESRX,fed beige book speak further contraction economic activity district report slow growth be silver line district note moderation pace decline several see sign stabilization
1850,ESRX,allegiant travel algt fall seesaw trading airline say wednesday expect post earning range share vs view
1851,ESRX,upside netease com nte turn loss gain chinese web portal also touch fresh time high
1852,ESRX,update stock step back ahead fed beige book
1853,ESRX,vincent mao
1854,ESRX,major index remain mixed condition have worsen just ahead fed beige book report
1855,ESRX,nyse composite be dow gain pull back pass mark meanwhile rise nasdaq be
1856,ESRX,turnover be again tracking lower exchange
1857,ESRX,economic news nahb well fargo housing market index jump april march biggest increase almost year homebuilder have be strong day strengthen follow release
1858,ESRX,meanwhile treasury survey say mortgage lend home equity line rise february ibd build residential commercial group rally datum suggest rebound housing sector
1859,ESRX,shanda interactive entertainment snda climb continue rebound tuesday drop week ibd chinese online gaming firm have be best performer recent week stock clear cup handle base march be then
1860,ESRX,downside burger king bkc gap tumble huge trade share fast food chain get grilled company report preliminary fiscal sale view
1861,ESRX,group mate red robin gourmet burger rrgb jack box jack mcdonald mcd fall respectively
1862,ESRX,neutral tandem tnmd reversed early gain drop erased tuesday move then provider wireless telecom service find support week move average last week
1863,ESRX,update broader market improve nasdaq still lag
1864,ESRX,vincent mao
1865,ESRX,most stock average strengthen early afternoon trading wednesday techs continue lag thank largely intel murky outlook
1866,ESRX,dow rise once again near mark nyse composite also gain rise meanwhile nasdaq fall deficit philadelphia semiconductor index drop
1867,ESRX,turnover be tracking sharply lower board
1868,ESRX,internet issue also come pressure amazon com amzn gap lose benchmark capital start coverage commerce giant sell rating
1869,ESRX,baidu com bidu fall continue lose ground tuesday reversal month high resistance week move average
1870,ESRX,netease com nte trim loss just chinese internet portal have already trade twice average volume lack news
1871,ESRX,upside cubic cub gap rally regain day move average needham upgrade share buy hold prospect better profitability cubic make military training communication system company have announce number contract recent week
1872,ESRX,update nasdaq sit loss midday
1873,ESRX,jonah keri
1874,ESRX,nasdaq continue trade lower midday wednesday lag performance major nyse index
1875,ESRX,tech laden nasdaq slide small cap edge upside dow industrial nyse composite inched add
1876,ESRX,volume drop board fall nasdaq nyse compare same period tuesday
1877,ESRX,genomic health ghdx fall more time normal trade provider clinical diagnostic test own robust sale growth go back many quarters be still search first profit company late tuesday say colon cancer test meet main clinical trial goal
1878,ESRX,express script esrx lose brisk trade pull back big gain stem purchase wellpoint wlp pharmacy benefit management business
1879,ESRX,upside chipotle grill cmg advanced twice normal turnover fast food chain be try build right side deep base earning growth have dry past quarters
1880,ESRX,federal reserve be slate release latest beige book report later afternoon
1881,ESRX,update stock remain mixed lighter volume
1882,ESRX,update barrage economic datum intel cloudy outlook downbeat comment wal mart ceo hit market wednesday major average end higher nyse composite climb dow nasdaq edge open lower stay red final minute session volume fall board mitigate gain leader fared well shanda interactive entertainment snda jump nearly twice average trade chinese online gaming firm regain good chunk tuesday loss group mate netease com nte rise more triple average volume today marked heaviest volume day feb chinese internet portal be nearly session lows chipotle grill cmg reversed early loss rise heavy trading stock shrug downgrade jeffery co cite pricing issue prospect soft traffic broker cut chipotle underperform hold tap thursday be build permit housing start initial jobless claim philly fed index earning calendar company due report include baxter international bax biogen idec biib blackrock blk google goog intuitive surgical isrg jpmorgan chase jpm update late rally send stock higherby vincent maostock finished higher rocky session wednesday final hour comeback seal day fate even nasdaq turn final minute trading lower bulk session accord preliminary datum nyse composite climb dow gain close mark meanwhile nasdaq turn loss gain advancer beat decliner more nyse slightly less nasdaq volume fall exchange update beige book fail inspireby vincent maostock weaken further fed release beige book economic condition dow nyse composite remain only index black be gain more slip nasdaq slump new session low volume be again tracking vastly lower board fed beige book speak further contraction economic activity district report slow growth be silver line district note moderation pace decline several see sign stabilization allegiant travel algt fall seesaw trading airline say wednesday expect post earning range share vs view upside netease com nte turn loss gain chinese web portal also touch fresh time high update stock step back ahead fed beige bookby vincent maothe major index remain mixed condition have worsen just ahead fed beige book report nyse composite be dow gain pull back pass mark meanwhile rise nasdaq be turnover be again tracking lower exchange economic news nahb well fargo housing market index jump april march biggest increase almost year homebuilder have be strong day strengthen follow release meanwhile treasury survey say mortgage lend home equity line rise february ibd build residential commercial group rally datum suggest rebound housing sector shanda interactive entertainment snda climb continue rebound tuesday drop week ibd chinese online gaming firm have be best performer recent week stock clear cup handle base march be then downside burger king bkc gap tumble huge trade share fast food chain get grilled company report preliminary fiscal sale view group mate red robin gourmet burger rrgb jack box jack mcdonald mcd fall respectively neutral tandem tnmd reversed early gain drop erased tuesday move then provider wireless telecom service find support week move average last week update broader market improve nasdaq still lagsby vincent maomost stock average strengthen early afternoon trading wednesday techs continue lag thank largely intel murky outlook dow rise once again near mark nyse composite also gain rise meanwhile nasdaq fall deficit philadelphia semiconductor index drop turnover be tracking sharply lower board internet issue also come pressure amazon com amzn gap lose benchmark capital start coverage commerce giant sell rating baidu com bidu fall continue lose ground tuesday reversal month high resistance week move average netease com nte trim loss just chinese internet portal have already trade twice average volume lack news upside cubic cub gap rally regain day move average needham upgrade share buy hold prospect better profitability cubic make military training communication system company have announce number contract recent week update nasdaq sit loss middayby jonah nasdaq continue trade lower midday wednesday lag performance major nyse index tech laden nasdaq slide small cap edge upside dow industrial nyse composite inched add volume drop board fall nasdaq nyse compare same period tuesday genomic health ghdx fall more time normal trade provider clinical diagnostic test own robust sale growth go back many quarters be still search first profit company late tuesday say colon cancer test meet main clinical trial goal express script esrx lose brisk trade pull back big gain stem purchase wellpoint wlp pharmacy benefit management business upside chipotle grill cmg advanced twice normal turnover fast food chain be try build right side deep base earning growth have dry past quarters federal reserve be slate release latest beige book report later afternoon update stock remain mixed lighter volume
1883,ESRX,update market launch fresh rally attempt tuesday turnaround bank strong show energy issue pull index higher heavy trading
1884,ESRX,day strong gain be nyse nasdaq composite first advance session
1885,ESRX,close first solar fslr slip report earning more double beating expectation company also report fourth quarter reduce production cost cent watt capacity industry first move share have gain regular session
1886,ESRX,president obama be schedule speak joint session congress evening propose other thing specific spending cut additional spending target energy education health care accord white house spokesman robert gibbs
1887,ESRX,wednesday market be look more comment fed chief ben bernanke report congressional leader national association realtor release exist home sale figure january
1888,ESRX,big slate earning report be tap start insurer ambac financial group abk dollar tree store dltr prior open california water service cwt fluor flr mantech mant medasset mda be long list slate report hour
1889,ESRX,update stock close strong gain
1890,ESRX,juan carlos arancibia
1891,ESRX,best day so far year stock market surge break lose skid
1892,ESRX,nyse composite soar nasdaq dow
1893,ESRX,volume rise add session favorable tone
1894,ESRX,market seem cheer fed chairman ben bernanke comment minimize chance bank nationalization also say recession end later year
1895,ESRX,financial lead rally spdr financial etf jump
1896,ESRX,update bank reverse higher strong volume
1897,ESRX,alan elliott
1898,ESRX,surge lead bank other financial hoist index best gain week
1899,ESRX,nyse financial index surge gain help nyse composite surge nasdaq composite hammer ahead dow grab gain liberty global lbtya marvell technology group mrvl lead nasdaq upside bank america bac citigroup general motor gm home depot hd lead dow
1900,ESRX,volume regain positive territory nyse higher nasdaq advance issue sprint ahead decliner nearly nyse lead nearly nasdaq
1901,ESRX,biotech drugmaker sepracor sepr surge solid volume move pull share back day move average stock attempt work way right side long term consolidation
1902,ESRX,quanta service pwr bolt higher double average trading high tech pipeline wiring service contractor trounce analyst view gain ep cent vs expectation cent company revenue also top view say be experience slow first quarter growth backlogged order point double digit ep growth rest year
1903,ESRX,update financial lead sudden surge
1904,ESRX,patrick
1905,ESRX,stock jump higher financial get boost unknown reason
1906,ESRX,dow be nyse composite nasdaq be higher
1907,ESRX,trade be fast board
1908,ESRX,financial be biggest mover midday rally citigroup rise morgan stanley ms bank america bac
1909,ESRX,buffalo wild wing bwld gain sport bar casual restaurant chain have see high volume move past session today be pace be different
1910,ESRX,express script esrx rise stock be straddle day move average line be consolidate late january
1911,ESRX,side target tgt lose percent report earning company say profit fall cent share miss view cent massive retailer be hurt consumer spending slowdown revenue be essential good
1912,ESRX,update volume firm broad base advance
1913,ESRX,alan elliott
1914,ESRX,energy issue continue lead nyse telecom head nasdaq gain index pressed higher afternoon trading
1915,ESRX,nyse composite add nasdaq composite rise dow
1916,ESRX,volume continue increase nyse nasdaq advance issue continue lead better exchange
1917,ESRX,homebuilder group surge analyst upgrade pulte home phm expect tumble december case shiller home price index pulte gain hovnanian enterprise hov soar lennar len horton dhi add
1918,ESRX,marvel entertainment mvl pop blow past analyst expectation jump ep company maintain guidance analyst expect decrease earning gap lift share just day move average
1919,ESRX,update stock retreat session high
1920,ESRX,vincent mao
1921,ESRX,stock pull back hit new session high tuesday halftime
1922,ESRX,nasdaq be intraday high nyse composite rise dow gain
1923,ESRX,volume be tracking higher exchange
1924,ESRX,speaking senate banking committee fed chairman ben bernanke say economy remain severe contraction expect shrinkage first month year bernanke also say recession end year fed use available tool see
1925,ESRX,break adverse feedback loop be essential continue complement fiscal stimulus strong government action stabilize financial institution financial market bernanke say prepared remark
1926,ESRX,corporate news reilly automotive orly rise follow upgrade friedman billing ramsey upgrade auto part retailer outperform underperform
1927,ESRX,last week auto part retailer rev higher market take beating
1928,ESRX,downside huron consult group hurn gap tumble week low open company deliver earning sale wall st expectation guide full year earning sale view
1929,ESRX,gold producer lose ground yellow metal pull back second session
1930,ESRX,barrick gold abx drop agnico eagle mine aem shed
1931,ESRX,december gold tumble ounce
1932,ESRX,update index push higher mixed trading
1933,ESRX,alan elliott
1934,ESRX,energy issue lead nyse telecom pull best advance nasdaq index edge higher late morning trading
1935,ESRX,nasdaq composite ride advance research motion rimm qualcomm qcom baidu com bidu post strong gain
1936,ESRX,nyse composite add jwn general motor gm home depot hd notch best gain
1937,ESRX,dow show higher
1938,ESRX,volume remain mixed higher nasdaq shade lower nyse
1939,ESRX,advance issue lead decliner nearly nyse better nasdaq
1940,ESRX,conference board consumer confidence index slump read february miss wide mark expectation more mild slip january confidence read be
1941,ESRX,crude oil natural gas future trade relatively flat gold slip nearly ounce dollar pare early loss vs euro make solid gain yen
1942,ESRX,education stock plow early gain corinthian college coco jump powerful trading itt educational service esi add capella education cpla devry dv rac gain
1943,ESRX,green mountain coffee roaster gmcr rebound average trading carve heavy volume loss monday move mark bounce stock week line support third week become new base
1944,ESRX,salt fertilizer maker compass mineral cmp surge busy action stock have drop straight week be feb high
1945,ESRX,downside oneok partner ok dove very heavy trading natural gas pipeline operator have be catch week decline
1946,ESRX,overseas financial commodity issue china drag shanghai composite lower year low hong kong hang seng index slump japan tokyo nikkei shave loss
1947,ESRX,european market be not hit quite so hard major index london frankfurt paris show deeper loss late trading
1948,ESRX,update stock fade higher open
1949,ESRX,vincent mao
1950,ESRX,stock open higher tuesday morning then pull back sharply testimony fed chairman ben bernanke get way
1951,ESRX,nasdaq gain nyse composite dow
1952,ESRX,volume be tracking mixed nyse lower nasdaq higher
1953,ESRX,economic news case shiller home price index tumble record december year earlier be sightly decline economist expect
1954,ESRX,meanwhile consumer confidence slump record low february revise read january be well expectation
1955,ESRX,company news financial be early winner citigroup well fargo wfc climb bank america bac rise
1956,ESRX,elsewhere onyx pharmaceutical onxx gap surge report smaller expect loss late monday morning boenn scattergood raise share outperform neutral
1957,ESRX,medco health solution mhs rise top view backed outlook open pharmacy benefit manager deliver earning cent share exclude item be prior year penny estimate sale grow also view medco backed full year profit outlook share vs view
1958,ESRX,downside american international group aig gap plunge report seek third dose government aid hurt ongoing credit crisis financial service giant be face fourth quarter loss
1959,ESRX,update stock poise higher open
1960,ESRX,vincent mao
1961,ESRX,monday beating wall street be poise upbeat open ahead testimony federal reserve chairman ben bernanke president obama
1962,ESRX,nasdaq future climb point vs fair value future rise point dow future gain point
1963,ESRX,bernanke speak senate banking committee monetary policy ll also address situation nation bank
1964,ESRX,president obama address congress tonight economy be headline topic
1965,ESRX,corporate news slew retailer report earning
1966,ESRX,share home depot hd rise pre market top fourth quarter profit view exclude item include cost related closure home improvement brand retailer earn cent share be prior year cent view sale fall expectation
1967,ESRX,macy report profit decline share be nickel estimate revenue fall also view look ahead department store operator see same store sale fall year share rise pre open
1968,ESRX,group mate jwn beat view late monday surge pre market
1969,ESRX,target tgt fall nearly pre market result miss mark discount retailer earning fall cent share cent view sale slip almost also expectation
1970,ESRX,meanwhile jpmorgan chase jpm late monday slash dividend nickel share effort preserve capital conference call chief executive jamie dimon say expect bank be profitable year
1971,ESRX,elsewhere consumer confidence february be economist expect read january update market launch fresh rally attempt tuesday turnaround bank strong show energy issue pull index higher heavy trading day strong gain be nyse nasdaq composite first advance session close first solar fslr slip report earning more double beating expectation company also report fourth quarter reduce production cost cent watt capacity industry first move share have gain regular session president obama be schedule speak joint session congress evening propose other thing specific spending cut additional spending target energy education health care accord white house spokesman robert gibbs wednesday market be look more comment fed chief ben bernanke report congressional leader national association realtor release exist home sale figure january big slate earning report be tap start insurer ambac financial group abk dollar tree store dltr prior open california water service cwt fluor flr mantech mant medasset mda be long list slate report hour update stock close strong gainsby juan carlos arancibiain best day so far year stock market surge break lose skid nyse composite soar nasdaq dow volume rise add session favorable tone market seem cheer fed chairman ben bernanke comment minimize chance bank nationalization also say recession end later year financial lead rally spdr financial etf jump update bank reverse higher strong volumeby alan elliotta surge lead bank other financial hoist index best gain week nyse financial index surge gain help nyse composite surge nasdaq composite hammer ahead dow grab gain liberty global lbtya marvell technology group mrvl lead nasdaq upside bank america bac citigroup general motor gm home depot hd lead dow volume regain positive territory nyse higher nasdaq advance issue sprint ahead decliner nearly nyse lead nearly nasdaq biotech drugmaker sepracor sepr surge solid volume move pull share back day move average stock attempt work way right side long term consolidation quanta service pwr bolt higher double average trading high tech pipeline wiring service contractor trounce analyst view gain ep cent vs expectation cent company revenue also top view say be experience slow first quarter growth backlogged order point double digit ep growth rest year update financial lead sudden surgeby patrick cainstock jump higher financial get boost unknown reason dow be nyse composite nasdaq be higher trade be fast board financial be biggest mover midday rally citigroup rise morgan stanley ms bank america bac buffalo wild wing bwld gain sport bar casual restaurant chain have see high volume move past session today be pace be different express script esrx rise stock be straddle day move average line be consolidate late january side target tgt lose percent report earning company say profit fall cent share miss view cent massive retailer be hurt consumer spending slowdown revenue be essential good update volume firm broad base advance alan elliottenergy issue continue lead nyse telecom head nasdaq gain index pressed higher afternoon trading nyse composite add nasdaq composite rise dow volume continue increase nyse nasdaq advance issue continue lead better exchange homebuilder group surge analyst upgrade pulte home phm expect tumble december case shiller home price index pulte gain hovnanian enterprise hov soar lennar len horton dhi add marvel entertainment mvl pop blow past analyst expectation jump ep company maintain guidance analyst expect decrease earning gap lift share just day move average update stock retreat session highsby vincent maostock pull back hit new session high tuesday halftime nasdaq be intraday high nyse composite rise dow gain volume be tracking higher exchange speaking senate banking committee fed chairman ben bernanke say economy remain severe contraction expect shrinkage first month year bernanke also say recession end year fed use available tool see break adverse feedback loop be essential continue complement fiscal stimulus strong government action stabilize financial institution financial market bernanke say prepared remark corporate news reilly automotive orly rise follow upgrade friedman billing ramsey upgrade auto part retailer outperform underperform last week auto part retailer rev higher market take beating downside huron consult group hurn gap tumble week low open company deliver earning sale wall st expectation guide full year earning sale view gold producer lose ground yellow metal pull back second session barrick gold abx drop agnico eagle mine aem shed december gold tumble ounce update index push higher mixed tradingby alan elliottenergy issue lead nyse telecom pull best advance nasdaq index edge higher late morning trading nasdaq composite ride advance research motion rimm qualcomm qcom baidu com bidu post strong gain nyse composite add jwn general motor gm home depot hd notch best gain dow show higher volume remain mixed higher nasdaq shade lower nyse advance issue lead decliner nearly nyse better nasdaq conference board consumer confidence index slump read february miss wide mark expectation more mild slip january confidence read be crude oil natural gas future trade relatively flat gold slip nearly ounce dollar pare early loss vs euro make solid gain yen education stock plow early gain corinthian college coco jump powerful trading itt educational service esi add capella education cpla devry dv rac gain green mountain coffee roaster gmcr rebound average trading carve heavy volume loss monday move mark bounce stock week line support third week become new base salt fertilizer maker compass mineral cmp surge busy action stock have drop straight week be feb high downside oneok partner ok dove very heavy trading natural gas pipeline operator have be catch week decline overseas financial commodity issue china drag shanghai composite lower year low hong kong hang seng index slump japan tokyo nikkei shave loss european market be not hit quite so hard major index london frankfurt paris show deeper loss late trading update stock fade higher openby vincent maostock open higher tuesday morning then pull back sharply testimony fed chairman ben bernanke get way nasdaq gain nyse composite dow volume be tracking mixed nyse lower nasdaq higher economic news case shiller home price index tumble record december year earlier be sightly decline economist expect meanwhile consumer confidence slump record low february revise read january be well expectation company news financial be early winner citigroup well fargo wfc climb bank america bac rise elsewhere onyx pharmaceutical onxx gap surge report smaller expect loss late monday morning boenn scattergood raise share outperform neutral medco health solution mhs rise top view backed outlook open pharmacy benefit manager deliver earning cent share exclude item be prior year penny estimate sale grow also view medco backed full year profit outlook share vs view downside american international group aig gap plunge report seek third dose government aid hurt ongoing credit crisis financial service giant be face fourth quarter loss update stock poise higher openby vincent maoafter monday beating wall street be poise upbeat open ahead testimony federal reserve chairman ben bernanke president obama nasdaq future climb point vs fair value future rise point dow future gain point bernanke speak senate banking committee monetary policy ll also address situation nation bank president obama address congress tonight economy be headline topic corporate news slew retailer report earning share home depot hd rise pre market top fourth quarter profit view exclude item include cost related closure home improvement brand retailer earn cent share be prior year cent view sale fall expectation macy report profit decline share be nickel estimate revenue fall also view look ahead department store operator see same store sale fall year share rise pre open group mate jwn beat view late monday surge pre market target tgt fall nearly pre market result miss mark discount retailer earning fall cent share cent view sale slip almost also expectation meanwhile jpmorgan chase jpm late monday slash dividend nickel share effort preserve capital conference call chief executive jamie dimon say expect bank be profitable year elsewhere consumer confidence february be economist expect read january
1972,ESRX,update index manage mixed finish be drag lower early trading commodity financial issue
1973,ESRX,nyse composite finished lower retreat twice resistance level session nasdaq gap open then retook break even mark close decisively higher
1974,ESRX,international stock be nyse achille heel exchange health care index post best gain
1975,ESRX,volume tapered higher level midday quiet finish
1976,ESRX,close athero communication athr report ep cent top consensus view cent share revenue fall still expectation share be fraction hour trading
1977,ESRX,multiline insurer aflac afl report ep cent cent analyst view company reiterate guidance current consensus call ep gain year company also say do not anticipate need seek additional capital share rise hour
1978,ESRX,tuesday datum pending home sale be due auto truck sale be schedule release
1979,ESRX,almost family afam daniel adm pnc financial service group pnc be company slate report december quarter result insurer unum group unm walt disney plan report close
1980,ESRX,update index rebound late close mixed
1981,ESRX,juan carlos arancibia
1982,ESRX,late burst cut nyse index loss nasdaq close higher
1983,ESRX,composite rise amazon com amzn intel intc other major component rise dow lose nyse composite be briefly positive
1984,ESRX,volume fall accord indication close bell spare nyse dow distribution day
1985,ESRX,toy industry group be day worst mattel mat plunge report result rival hasbro have slide sympathy
1986,ESRX,update stock deteriorate late trading
1987,ESRX,vincent mao
1988,ESRX,stock worsen late trading monday most major index pace close lower third straight session
1989,ESRX,dow drop lead loss mmm procter gamble pg ibm ibm nyse composite fall meanwhile nasdaq edge briefly dip negative territory
1990,ESRX,potential distribution day be shape nyse index turnover continue track higher nasdaq volume be also tracking higher
1991,ESRX,symantec symc erased early gain drop fast trade downturn also wipe security software maker earning inspire gain thursday
1992,ESRX,sandisk sndk gap fall ahead earning report bell analyst expect maker flash memory product lose cent share
1993,ESRX,upside school stock maintain bulk gain
1994,ESRX,apollo group apol rally brisk volume stock be try emerge pullback week move average
1995,ESRX,itt educational service esi rise credit suisse raise stock outperform neutral
1996,ESRX,update stock sour nasdaq macy slide
1997,ESRX,patrick
1998,ESRX,stock start sell major retailer announce job cut dividend reduction
1999,ESRX,dow be nyse nasdaq however be
2000,ESRX,volume be tracking higher board
2001,ESRX,macy plunge department store chain announce weak january same store sale company say plan cut job trim dividend
2002,ESRX,toy maker hasbro have plunge top rival mattel mat say earning fall send share typically toy industry be not so hard economic downturn hasbro report earning feb
2003,ESRX,insituform technology insu fall underground piping company agree acquire corr pro pink sheet company corrpro be corrosion control engineering service company
2004,ESRX,upside haemonetic hae break cup base short handle maker system help collect blood product donor be release better expect earning
2005,ESRX,update stock improve midday trade go green
2006,ESRX,vincent mao
2007,ESRX,stock continue improve midday trading monday
2008,ESRX,nasdaq push new session high rise gain google goog express script esrx amazon com amzn lift tech heavy index
2009,ESRX,rise join nasdaq positive territory meanwhile dow nyse composite slip
2010,ESRX,turnover be tracking sharply higher nyse tad higher nasdaq
2011,ESRX,humana hum stage huge turnaround jump regain day move average hmo be early follow latest quarterly report morning
2012,ESRX,cec entertainment cec rally upgrade morning morgan keegan raise operator chuck cheese restaurant outperform market perform broker note cec lower cheese cost cash flow
2013,ESRX,ibd firm sxc health solution sxci climb best level august be news drive move analyst see health care service firm profit growth fall quarter follow period sale growth be expect rocket more same quarters
2014,ESRX,downside sequenom sqnm gap drop heavy trading stock pare loss bounce day move average company make genetic analysis product
2015,ESRX,update stock linger mixed territory
2016,ESRX,vincent mao
2017,ESRX,stock be again mixed monday halftime major index have weaken somewhat
2018,ESRX,nasdaq be intraday high still nyse composite slump dow
2019,ESRX,volume be tracking modestly higher nyse barely higher nasdaq
2020,ESRX,vistaprint vprt rise best level month last week provider online printing service deliver jump fiscal profit best quarters stock have face resistance day move average point ahead
2021,ESRX,netflix nflx reversed early loss gain fast trade stock be past buy point cup handle pattern tough time online movie rental firm earning sale growth accelerate recent quarters
2022,ESRX,downside hasbro have gap slump week low fall sympathy fellow toy maker mattel mat report drop earning earlier hasbro report earning feb analyst be expect loss dime share
2023,ESRX,insituform technology insu gap day move average tumble stock pare loss find support day line open maker trenchless pipe announce buyout total value company fund deal debt common stock offer share
2024,ESRX,update index mixed financial energy head downside
2025,ESRX,alan elliott
2026,ESRX,cross section lead stock moved higher economic datum analyst downgrade slumping commodity price hold overall market mixed trading
2027,ESRX,nyse composite lead downside largest loss financial energy sector dow backed drag lower boee ba general electric ge procter gamble pg
2028,ESRX,slip nasdaq show gain akamai technology akam steel dynamic stld post nasdaq strongest gain
2029,ESRX,volume be solidly higher exchange
2030,ESRX,commerce department report construction spending slip slightly more expect december vs consensus expectation decline slip make third straight month decline bring total record drop
2031,ESRX,march crude oil contract remain dollar hold just barrel commodity trade broadly lower dollar jump higher vs euro pound give ground yen
2032,ESRX,education stock roar back tough week
2033,ESRX,itt educational service esi jump apollo group apol add devry dv edge higher big trading volume
2034,ESRX,haemonetic hae spiked heavyweight trading maker blood salvage recycling equipment bag ep cent gain few click analyst take company also boost ep guidance range have be scoop nice cup base september
2035,ESRX,compass mineral cmp pop huge trading distributor table road salt be just retake week move average tumble right side month long base
2036,ESRX,overseas financial lead market europe be firmly lower credit rating downgrade barclay bank moody investor service cac paris fall frankfurt dax slip ftse london give
2037,ESRX,china shanghai market jump higher first day trading new year holiday shanghai composite sprung gain hong kong go other direction benchmark hang seng index tumble weigh heavy selling base bank hsbc japan tokyo nikkei slip
2038,ESRX,update stock bounce back early stumble
2039,ESRX,vincent mao
2040,ESRX,stock wobble gate monday follow more weak economic corporate news have turn mixed
2041,ESRX,nasdaq rise help gain apple aapl apollo group apol google goog nyse composite be fall dow
2042,ESRX,volume be tracking mixed nyse nasdaq slightly
2043,ESRX,ism manufacturing index january improve revise expectation read index pare loss news
2044,ESRX,financial be again pressure piper jaffray pjc gap drop swung loss come analyst expectation
2045,ESRX,barclay bcs gap tumble moody investor service downgrade long term debt rating
2046,ESRX,other decliner include hsbc hbc fall citigroup well fargo wfc lose respectively
2047,ESRX,meanwhile rockwell automation rok gap slump miss view slash outlook open maker control power system report earning cent share prior year penny expectation sale decline also view
2048,ESRX,rockwell lower full year profit guidance share vs prior guidance analyst expect share
2049,ESRX,update stock poise bad open
2050,ESRX,vincent mao
2051,ESRX,stock future point nasty open monday continue economic wo more weak corporate earning report didn help
2052,ESRX,nasdaq future drop point vs fair value future shed point dow future tumble point
2053,ESRX,personal spending fall december accord commerce department be sixth straight monthly decline economist forecast drop november spending be downwardly revise personal income slip smaller expect
2054,ESRX,ism manufacturing index january be datum december construction spending also be
2055,ESRX,key piece economic datum be friday job report
2056,ESRX,senate week be expect vote president obama stimulus plan be pass house last week republican support senate republican be likely ask more help housing market include government backed mortgage more home buyer credit day moratorium foreclosure
2057,ESRX,corporate news mattel mat dive pre market badly miss view toy maker earning tumble cent share cent view mattel be hurt strong dollar weak holiday season sale fall vs estimate
2058,ESRX,corn product international cpo fall pre open miss view give weak outlook food ingredient maker deliver profit cent share flat year earlier cent view revenue edge vs view corn product peg full year earning range share well analyst estimate
2059,ESRX,humana hum also report weak earning hmo profit fall share prior year cent estimate humana guide full year earning share vs view share fall pre market
2060,ESRX,miner rio rtp rise pre market confirm talk aluminum corp china buy minority stake rio operation update index manage mixed finish be drag lower early trading commodity financial issue nyse composite finished lower retreat twice resistance level session nasdaq gap open then retook break even mark close decisively higher international stock be nyse achille heel exchange health care index post best gain volume tapered higher level midday quiet finish close athero communication athr report ep cent top consensus view cent share revenue fall still expectation share be fraction hour trading multiline insurer aflac afl report ep cent cent analyst view company reiterate guidance current consensus call ep gain year company also say do not anticipate need seek additional capital share rise hour tuesday datum pending home sale be due auto truck sale be schedule release almost family afam daniel adm pnc financial service group pnc be company slate report december quarter result insurer unum group unm walt disney plan report close update index rebound late close mixed juan carlos arancibiaa late burst cut nyse index loss nasdaq close higher composite rise amazon com amzn intel intc other major component rise dow lose nyse composite be briefly positive volume fall accord indication close bell spare nyse dow distribution day toy industry group be day worst mattel mat plunge report result rival hasbro have slide sympathy update stock deteriorate late tradingby vincent maostock worsen late trading monday most major index pace close lower third straight session dow drop lead loss mmm procter gamble pg ibm ibm nyse composite fall meanwhile nasdaq edge briefly dip negative territory potential distribution day be shape nyse index turnover continue track higher nasdaq volume be also tracking higher symantec symc erased early gain drop fast trade downturn also wipe security software maker earning inspire gain thursday sandisk sndk gap fall ahead earning report bell analyst expect maker flash memory product lose cent share upside school stock maintain bulk gain apollo group apol rally brisk volume stock be try emerge pullback week move average itt educational service esi rise credit suisse raise stock outperform neutral update stock sour nasdaq macy slidesby patrick cainstock start sell major retailer announce job cut dividend reduction dow be nyse nasdaq however be volume be tracking higher board macy plunge department store chain announce weak january same store sale company say plan cut job trim dividend toy maker hasbro have plunge top rival mattel mat say earning fall send share typically toy industry be not so hard economic downturn hasbro report earning feb insituform technology insu fall underground piping company agree acquire corr pro pink sheet company corrpro be corrosion control engineering service company upside haemonetic hae break cup base short handle maker system help collect blood product donor be release better expect earning update stock improve midday trade go greenby vincent maostock continue improve midday trading monday nasdaq push new session high rise gain google goog express script esrx amazon com amzn lift tech heavy index rise join nasdaq positive territory meanwhile dow nyse composite slip turnover be tracking sharply higher nyse tad higher nasdaq humana hum stage huge turnaround jump regain day move average hmo be early follow latest quarterly report morning cec entertainment cec rally upgrade morning morgan keegan raise operator chuck cheese restaurant outperform market perform broker note cec lower cheese cost cash flow ibd firm sxc health solution sxci climb best level august be news drive move analyst see health care service firm profit growth fall quarter follow period sale growth be expect rocket more same quarters downside sequenom sqnm gap drop heavy trading stock pare loss bounce day move average company make genetic analysis product update stock linger mixed territoryby vincent maostock be again mixed monday halftime major index have weaken somewhat nasdaq be intraday high still nyse composite slump dow volume be tracking modestly higher nyse barely higher nasdaq vistaprint vprt rise best level month last week provider online printing service deliver jump fiscal profit best quarters stock have face resistance day move average point ahead netflix nflx reversed early loss gain fast trade stock be past buy point cup handle pattern tough time online movie rental firm earning sale growth accelerate recent quarters downside hasbro have gap slump week low fall sympathy fellow toy maker mattel mat report drop earning earlier hasbro report earning feb analyst be expect loss dime share insituform technology insu gap day move average tumble stock pare loss find support day line open maker trenchless pipe announce buyout total value company fund deal debt common stock offer share update index mixed financial energy head downside alan elliotta cross section lead stock moved higher economic datum analyst downgrade slumping commodity price hold overall market mixed trading nyse composite lead downside largest loss financial energy sector dow backed drag lower boee ba general electric ge procter gamble pg slip nasdaq show gain akamai technology akam steel dynamic stld post nasdaq strongest gain volume be solidly higher exchange commerce department report construction spending slip slightly more expect december vs consensus expectation decline slip make third straight month decline bring total record drop march crude oil contract remain dollar hold just barrel commodity trade broadly lower dollar jump higher vs euro pound give ground yen education stock roar back tough week itt educational service esi jump apollo group apol add devry dv edge higher big trading volume haemonetic hae spiked heavyweight trading maker blood salvage recycling equipment bag ep cent gain few click analyst take company also boost ep guidance range have be scoop nice cup base september compass mineral cmp pop huge trading distributor table road salt be just retake week move average tumble right side month long base overseas financial lead market europe be firmly lower credit rating downgrade barclay bank moody investor service cac paris fall frankfurt dax slip ftse london give china shanghai market jump higher first day trading new year holiday shanghai composite sprung gain hong kong go other direction benchmark hang seng index tumble weigh heavy selling base bank hsbc japan tokyo nikkei slip update stock bounce back early stumbleby vincent maostock wobble gate monday follow more weak economic corporate news have turn mixed nasdaq rise help gain apple aapl apollo group apol google goog nyse composite be fall dow volume be tracking mixed nyse nasdaq slightly ism manufacturing index january improve revise expectation read index pare loss news financial be again pressure piper jaffray pjc gap drop swung loss come analyst expectation barclay bcs gap tumble moody investor service downgrade long term debt rating other decliner include hsbc hbc fall citigroup well fargo wfc lose respectively meanwhile rockwell automation rok gap slump miss view slash outlook open maker control power system report earning cent share prior year penny expectation sale decline also view rockwell lower full year profit guidance share vs prior guidance analyst expect share update stock poise bad openby vincent maostock future point nasty open monday continue economic wo more weak corporate earning report didn help nasdaq future drop point vs fair value future shed point dow future tumble point personal spending fall december accord commerce department be sixth straight monthly decline economist forecast drop november spending be downwardly revise personal income slip smaller expect ism manufacturing index january be datum december construction spending also be key piece economic datum be friday job report senate week be expect vote president obama stimulus plan be pass house last week republican support senate republican be likely ask more help housing market include government backed mortgage more home buyer credit day moratorium foreclosure corporate news mattel mat dive pre market badly miss view toy maker earning tumble cent share cent view mattel be hurt strong dollar weak holiday season sale fall vs estimate corn product international cpo fall pre open miss view give weak outlook food ingredient maker deliver profit cent share flat year earlier cent view revenue edge vs view corn product peg full year earning range share well analyst estimate humana hum also report weak earning hmo profit fall share prior year cent estimate humana guide full year earning share vs view share fall pre market miner rio rtp rise pre market confirm talk aluminum corp china buy minority stake rio operation
2061,ESRX,update stock finished mostly lower follow mixed economic datum tuesday housing datum be better expect consumer confidence unexpectedly fall
2062,ESRX,nasdaq tumble hurt internet chip issue baidu bidu gap dive stock close session high day move average
2063,ESRX,philadelphia semiconductor index shed slice day line
2064,ESRX,meanwhile nyse composite lose respectively
2065,ESRX,dow manage gain
2066,ESRX,volume rise nasdaq nyse
2067,ESRX,many leader get hit heavy trade ibd component finished lower
2068,ESRX,interactive intelligence inin dive slice day line software maker get hit report earning view late monday be biggest percentage loser ibd
2069,ESRX,home inn hotel hmin tumble more triple average trade stock also slice day move average
2070,ESRX,fuqi international fuqi dive further day line stumble more twice average volume
2071,ESRX,carter cri plunge slice day line due accounting issue child apparel retailer delay third quarter report company be suppose report tuesday now expect report nov
2072,ESRX,upside abovenet abvt jump time high communication infrastructure firm report earning nov analyst see profit rise cent share
2073,ESRX,earning wednesday agnico eagle mine aem akamai technology akam asiainfo holding asia cerner cern commvault system cvlt conocophillip cop express script esrx first solar fslr general dynamic gd human genome science hgsi taleo tleo transcend service trcr wellpoint wlp
2074,ESRX,durable order new home sale also be wednesday
2075,ESRX,update dow gain other fall
2076,ESRX,vincent mao
2077,ESRX,blue chip tick broader average finished lower seesaw session tuesday
2078,ESRX,nasdaq drop nyse composite fall meanwhile dow eke gain thank advance exxon mobil xom chevron cvx american express axp
2079,ESRX,volume tick nasdaq slip nyse decliner beat advancer ratio exchange
2080,ESRX,leisure internet apparel manufacturer be day worst group hmo tobacco group buck trend
2081,ESRX,update dow hang tough late trade
2082,ESRX,vincent mao
2083,ESRX,stock remain mixed regain ground late trading tuesday
2084,ESRX,dow rise bounce back briefly dip negative territory gain chevron cvx exxon mobil xom ibm ibm boost index
2085,ESRX,meanwhile nyse composite slip nasdaq trim loss
2086,ESRX,volume be tracking slightly higher nasdaq still lower nyse
2087,ESRX,dollar thrifty automotive dtg fuqi international fuqi extend loss respectively
2088,ESRX,upside abaxis abax advent software advs be slightly higher ahead earning report close
2089,ESRX,update stock deteriorate afternoon trading
2090,ESRX,vincent mao
2091,ESRX,stock again worsen major average negative territory
2092,ESRX,dow pare gain nyse composite turn lower
2093,ESRX,meanwhile nasdaq stumble new session lows fall
2094,ESRX,volume be again tracking slightly lower exchange
2095,ESRX,baidu bidu gap tumble stock fall back day move average reclaim line earlier
2096,ESRX,schnitzer steel industry schn gap lose report result beat view stock be near potential support day move average
2097,ESRX,apple aapl erased early gain slip active trading fall back level
2098,ESRX,update index still mixed early afternoon trade
2099,ESRX,vincent mao
2100,ESRX,stock remain mixed early afternoon trading tuesday have worsen bit
2101,ESRX,thank ibm ibm dow outshined gain big blue board director approve quarterly dividend cent share authorize additional share buyback
2102,ESRX,meanwhile nyse composite be fractionally higher nasdaq lose drag loss baidu bidu wynn resort wynn chip also weigh nasdaq philadelphia semiconductor index drop fall day move average
2103,ESRX,volume be tracking lower exchange
2104,ESRX,leader continue get hit
2105,ESRX,fuqi international fuqi erased morning gain shed heavy trading chinese jewelry maker be now week high fuqi break support
2106,ESRX,pegasystem pega reversed early gain dump slice day move average stock have yet close line late july pegasystem accumulation distribution rating have wane late august
2107,ESRX,wm industry wm gap dump slice day move average late monday gaming equipment maker deliver fiscal sale view give weak revenue outlook stock have already trade more twice average daily volume
2108,ESRX,upside inverness medical innovation ima be earlier high still open diagnostic product maker report earning cent share cent view sale grow also view
2109,ESRX,update major index mixed midday
2110,ESRX,jonah keri
2111,ESRX,stock turn mixed midday trading tuesday
2112,ESRX,nyse composite climb dow downside nasdaq dip
2113,ESRX,volume swell board rise nyse nasdaq compare same period monday
2114,ESRX,carter cri crash massive volume maker apparel baby young child plunge delay third quarter earning report
2115,ESRX,dollar thrifty automotive dtg slump huge trade car rental company say expect return positive rental revenue growth company also announce offer common share help send stock lower
2116,ESRX,chipmaker tessera technology tsra slide elevated volume slice day move average buy point break oct
2117,ESRX,upside tupperware brand tup rise brisk turnover food container maker stock have hold firm gapping new high wednesday
2118,ESRX,update leader struggle market rebound
2119,ESRX,update stock finished mostly lower follow mixed economic datum tuesday housing datum be better expect consumer confidence unexpectedly fall nasdaq tumble hurt internet chip issue baidu bidu gap dive stock close session high day move average philadelphia semiconductor index shed slice day line meanwhile nyse composite lose respectively dow manage gain volume rise nasdaq nyse many leader get hit heavy trade ibd component finished lower interactive intelligence inin dive slice day line software maker get hit report earning view late monday be biggest percentage loser ibd home inn hotel hmin tumble more triple average trade stock also slice day move average fuqi international fuqi dive further day line stumble more twice average volume carter cri plunge slice day line due accounting issue child apparel retailer delay third quarter report company be suppose report tuesday now expect report nov upside abovenet abvt jump time high communication infrastructure firm report earning nov analyst see profit rise cent share earning wednesday agnico eagle mine aem akamai technology akam asiainfo holding asia cerner cern commvault system cvlt conocophillip cop express script esrx first solar fslr general dynamic gd human genome science hgsi taleo tleo transcend service trcr wellpoint wlp durable order new home sale also be wednesday update dow gain other fallby vincent maoblue chip tick broader average finished lower seesaw session tuesday nasdaq drop nyse composite fall meanwhile dow eke gain thank advance exxon mobil xom chevron cvx american express axp volume tick nasdaq slip nyse decliner beat advancer ratio exchange leisure internet apparel manufacturer be day worst group hmo tobacco group buck trend update dow hang tough late tradeby vincent maostock remain mixed regain ground late trading tuesday dow rise bounce back briefly dip negative territory gain chevron cvx exxon mobil xom ibm ibm boost index meanwhile nyse composite slip nasdaq trim loss volume be tracking slightly higher nasdaq still lower nyse dollar thrifty automotive dtg fuqi international fuqi extend loss respectively upside abaxis abax advent software advs be slightly higher ahead earning report close update stock deteriorate afternoon tradingby vincent maostock again worsen major average negative territory dow pare gain nyse composite turn lower meanwhile nasdaq stumble new session lows fall volume be again tracking slightly lower exchange baidu bidu gap tumble stock fall back day move average reclaim line earlier schnitzer steel industry schn gap lose report result beat view stock be near potential support day move average apple aapl erased early gain slip active trading fall back level update index still mixed early afternoon tradeby vincent maostock remain mixed early afternoon trading tuesday have worsen bit thank ibm ibm dow outshined gain big blue board director approve quarterly dividend cent share authorize additional share buyback meanwhile nyse composite be fractionally higher nasdaq lose drag loss baidu bidu wynn resort wynn chip also weigh nasdaq philadelphia semiconductor index drop fall day move average volume be tracking lower exchange leader continue get hit fuqi international fuqi erased morning gain shed heavy trading chinese jewelry maker be now week high fuqi break support pegasystem pega reversed early gain dump slice day move average stock have yet close line late july pegasystem accumulation distribution rating have wane late august wm industry wm gap dump slice day move average late monday gaming equipment maker deliver fiscal sale view give weak revenue outlook stock have already trade more twice average daily volume upside inverness medical innovation ima be earlier high still open diagnostic product maker report earning cent share cent view sale grow also view update major index mixed middayby jonah keristock turn mixed midday trading tuesday nyse composite climb dow downside nasdaq dip volume swell board rise nyse nasdaq compare same period monday carter cri crash massive volume maker apparel baby young child plunge delay third quarter earning report dollar thrifty automotive dtg slump huge trade car rental company say expect return positive rental revenue growth company also announce offer common share help send stock lower chipmaker tessera technology tsra slide elevated volume slice day move average buy point break oct upside tupperware brand tup rise brisk turnover food container maker stock have hold firm gapping new high wednesday update leader struggle market rebound
2120,ESRX,update major index finished mixed investor digest flood corporate earning report news economic datum
2121,ESRX,nasdaq rise nearly best july high gain intuitive surgical isrg teva pharmaceutical industry teva celgene celg amgen amgn check point software chkp boost index
2122,ESRX,narrower nasdaq also rise hit month high
2123,ESRX,meanwhile nyse composite fall dow
2124,ESRX,turnover rise board especially nyse higher trade give distribution day nyse composite
2125,ESRX,buffalo wild wing bwld reversed early loss rally time average trade late monday sport bar grill operator beat view jump earning rise sale stock be quickly build right side cup base
2126,ESRX,groupmate chipotle grill cmg add new week high stock be now past buy point cup handle pattern
2127,ESRX,sohu com sohu gain upgrade stock close just day move average
2128,ESRX,downside dineequity din reversed good gain slump slice day line restaurant operator report disappointing earning file sell mixed security
2129,ESRX,shanda interactive entertainment snda erased early gain lose twice average trade marked chinese online gamer fourth straight decline heavy volume stock accumulation distribution rating have drop worst possible
2130,ESRX,earning wednesday akamai technology akam arcelormittal mt asiainfo asia digital river driv express script esrx euronet eeft general dynamic gd green mountain coffee roaster gmcr medco health solution mhs moody mco netlogic microsystem netl nice system nice oceaneering international oii penn national gaming penn sprint nextel tetra tech ttek visa watson pharmaceutical wpi wellpoint wlp
2131,ESRX,datum durable good fed beige book also be wednesday
2132,ESRX,update stock close split fashion
2133,ESRX,vincent mao
2134,ESRX,stock close mixed none less session high tuesday
2135,ESRX,nasdaq be lone gainer nyse composite drop dow
2136,ESRX,accord preliminary datum volume rise exchange
2137,ESRX,medical airline datum storage firm be best performer electronic part distributor metal be couple worst performer
2138,ESRX,update buyer return late trade
2139,ESRX,vincent mao
2140,ESRX,stock turn mixed hour left tuesday trading late buyer again step
2141,ESRX,tech laden nasdaq rise big winner be intuitive surgical isrg celgene celg amgen amgn check point software chkp
2142,ESRX,meanwhile nyse composite fall dow
2143,ESRX,tech pharmacal hitk gap gain near year high drugmaker earlier month deliver pop fiscal earning
2144,ESRX,amazon com amzn reversed earlier loss rise turn higher bounce day move average
2145,ESRX,advent software advs slip ahead earning report close investment software maker be expect earn cent share sale
2146,ESRX,panera bread pnra peet coffee tea peet also report result close be slightly higher
2147,ESRX,update stock shave more loss
2148,ESRX,vincent mao
2149,ESRX,hour left session stock continue trim loss
2150,ESRX,nyse composite be dow nasdaq be have be much session low
2151,ESRX,volume be again tracking sharply higher nyse roughly even nasdaq
2152,ESRX,inverness medical innovation ima drop slice day move average maker diagnostic product fall first time session report result beat view
2153,ESRX,starent network star reversed early gain fall slice day line stock have be line more month
2154,ESRX,upside teva pharmaceutical industry teva gap rise new high earlier morning maker generic drug report mixed result earning top view sale miss company expect greater synergy last year buyout barr laboratory
2155,ESRX,update index rebound early afternoon trade
2156,ESRX,vincent mao
2157,ESRX,stock trim loss fall new session lows early afternoon trading tuesday
2158,ESRX,hurt partly metal energy issue nyse composite drop deficit
2159,ESRX,fall dow nasdaq
2160,ESRX,turnover be again tracking sharply higher nyse tad lower nasdaq
2161,ESRX,dineequity din reversed early gain dive slice day move average open operator applebee ihop chain deliver earning trounce view sale drop wider expect company also file shelf registration sell mixed security
2162,ESRX,coach coh shed heavy trading earlier morning luxury good retailer report fiscal earning line view sale miss estimate stock trim loss find support day move average
2163,ESRX,upside capella education cpla rally new week high school operator beat view jump earning increase sale guide sale view
2164,ESRX,sohu com sohu rally upgrade morgan stanley raise chinese web portal operator weight equal weight
2165,ESRX,update stock loss intensify midday
2166,ESRX,jonah keri
2167,ESRX,market loss picked midday tuesday spur weak consumer confidence report mixed earning result
2168,ESRX,nasdaq drop dow nyse composite
2169,ESRX,volume remain mixed climb nyse fall nasdaq compare same period monday
2170,ESRX,green mountain coffee roaster gmcr start session higher coffee roaster distributor reversed be now brisk trade still stock have hold gain breaking short consolidation july
2171,ESRX,orion marine group orn tumble brisk turnover provider marine construction service reversed lower hit new high monday
2172,ESRX,upside genpact vault nearly time usual volume service stock be highest point september last year
2173,ESRX,hms holding hmsy advanced average turnover provider financial logistical service health care company have be uptrend recently find support day move average
2174,ESRX,unite natural food unfi picked close double average trade distributor organic natural grocery have be trading tight range past week
2175,ESRX,update stock fall consumer confidence datum
2176,ESRX,update major index finished mixed investor digest flood corporate earning report news economic datum nasdaq rise nearly best july high gain intuitive surgical isrg teva pharmaceutical industry teva celgene celg amgen amgn check point software chkp boost index narrower nasdaq also rise hit month high meanwhile nyse composite fall dow turnover rise board especially nyse higher trade give distribution day nyse composite buffalo wild wing bwld reversed early loss rally time average trade late monday sport bar grill operator beat view jump earning rise sale stock be quickly build right side cup base groupmate chipotle grill cmg add new week high stock be now past buy point cup handle pattern sohu com sohu gain upgrade stock close just day move average downside dineequity din reversed good gain slump slice day line restaurant operator report disappointing earning file sell mixed security shanda interactive entertainment snda erased early gain lose twice average trade marked chinese online gamer fourth straight decline heavy volume stock accumulation distribution rating have drop worst possible earning wednesday akamai technology akam arcelormittal mt asiainfo asia digital river driv express script esrx euronet eeft general dynamic gd green mountain coffee roaster gmcr medco health solution mhs moody mco netlogic microsystem netl nice system nice oceaneering international oii penn national gaming penn sprint nextel tetra tech ttek visa watson pharmaceutical wpi wellpoint wlp datum durable good fed beige book also be wednesday update stock close split fashionby vincent maostock close mixed none less session high tuesday nasdaq be lone gainer nyse composite drop dow accord preliminary datum volume rise exchange medical airline datum storage firm be best performer electronic part distributor metal be couple worst performer update buyer return late tradeby vincent maostock turn mixed hour left tuesday trading late buyer again step tech laden nasdaq rise big winner be intuitive surgical isrg celgene celg amgen amgn check point software chkp meanwhile nyse composite fall dow tech pharmacal hitk gap gain near year high drugmaker earlier month deliver pop fiscal earning amazon com amzn reversed earlier loss rise turn higher bounce day move average advent software advs slip ahead earning report close investment software maker be expect earn cent share sale panera bread pnra peet coffee tea peet also report result close be slightly higher update stock shave more lossesby vincent maowith hour left session stock continue trim loss nyse composite be dow nasdaq be have be much session low volume be again tracking sharply higher nyse roughly even nasdaq inverness medical innovation ima drop slice day move average maker diagnostic product fall first time session report result beat view starent network star reversed early gain fall slice day line stock have be line more month upside teva pharmaceutical industry teva gap rise new high earlier morning maker generic drug report mixed result earning top view sale miss company expect greater synergy last year buyout barr laboratory update index rebound early afternoon tradeby vincent maostock trim loss fall new session lows early afternoon trading tuesday hurt partly metal energy issue nyse composite drop deficit fall dow nasdaq turnover be again tracking sharply higher nyse tad lower nasdaq dineequity din reversed early gain dive slice day move average open operator applebee ihop chain deliver earning trounce view sale drop wider expect company also file shelf registration sell mixed security coach coh shed heavy trading earlier morning luxury good retailer report fiscal earning line view sale miss estimate stock trim loss find support day move average upside capella education cpla rally new week high school operator beat view jump earning increase sale guide sale view sohu com sohu rally upgrade morgan stanley raise chinese web portal operator weight equal weight update stock loss intensify middayby jonah market loss picked midday tuesday spur weak consumer confidence report mixed earning result nasdaq drop dow nyse composite volume remain mixed climb nyse fall nasdaq compare same period monday green mountain coffee roaster gmcr start session higher coffee roaster distributor reversed be now brisk trade still stock have hold gain breaking short consolidation july orion marine group orn tumble brisk turnover provider marine construction service reversed lower hit new high monday upside genpact vault nearly time usual volume service stock be highest point september last year hms holding hmsy advanced average turnover provider financial logistical service health care company have be uptrend recently find support day move average unite natural food unfi picked close double average trade distributor organic natural grocery have be trading tight range past week update stock fall consumer confidence datum
2177,ESRX,update stock squander promising start close mixed thursday major index finished higher second straight month
2178,ESRX,nasdaq give bulk gain near day move average close
2179,ESRX,meanwhile dow fall nyse composite slip
2180,ESRX,volume climb exchange
2181,ESRX,month nasdaq jump best jump week end oct nyse composite rally dow
2182,ESRX,green mountain coffee roaster gcmr gap rocket nearly time average trade stock surge stellar fiscal result news distribution deal wal mart store wmt earning news be announce late wednesday
2183,ESRX,fellow coffee related stock starbucks sbux rally nearly more twice average trade peet coffee tea peet add
2184,ESRX,neutral tandem tndm gap climb almost heavy trading provider wireless telecom service top view quarter triple digit earning growth
2185,ESRX,elsewhere dow chemical dow gap surge deliver surprising profit revenue however miss analyst estimate
2186,ESRX,economic calendar friday university michigan sentiment index factory order ism index
2187,ESRX,earning allergan agn chevron cvx clorox clx dean food df mastercard
2188,ESRX,update stock finish mixed rocky trading
2189,ESRX,vincent mao
2190,ESRX,rocky trading session end mixed result thursday nasdaq be lone gainer
2191,ESRX,nasdaq rise well intraday high pare gain come point day move average
2192,ESRX,dow fall nyse composite lose
2193,ESRX,volume climb board advancer edge decliner nyse nasdaq advancer decliner be even
2194,ESRX,genetic homebuilder be biggest decliner alternative energy heavy machinery score nice gain
2195,ESRX,update index rebound late trade
2196,ESRX,vincent mao
2197,ESRX,major index bounce back late trading thursday be still well session high
2198,ESRX,nasdaq be nyse composite dow
2199,ESRX,turnover be again tracking higher exchange pace slow
2200,ESRX,vistaprint vprt climb nearly fresh month high report earning close analyst see profit rise cent share earlier thursday provider online printing service inked multiyear pact fedex fdx
2201,ESRX,athenahealth athn rise regain day move average ahead earning report close provider bill collection service be expect earn cent share sale
2202,ESRX,downside pantry ptry reversed early gain fall convenience store operator report earning analyst see loss cent share
2203,ESRX,update nasdaq hang tough other falter
2204,ESRX,vincent mao
2205,ESRX,stock turn mixed leave nasdaq only index black
2206,ESRX,dow slip have be much respectively nyse composite be mostly unchanged meanwhile nasdaq be thank strength big cap techs
2207,ESRX,volume be run sharply higher board
2208,ESRX,akamai technology akam gap rally month high technically stock clear week tight pattern setup usually take place late wednesday provider content delivery service beat view rise earning also announce share buyback earlier thursday goldman sachs raise share neutral sell
2209,ESRX,citrix system ctxs gap gain heavy trading wednesday close virtualization software maker deliver smaller expect drop profit broaden share buyback program company also expect flat slightly lower sale current quarter
2210,ESRX,downside silgan holding slgn gap day move average drop slice day line open container maker report disappointing sale hurt lower average sale price also guide full year earning view
2211,ESRX,fellow container maker crown holding cck lose sympathy
2212,ESRX,update rally fade early afternoon trading
2213,ESRX,vincent mao
2214,ESRX,major stock index pull back sharply early afternoon trade thursday nasdaq nearly hit day move average
2215,ESRX,tech laden index be much trimming gain nyse composite rise dow add
2216,ESRX,volume be tracking vastly higher board
2217,ESRX,first solar fslr gap day move average surge heavy trading late wednesday maker solar module smash view pop earning jump sale stock have be trading day line september
2218,ESRX,group mate sunpower spwra rally upgrade suntech power holding stp gain
2219,ESRX,peet coffee tea peet add trade month high brisk volume coffee shop operator rally competitor starbucks sbux peet sit buy point cup base watch possible handle
2220,ESRX,peet report result tuesday beating estimate earning miss sale starbucks report wednesday edge past view earning miss sale
2221,ESRX,downside medasset mda gap lower fall downgrade be more session lows jeffery co cut share hold buy medasset make software health care provider
2222,ESRX,update major index trim gain slightly midday
2223,ESRX,jonah keri
2224,ESRX,stock pare rally back bit midday thursday most morning gain remain intact
2225,ESRX,nasdaq gain dow nyse composite small cap fared best motor
2226,ESRX,volume surge board rise nyse nasdaq compare same period wednesday
2227,ESRX,peet coffee tea peet jump brisk trade chain be rally step starbucks sbux green mountain coffee roaster gmcr bullish earning report
2228,ESRX,electronic medical record management software maker quality system qsii vault average volume hit time high financial software maker advent software advs picked
2229,ESRX,newmarket neu gain twice typical turnover chemical additive maker be pace eighth straight day gain
2230,ESRX,update stock maintain rally chrysler bankruptcy news
2231,ESRX,update stock squander promising start close mixed thursday major index finished higher second straight month nasdaq give bulk gain near day move average close meanwhile dow fall nyse composite slip volume climb exchange month nasdaq jump best jump week end oct nyse composite rally dow green mountain coffee roaster gcmr gap rocket nearly time average trade stock surge stellar fiscal result news distribution deal wal mart store wmt earning news be announce late wednesday fellow coffee related stock starbucks sbux rally nearly more twice average trade peet coffee tea peet add neutral tandem tndm gap climb almost heavy trading provider wireless telecom service top view quarter triple digit earning growth elsewhere dow chemical dow gap surge deliver surprising profit revenue however miss analyst estimate economic calendar friday university michigan sentiment index factory order ism index earning allergan agn chevron cvx clorox clx dean food df mastercard update stock finish mixed rocky tradingby vincent maoa rocky trading session end mixed result thursday nasdaq be lone gainer nasdaq rise well intraday high pare gain come point day move average dow fall nyse composite lose volume climb board advancer edge decliner nyse nasdaq advancer decliner be even genetic homebuilder be biggest decliner alternative energy heavy machinery score nice gain update index rebound late tradeby vincent maomajor index bounce back late trading thursday be still well session high nasdaq be nyse composite dow turnover be again tracking higher exchange pace slow vistaprint vprt climb nearly fresh month high report earning close analyst see profit rise cent share earlier thursday provider online printing service inked multiyear pact fedex fdx athenahealth athn rise regain day move average ahead earning report close provider bill collection service be expect earn cent share sale downside pantry ptry reversed early gain fall convenience store operator report earning analyst see loss cent share update nasdaq hang tough other falterby vincent maostock turn mixed leave nasdaq only index black dow slip have be much respectively nyse composite be mostly unchanged meanwhile nasdaq be thank strength big cap techs volume be run sharply higher board akamai technology akam gap rally month high technically stock clear week tight pattern setup usually take place late wednesday provider content delivery service beat view rise earning also announce share buyback earlier thursday goldman sachs raise share neutral sell citrix system ctxs gap gain heavy trading wednesday close virtualization software maker deliver smaller expect drop profit broaden share buyback program company also expect flat slightly lower sale current quarter downside silgan holding slgn gap day move average drop slice day line open container maker report disappointing sale hurt lower average sale price also guide full year earning view fellow container maker crown holding cck lose sympathy update rally fade early afternoon tradingby vincent maomajor stock index pull back sharply early afternoon trade thursday nasdaq nearly hit day move average tech laden index be much trimming gain nyse composite rise dow add volume be tracking vastly higher board first solar fslr gap day move average surge heavy trading late wednesday maker solar module smash view pop earning jump sale stock have be trading day line september group mate sunpower spwra rally upgrade suntech power holding stp gain peet coffee tea peet add trade month high brisk volume coffee shop operator rally competitor starbucks sbux peet sit buy point cup base watch possible handle peet report result tuesday beating estimate earning miss sale starbucks report wednesday edge past view earning miss sale downside medasset mda gap lower fall downgrade be more session lows jeffery co cut share hold buy medasset make software health care provider update major index trim gain slightly middayby jonah keristock pare rally back bit midday thursday most morning gain remain intact nasdaq gain dow nyse composite small cap fared best motor volume surge board rise nyse nasdaq compare same period wednesday peet coffee tea peet jump brisk trade chain be rally step starbucks sbux green mountain coffee roaster gmcr bullish earning report electronic medical record management software maker quality system qsii vault average volume hit time high financial software maker advent software advs picked newmarket neu gain twice typical turnover chemical additive maker be pace eighth straight day gain update stock maintain rally chrysler bankruptcy news
2232,ESRX,update straight week gain stock open lower monday general motor gm bankruptcy fear weigh equity battle back close mixed only dow finished lower
2233,ESRX,nyse composite climb have be financial steel stock boost index
2234,ESRX,meanwhile rise nasdaq add less dow slip
2235,ESRX,volume end sharply lower exchange
2236,ESRX,be nice day leader especially chinese internet issue
2237,ESRX,shanda interactive entertainment snda gap surge more twice average volume online gaming firm be more clear buy point cup handle last month
2238,ESRX,fellow gaming firm recent ipo com also gain new high
2239,ESRX,elsewhere netflix nflx reversed early loss climb heavy trading good time high online movie rental firm be now past buy point
2240,ESRX,bell goldman sachs gs report earning share more double view investment bank be slate report tuesday morning huge beat share slip hour trading
2241,ESRX,come tuesday earning dow component johnson johnson jnj view be profit share year
2242,ESRX,march producer price retail sale also be tap
2243,ESRX,update stock open lower close mixed
2244,ESRX,vincent mao
2245,ESRX,stock spend most session lower fight back mixed finish monday
2246,ESRX,flank financial steel issue nyse composite climb index nearly pull degree turn point
2247,ESRX,edge nasdaq rise fraction dow slip hurt loss boee ba exxon mobil xom chevron cvx
2248,ESRX,volume fall sharply exchange
2249,ESRX,update broader market slip financial material rise
2250,ESRX,vincent mao
2251,ESRX,stock be mostly lower late trading monday few sector buck trend
2252,ESRX,nyse composite rise thank largely financial steel issue citigroup extend gain bank america bac jump
2253,ESRX,steel giant arcelormittal mt rally steel climb
2254,ESRX,meanwhile turn flat poke positive territory dow nasdaq lose respectively
2255,ESRX,turnover be again tracking lower board
2256,ESRX,allegiant travel algt reversed earlier loss climb nearly fresh time high put air carrier past buy point cup base
2257,ESRX,diamond food dmnd add trade month high now sit past buy point cup base analyst see snack food producer earning double cent share quarter stock rank week ibd
2258,ESRX,hunt transportation service jbht retailer talbot tlb report earning bell hunt slip talbot surge
2259,ESRX,update comeback strengthen nyse composite go green
2260,ESRX,vincent mao
2261,ESRX,be more session lows major stock index again improve have turn mixed
2262,ESRX,nyse composite rise deficit be flirt positive territory meanwhile dow lose nasdaq
2263,ESRX,volume be sharply lower exchange
2264,ESRX,recent initial public offer com surge new record high chinese online gaming firm be spun sohu com sohu earlier month com sale growth have range past quarters
2265,ESRX,groupmate shanda interactive entertainment snda netease com nte continue have nice day rise respectively
2266,ESRX,netflix nflx reversed early loss gain new record high heavy trading put online movie rental firm past buy point pullback week move average
2267,ESRX,downside machinery industrial related issue sell spx corp spw cut first quarter full year outlook earning sale spx share gap dive slice day move average
2268,ESRX,flowserve fls parker hannifin ph lose
2269,ESRX,update stock trim loss afternoon trade
2270,ESRX,vincent mao
2271,ESRX,stock remain lower early afternoon trading monday have shave chunk morning loss
2272,ESRX,dow be deficit nasdaq lose respectively meanwhile nyse composite slip mild
2273,ESRX,turnover be again run lower board be tracking lower nyse lower nasdaq
2274,ESRX,financial largely buck trend many bank get ready report earning
2275,ESRX,citigroup jump news sell more japanese asset citi report earning friday analyst be expect loss cent share
2276,ESRX,bank america bac rally be cut hold buy nab research bofa report monday
2277,ESRX,goldman sachs gs rise highest level month former investment bank be due release earning tuesday view be profit share year
2278,ESRX,elsewhere daniel adm reversed early loss climb brisk trade agriculture firm double october low be stick range past month
2279,ESRX,downside network ffiv fall follow downgrade mcadam cut application delivery firm hold buy still stock have logged gain straight week mostly heavy volume last week raise fiscal profit outlook
2280,ESRX,update stock hold lower midday
2281,ESRX,jonah keri
2282,ESRX,major index drop session lows midday monday
2283,ESRX,dow slide nasdaq shed lose elsewhere nyse composite give small cap fared worst small cap drop
2284,ESRX,volume be run lower board fall nasdaq nyse compare same period thursday
2285,ESRX,china base stock have rally morning buck broader market decline
2286,ESRX,baidu com bidu joined chinese peer upside rise brisk trade huge winner china base search engine provider tank have rebound quickly so far year be work become straight week gain
2287,ESRX,downside apply signal technology apsg drop elevated volume provider digital surveillance system slice day move average
2288,ESRX,buckle bke fall nearly twice typical turnover global hunter security downgrade retail clothing accessory chain neutral buy rating
2289,ESRX,update market trim early loss
2290,ESRX,update straight week gain stock open lower monday general motor gm bankruptcy fear weigh equity battle back close mixed only dow finished lower nyse composite climb have be financial steel stock boost index meanwhile rise nasdaq add less dow slip volume end sharply lower exchange be nice day leader especially chinese internet issue shanda interactive entertainment snda gap surge more twice average volume online gaming firm be more clear buy point cup handle last month fellow gaming firm recent ipo com also gain new high elsewhere netflix nflx reversed early loss climb heavy trading good time high online movie rental firm be now past buy point bell goldman sachs gs report earning share more double view investment bank be slate report tuesday morning huge beat share slip hour trading come tuesday earning dow component johnson johnson jnj view be profit share year march producer price retail sale also be tap update stock open lower close mixedby vincent maostock spend most session lower fight back mixed finish monday flank financial steel issue nyse composite climb index nearly pull degree turn point edge nasdaq rise fraction dow slip hurt loss boee ba exxon mobil xom chevron cvx volume fall sharply exchange update broader market slip financial material riseby vincent maostock be mostly lower late trading monday few sector buck trend nyse composite rise thank largely financial steel issue citigroup extend gain bank america bac jump steel giant arcelormittal mt rally steel climb meanwhile turn flat poke positive territory dow nasdaq lose respectively turnover be again tracking lower board allegiant travel algt reversed earlier loss climb nearly fresh time high put air carrier past buy point cup base diamond food dmnd add trade month high now sit past buy point cup base analyst see snack food producer earning double cent share quarter stock rank week ibd hunt transportation service jbht retailer talbot tlb report earning bell hunt slip talbot surge update comeback strengthen nyse composite go greenby vincent maoafter be more session lows major stock index again improve have turn mixed nyse composite rise deficit be flirt positive territory meanwhile dow lose nasdaq volume be sharply lower exchange recent initial public offer com surge new record high chinese online gaming firm be spun sohu com sohu earlier month com sale growth have range past quarters groupmate shanda interactive entertainment snda netease com nte continue have nice day rise respectively netflix nflx reversed early loss gain new record high heavy trading put online movie rental firm past buy point pullback week move average downside machinery industrial related issue sell spx corp spw cut first quarter full year outlook earning sale spx share gap dive slice day move average flowserve fls parker hannifin ph lose update stock trim loss afternoon tradeby vincent maostock remain lower early afternoon trading monday have shave chunk morning loss dow be deficit nasdaq lose respectively meanwhile nyse composite slip mild turnover be again run lower board be tracking lower nyse lower nasdaq financial largely buck trend many bank get ready report earning citigroup jump news sell more japanese asset citi report earning friday analyst be expect loss cent share bank america bac rally be cut hold buy nab research bofa report monday goldman sachs gs rise highest level month former investment bank be due release earning tuesday view be profit share year elsewhere daniel adm reversed early loss climb brisk trade agriculture firm double october low be stick range past month downside network ffiv fall follow downgrade mcadam cut application delivery firm hold buy still stock have logged gain straight week mostly heavy volume last week raise fiscal profit outlook update stock hold lower middayby jonah major index drop session lows midday monday dow slide nasdaq shed lose elsewhere nyse composite give small cap fared worst small cap drop volume be run lower board fall nasdaq nyse compare same period thursday china base stock have rally morning buck broader market decline baidu com bidu joined chinese peer upside rise brisk trade huge winner china base search engine provider tank have rebound quickly so far year be work become straight week gain downside apply signal technology apsg drop elevated volume provider digital surveillance system slice day move average buckle bke fall nearly twice typical turnover global hunter security downgrade retail clothing accessory chain neutral buy rating update market trim early loss
2291,ESRX,danish pharmaceutical giant nordisk nvo miss sale estimate lower full year revenue forecast thursday profit be line stock be more early trading stock market today
2292,ESRX,make cent share quarter year earlier quarter danish kroner penny analyst consensus sale increase kroner equivalent miss consensus
2293,ESRX,company lower sale growth guidance previous range maintain operate profit growth ceo lar sorensen say know year be challenge pharmacy benefit manager express script esrx take drug victoza novolog prefer treatment list lower reimbursement drug management be also see more competition diabetes market especially new sglt inhibitor class
2294,ESRX,johnson johnson jnj invokana be first class be approve last year astrazeneca azn farxiga be approve january more be come pike astella roche rhhby eli lilly lly
2295,ESRX,be also face generic competition year oral glucose lower drug prandin
2296,ESRX,bright side company say launch tresiba new long act insulin product be go smoothly sale multiply ninefold year earlier quarter have now launch product country be still work fda approval be unexpectedly delay last year agency ask more datum tresiba heart risk
2297,ESRX,sorensen say study fda request be ahead schedule interim analysis datum be available mid
2298,ESRX,stock hold excellent ibd composite rating stock have be consolidate hit time high feb midmorning thursday stock be trading
2299,ESRX,follow amy reeve twitter ibd_areeve
2300,ESRX,related pfizer confirm pursuit pharmaceutical giant nordisk nvo miss sale estimate lower full year revenue forecast thursday profit be line stock be more early trading stock market today make cent share quarter year earlier quarter danish kroner penny analyst consensus sale increase kroner equivalent miss consensus company lower sale growth guidance previous range maintain operate profit growth ceo lar sorensen say know year be challenge pharmacy benefit manager express script esrx take drug victoza novolog prefer treatment list lower reimbursement drug management be also see more competition diabetes market especially new sglt inhibitor class johnson johnson jnj invokana be first class be approve last year astrazeneca azn farxiga be approve january more be come pike astella roche rhhby eli lilly lly be also face generic competition year oral glucose lower drug prandin bright side company say launch tresiba new long act insulin product be go smoothly sale multiply ninefold year earlier quarter have now launch product country be still work fda approval be unexpectedly delay last year agency ask more datum tresiba heart risk sorensen say study fda request be ahead schedule interim analysis datum be available mid stock hold excellent ibd composite rating stock have be consolidate hit time high feb midmorning thursday stock be trading follow amy reeve twitter pfizer confirm pursuit astrazeneca
2301,ESRX,pharmacy benefit manager handle roughly third american prescription drug benefit thrive size bigger become more negotiating power gain drug manufacturer pharmacy
2302,ESRX,express script esrx fill drug prescription year behemoth leverage size contain cost customer include health plan big employer government health care program
2303,ESRX,base st loui express script have employee founder company complete acquisition medco health solution deal make express script america largest pharmacy benefit manager pbm
2304,ESRX,generic biotech drug
2305,ESRX,george paz chairman ceo express script hold co frequently talk term alignment emphasize company business model revolve aligning interest customer patient make money client patient save money say choose generic drug home delivery
2306,ESRX,express script have do best job structuring company set business model be total alignment client say john kreger principal health care equity research analyst william blair co chicago have be first goal long remember company focus very consistently
2307,ESRX,example specialty pharmaceutical get inject infuse patient be become more popular drug be typically much more expensive harder administer company recently create online platform call expresspath doctor manage process
2308,ESRX,kreger note few year generic bask spotlight just express script benefit growth generic be now position profit next wave specialty biotech drug
2309,ESRX,ve have overarch goal restrain health care cost especially drug spending kreger say express script have go restrain cost very dynamic way year try anticipate health care industry be go ve be nimble
2310,ESRX,other pbms express script have gobble company build size negotiating muscle blockbuster medco acquisition be particularly bold move
2311,ESRX,express script have excel term know company acquire integrate company achieve maximum earning accretion say herman saftla pharmaceutical analyst capital iq new york city
2312,ESRX,add even prescription drug utilization have not grow recent year express script continue outperform stay step ahead move client mail order generic instance help company increase margin also improve customer satisfaction accuracy fill order health outcome
2313,ESRX,company be also very good formulary management capital management saftla say pharmacy benefit manager handle roughly third american prescription drug benefit thrive size bigger become more negotiating power gain drug manufacturer pharmacy express script esrx fill drug prescription year behemoth leverage size contain cost customer include health plan big employer government health care program base st loui express script have employee founder company complete acquisition medco health solution deal make express script america largest pharmacy benefit manager pbm generic biotech drugsgeorge paz chairman ceo express script hold co frequently talk term alignment emphasize company business model revolve aligning interest customer patient make money client patient save money say choose generic drug home delivery express script have do best job structuring company set business model be total alignment client say john kreger principal health care equity research analyst william blair co chicago have be first goal long remember company focus very consistently example specialty pharmaceutical get inject infuse patient be become more popular drug be typically much more expensive harder administer company recently create online platform call expresspath doctor manage process kreger note few year generic bask spotlight just express script benefit growth generic be now position profit next wave specialty biotech drug ve have overarch goal restrain health care cost especially drug spending kreger say express script have go restrain cost very dynamic way year try anticipate health care industry be go ve be nimble other pbms express script have gobble company build size negotiating muscle blockbuster medco acquisition be particularly bold move express script have excel term know company acquire integrate company achieve maximum earning accretion say herman saftla pharmaceutical analyst capital iq new york city add even prescription drug utilization have not grow recent year express script continue outperform stay step ahead move client mail order generic instance help company increase margin also improve customer satisfaction accuracy fill order health outcome company be also very good formulary management capital management saftla say
2314,ESRX,unitedhealth group nation largest health insurer report first quarter earning decline thursday blame obamacare taxe medicare advantage cut gilead science costly hepatitis drug minnetonka minn base company earning share drop vs year earlier analyst poll thomson reuter expect revenue rise miss estimate nearly
2315,ESRX,biotech stock be selling hard friday consensus wall street seem pin blame letter send several house democrat gilead science gild ask briefing price hepatitis blockbuster sovaldi letter sign rep henry waxman frank pallone diana degete date thursday expressed concern
2316,ESRX,stock open tightly mixed then upshifted strong trade friday weak read january home sale
2317,ESRX,dow jone industrial average jump gain nearly nasdaq be
2318,ESRX,option expiration help boost volume stock market today nasdaq trading thursday open level nyse volume
2319,ESRX,january exist home sale slow annualize rate slowest pace month national association realtor say be december pace economist expectation bad weather tight credit rise mortgage rate play part group say tight inventory continue prop price
2320,ESRX,stock chevron cvx wal mart wmt weigh dow nasdaq express script esrx dive heavy trade report result late thursday intuit intu apollo education apol rise
2321,ESRX,ibd stock amira nature food anfi bag gain big trade open unite arab emirate base rice distributor open session already extend rebound support week move average friday move put share ahead nearly week
2322,ESRX,priceline com pcln climb extremely heavy volume follow solid result report late thursday gain shot share new high flat base buy point
2323,ESRX,spirit airline save knock advance increase volume budget airline report strong earning wednesday move left share ahead week extend rebound week line stock open tightly mixed then upshifted strong trade friday weak read january home sale dow jone industrial average jump gain nearly nasdaq be option expiration help boost volume stock market today nasdaq trading thursday open level nyse volume january exist home sale slow annualize rate slowest pace month national association realtor say be december pace economist expectation bad weather tight credit rise mortgage rate play part group say tight inventory continue prop price stock chevron cvx wal mart wmt weigh dow nasdaq express script esrx dive heavy trade report result late thursday intuit intu apollo education apol rise ibd stock amira nature food anfi bag gain big trade open unite arab emirate base rice distributor open session already extend rebound support week move average friday move put share ahead nearly week priceline com pcln climb extremely heavy volume follow solid result report late thursday gain shot share new high flat base buy point spirit airline save knock advance increase volume budget airline report strong earning wednesday move left share ahead week extend rebound week line
2324,ESRX,update first full trading week ground finish leave major index sharply lower week
2325,ESRX,nasdaq composite hold low card day friday finishing nyse composite close decline index settle bottom trading range rest day support lose dow give
2326,ESRX,week dow slump drop nyse nasdaq composite give respectively
2327,ESRX,private college operator top friday short list advance industry group lead strayer education stra apollo group apol devry dv week group climb less volume run average
2328,ESRX,many lead stock take beating week confirm rally take distribution day monday revert rally pressure status end day wednesday
2329,ESRX,major economic report be tap monday charle schwab schw alcoa aa be schedule release december quarter financial result
2330,ESRX,update index close lows cap week
2331,ESRX,juan carlos arancibia
2332,ESRX,market finished session lows friday gloomy employment report
2333,ESRX,nasdaq give nyse composite dow accord preliminary figure
2334,ESRX,volume be lower again bounceback fade quickly news robert rubin resign citigroup board citi share slide
2335,ESRX,energy metal consumer related industry group tumble market backed away economy sensitive sector
2336,ESRX,major index close week loss
2337,ESRX,update index run place volume unchanged
2338,ESRX,alan elliott
2339,ESRX,index hold lows break even line late trading
2340,ESRX,dow slip nyse composite give respectively nasdaq composite fall
2341,ESRX,wal mart wmt post minor gain only dow component move average volume education stock continue dominate lead issue apollo group apol clinch top volume move nasdaq
2342,ESRX,volume remain lower exchange
2343,ESRX,euro dive cent bad job report be trader have expect
2344,ESRX,fall stock include intuitive surgical isrg dive strong volume put maker robotic surgical instrument lowest mark february
2345,ESRX,express script esrx slip heavy trading lose battle hold support day move average competitor cvs caremark cvs deliver gloomy forecast pharmacy benefit manager
2346,ESRX,upside residential builder kb home kbh reversed early loss ink mild gain heavy trade company deliver result far expectation morning management outlook give investor little hope
2347,ESRX,update stock continue fall medical falter
2348,ESRX,patrick
2349,ESRX,stock remain lower market midday march break even level be put hold
2350,ESRX,dow fall nasdaq nyse composite lose
2351,ESRX,volume be lower number high rate stock health care market lead sector fall volume
2352,ESRX,china sky medical cski be take bruise third straight session chinese provider herbal medicine fall today fall stock have completely reversed gain early week
2353,ESRX,sxc health solution sxci be provider pharmacy benefit management service be much stock be thinly trade
2354,ESRX,home bancshare homb bank hold company plunge company have announce close thursday expect cent share loss however include time item
2355,ESRX,masimo masi maker patient monitoring product sank stock fall high volume week end hope look be possible right side double bottom base
2356,ESRX,update soft broad selling pressure hold index
2357,ESRX,alan elliott
2358,ESRX,index hold lows maintain firm loss nearly industry sector afternoon trading
2359,ESRX,nasdaq ease loss nasdaq issue apollo group apol first solar fslr research motion rimm post solid gain
2360,ESRX,hold loss vs slip nyse composite dow post decline
2361,ESRX,volume slip lower exchange decline issue lead advancer better nyse margin nasdaq
2362,ESRX,commercial school group post day largest gain thus far
2363,ESRX,shipping stock also thunder higher group add share trading hand nearly double group prior volume record set wednesday dryship drys jump oceanfreight ocnf leap tbsi international tbsi grab gain
2364,ESRX,stryker syk kick powerful trading maker orthopedic implant report friday sale earning result top analyst expectation stronger sale outweigh sale decline overseas stock be deep month base just set test resistance day move average company plan full report result jan
2365,ESRX,medical software maker cerner cern jump average volume take back piece thursday loss share remain day move average
2366,ESRX,downside gentiva health service gtiv slip start sixth day decline stock have fail successfully clear buy point friday slip douse day move average
2367,ESRX,homebuilder lennar len topple session heaviest volume move document raise question company project late surface internet web site apparently trigger rush trading drive share lower end trading thursday lennar share have gain nov low
2368,ESRX,update stock pare loss session halftime
2369,ESRX,vincent mao
2370,ESRX,stock pare back loss halfway point friday session
2371,ESRX,nasdaq lose improvement earlier deficit nyse composite fall dow
2372,ESRX,volume be tracking lower exchange
2373,ESRX,decliner beat advancer exchange
2374,ESRX,rebound leader get hit
2375,ESRX,emergent biosolution ebs gap tumble lower sale forecast biotech peg full year revenue vs view expect sale range vs consensus estimate stock have dive session low
2376,ESRX,bio reference laboratory brli gap day move average pierce day line drop oppenheimer cut laboratory service provider perform outperform
2377,ESRX,upside quality system qsii rally fast trade thursday stock find support day move average company make information system health care industry
2378,ESRX,elsewhere crude oil fall barrel
2379,ESRX,update index carve lower broad selling
2380,ESRX,alan elliott
2381,ESRX,energy transportation financial sector lead market lower weak job report oil price fall
2382,ESRX,nasdaq composite dove deepest cut lower nyse composite carved respectively dow slide lower
2383,ESRX,volume turn mixed drop lower nyse hold fraction higher nasdaq vs average trading thursday
2384,ESRX,energy stock pull sharply lower crude oil future slip nearly send price nyse heavily weight energy index dump lead stock broad palette sector take lump
2385,ESRX,almost family afam slump heavy trading pierce support stock day move average
2386,ESRX,lhc group lhcg crumble time average volume fall break stock recent trend tight trading leave deep day move average
2387,ESRX,upside education issue continue dominate list lead stock post gain
2388,ESRX,apollo group apol jump itt educational service esi hop devry dv add capella education cpla book gain
2389,ESRX,badly beaten palm palm scream massive surge trading sub stock jump thursday new palm pre smart phone operate system receive strong reviews la vegas consumer electronic show
2390,ESRX,computer component distributor synnex snx gap nab gain time average trading volume boost outlook move power share day move average stock be attempt climb deep month correction
2391,ESRX,market asia even china finished friday session mixed shanghai composite sprang gain first advance day power utility drive bulk gain speculation chinese regulator be set implement subsidy index post gain first week new year
2392,ESRX,hong kong see such jump hang seng index backed session end week japan nikkei take hit leave week first weekly decline month
2393,ESRX,stock europe moved generally lower morning weak job datum frankfurt dax dove ftse slip cac paris hunker
2394,ESRX,update stock job report earning warning
2395,ESRX,vincent mao
2396,ESRX,mixed open quickly worsen friday hit stock heavy loss follow dismal job report number profit warning
2397,ESRX,nasdaq be nyse composite dow lose breach day move average volume be tracking higher exchange especially nasdaq
2398,ESRX,cvs caremark cvs gap tumble say earning be likely come expectation drugstore operator peg earning range share vs view
2399,ESRX,coach coh gap drop cut outlook cite poor holiday sale tough retail environment luxury good retailer now expect fiscal earning cent share prior outlook cent
2400,ESRX,chevron cvx slip fall oil price cause lower profit outlook late thursday oil giant warn sharply lower earning didn give specific figure morning jpmorgan upgrade share overweight neutral
2401,ESRX,upside apollo group apol gap gain follow strong earning report late thursday school operator say fiscal profit rise share well view cent marked third straight quarter accelerate earning growth revenue climb also view
2402,ESRX,statement apollo chief executive cha edelstein cite macro factor firm recent strength say quantify significance current economy growth believe be experience positive impact
2403,ESRX,other school operator rally well strayer education stra devry dv gain respectively
2404,ESRX,update stock set split open job datum
2405,ESRX,vincent mao
2406,ESRX,stock future signale narrowly mixed open friday follow grim december job report
2407,ESRX,nasdaq future fall point vs fair value future rise point dow future gain point
2408,ESRX,economic news labor department say nonfarm payroll tumble last month drive unemployment rate highest level almost year
2409,ESRX,forecast call loss job december estimate be north november job loss be revise upward october loss be revise
2410,ESRX,payroll loss be widespread only education health care see gain
2411,ESRX,economy lose job most loss come last month year average hourly earning rise better expect
2412,ESRX,corporate news best buy bby narrow earning outlook range share prior estimate view be share share fall pre open
2413,ESRX,donnelley son rrd decline pre market cut full year profit outlook cite tight credit market uncertainty economy business service provider now expect earning range share prior guidance view be share also declare quarterly dividend cent share
2414,ESRX,kb home kbh post fourth quarter loss share far view shortfall sale fall prior year statement chief executive jeffrey mezger say housing market general economic condition be expect remain difficult possibly worsen timing meaningful recovery homebuilding industry remain uncertain share lose pre market friday week
2415,ESRX,update first full trading week ground finish leave major index sharply lower week nasdaq composite hold low card day friday finishing nyse composite close decline index settle bottom trading range rest day support lose dow give week dow slump drop nyse nasdaq composite give respectively private college operator top friday short list advance industry group lead strayer education stra apollo group apol devry dv week group climb less volume run average many lead stock take beating week confirm rally take distribution day monday revert rally pressure status end day wednesday major economic report be tap monday charle schwab schw alcoa aa be schedule release december quarter financial result update index close lows cap weekby juan carlos market finished session lows friday gloomy employment report nasdaq give nyse composite dow accord preliminary figure volume be lower again bounceback fade quickly news robert rubin resign citigroup board citi share slide energy metal consumer related industry group tumble market backed away economy sensitive sector major index close week loss update index run place volume unchangedby alan elliottindex hold lows break even line late trading dow slip nyse composite give respectively nasdaq composite fall wal mart wmt post minor gain only dow component move average volume education stock continue dominate lead issue apollo group apol clinch top volume move nasdaq volume remain lower exchange euro dive cent bad job report be trader have expect fall stock include intuitive surgical isrg dive strong volume put maker robotic surgical instrument lowest mark february express script esrx slip heavy trading lose battle hold support day move average competitor cvs caremark cvs deliver gloomy forecast pharmacy benefit manager upside residential builder kb home kbh reversed early loss ink mild gain heavy trade company deliver result far expectation morning management outlook give investor little hope update stock continue fall medical falterby patrick cainstock remain lower market midday march break even level be put hold dow fall nasdaq nyse composite lose volume be lower number high rate stock health care market lead sector fall volume china sky medical cski be take bruise third straight session chinese provider herbal medicine fall today fall stock have completely reversed gain early week sxc health solution sxci be provider pharmacy benefit management service be much stock be thinly trade home bancshare homb bank hold company plunge company have announce close thursday expect cent share loss however include time item masimo masi maker patient monitoring product sank stock fall high volume week end hope look be possible right side double bottom base update soft broad selling pressure hold index downby alan elliottindex hold lows maintain firm loss nearly industry sector afternoon trading nasdaq ease loss nasdaq issue apollo group apol first solar fslr research motion rimm post solid gain hold loss vs slip nyse composite dow post decline volume slip lower exchange decline issue lead advancer better nyse margin nasdaq commercial school group post day largest gain thus far shipping stock also thunder higher group add share trading hand nearly double group prior volume record set wednesday dryship drys jump oceanfreight ocnf leap tbsi international tbsi grab gain stryker syk kick powerful trading maker orthopedic implant report friday sale earning result top analyst expectation stronger sale outweigh sale decline overseas stock be deep month base just set test resistance day move average company plan full report result jan medical software maker cerner cern jump average volume take back piece thursday loss share remain day move average downside gentiva health service gtiv slip start sixth day decline stock have fail successfully clear buy point friday slip douse day move average homebuilder lennar len topple session heaviest volume move document raise question company project late surface internet web site apparently trigger rush trading drive share lower end trading thursday lennar share have gain nov low update stock pare loss session halftimeby vincent maostock pare back loss halfway point friday session nasdaq lose improvement earlier deficit nyse composite fall dow volume be tracking lower exchange decliner beat advancer exchange rebound leader get hit emergent biosolution ebs gap tumble lower sale forecast biotech peg full year revenue vs view expect sale range vs consensus estimate stock have dive session low bio reference laboratory brli gap day move average pierce day line drop oppenheimer cut laboratory service provider perform outperform upside quality system qsii rally fast trade thursday stock find support day move average company make information system health care industry elsewhere crude oil fall barrel update index carve lower broad selling alan elliottenergy transportation financial sector lead market lower weak job report oil price fall nasdaq composite dove deepest cut lower nyse composite carved respectively dow slide lower volume turn mixed drop lower nyse hold fraction higher nasdaq vs average trading thursday energy stock pull sharply lower crude oil future slip nearly send price nyse heavily weight energy index dump lead stock broad palette sector take lump almost family afam slump heavy trading pierce support stock day move average lhc group lhcg crumble time average volume fall break stock recent trend tight trading leave deep day move average upside education issue continue dominate list lead stock post gain apollo group apol jump itt educational service esi hop devry dv add capella education cpla book gain badly beaten palm palm scream massive surge trading sub stock jump thursday new palm pre smart phone operate system receive strong reviews la vegas consumer electronic show computer component distributor synnex snx gap nab gain time average trading volume boost outlook move power share day move average stock be attempt climb deep month correction market asia even china finished friday session mixed shanghai composite sprang gain first advance day power utility drive bulk gain speculation chinese regulator be set implement subsidy index post gain first week new year hong kong see such jump hang seng index backed session end week japan nikkei take hit leave week first weekly decline month stock europe moved generally lower morning weak job datum frankfurt dax dove ftse slip cac paris hunker update stock job report earning warningsby vincent maoa mixed open quickly worsen friday hit stock heavy loss follow dismal job report number profit warning nasdaq be nyse composite dow lose breach day move average volume be tracking higher exchange especially nasdaq cvs caremark cvs gap tumble say earning be likely come expectation drugstore operator peg earning range share vs view coach coh gap drop cut outlook cite poor holiday sale tough retail environment luxury good retailer now expect fiscal earning cent share prior outlook cent chevron cvx slip fall oil price cause lower profit outlook late thursday oil giant warn sharply lower earning didn give specific figure morning jpmorgan upgrade share overweight neutral upside apollo group apol gap gain follow strong earning report late thursday school operator say fiscal profit rise share well view cent marked third straight quarter accelerate earning growth revenue climb also view statement apollo chief executive cha edelstein cite macro factor firm recent strength say quantify significance current economy growth believe be experience positive impact other school operator rally well strayer education stra devry dv gain respectively update stock set split open job databy vincent maostock future signale narrowly mixed open friday follow grim december job report nasdaq future fall point vs fair value future rise point dow future gain point economic news labor department say nonfarm payroll tumble last month drive unemployment rate highest level almost year forecast call loss job december estimate be north november job loss be revise upward october loss be revise payroll loss be widespread only education health care see gain economy lose job most loss come last month year average hourly earning rise better expect corporate news best buy bby narrow earning outlook range share prior estimate view be share share fall pre open donnelley son rrd decline pre market cut full year profit outlook cite tight credit market uncertainty economy business service provider now expect earning range share prior guidance view be share also declare quarterly dividend cent share kb home kbh post fourth quarter loss share far view shortfall sale fall prior year statement chief executive jeffrey mezger say housing market general economic condition be expect remain difficult possibly worsen timing meaningful recovery homebuilding industry remain uncertain share lose pre market friday week
2416,ESRX,update stock rally wednesday shake expect read first quarter gdp reassure comment federal reserve slowdown economic contraction also boost sentiment major index climb news first death swine flu
2417,ESRX,nyse composite climb respectively hit month high nasdaq push new month high gain meanwhile dow rise
2418,ESRX,turnover climb sharply board
2419,ESRX,peet coffee tea peet gap rally nearly triple average volume stock rally mixed report release late tuesday
2420,ESRX,fti consult fcn gap jump double average trade company report earning sale view stock close just day move average poke intraday
2421,ESRX,thoratec thor add heavy trading provider circulatory support product follow clear buy point handle tuesday note recent ibd base analysis column volume thoratec base be questionable stock relative strength line have lag
2422,ESRX,downside leader get hurt
2423,ESRX,buffalo wild wing bwld drop nearly time average trade late tuesday sport bar grill operator deliver result view full year sale growth forecast come soft
2424,ESRX,panera bread pnra advent software advs tumble respectively upbeat earning report
2425,ESRX,elsewhere astrazeneca azn capella education cpla celgene celg colgate palmolive cl corinthian college coco dow chemical dow general motor gm motorola neutral tandem tndm procter gamble pg strayer education stra report earning thursday
2426,ESRX,update stock bounce back higher trade
2427,ESRX,vincent mao
2428,ESRX,stock rebound session pullback wednesday late day retreat trim chunk day gain
2429,ESRX,nyse composite close gain session peak nasdaq rally intraday high tech rich index be point day move average meanwhile climb dow rise
2430,ESRX,accord preliminary datum volume climb sharply exchange advancer trounce decliner more nyse better nasdaq
2431,ESRX,bank alternative energy issue score nice gain apparel number retail issue sell
2432,ESRX,update index retreat late trade
2433,ESRX,vincent mao
2434,ESRX,major index step back pre fed announcement level touch new session high late trade wednesday
2435,ESRX,still stock be pace snap session pullback
2436,ESRX,nyse composite rally nasdaq dow
2437,ESRX,volume be tracking higher board especially nasdaq
2438,ESRX,visa rise ahead earning bell analyst see credit card firm profit rise cent share
2439,ESRX,express script esrx also report close bell pharmacy benefit manager be expect earn cent share sale
2440,ESRX,update stock maintain rally fed statement
2441,ESRX,ed carson vincent mao
2442,ESRX,stock hold fast impressive gain federal reserve keep rate record lows say economy pace contraction appear be somewhat slower
2443,ESRX,policymaker quickly add post meeting statement economic activity be likely remain weak time
2444,ESRX,expect fed left fed fund target rate record low expect rate inflation remain low time
2445,ESRX,fed say use tool available bolster growth reaffirm plan buy treasury autumn well agency mortgage backed security agency debt year end
2446,ESRX,edt nyse composite be nasdaq dow volume be higher nasdaq lower nyse
2447,ESRX,bank stock be notable gainer fox pitt kelton raise sector rating first time year broker upgrade bank market weight underweight
2448,ESRX,individual stock peet coffee tea peet gap gain month high mixed result late tuesday company beat view jump earning sale miss
2449,ESRX,rival starbucks sbux rise nearly ahead earning close
2450,ESRX,medco health solution mhs trim nearly deficit open pharmacy benefit manager report result beat expectation also backed full year profit outlook
2451,ESRX,update stock pull back early afternoon trading
2452,ESRX,update stock rally wednesday shake expect read first quarter gdp reassure comment federal reserve slowdown economic contraction also boost sentiment major index climb news first death swine flu nyse composite climb respectively hit month high nasdaq push new month high gain meanwhile dow rise turnover climb sharply board peet coffee tea peet gap rally nearly triple average volume stock rally mixed report release late tuesday fti consult fcn gap jump double average trade company report earning sale view stock close just day move average poke intraday thoratec thor add heavy trading provider circulatory support product follow clear buy point handle tuesday note recent ibd base analysis column volume thoratec base be questionable stock relative strength line have lag downside leader get hurt buffalo wild wing bwld drop nearly time average trade late tuesday sport bar grill operator deliver result view full year sale growth forecast come soft panera bread pnra advent software advs tumble respectively upbeat earning report elsewhere astrazeneca azn capella education cpla celgene celg colgate palmolive cl corinthian college coco dow chemical dow general motor gm motorola neutral tandem tndm procter gamble pg strayer education stra report earning thursday update stock bounce back higher tradeby vincent maostock rebound session pullback wednesday late day retreat trim chunk day gain nyse composite close gain session peak nasdaq rally intraday high tech rich index be point day move average meanwhile climb dow rise accord preliminary datum volume climb sharply exchange advancer trounce decliner more nyse better nasdaq bank alternative energy issue score nice gain apparel number retail issue sell update index retreat late tradeby vincent maomajor index step back pre fed announcement level touch new session high late trade wednesday still stock be pace snap session pullback nyse composite rally nasdaq dow volume be tracking higher board especially nasdaq visa rise ahead earning bell analyst see credit card firm profit rise cent share express script esrx also report close bell pharmacy benefit manager be expect earn cent share sale update stock maintain rally fed statementby ed carson vincent maostock hold fast impressive gain federal reserve keep rate record lows say economy pace contraction appear be somewhat slower policymaker quickly add post meeting statement economic activity be likely remain weak time expect fed left fed fund target rate record low expect rate inflation remain low time fed say use tool available bolster growth reaffirm plan buy treasury autumn well agency mortgage backed security agency debt year end edt nyse composite be nasdaq dow volume be higher nasdaq lower nyse bank stock be notable gainer fox pitt kelton raise sector rating first time year broker upgrade bank market weight underweight individual stock peet coffee tea peet gap gain month high mixed result late tuesday company beat view jump earning sale miss rival starbucks sbux rise nearly ahead earning close medco health solution mhs trim nearly deficit open pharmacy benefit manager report result beat expectation also backed full year profit outlook update stock pull back early afternoon trading
2453,ESRX,stock recoup prior session heavy loss wednesday market shake downgrade spain extend gain fed again stand pat interest rate
2454,ESRX,rise dow nyse composite climb nasdaq manage tiny gain volume fall board
2455,ESRX,valeant pharmaceutical vrx rally drugmaker agree buy dermatology firm vital science canadian valeant nearly test day move average wednesday tuesday
2456,ESRX,gildan activewear gil rise more twice average turnover rbc capital market raise shirt maker outperform sector perform gildan be past buy point double bottom base
2457,ESRX,downside lead retail stock get hit hard
2458,ESRX,dineequity din shed nearly heavy trading erased gain last week company run ihop applebee chain report earning cheesecake factory cake tumble more double average volume stock close slightly day move average
2459,ESRX,round restaurant loser panera bread pnra shed bj restaurant bjri texas roadhouse txrh drop
2460,ESRX,close hewlett packard hpq announce buy smart phone maker palm palm deal stock fall extend trading
2461,ESRX,green mountain coffee roaster gmcr dive guide fiscal earn view
2462,ESRX,earning thursday include acme packet apkt expedia expe imax imax lubrizol lz netlogic microsystem netl perrigo prgo strayer education stra wynn resort wynn
2463,ESRX,stock gain choppy session
2464,ESRX,vincent mao
2465,ESRX,stock climb choppy trading session wednesday
2466,ESRX,rise dow nyse composite gain nasdaq eke fractional gain accord preliminary datum nyse volume fall nasdaq trade tick
2467,ESRX,gold producer be session best performer yellow metal climb fourth straight session medical related group also gain restaurant other retail group be session worst performer
2468,ESRX,stock high late trade
2469,ESRX,vincent mao
2470,ESRX,major stock average strengthen late trading wednesday
2471,ESRX,climb nyse composite dow gain nasdaq edge turnover continue track lower exchange
2472,ESRX,encore capital group ecpg rise heavy trading late tuesday debt collector report quarterly earning view sale miss stock clear buy point cup handle base last week
2473,ESRX,green mountain coffee roaster gmcr shed earlier loss edge ahead fiscal result close coffee distributor be expect post earning cent share year sale be slate climb
2474,ESRX,express script esrx visa visa also report quarterly result close
2475,ESRX,dsw dsw erased open gain drop heavy trading tuesday dsw surge clear cup base boost full year profit outlook
2476,ESRX,fed leave rate unchanged stock steady
2477,ESRX,scott stoddard
2478,ESRX,economy be strengthen job market be improve federal reserve say wednesday reiterate longstanding vow keep interest rate low extend period expectation moderate growth low inflation
2479,ESRX,stock find strength news
2480,ESRX,policymaker vote keep benchmark fed fund rate record low range most analyst expect fed late year early raise rate
2481,ESRX,datum fed last meeting march suggest economic activity have continue strengthen labor market be begin improve central bank say post meeting statement
2482,ESRX,add growth household spending have picked recently remain constrain high unemployment modest income growth lower housing wealth tight credit
2483,ESRX,meanwhile fed say business spending equipment software have rise significantly
2484,ESRX,kansa city fed president thomas hoenig dissent third straight meeting say condition have improve enough end vow keep rate low extend period inflation hawk fear huge fed cash infusion cause price soar economy accelerate
2485,ESRX,fed expect moderate economic growth time inflation remain subdue tight credit expectation unemployment remain high
2486,ESRX,fed say investment nonresidential structure be decline housing start edge remain depress level
2487,ESRX,market return session high fed announcement dow be nyse composite nasdaq volume remain lower board
2488,ESRX,stock stay mixed ahead fed
2489,ESRX,stock recoup prior session heavy loss wednesday market shake downgrade spain extend gain fed again stand pat interest rate rise dow nyse composite climb nasdaq manage tiny gain volume fall board valeant pharmaceutical vrx rally drugmaker agree buy dermatology firm vital science canadian valeant nearly test day move average wednesday tuesday gildan activewear gil rise more twice average turnover rbc capital market raise shirt maker outperform sector perform gildan be past buy point double bottom base downside lead retail stock get hit hard dineequity din shed nearly heavy trading erased gain last week company run ihop applebee chain report earning cheesecake factory cake tumble more double average volume stock close slightly day move average round restaurant loser panera bread pnra shed bj restaurant bjri texas roadhouse txrh drop close hewlett packard hpq announce buy smart phone maker palm palm deal stock fall extend trading green mountain coffee roaster gmcr dive guide fiscal earn view earning thursday include acme packet apkt expedia expe imax imax lubrizol lz netlogic microsystem netl perrigo prgo strayer education stra wynn resort wynn stock gain choppy sessionby vincent maostock climb choppy trading session wednesday rise dow nyse composite gain nasdaq eke fractional gain accord preliminary datum nyse volume fall nasdaq trade tick gold producer be session best performer yellow metal climb fourth straight session medical related group also gain restaurant other retail group be session worst performer stock high late tradeby vincent maothe major stock average strengthen late trading wednesday climb nyse composite dow gain nasdaq edge turnover continue track lower exchange encore capital group ecpg rise heavy trading late tuesday debt collector report quarterly earning view sale miss stock clear buy point cup handle base last week green mountain coffee roaster gmcr shed earlier loss edge ahead fiscal result close coffee distributor be expect post earning cent share year sale be slate climb express script esrx visa visa also report quarterly result close dsw dsw erased open gain drop heavy trading tuesday dsw surge clear cup base boost full year profit outlook fed leave rate unchanged stock steadyby scott economy be strengthen job market be improve federal reserve say wednesday reiterate longstanding vow keep interest rate low extend period expectation moderate growth low inflation stock find strength news policymaker vote keep benchmark fed fund rate record low range most analyst expect fed late year early raise rate datum fed last meeting march suggest economic activity have continue strengthen labor market be begin improve central bank say post meeting statement add growth household spending have picked recently remain constrain high unemployment modest income growth lower housing wealth tight credit meanwhile fed say business spending equipment software have rise significantly kansa city fed president thomas hoenig dissent third straight meeting say condition have improve enough end vow keep rate low extend period inflation hawk fear huge fed cash infusion cause price soar economy accelerate fed expect moderate economic growth time inflation remain subdue tight credit expectation unemployment remain high fed say investment nonresidential structure be decline housing start edge remain depress level market return session high fed announcement dow be nyse composite nasdaq volume remain lower board stock stay mixed ahead fed
2490,ESRX,stock be mostly higher early afternoon trading wednesday broad market recoup prior session heavy loss blue chip struggle direction nasdaq be nyse composite meanwhile dow be unchanged winner loser stock index be virtually even turnover be again tracking sharply lower board krono worldwide kro gap leap nearly active trading tuesday stock reversed higher find support day move average krono make titanium dioxide pigment used coating plastic cosmetic company lose money past year slate turn profit share year share coach coh climb fast trade stock re-trace tuesday loss come close nov peak last month high end handbag retailer beat view rise fiscal earning other luxury good retailer include jwn sak fifth avenue sk have recently deliver upbeat quarterly earning rise downside solar stock take heat credit suisse downgrade sector market weight say demand couldn keep grow supply credit suisse cut trina solar tsl neutral outperform stock gap day move average fall first solar fslr fall receive same downgrade amtech system asys tumble slice day move average company produce equipment used make solar cell semiconductor device
2491,ESRX,update whiplash reversal haul index deep loss broad gain volume pressed highest upside show oct
2492,ESRX,nyse composite vault chasing jump energy index soar dow nasdaq composite pound gain
2493,ESRX,procter gamble pg caterpillar cat exxon mobil xom be dow top draw nasdaq microsoft msft cisco system csco google goog post powerful gain
2494,ESRX,volume power higher session preliminary datum show trading action higher nyse higher nasdaq vs wednesday healthy level
2495,ESRX,intense action launch new rally attempt just day brutal drop kill struggle rally market recent volatile action make almost anything possible good bad watch be follow day rise more strong volume follow arrive early tuesday rally attempt stay alive tuesday be day normally earliest follow day occur
2496,ESRX,advance issue trail morning trading take late day lead decliner close nearly exchange
2497,ESRX,industry group track ibd gain ground day auto truck tire maker part maker steel producer hold lead slot
2498,ESRX,almost family afam stage muscular reversal rebound support week line power strong volume wednesday market tumble hadn snuff rally almost family move have place share buy range pullback week move average
2499,ESRX,procter gamble squeeze gain close consumer good maker earlier week report larger expect gain sale folger coffee division estimate proceed sale cent share vs earlier guidance cent gain
2500,ESRX,procter gamble agree june sell lead retail package coffee business smucker sjm stock deal give shareholder stake smucker
2501,ESRX,axys technology axys also stage nice reversal drive higher end absolute top trading range day move marked rebound day move average left share firmly plant day line stock be build handle double bottom base begin august
2502,ESRX,update stock battle back trade pick
2503,ESRX,vincent maothe major stock index have big change heart be pace erase loss snap recent lose streak
2504,ESRX,nyse composite surge dow dow bounce back fall more point nasdaq erased deficit gain
2505,ESRX,turnover be still tracking heavier board have picked sharply
2506,ESRX,crude oil end barrel
2507,ESRX,world fuel int jump month high brisk volume provider fuel service have be positive session long
2508,ESRX,eog resource eog reversed erased early loss climb oil gas producer meet resistance day move average
2509,ESRX,ralcorp rah run active trading add second day gain follow wednesday earning report
2510,ESRX,financial be lower senate panel take aim big bank
2511,ESRX,bank america bac lose earlier tumble year low
2512,ESRX,citigroup also bounce back year low shed just
2513,ESRX,update index dive new lows
2514,ESRX,vincent mao
2515,ESRX,trading seesaw fashion seller turn heat push stock new session lows midday thursday
2516,ESRX,nasdaq have tumble nyse composite plunge new multus year lows last few minute dow slide close oct low
2517,ESRX,volume be tracking sharply higher board decliner beat advancer wide margin
2518,ESRX,intel intc sale warning ripple tech land
2519,ESRX,synaptic syna dive month low heavy trading lazard capital cut stock sell hold drop earning estimate share synaptic make control computer electronic device
2520,ESRX,dell dell tumble year low goldman sachs add computer maker conviction sell list bmo capital market cut share market perform outperform
2521,ESRX,hewlett packard hpq lose apple aapl soured seventh straight session ease
2522,ESRX,market fluctuation few ibd issue reversed earlier loss
2523,ESRX,almost family afam be volatile fall climb be trading virtually flat
2524,ESRX,genoptix gxdx gain fast trade laboratory service provider pull degree turn
2525,ESRX,myriad genetic mygn have be higher fall slightly market selling step
2526,ESRX,update index start stall volume churn higher
2527,ESRX,index give back most brief surge higher ground slide financial issue outbattled rise energy sector stock
2528,ESRX,nyse composite hold gain nasdaq composite dow hover break even territory
2529,ESRX,procter gamble pg exxon mobil xom jpmorgan chase jpm do heavy lift dow amgen amgn gilead science gild express script esrx pull higher nasdaq
2530,ESRX,volume track higher third straight session nyse higher nasdaq earlier trading nasdaq dip undercut oct low cut month low
2531,ESRX,crude oil price hold barrel press month lows wednesday natural gas gold copper silver post modest decline bond price also slip dollar fall vs euro gain yen
2532,ESRX,stock procter gamble squeeze gain consumer good maker report earlier week larger expect gain sale folger coffee division estimate proceed sale cent share vs earlier guidance cent gain procter gamble agree june sell lead retail package coffee business smucker sjm stock deal give shareholder stake smucker
2533,ESRX,downside american public education apei crumble online educator wednesday easily top analyst earning estimate post gain cent share revenue jump rise enrollment
2534,ESRX,company also register resale share common share now hold fund associate ab capital partner gap loss rebound stock day move average put serious crimp handle have be build week cup shape base
2535,ESRX,overseas most market asia drive lower exception shanghai composite power ahead chinese regulator moved implement economic stimulus program statement construction bank say increase annual lend target much yuan prescribe government plan target railway road airport project
2536,ESRX,hong kong hang seng index drop week low lead hsbc bank hbc
2537,ESRX,japan nikkei tokyo shed also week low hit hard weak earning report firm yen
2538,ESRX,european index edge higher afternoon trading cac paris jump frankfurt dax turn london ftse follow energy issue lower give
2539,ESRX,update early gain wane nasdaq undercut
2540,ESRX,vincent mao
2541,ESRX,major stock index trade mostly lower early thursday open gain quickly fade nasdaq lead way downside breach oct trough
2542,ESRX,nasdaq be lead loss intuitive surgical isrg research motion rimm dow fall nyse composite inched fraction
2543,ESRX,volume be tracking higher board especially nasdaq
2544,ESRX,emergent biosolution ebs fall fast trade late wednesday biotech file shelf registration mixed security
2545,ESRX,sina sina lose downgrade needham co cut chinese internet firm hold buy
2546,ESRX,group mate google goog continue slide level share lose
2547,ESRX,update stock set mixed open
2548,ESRX,vincent mao
2549,ESRX,follow session sell stock be poise mixed open thursday
2550,ESRX,nasdaq future fall point vs fair value future tick fraction point dow future rise point
2551,ESRX,economic front initial jobless claim week end nov increase estimate number continue claim climb highest year
2552,ESRX,future actually trim loss follow news
2553,ESRX,cleveland fed president sandra pianalto speak credit crisis
2554,ESRX,follow disappointing outlook share intel intc drop year low pre market late wednesday world biggest chipmaker cut sale target range prior guidance analyst have expect
2555,ESRX,wal mart wmt report earning continue operation cent share prior year penny view sale grow view due currency fluctuation world biggest retailer peg profit range share vs view guide full year earning view
2556,ESRX,urban outfitter urbn deliver earning gain cent share line view sale rise slightly view share climb pre market
2557,ESRX,datum october retail sale be friday economist expect decline
2558,ESRX,american public education apei tumble pre open strong earning report be offset news shareholder ab capital partner sell more share share available trading update whiplash reversal haul index deep loss broad gain volume pressed highest upside show oct nyse composite vault chasing jump energy index soar dow nasdaq composite pound gain procter gamble pg caterpillar cat exxon mobil xom be dow top draw nasdaq microsoft msft cisco system csco google goog post powerful gain volume power higher session preliminary datum show trading action higher nyse higher nasdaq vs wednesday healthy level intense action launch new rally attempt just day brutal drop kill struggle rally market recent volatile action make almost anything possible good bad watch be follow day rise more strong volume follow arrive early tuesday rally attempt stay alive tuesday be day normally earliest follow day occur advance issue trail morning trading take late day lead decliner close nearly exchange industry group track ibd gain ground day auto truck tire maker part maker steel producer hold lead slot almost family afam stage muscular reversal rebound support week line power strong volume wednesday market tumble hadn snuff rally almost family move have place share buy range pullback week move average procter gamble squeeze gain close consumer good maker earlier week report larger expect gain sale folger coffee division estimate proceed sale cent share vs earlier guidance cent gain procter gamble agree june sell lead retail package coffee business smucker sjm stock deal give shareholder stake smucker axys technology axys also stage nice reversal drive higher end absolute top trading range day move marked rebound day move average left share firmly plant day line stock be build handle double bottom base begin august update stock battle back trade pick upby vincent maoat nyse composite surge dow dow bounce back fall more point nasdaq erased deficit gain turnover be still tracking heavier board have picked sharply crude oil end barrel world fuel int jump month high brisk volume provider fuel service have be positive session long eog resource eog reversed erased early loss climb oil gas producer meet resistance day move average ralcorp rah run active trading add second day gain follow wednesday earning report financial be lower senate panel take aim big bank bank america bac lose earlier tumble year low citigroup also bounce back year low shed just update index dive new lowsby vincent maoafter trading seesaw fashion seller turn heat push stock new session lows midday thursday nasdaq have tumble nyse composite plunge new multus year lows last few minute dow slide close oct low volume be tracking sharply higher board decliner beat advancer wide margin intel intc sale warning ripple tech land synaptic syna dive month low heavy trading lazard capital cut stock sell hold drop earning estimate share synaptic make control computer electronic device dell dell tumble year low goldman sachs add computer maker conviction sell list bmo capital market cut share market perform outperform hewlett packard hpq lose apple aapl soured seventh straight session ease market fluctuation few ibd issue reversed earlier loss almost family afam be volatile fall climb be trading virtually flat genoptix gxdx gain fast trade laboratory service provider pull degree turn myriad genetic mygn have be higher fall slightly market selling step update index start stall volume churn higherindex give back most brief surge higher ground slide financial issue outbattled rise energy sector stock nyse composite hold gain nasdaq composite dow hover break even territory procter gamble pg exxon mobil xom jpmorgan chase jpm do heavy lift dow amgen amgn gilead science gild express script esrx pull higher nasdaq volume track higher third straight session nyse higher nasdaq earlier trading nasdaq dip undercut oct low cut month low crude oil price hold barrel press month lows wednesday natural gas gold copper silver post modest decline bond price also slip dollar fall vs euro gain yen stock procter gamble squeeze gain consumer good maker report earlier week larger expect gain sale folger coffee division estimate proceed sale cent share vs earlier guidance cent gain procter gamble agree june sell lead retail package coffee business smucker sjm stock deal give shareholder stake smucker downside american public education apei crumble online educator wednesday easily top analyst earning estimate post gain cent share revenue jump rise enrollment company also register resale share common share now hold fund associate ab capital partner gap loss rebound stock day move average put serious crimp handle have be build week cup shape base overseas most market asia drive lower exception shanghai composite power ahead chinese regulator moved implement economic stimulus program statement construction bank say increase annual lend target much yuan prescribe government plan target railway road airport project hong kong hang seng index drop week low lead hsbc bank hbc japan nikkei tokyo shed also week low hit hard weak earning report firm yen european index edge higher afternoon trading cac paris jump frankfurt dax turn london ftse follow energy issue lower give update early gain wane nasdaq undercutsby vincent maothe major stock index trade mostly lower early thursday open gain quickly fade nasdaq lead way downside breach oct trough nasdaq be lead loss intuitive surgical isrg research motion rimm dow fall nyse composite inched fraction volume be tracking higher board especially nasdaq emergent biosolution ebs fall fast trade late wednesday biotech file shelf registration mixed security sina sina lose downgrade needham co cut chinese internet firm hold buy group mate google goog continue slide level share lose update stock set mixed openby vincent maofollow session sell stock be poise mixed open thursday nasdaq future fall point vs fair value future tick fraction point dow future rise point economic front initial jobless claim week end nov increase estimate number continue claim climb highest year future actually trim loss follow news cleveland fed president sandra pianalto speak credit crisis follow disappointing outlook share intel intc drop year low pre market late wednesday world biggest chipmaker cut sale target range prior guidance analyst have expect wal mart wmt report earning continue operation cent share prior year penny view sale grow view due currency fluctuation world biggest retailer peg profit range share vs view guide full year earning view urban outfitter urbn deliver earning gain cent share line view sale rise slightly view share climb pre market datum october retail sale be friday economist expect decline american public education apei tumble pre open strong earning report be offset news shareholder ab capital partner sell more share share available trading
2559,ESRX,merger acquisition activity globe hit record high first half drive grow ambition american company accord latest thomson reuter deal intelligence datum global merger acquisition totale more year level marked strongest year date period record begin rise merger be track surpass top highest yearly total record read play surge global etfs massive increase activity come grow global trade tension unite state volume climb country strongest period deal make record be follow european deal nearly double first half most boost come medium healthcare deal propose medium have totale so far more time year level sector be poise more consolidation come month federal judge ruling free report purchase time warner set stage wave medium space change landscape industry read comcast outbid disney fox asset medium etfs surge big deal have drive much activity total number deal value more surge first half constitute deal nearly activity bidding war rupert murdoch first century fox foxa free report be largest contributor be follow health insurer cigna ci free report deal purchase express script hold esrx free report japan takeda pharmaceutical purchase deal shire read cigna buy express script healthcare etfs focus boom be likely continue give accelerate economy still low interest rate tax reform allow company bring offshore cash back home potential cost saving merger be further fuel urge merge current ultra competitive environment tap investor easily take advantage surge deal employ merger arbitrage strategy portfolio strategy look tap price differential spread stock price target company public announcement propose acquisition price offer acquirer pay stock target company be especially true give investor go long target acquire company short acquire company deal be complete share target company increase full deal price case slightly deal price give investor nice profit have highlighted merger etfs ride surge increase deal make compelling option investor seek implement low correlation strategy portfolio iq merger arbitrage etf mna free report fund offer capital appreciation investing global company have be public announcement takeover acquirer same time provide short exposure global equity partial equity market hedge be do tracking iq merger arbitrage index fund have holding basket largest allocation rockwell collin col free report andeavor andv free report long side accounting more share product have amassed asset base trade average volume share day charge bps annual fee etf have lose year date see hedge fund etfs here proshare merger etf mrgr free report product provide exposure global merger arbitrage strategy seek capture spread price stock company target trade propose acquisition be announce value cash stock acquire company have propose pay stock target spread be easily do merger arbitrage index fund hold well diversify portfolio stock charge bps annual fee healthcare financial real estate technology be top sector etf have be able manage asset worth see light volume just share day be nearly so far year bottom line investor capitalize merger arbitrage trading particular target company stock etfs provide diversify exposure basket form lower risk further be excellent choice investor rocky market due low correlation overall market be company merger acquisition deal generally move independently ignore other issue influence movement other stock result investor definitely focus product relatively higher return type market want key etf info deliver straight inbox zack free fund newsletter brief top news analysis well top perform etfs week get free
2560,ESRX,here be stock add zack rank strong sell list today bristow group inc brs free report be provider industrial aviation service zack consensus estimate current year earning have be revise downward last day jetblue airway corporation jblu free report be passenger carrier company zack consensus estimate current year earning have be revise downward last day kyocera corporation be developer industrial component information equipment zack consensus estimate current year earning have be revise downward last day ichor holding ltd ichr free report be designer fluid delivery subsystem component semiconductor capital equipment zack consensus estimate current year earning have be revise downward last day express script hold company esrx free report be pharmacy benefit management company zack consensus estimate current year earning have be revise downward last day view entire zack rank list
2561,ESRX,walgreen boot alliance wba free report have achieve historic feat yesterday emerge youngest participant dow jone industrial average dji djia be momentous exploit not just goliath stock have enter world most coveted index more so dramatically replace dow oldest member general electric company ge free report success walgreen stall ge uninterrupted run exchange long year change be effective jun market open let delve deeper significance decision dow investor ge boot far be logical dow jone index report say general electric be original member djia member continuously however index decision be prompt ge stock persistent trading low price late affected entire index price performance turn go report djia be price weight index range price constitute matter low price ge share mean company have weight index less half percentage point overall ge market capitalization rise have shrink unbelievably year present past year share ge have nose dive more significant plunge justify logic compare stock broader industry stock have plummet compare industry decline same time frame djia have rally seek index remain slightly growth index however remain far general electric tally walgreen djia foray do make sense talk decision incorporate walgreen djia index dow jone index report inform walgreen contribute more meaningfully index share price be higher ge stock also help index represent market economy better way investment world have already be dissect respect impactful decision david blitzer chairman index committee industrial company ge longer hold prominence american economy healthcare bank tech consumer company race front runner now walgreen point view world first pharmacy lead health wellbeing enterprise have never have be shove away limelight courtesy consistent flow strategic development company have be form combination legacy walgreen alliance boot merger bring together couple company compelling portfolio iconic brand complementary geography share value trust health care service pharmaceutical wholesale community pharmacy care recently bid ensure availability specialty brand drug walgreen have tie express script esrx free report announce plan expand exist group purchasing effort also walgreen rite aid rad free report contract extend growth strategy offer operational well financial benefit follow news share walgreen gain yesterday close opposite viewon flip side be question practicality substitution cvs health cvs free report be bigger contender walgreen similar field term market cap volume prescription revenue accord analyst walgreen incur immense debt maintain expansion acquisition strategy company long term debt shot february august wall street journal report moreover cvs health be currently process complete aetna aet free report deal decision buy health insurerha be take quite positively investment world economist be look forward development think vertical integration finally put brake america mount health care cost spite huge prospect cvs health not present list dow member be putt investor sort dilemma walgreen stock performance too be currently not look much convince past year share walgreen have lose outperform djia index broader industry have witness decline bloomberg report paper walgreen boot alliance inc be underwhelm choice inclusion world most famous stock index significant delete replacement be accord many investment expert general electric walgreen case be more publicity stance dow gradually lose sheen economic recession go reuter article ge be currently sixth smallest member dow market value sport index lowest stock price make least influential component price weight average lipper datum also conclude just be invest exchange trade fund attach dow etfs tracking index have asset undoubtedly next week ge exit walgreen entry not have relevant effect performance index make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2562,ESRX,here be stock add zack rank strong sell list today ambarella inc amba free report be developer semiconductor process solution zack consensus estimate current year earning have be revise downward last day capital southwest corporation cswc free report be business development company zack consensus estimate current year earning have be revise downward last day express script hold company esrx free report be pharmacy benefit management company zack consensus estimate current year earning have be revise downward last day dycom industry inc dy free report be provider specialty contract service zack consensus estimate current year earning have be revise downward last day chromadex corporation cdxc free report be nutraceutical company zack consensus estimate current year earning have be revise downward last day view entire zack rank list
2563,ESRX,express script hold company esrx free report have underperform broader industry last month company share have gain versus industry rally rapidly change healthcare environment unite state loss client stiff competition niche space be significant headwind company batter such challenge zack consensus estimate second quarter adjust earning be currently peg share last month same revenue be pin reflect year year decline stock have zack rank sell take sneak peek major issue plague express script loss patient mo base pharmacy benefit manager lose certain public sector client result year year decline adjust network claim last report quarter moreover adjust home delivery specialty claim totale quarter year year express script get script recently announce be get acquire cigna corporation global health insurance company acquisition be expect be conclude dec cigna take express script cash stock transaction worth competition rifeexpres script face intense competition patient benefit management industry independent pbms medimpact navitus health solution moreover pbm space be dominate bigwig cvs aetna cigna other guidance express script adjust earning share be estimate band significantly previous range key pickssome better rank stock broader medical space be abiom inc abmd free report stryker corporation syk free report intuitive surgical inc isrg free report intuitive surgical have expect long term earning growth rate stock sport zack rank strong buy see complete list today zack rank stock here stryker have project long term earning growth rate stock carry zack rank buy abiom have project long term earning growth rate stock hold zack rank wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
2564,ESRX,express script esrx free report partially own subsidiary rx recently announce agreement veteran foreign war vfw aim be help vfw member family benefit free rx card part rx prescription saving program provide express script veteran customer wider range choice affordable price rx platform glanceinside rx be prescription saving program power express script nation lead independent pharmacy benefit manager pbm notably platform recently garner medication saving american be uninsured pay pocket prescription rx recently make additional brand medication mean person currently pay full list price prescription veteran customer rx card offer more brand medication allow average saving veteran be uninsured underinsured card be used more pharmacy unite state rx card be easily download provide customer detail list participate pharmacy catalog medicine term usage patient only need present discount card participate pharmacy include national chain such cvs healthcare cvs free report kroger family pharmacy walgreen wba free report study economist mariacristina nardi federal reserve bank chicago healthcare spending american age aboveis approximately person year hence express script move have be timely strategic other solid express script announce new rare condition care value rccv program partnership pinnaclecare private health advisory firm offer personalize guidance expert case review provide member free access support service know second opinion name suggest be life alter service offer second opinion top specialist field additionally express script value base safeguardrx program have proven be effective improve clinical outcome lower drug spend patient accord datum release company endeavor clearly show express script have fortify position biggest pbm country price performancebuoy slew development express script share have rally compare industry gain year time zack rank key pickexpress script carry zack rank sell better rank stock broader medical sector be abiom inc abmd free report abiom have long term growth rate stock sport zack rank strong buy see complete list today zack rank stock here hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
2565,ESRX,month have go last earning report express script hold company esrx free report share have add time frame recent positive trend continue lead next earning release be esrx due pullback dive investor analyst have react late let take quick look most recent earning report order get better handle important catalyst recent earningsexpress script post first quarter adjust earning share beat zack consensus estimate penny further adjust earning improve year year revenue edge past zack consensus estimate inched year year upside be drive operational cost improvement backed focus technology digital tool home delivery specialty service patient claim volume script first quarter witness year year decline patient claim adjust network claim be year year adjust home delivery specialty claim be report quarter year year result net adjust claim first quarter be year year basis decline be primarily drive loss certain public sector client margin detailsadjust gross profit first quarter be year year percentage revenue adjust gross margin be flat year year adjust selling general administrative expense be prior year quarter guidanceadjust earning share second quarter be estimate range represent growth year year notably zack consensus estimate earning be currently peg be project range company expect total adjust claim second quarter range be attributable core business adjust earning be estimate band significantly previous range share be suspension share repurchase program notably zack consensus estimate earning be currently peged lie significantly guidance revenue be expect band zack consensus estimate revenue be currently peg lie guidance adjust ebitda be expect have estimate be move then past month investor have witness downward trend fresh estimate have be revision higher current quarter compare lower express script hold company price consensus express script hold company price consensus express script hold company quotevgm scoresat time esrx have strong growth score be lag bit momentum front stock be also allocate grade value side putt top investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested base score stock be equally suitable value growth investor momentum investor want look elsewhere outlookestimate have be broadly trend downward stock magnitude revision indicate downward shift surprise esrx have zack rank sell expect average return stock next few month
2566,ESRX,wellcare health plan inc wcg free report be set acquire meridian health plan michigan illinois meridianrx pharmacy benefit manager pbm become top most medicaid provider aforementioned state company be pay total cash transaction be expect close end year deal wellcare be able add medicaid member michigan illinois zack rank strong buy company be also expect generate more total revenue meridian business acquire integrate pbm platform see complete list today zack rank stock here wellcare have always pursue strategic acquisition accelerate growth strengthen portfolio company have acquire arizona medicaid asset phoenix health plan universal american corp acquisition largest privately hold profit manage care organization unite state be reminiscent increase merger acquisition take place healthcare industry player be busy transform business become comprehensive healthcare provider same vein mega acquisition express script hold company esrx free report cigna corp ci free report aetna inc aet free report cvs health corp cvs free report be already underway rise medical cost shift value base care threat competition online retailer amazon com inc demographic change increase regulation be catalyst drive merger acquisition healthcare industry wellcare meridian transaction be expect add cent share company adjust earning cent share more share be inclusive synergy ramp upcoming year exclusive time transaction related expense cumulative integration related expense wellcare expect fund transaction combination cash hand undrawn revolve credit facility issue new equity new debt company also announce have secure commit bridge financing share wellcare have rally year date outperform industry average today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
2567,ESRX,buoy tax reform unite state resurgent europe first quarter record time high tally global merger acquisition activity portray intense consolidation wave diverse market most firm aim capitalize bullish macroeconomic sentiment pursue deal accord thomson reuter datum surge year year total number transaction decline imply average deal size increase clarity tax solid equity debt market swell corporate cash coffer help top management loosen purse string transaction be also not concentrated particular geographic region be well spread volume double europe increase unite state asia respectively deal inked health insurer cigna corporation ci free report acquire pharmacy chain express script hold company esrx free report be biggest deal quarter be follow deal german energy firm acquire renewable energy business rwe game change transaction quarter witness intense volatility equity market president trump impose trade tariff chinese good perhaps rob company suitable acquisition opportunity corporate valuation remain high management become more cautious trade inflate price level regulatory risk also increase quarter exemplify heighten threat perceive government propose hostile bid singapore base broadcom limit avgo free report domestic chip maker qualcomm incorporate qcom free report transaction be block concern national security government fear lose technological prowess chinese counterpart quarter further witness uncertainty antitrust activity department justice thwart deal inc free report acquire time warner inc concern be raise deal affect different sector deal therefore be summarily reject nonetheless first quarter make perfect start year be likely give more firepower government well top management firm pursue more strategic transaction swim tide hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
2568,ESRX,have be month last earning report express script hold company esrx free report share have lose time frame recent negative trend continue lead next earning release be esrx due dive investor analyst have react late let take quick look most recent earning report order get better handle important catalyst recent earningsexpress script hold company post fourth quarter adjust earning share beat zack consensus estimate further adjust earning improve share year quarter revenue also beat zack consensus estimate increase year quarter patient claim volume script fourth quarter result benefit rise patient claim strong customer retention adjust network claim be year year adjust home delivery specialty claim be fourth quarter year year result net adjust claim fourth quarter be flat year year basis notably adjust ebitda earning interest tax depreciation amortization adjust patient claim fourth quarter be higher report year quarter margin detailsadjust gross profit fourth quarter be year year percentage revenue adjust gross margin expand basis point bps net revenue adjust selling general administrative expense be prior year quarter upside margin be drive operational cost improvement backed focus technology digital tool home delivery specialty service balance sheetnet cash flow provide operate activity be year year company exit quarter cash cash equivalent year quarter total debt end quarter be end fact company be strive reduce debt level guidanceadjust claim first quarter be expect range adjust earning share first quarter be estimate range represent growth year year basis full year adjust earning be estimate band reflect growth year year revenue be expect band adjust ebitda be expect come guidance express script core business total adjust claim be expect range first quarter total adjust claim core business be expect net revenue be estimate range have estimate be move then past month investor have witness downward trend fresh estimate have be revision higher current quarter compare lower look back additional day see even more upward momentum express script hold company price consensus express script hold company price consensus express script hold company quotevgm scoresat time esrx have great growth score be lag bit momentum front charting somewhat similar path stock be allocate grade value side putt top quintile investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested base score stock be equally suitable value growth investor momentum investor want look elsewhere outlookestimate have be broadly trend downward stock magnitude revision indicate downward shift interestingly esrx have zack rank hold expect line return stock next few month
2569,ESRX,strong operate performance health insurer past many year continue first quarter higher medical enrollment surge revenue medical cost management increase share revenue complementary service help result most major player raise earning guidance reflect solid operate environment road moreover strong economy have hold health insurance industry good stead record low unemployment rate gradual wage increase bode well space high employment wage growth fuel demand health insurance various other health related service provide insurer overall bullishness reinforce sentiment growth cadence sector continue be tie strict regulatory regime fast change industry backdrop insurer have time again emerge winner put perspective revenue earning almost dominant health insurer have show secular rise sweeping historical health care reform be put effect ex president obama ever enactment healthcare reform act numerous change have go effect have alter traditional operate model health insurer ensue change be take sportingly health insurer then adapt change industry dynamic shift business mix commercial government way care be deliver fee service value care greater emphasis medical cost management grow consumerism technical innovation have be game changer rapid evolution be however continue industry give need hour player industry be take concerted effort transform comprehensive health care provider earlier role be traditional payer same be be effectuate cross sector collaboration health insurer be foraying realm health care sector such pharmacy benefit management ambulatory care physician service deal be underway vein be merger cvs health corp cvs free report aetna inc aet free report cigna corp ci free report take od express script hold co esrx free report well unitedhealth group inc unh free report acquisition davita inc dva free report say industry have remain outperformer have generate return higher index year past year health insurance industry have return whopping compare index gain be further upside potential left industry have outperformed broader market valuation remain same level industry zack hmo industry be currently trading forward month price earning ratio be index whole last year industry have trade range median therefore go bit further look peg ratio bake growth rate industry industry peg ratio be compare favorably industry peg ratio show industry be undervalue have room upside zack industry rank zack industry classification health insurer be broadly group medical sector zack sector rank industry zack sector base earning outlook fundamental strength constituent company industry club industry group top half industry best average zack rank bottom half industry worst average zack rank last year used week rebalance top half beat bottom half factor more learn more visit zack industry rank stock worth add past performance do not guarantee future return strong industry fundamental keep confidence undeterred therefore investing stock health insurance industry be good investment decision follow stock solid fundamental favorable zack rank make perfect pick wellcare health plan inc wcg free report zack rank strong buy stock have see zack consensus estimate current year earning be revise upward last day see complete list today zack rank stock here anthem inc antm free report zack rank buy stock have see zack consensus estimate current year earning be revise upward last day triple management corp gts free report zack rank stock have see zack consensus estimate current year earning be revise upward last day make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2570,ESRX,president donald trump friday unveil plan lower drug price keep promise make run presidential election pharmaceutical company broader industry have be anticipate trump come heavily have long criticize drugmaker get away murder charge way too much product however fear be dispel trump proposal actually not directly hamper profitability drug company instead reform be aim increase competition medicine cut list price reduce patient pocket cost pleasant surprise give stock pharmaceutical company boost long standing drug price be trump presidential campaign promise have commit take big drug company be also support trump democrat opponent hillary clinton then trump have time again criticize drug manufacture pharmaceutical company charge too much product have keep pharmaceutical company reel pressure quite time have fear trump pharma plan hurt profit broader pharma sector spdr pharmaceutical xph have decline year date industry have fear further loss apprehend harsh measure trump friday raise competition twist tale come trump stress increase competition medicine be highpoint speech friday frame plan most sweeping action history lower price prescription drug american person describe american patient first layer policy intend increase pharmaceutical competition power negotiation lower patient pocket cost trump policy also aim create incentive lower list price prescription drug reform certainly be ray hope american patient rise cost healthcare be nagging concern american patient first plan have immediate action well future opportunity lower pocket cost face patient reduce drug price interestingly trump refrain raise direct medicare price negotiation friday be agenda presidential campaign pharma stock rally trump reformsclearly trump american patient first plan doesn seem be threat pharmaceutical company profit fact be very much line financial interest drugmaker health insurer way hamper profit fear have often result share pharma company take hit last few month finally see bounce back friday sector decline initially friday stock start rally time trump have finished speech share regeneron pharmaceutical inc regn free report increase also share cvs health corporation cvs free report merck co inc mrk free report pfizer inc pfe free report walgreen boot alliance inc wba free report be respectively merck co have zack rank buy see complete list today zack rank strong buy stock here trump spare biggest reason rally be trump plan actually doesn hurt pharmaceutical company fact administration keep place few case extend role drug middleman have be often be blame spiking drug cost trump plan call drug company display price ad restrict gag clause pharmacist proposal come pharmacy pharmacy benefit manager pbm have contract donot allow pharmacist let patient know drug cash counter be cheaper be purchase insurance however trump splan give company new power medicare part program senior get drug coverage allow medicare change list cover drug midyear order push back price hike generic drugsthat donot actually have so much competition lead share healthcare service company mckesson corporation mck free report express script hold company esrx free report corporation abc free report cardinal health inc cah free report rise respectively sum uptrump american patient first come set reform have spark fear pharmaceutical company quite time however fear seem have subside somewhat new plan doesn hurt drugmaker profit see investor confidence finally get reinstate pharma biotech stock rally medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
2571,ESRX,launch iq merger arbitrage etf mna free report be smart beta exchange trade fund offer broad exposure hedge fund etfs category equity market be smart beta etfs etf industry have long be dominate product base market cap weight index strategy create reflect market particular market segment good option investor believe market efficiency market cap weight index offer low cost convenient transparent way replicate market return however investor believe possibility beating market exceptional stock selection choose different type fund track cap weight strategy smart beta attempt pick stock have better chance risk return performance cap weight index be base certain fundamental characteristic combination such space offer number choice investor include simplest equal weighting fundamental weighting volatility momentum base weighting methodology not strategy have be able deliver superior result fund sponsor indexmna be manage indexiq fund have amassed make largest etf hedge fund etfs particular fund fee expense seek match performance iq merger arbitrage index iq merger arbitrage index seek achieve capital appreciation investing global company have be public announcement takeover acquirer differentiate approach be base passive strategy own certain announce takeover target goal generate return be representative global merger arbitrage activity cost other also pay attention etf expense ratio lower cost product produce better result higher cost assume other metric remain same operate expense annual basis be etf make least expensive product space fund have month trail dividend yield sector exposure top holdingseven etfs offer diversify exposure minimize single stock risk investor also look actual holding fund luckily most etfs be very transparent product disclose holding daily basis look individual holding morgan stanley ilf trea cash free report account total asset follow rockwell collin inc col free report express script hold co esrx free report top holding account total asset management performance fund year date return have lose be last year mna have trade past week period mna have beta standard deviation trail year period holding effectively diversify company specific risk bottom lineto learn more product other etfs screen product match investment objective read article latest development etf investing universe please visit zack etf center
2572,ESRX,express script hold company esrx free report post first quarter adjust earning share beat zack consensus estimate penny further adjust earning improve year year revenue edge past zack consensus estimate inched year year upside be drive operational cost improvement backed focus technology digital tool home delivery specialty service stock have zack rank sell express script have outperformed industry year time stock have gain period compare industry rise patient claim volume script first quarter witness year year decline patient claim adjust network claim be year year adjust home delivery specialty claim be report quarter year year result net adjust claim first quarter be year year basis decline be primarily drive loss certain public sector client express script hold company price consensus ep surprise express script hold company price consensus ep surprise express script hold company quote margin detailsadjust gross profit first quarter be year year percentage revenue adjust gross margin be flat year year adjust selling general administrative expense be prior year quarter express script get medical care pharmacy benefit roof express script recently announce be get acquire cigna corporation global health insurance company acquisition be expect be conclude dec cigna take express script cash stock transaction worth term deal cigna pay cash share stock newly combine company closure express script shareholder own approximately combine company transaction result total cost synergy guidanceadjust earning share second quarter be estimate range represent growth year year notably zack consensus estimate earning be currently peg be project range company expect total adjust claim second quarter range be attributable core business adjust earning be estimate band significantly previous range share be suspension share repurchase program notably zack consensus estimate earning be currently peged lie significantly guidance revenue be expect band zack consensus estimate revenue be currently peg lie guidance adjust ebitda be expect script end first quarter strong note beating consensus mark count however lackluster guidance be indicate concern stock moreover company face stiff competition raise concern buoy strong result quarter express script enterprise value initiative be estimate range notably management expect cumulative saving nearly earning medtech major glancea few better rank stock broader medical space report solid earning season be baxter international inc bax free report varian medical system inc var free report intuitive surgical inc isrg free report intuitive surgical varian sport zack rank strong buy baxter carry zack rank buy see complete list today zack rank stock here intuitive surgical report adjust earning share surpass zack consensus estimate revenue totale beat zack consensus estimate varian report second quarter fiscal adjust earning share beat zack consensus estimate adjust earning improve year year basis baxter report first quarter adjust earning share cent beat zack consensus estimate improve year quarter figure cent medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
2573,ESRX,global week ahead let rank world market theme put reuter london start thought latest theme show compelling event lieu be watch most closely fall more subtle variety factor possible inflation surprise tariff fallout ecb talk fx volatility usa be key matter first trader watch change consumer inflation tuesday read cause biggest reaction stock market week second trader watch tariff fallout also introduce downside pressure outside usa watch mario draghi speaking monetary policy watch currency pound hong kong dollar list theme order importance watch market consumer inflation hit tuesdaywall street be demonstrate heighten sensitivity sign rise price worry result more aggressive interest rate hike fed so consumer price datum february be closely watch tuesday worth remember recent stock market tumble kick january job datum stoke inflation fear report biggest wage gain more year february employment report release friday show strongest job growth more year slowdown wage gain cpi rise percent year year january punchy percent month month stock market again come pressure february datum show inflationary pressure be build investor move pricing fed hike year rather watch tariff internal friction external falloutit say war have winner certainly apply trade war unite state initiator latest battle big trade budget deficit make dollar vulnerable do fact fed european japanese counterpart cut interest rate thing get too nasty company earn half profit overseas likely suffer outbreak trade hostility other be harder hit many reckon dollar decline less steel war current account gap be smaller growth be stronger other currency small open develop economy such canada new australia fall emerge market suffer global economic trade growth slow metal tariff alone win much dent china south korea taiwan india steel export unite state comprise percent korea gdp instance escalation other sector hurt first equity outflow then feed currency especially dollar firm market trade reliant country such korea taiwan be hurt more domestic focuse one such india brazil watch cue ecb monetary policy normalization central bank journey back something resemble policy normalization go gear last week ecb drop pledge increase qe need mario draghi soothe market concern subsequent press conference stress policy remain super loose be enough push euro bond yield bond spread back again draghi softly softly approach look begin end ecb post crisis measure be sight question market now be quickly slowly ecb move other hand bank japan governor haruhiko kuroda quash creep speculation boj tighten policy soon signale readiness ramp stimulus need be draghi several other ecb official be schedule speak week so be further guidance pace change ahead be speech fed official schedule week jerome powell head first policy meeting fed chair follow week watch pound brexit news be underlie driversterling start best monthly performance dollar renew uncertainty britain european union agree future trading relationship have undermined pound rally recent week more hawkish central bank next week prove crucial investor unsure trade pound give relative resilience uk economy stream negative brexit headline uk finance minister philip hammond give half yearly update economy tuesday improvement public finance nervousness outlook trader also be look closely progress talk eu believe brexit transition deal britain have say unveil late march not be delay edgy trader briefly push pound month low versus euro wednesday eu reject britain propose trade deal dollar sterling be largely unmoved week brexit headline be stick trading cent post brexit vote peak hit january market pricing percent probability bank england rate hike risk be delay transition deal stay boe hand tighten policy give britain large trade deficit vulnerability extend trade war also weigh pound watch hong kong dollar have fall year lowthe hong kong dollar exchange rate isn normally expect see too much movement confine trading band set manage hong kong monetary authority week currency fall year low market be high alert hkma intervention approach weaker end trading band dollar hit force hkma mop excess liquidity narrow interest rate gap have push spread hong kong interbank rate widest financial crisis hkma last intervene defend hk dollar peg fx market sell bond last year mop cash have be absent time attack trading band be unlikely succeed however hkma have firepower question be market correct hkma be compel hold regular liquidity drain operation investor be precedent lean gateway asian economy money keep pour hong kong territory be unlikely suffer shortage cash time soon even chinese money move back mainland top zack rank strong buy stock express script esrx free report be market cap stock medical service industry long term zack vgm score last week cigna offer buy company come month aetna buy cvs health corp nissan motor nsany free report be market cap automaker base japan long term zack vgm score be nafta talk underway steel aluminum tariff announce let discuss north american operation nissan north america employ more person unite state canada mexico generate nearly job nissan infinity dealership continent hca holding hca free report be hospital chain usa long term zack vgm score be company operate network acute care hospital outpatient facility clinic other patient care delivery setting company also own manage freestand surgery center diagnostic imaging center radiation oncology therapy center rehabilitation physical therapy center various other facility do stock forward be nice low key global macro week ahead watch multiple threat retaliation steel aluminum tariff introduce trump administration tuesday study result pennsylvania special house election be mindful latest consumer price inflation rate cpi also tuesday outside usa organization economic cooperation development oecd release new forecast growth major economieson friday fresh datum usa housing permit start get close scrutiny trader monday antad broad retail measure same store sale mexico come prior read be rise comparison singapore retail sale also come prior be very similar mexico tuesday renew south africa get latest manufacturing production number prior be brazil broad retail sale datum come prior be latest look be cpi ex food energy come look south korea unemployment rate be wednesday germany hicp consumer inflation rate come have be eurozone industrial production come have be strong thursday unemployment rate netherlands come have be turkey unemployment rate also come have be switzerland central bank snb discuss sight deposit rate be negative rate not typo folk initial claim unemployment come prior be friday eurozone hicp consumer inflation rate come have be low build permit housing start come permit have be start be capacity utilization come have be
2574,ESRX,health insurer continue gain traction increase enrollment product development business diversification cost control effort increase operate efficiency strong capital position lead top bottom line growth most player field many industry have also keep raise full year guidance end quarter thus indicate rise operational excellence banking positive industry have gain nearly year time outperform average zack hmo industry be place top zack rank industry nevertheless higher medical cost public exchange wo stiff competition stringent regulation compliance cost be drag government plan look prevalent uncertainty surround effort repeal replace obamacare industry continue put good show see sustainable growth potential expand government program recent announcement center medicare medicaid service regard raise medicare advantage reimbursement rate also prove action definitely attract private health insurance player aim increase manage care participation government plan have already be highly profitable health insurer increase participation be likely result significant top bottom line growth apart upside increase focus preventive value base care grow accountable care organization international business expansion merger acquisition also keep industry growth trend alive thrive economy rise interest rate change demography fuel growthgrow demand health insurance product service back change demographic increase income low unemployment jobless claim continue aid insurance stock strong economy enable person spend more healthcare need again open scope health insurer agee population also boost demand medicare advantage plan especially design retiree control rise medicare cost turn encourage more participation health insurer ensure profitability ground additionally recent interest rate hike federal reserve also bode well health insurer manage care company benefit rise rate owing generally sizeable investment security portfolio couple manageable debt level consolidation industryof late increase consolidation have be major phenomenon health insurance industry turn lead market concentration help player enhance operational scale well gain substantial market share health insurer be try integrate pharmacy benefit manager streamline cut cost drug supply chain recently announce acquisition express script hold company esrx free report cigna corporation ci free report aetna inc aet free report cvs health corporation cvs free report underline grow trend healthcare sector industry come together amicably provide comprehensive care retailer have also expressed interest health insurance industry humana have be talk get acquire walmart inc eyee reward medicare business provide surge baby boomer population retail major intend invest big time health insurance industry recently amazon have also enter joint venture jp morgan berkshire hathaway manage insurance employee be further look ceo helm healthcare joint venture stock bet zero stock poise earning beat second quarter proven model show stock favorable zack rank strong buy buy hold combine positive earning esp have potential beat earning screening also pin point stock have witness positive estimate revision past day humana inc hum free report be largest health care plan provider unite state company zack rank earning esp strengthen potential second quarter earning beat stock have also see zack consensus estimate current year earning be revise upward last day company expect long term earning growth rate be peg industry average share humana have surge outperform industry rally year time magellan health inc mgln free report be american profit manage health care company company zack rank earning esp heighten potential second quarter beat stock have also see zack consensus estimate earning be revise upward last day expect long term earning growth rate company be better industry average share magellan health have surge outperform industry rise year time molina healthcare inc moh free report be multus state manage care organization participate exclusively government sponsored healthcare program company zack rank earning esp bolster possibility second quarter success stock have also see zack consensus estimate bottom line be moved north last day company estimate long term earning growth rate stand more industry average share molina healthcare have soar outperform industry increase last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
2575,ESRX,value investing be easily most popular way find great stock market environment wouldn want find stock be fly radar be compelling buy offer tantalize discount compare fair value way find company be look several key metric financial ratio many be crucial value stock selection process let put express script hold company esrx free report stock equation find be good choice value oriented investor right now investor subscribe methodology look elsewhere top pick pe ratioa key metric value investor always look be price earning ratio pe short show much investor be willing pay dollar earning give stock be easily most popular financial ratio world best use pe ratio be compare stock current pe ratio ratio have be past compare average industry sector compare market whole front express script hold have trail month pe ratio see chart level actually compare pretty favorably market large pe stand focus long term pe trend express script hold current pe level put midpoint past year moreover current level stand well high stock suggest be solid entry point further stock pe compare favorably zack medical sector trail month pe ratio stand very least indicate stock be relatively undervalue right now compare peer also point express script hold have forward pe ratio price relative year earning just so be fair say slightly more value oriented path be ahead express script hold stock term too ratioanother key metric note be price sale ratio approach compare give stock price total sale lower read be generally consider better person metric more other value focuse one look sale something be far harder manipulate accounting trick earning right now express script hold have ratio be much lower average come right now broad value outlookin aggregate express script hold currently have value score putt top stock cover look make express script hold solid choice value investor other key metric make pretty clear too example peg ratio express script hold be just level be far lower industry average peg ratio be modify pe ratio take account stock earning growth rate additionally cf ratio great indicator value come be far better industry average clearly esrx be solid choice value front multiple angle stock overall express script hold be good choice value investor be plenty other factor consider investing name particular be worth note company have growth score momentum score give esrx zack vgm score overarch fundamental grade read more zack style score here meanwhile company recent earning estimate have be mixed best current quarter have see estimate go higher past day compare lower full year estimate have see upward downward revision same time period have have positive impact consensus estimate current quarter consensus estimate have rise past month full year estimate have jump see consensus estimate trend recent price action stock chart express script hold company price consensus express script hold company price consensus express script hold company quotehowever bullish trend have likely not yet be reflect stock have just zack rank hold indicate expectation line performance term nonetheless bullish analyst sentiment indicate stock prospect term look good bottom lineexpress script hold be inspire choice value investor be hard beat incredible lineup statistic front have zack rank stock belong industry be rank top more zack industry indicate broader factor be favorable company so pay value investor delve deeper company prospect fundamental indicate stock be compelling pick make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2576,ESRX,centene corporation cnc free report have make initial investment rxadvance be full service pharmacy benefit manager pbm deal not only establish customer relationship company be also strategic investment centene transaction aim used rxadvance best class technology platform help centene improve health outcome control administrative well medical cost related drug term transaction centene expand equity investment rxadvance future envolve division centene have be provide comprehensive integrate specialty service long include pharmacy management service envolve division help envolve clinical competency rxadvance collaborative pbm cloud platform centene be able deliver integrate real time datum drive pharmacy management service centene management believe partnership enable company build next generation pharmacy management solution rxadvance rxadvance be famous collaborative pbm cloud platform cloud platform help reduction overall pharmacy cost avoidable drug impact medical cost optimize specialty spend rxadvance transparent unique approach combine disruptive technology be expect facilitate centene further improvement health outcome member other customer also bring overall healthcare cost centene inorganic growthcentene have be deploy capital numerous acquisition merger well alliance inorganic growth strategy aim expand company market increase medicaid membership march company acquire health net substantially add top line price inorganic growth effort have significantly boost top line effort have also be appreciate shareholder share have rally year time outperform industry gain recent investment be likely drive share higher pact industrymerger acquisition have be key driver healthcare space lately fact health insurer be try consolidate pharmacy benefit manager streamline cut cost drug supply chain recent announcement acquisition express script hold company esrx free report cigna corporation ci free report aetna inc aet free report cvs health corporation point grow trend industry healthcare sector come together provide comprehensive care amicable way zack rankcentene sport zack rank strong buy see complete list today zack rank stock here hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
2577,ESRX,regeneron pharmaceutical inc regn free report report mixed result first quarter earning top expectation sale miss same nevertheless company share be trading pre market trading regeneron stock have lose last month compare industry decline company report earning share quarter beating zack consensus estimate record year quarter total revenue quarter increase year year drive strong sale eylea revenue however miss zack consensus estimate regeneron pharmaceutical inc price consensus ep surprise regeneron pharmaceutical inc price consensus ep surprise regeneron pharmaceutical inc quote regeneron have co develop eylea healthcare unit bayer ag bayry free report company be solely responsible sale eye drug be entitle profit unite state however share profit loss equally bayer ex eylea sale japan company receive royalty net sale quarterly highlightsnet product sale increase quarter year year majority sale come eylea unite state sale also include sanofi sny free report bayer collaboration revenue compare year quarter however collaboration revenue sanofi decrease primarily due end discovery preclinical development agreement sanofi dec lower reimbursement dupixent development activity increase company share dupixent expense bayer collaboration revenue grow due increase share net profit connection higher sale eylea outside unite state praluent record global net sale quarter year quarter note praluent have be develop collaboration sanofi product sale praluent dupixent kevzara be record sanofi regeneron share profit loss drug dupixent sale come drug be approve treatment adult moderate severe atopic dermatitis kevzara record sale expense decrease selling general administrative sg expense increase quarter decrease expense be primarily due due decrease clinical manufacturing cost decrease dupilumab development cost sg expense increase due higher headcount headcount related cost increase related expense support launch dupixent outlook revenue sanofi be now project compare previous guidance company now expect adjust unreimburse expense range compare previous projection pipeline fda have accept review company supplemental biologic license application sbla label expansion eylea injection company be seek approval week dose interval eylea injection patient wet age related macular degeneration wet amd base physician assessment action date set fda be aug first quarter regeneron announce positive top line result phase iii study panorama eylea moderately severe severe proliferative diabetic retinopathy study result form basis sbla company expect submit fda end company receive significant boost fda approve dupixent dupilumab injection treatment adult moderate severe atopic dermatitis be now look expand dupixent label dupilumab be be evaluate asthma adolescent pediatric atopic dermatitis nasal polyp eosinophilic esophagitis additional study plan datum phase iii study patient nasal polyp adolescent patient atopic dermatitis be expect sbla dupixent add maintenance treatment certain adult adolescent year age older moderate severe asthma be file fda regulatory body have set target action date oct additionally phase ii iii study younger pediatric patient month year age severe atopic dermatitis be initiate first quarter phase iii study evaluate praluent homozygous familial be initiate fourth quarter sbla use praluent apheresis be file fda have set target action date aug quarter regeneron sanofi announce odyssey outcome trial meet primary endpoint trial show high risk patient add praluent maximally tolerate statin experience significantly fewer major adverse cardiovascular event compare maximally tolerate statin alone addition study add praluent maximally tolerate statin be associate reduce death cause moreover company have decide lower net price praluent exchange straightforward more affordable patient access express script esrx free report praluent become exclusive pcsk inhibitor therapy express script national formulary fda also accept priority review bla cemiplimab treatment patient metastatic cscc patient locally advanced cscc be not candidate surgery set target action date oct takeregeneron first quarter result be mixed earning beating expectation sale miss same nevertheless be encourage pipeline progress potential label expansion eylea patient wet age related macular degeneration further boost sale action date set fda be aug positive outcome boost investor sentiment well company have earlier suffer setback decide not advance nesvacumab eylea combination study phase iii development phase ii study evaluate combination therapy fail show additional benefit eylea monotherapy patient diabetic macular edema wet age related macular degeneration meanwhile dupixent uptake unite state moderate severe atopic dermatitis be encourage moreover company be also look expand dupixent label zack rankregeneron currently carry zack rank hold see complete list today zack strong buy rank stock here medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
2578,ESRX,express script hold company esrx free report be schedule report first quarter result market close solid performance pharmacy benefit management segment pbm be likely drive company top line however company be get acquire cigna corporation end last report quarter express script deliver adjust earning share beat zack consensus estimate further adjust earning improve year quarter revenue also beat zack consensus estimate first quarter zack consensus estimate revenue be peg reflect rise year year zack consensus estimate earning be peg indicate increase year year let dig deeper analyze thing be shape earning announcement pbm focusexpress script be largest pbm north america company have be consistently try expand core pbm business meanwhile zack consensus estimate pbm revenue be peg believe company unique offering home delivery pharmacy care specialty pharmacy care specialty benefit management medical drug datum analysis service buoy optimism express script also distribute full range product provide extensive cost management patient care service company inked agreement acquire privately hold evicore healthcare october transaction be close fourth quarter evicore provide evidence base integrate medical benefit management service mbm solution drive cost reduction quality care outcome acquisition be expect prove accretive express script adjust diluted earning share first full year operation first quarter be exception express script hold company price ep surprise express script hold company price ep surprise express script hold company quoteexpress script pbm service couple evicore complementary medical benefit management be likely build solution strong demand company solution continue quarter review company expect solid demand safeguardrx day supply chronic medication exclusive accredo specialty pharmacy advanced opioid solution program well many other express script deliver superior care patient affordable cost company latest offer multiple sclerosis care value program have be launch jan program extend company differentiate payment model shielding payer cost associate discontinue therapy express script already enrolled life yet management claim most successful launch date other factor adjust claim first quarter be expect range adjust earning share first quarter be estimate range represent growth year year basis full year adjust earning be estimate band reflect growth year year revenue be expect band adjust ebitda be expect come guidance express script core business total adjust claim be expect range first quarter client retention rate positive express script enter strong market momentum continue witness success retain key client end previous quarter company create trust client relationship deliver exceptional care patient control cost favorable drug trend result be clearly indicative fact buoy strong prospect express script expect provide retention rate guidance express script get acquire declare express script be lose biggest customer lead health insurer anthem inc company recently announce be get acquire cigna global health insurance company acquisition be expect be complete dec definitive agreement cigna take express script cash stock transaction worth notably include cigna assumption approximately debt express script fact moody investor service rating service arm moody corporation be worry express script high customer concentration pricing pressure moody express script be likely experience decline script volume higher typical customer loss day come other challenge include fewer generic drug introduction softening mail order growth trend client focus cost saving transparency earning whispersour proven model do not show earning beat express script quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp express script have earning esp uncover best stock buy sell re report earning esp filter zack rank express script carry zack rank here be few medical stock worth consider have right combination element post earning beat quarter cooper company inc coo free report have earning esp zack rank see complete list today zack rank stock here teleflex incorporate tfx free report have earning esp zack rank abbvie inc abbv free report have earning esp zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2579,ESRX,here be stock add zack rank strong buy list today express script hold company esrx free report pharmacy benefit management pbm company have see zack consensus estimate current year earning increase last day express script hold company price consensus express script hold company price consensus chart express script hold company quoteunique fabricate inc ufab free report company manufacture multus material foam rubber plastic component have see zack consensus estimate current year earning increase last day unique fabricate inc price consensus unique fabricate inc price consensus chart unique fabricate inc quotezebra technology corporation zbra free report manufacturer seller range automatic identification datum capture aidc product have see zack consensus estimate current year earning increase last day zebra technology corporation price consensus zebra technology corporation price consensus chart zebra technology corporation quoteair lease corporation al free report aircraft lease company have see zack consensus estimate current year earning increase last day air lease corporation price consensus air lease corporation price consensus chart air lease corporation quotealmost family inc afam provider home healthcare service have see zack consensus estimate current year earning increase last day almost family inc price consensus almost family inc price consensus chart almost family inc see complete list today zack rank strong buy stock hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
2580,ESRX,wave merger acquisition have be heating healthcare space year change landscape healthcare business be especially true give health insurer be try consolidate pharmacy benefit manager streamline cut cost drug supply chain latest catalyst be health insurer cigna ci free report have plan acquire largest pharmacy benefit manager express script hold esrx free report include debt move come month drug chain pharmacy giant cvs health corp cvs free report agree buy nation third largest health insurer aetna aet free report share read etfs gain cvs aetna deal term deal cigna pay cash share stock newly combine company closure cigna shareholder own approximately combine company merged company create stop shop customer healthcare need range sale drug insurance cover benefit consumer bring together medical care pharmacy benefit roof improve treatment lower cost combine company bigger threat unitedhealth group inc unh free report largest health insurer have own pharmacy benefit unit cvs complete merger aetna move be also stave threat amazon com inc amzn free report be make huge expansion world pharmacy business commerce giant recently announce joint venture jpmorgan chase jpm free report warren buffett berkshire hathaway brk free report order curb medical cost employee transaction result total cost synergy double digit accretion earning first year close result cigna expect deal increase earning share deal be expect close dec be subject approval shareholder company trust regulatory approval see healthcare etfs here etf announce merger have put spotlight few healthcare etfs be best way investor tap opportunity arise ci esrx deal ishare healthcare provider etf ihf free report etf follow dow jone select healthcare provider index exposure company provide health insurance diagnostic specialize treatment total fund hold security basket cigna esrx occupy fourth fifth position accounting share fund have amassed asset base volume be light share day average charge bps annual fee have zack etf rank strong buy medium risk outlook read trump budget blueprint etf winner loser spdr health care service etf xhs free report fund used equal weight methodology security tracking health care service select industry index hold stock basket ci esrx account share fund have accumulate asset base trade paltry volume share day expense ratio come etf have zack etf rank buy medium risk outlook read sector etfs stock set explode higher tax cut first trust health care alphadex fund fxh fund follow alphadex methodology rank stock space various growth value factor eliminate bottom rank stock approach result basket stock esrx ci take share respectively health care provider service be top sector allocation follow healthcare equipment biotech fund have aum asset base trade volume share expense ratio come annually fund have zack etf rank buy medium risk outlook health care select sector spdr fund xlv free report most popular healthcare etf xlv follow health care select sector index fund manage nearly asset base trade heavy volume share expense ratio come annually total fund hold security basket ci esrx accounting asset pharma take largest share sector look healthcare provider service biotech healthcare equipment supply make double digit exposure have zack etf rank hold medium risk outlook want key etf info deliver straight inbox zack free fund newsletter brief top news analysis well top perform etfs week get free
2581,ESRX,share express script hold company esrx free report surge cigna corp ci announce plan acquire former coca cola company ko free report share surge company announce plan launch first ever alcoholic drink japanshare caesar entertainment corporation czr free report surge report fourth quarter earning share surpass zack consensus estimate tronc inc trnc free report share plummet post fourth quarter earning share zack consensus estimate
2582,ESRX,masimo corporation masi free report recently announce favorable result study evaluate performance noninvasive hemodynamic monitoring nihm used masimo noninvasive continuous hemoglobin sphb masimo share price rally feb post announcement result notably sphb monitoring offer real time visibility change lack change hemoglobin blood sample clinician often get limit access invasive method delay laboratory result conduct michigan state university comparison be draw invasive laboratory hemoglobin labhb monitoring trauma patient have solid organ injury severity score status blood flow be assessed used physical examination normal institutional pediatric trauma guideline masimo corporation price consensus masimo corporation price consensus masimo corporation quote nihm used masimo sphb be conduct continuously used masimo radical pulse co oximeter sphb value be record multiple time correspond labhb blood draw study result reflect nihm used masimo sphb clinically acceptable precision follow hemoglobin trend defined pediatric trend patient population researcher have further deduce nihm be valuable addition traditional laboratory hemoglobin monitoring market prospectsper forecast make research market global hemoglobin testing market be project see cagr gradual shift traditional poct point care testing method laboratory boost market consequently proven study result masimo sphb be likely fortify company hold niche hemoglobin monitoring apart drive customer base price performancein past year masimo have underperform industry term price stock have lose industry rally zack rank key picksmasimo carry zack rank hold few better rank stock broader medical space be athenahealth inc athn free report express script hold company esrx free report bioverativ inc stock sport zack rank strong buy see complete list today zack rank stock here athenahealth have expect long term growth rate past month stock have gain express script have project long term growth rate past month stock have return bioverativ have expect long term growth rate past month stock have return make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2583,ESRX,bid ensure availability specialty brand drug express script hold company esrx free report walgreen boot alliance wba free report recently announce plan expand exist group purchasing effort biosimilar have potential lower production cost move be consider be prudent timely valoremrx specialty solution llc assist company carry move help pharmacy selling expensive drug simplify global supply chain lower cost patient client used specialty pharmacy express script accredo walgreen express script hold company price consensus express script hold company price consensus express script hold company quoteexpress script joined walgreen boot alliance development gmbh wbad group wholly own subsidiary innovative product alignment llc notably wbad be global group purchasing organization source contract generic pharmaceutical behalf member move make innovative product alignment member wbad rationale movespecialty medication include costly complex drug be prescribe regular basis latest pact improve express script supply chain make medicine include biosimilar affordable accessible patient research conduct rand corporation biosimilar arthritis cancer have potential yield billion cost saving unite state lead reduction direct spending biologic drug promising marketper study sns research approve biosimilar account nearly revenue end regulatory effort reduce healthcare cost be likely aid growth give potential market hold believe latest move medical behemoth be strategic timely share price performanceover year express script have outperformed broader industry stock have return compare industry gain zack rank other stock considerexpress script carry zack rank buy few other top rank stock broader medical space be centene corp cnc free report bioverativ inc stock sport zack rank strong buy see complete list today zack rank stock here centene project long term growth rate be stock have return past month bioverativ have expect long term growth rate stock have return whopping past month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
2584,ESRX,express script hold company esrx free report be schedule release fourth quarter earning feb market close notably company deliver average earning surprise trail quarters moreover past year express script have outperformed industry stock have gain compare industry rally let take look thing be shape release pbm focusexpress script be largest pharmacy benefit manager pbm north america company have be consistently try expand core pbm business express script hold company price consensus express script hold company price consensus express script hold company quotehowever major revenue segment pbm unit pbm product network be expect reflect decline quarter notably zack consensus estimate pbm product network revenue stand reflect sequential decline be expect mar fourth quarter result expect improvement other segment help company generate solid result season interestingly zack consensus estimate pbm home delivery revenue be peg show rise sequentially believe company unique offering home delivery pharmacy care specialty pharmacy care specialty benefit management medical drug datum analysis service buoy optimism express script also distribute full range product provide extensive cost management patient care service additionally zack consensus estimate pbm service sale be pin show increase sequentially other factor playview upbeat prior fourth quarter earning release management raise previously issue adjust earning share guidance indicate year year growth midpoint management raise project range be attribute combination accretive acquisition strategic tax plan initiative notably company have issue guidance expect acquisition evicore healthcare prove accretive earning favorable estimate revision trend zack consensus estimate current quarter revenue be peg show year year growth additionally zack consensus estimate current quarter earning share stand reflect growth year year benefit generic utilization express script stand benefit increase generic utilization shift mail order strong specialty growth age population company be focuse specialty drug well generic late notable development express script recently close acquisition evicore healthcare view drive growth earning cash flow buyout company intend provide improve healthcare control unnecessary spending pharmacy medical recently accredo specialty pharmacy express script earn accreditation urac washington dc base independent accreditor health care management organization earning whispersour proven model do not conclusively show earning beat express script fourth quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp express script have earning esp uncover best stock buy sell re report earning esp filter zack rank express script carry zack rank stock considerhere be few medical stock worth consider have right combination element post earning beat quarter universal health service uhs free report have earning esp zack rank see complete list today zack rank stock here exelixis exel free report have earning esp zack rank amphastar pharmaceutical amph free report have earning esp zack rank hacker put money portfolio earlier month credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
2585,ESRX,market shake news commerce giant amazon com amzn free report announce be partner warren buffett berkshire hathaway jpmorgan chase jpm free report build healthcare company order cut cost employee improve worker satisfaction result share health sector company be slide intraday trading insurance player anthem antm free report cigna ci free report aetna aet free report humana hum free report be pharmacy giant cvs health cvs free report walgreen boot alliance wba rite aid rad free report dip pharmacy benefit manager express script esrx free report be nearly well goal partnership be create company sole intention provide healthcare workforce future entity not aim make profit instead focus technology provide simplified high quality transparent healthcare amazon berkshire jpmorgan say kind healthcare be provide employee be long term hope bypass frustration associate secure healthcare third party provider be ultimately concern own bottom line ballooning cost healthcare act hungry tapeworm american economy say berkshire chairman ceo buffett group do not come problem answer also do not inevitable amazon founder jeff bezos say hard form new healthcare company be reduce healthcare burden economy improve outcome employee family be worth effort jpmorgan chief executive jamie dimon say ultimate goal be create solution benefit employee family potentially american have be rumor amazon entry pharmacy business now so call amazon effect so announcement be not entirely surprise healthcare company be still early plan stage be temporary management team place leader organization don even think buy bitcoin read most popular cryptocurrency sky-rocket last year give investor chance bank return even more gain however come serious volatility risk bitcoin sank more time zack have just release new special report help reader capitalize explosive profit potential bitcoin other cryptocurrency significantly less volatility buy directly see crypto related stock now
2586,ESRX,express script hold company esrx free report be big mover last session company see share rise nearly day move come solid volume too far more share change hand normal session break recent trend company stock be now trading volatile price range past month time frame stock gain cigna agree buy company include debt company have see positive estimate revision past few week zack consensus estimate current quarter have also moved higher past few week suggest more solid trading be ahead express script so make sure keep eye stock go forward see recent jump turn more strength road express script currently have zack rank buy earning esp be negative express script hold company price express script hold company price express script hold company quoteanother stock worth consider medical service industry be healthway inc tvty free report carry zack rank strong buy see complete list today zack rank stock here be esrx go predict see other think downdon even think buy bitcoin read most popular cryptocurrency sky-rocket last year give investor chance bank return even more gain however come serious volatility risk bitcoin sank more time zack have just release new special report help reader capitalize explosive profit potential bitcoin other cryptocurrency significantly less volatility buy directly see crypto related stock now
2587,ESRX,small biotech firm spark therapeutic once free report recently announce new gene therapy be design treat rare inherited retinal disease cause blindness approve fda luxturna cost eye spark do reveal payment access program help astronomical price tag company say be explore payment luxturna installment well tie payment well therapy work instance spark want offer discount base not drug initially work remain effective be roughly patient suffer kind inherited retinal disease cause mutant gene spark be also propose bypass hospital healthcare provider selling directly insurance company specialty pharmacy accord bloomberg company be already talk express script esrx free report such deal pharmacy benefit manager look be big proponent luxturna well steve miller express chief medical officer say many person be anticipate retinal disease treatment be more dollar end be revolutionary product think most plan be cover phone interview bloomberg spark ceo jeff marrazzo say believe price reflect not only breakthrough life alter value time luxturna enable continue invest build revolutionary science support not only luxturna rest pipeline be luxturna deliver luxturna be gene therapy involve delivery healthy copy gene used alter virus order make be deficient cause disease case retinal dystrophy luxturna be deliver patient just once clinical study patient sight be examine base ability navigate obstacle course vary light level receive treatment show huge sign improvement do so low light year period note cnbc also describe be able read again see snowflake first time panel fda adviser share once close share investor alert breakthrough pendinga medical advance be now flashpoint theory realization billion dollar research have pour company be already generate substantial revenue even more wondrous product be pipeline cure variety deadly disease be sight so be big potential profit early investor zack name stock buy now click here see
2588,ESRX,year have fail turn thing cvs health cvs free report lead provider integrate service entire spectrum pharmacy care have underperform market year date stock have lose market gain first quarter earning call cvs health president chief executive officer larry merlo say continue expect be rebuild year goal remain clear fully intend return healthy level growth unfortunately little materialize company be still grapple issue past other challenge deal major blowscvs health be still try recover setback cause prime therapeutic collaboration walgreen boot alliance inc wba free report august owing cvs health lose access prime member notably prime therapeutic be fourth largest pharmacy benefit manager pbm unite state own lead blue cross blue shield health plan major blow be dealt end tricare retail pharmacy network manage express script esrx free report restrict cvs pharmacy include target store participate network more location include walgreen boot member instead thank development cvs health share lose last month hasn be kind wellcv health retail long term care ltc business have be sluggish first quarter largely due decline same store sale continue reimbursement pressure rise generic dispense rate proportion generic prescription total number prescription dispense company retail ltc business be also majorly impact weak operation hurricane ravage area texas louisiana florida puerto rico company have value hurricane impact primarily cost cover insurance deductible speculate entry amazon com inc amzn free report pbm market have aggravate matter cvs health counter competition cvs health have add more digital customer friendly program cvs health force reckon be struggle be progress nothing be more apt remark frederick douglass cvs health massive market cap have be leave stone unturned bounce back merger acquisition strengthen pbm businessin historic decision cvs health decide acquire unite state third largest health insurance company aetna aet cash stock deal worth share almost consider rough estimate aetna debt total transaction value be project company expect takeover close second half subject approval company shareholder regulatory body well fulfillment certain other customary close condition cvs health expect term synergy deal low mid single digit accretion second year post closure transaction many view merger vertical integration instead horizontal lead efficiency gain solid cost cut cvs health pbm business apart aetna deal cvs health have announce plan set new store performance base pharmacy network well community base independently own pharmacy unite state initiative company intend promote cost save enhance clinical outcome eventually reduce cost cvs health pbm customer initiative boost retail ltc company have also be strive return growth retail ltc business management claim cvs health be focuse work payer drive volume capture market share company tie optumrx part unitedhealth group unh free report provide day pharmacy solution optumrx commercial client be make available begin july cvs health be also poise gain program such health tag extracare health card subsequently company be plan collaborate pbms health plan offer menu service such minuteclinic service infusion long term care also store brand be area strength opportunity cvs health company latest initiative next day same day delivery automatic refill prescription text message also seem promising recognize grow opportunity digital market cvs health have also be focuse enhance online mobile capability build strength digital tool pharmacy patient used company be focuse offer advanced service customer service range curbside program same day delivery option well enhance mobile functionality extracare moreover cvs health have be work instacart be now deliver store be rebound card cvs health have be fire cylinder late company recently inked year agreement anthem inc antm free report provide service include claim process prescription fulfillment support ingeniorx new pbm notably agreement be implement jan run dec such measure help smoothen bumpy ride company come fresh set surprise challenge look best stock be first see top stock portfolio here broadly speaking effect massive corporate tax cut propose tax reform bill be yet be implement analyst bill result substantial decline effective tax rate company also zack rank hold company favorable value style score raise confidence stock value style score highlight valuation metric represent score caution investor regard value trap help find stock be actually trading discount company also have favorable price earning ratio compare market broader industry bottom linein market merger acquisition have be historically alter landscape challenge legal regulation reimbursement pressure be interesting see cvs health deal odd deliver promise long term earning growth look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
2589,ESRX,express script hold company esrx free report recently complete buyout evicore healthcare notably evicore provide evidence base integrate medical benefit management service mbm solution help reduce cost provide quality care post acquisition evicore operate standalone business unit express script enhance capacity provide better clinical outcome saving health plan purchaser patient express script pharmacy benefit management couple evicore complementary mbm platform be likely build comprehensive patient benefit management pbm solution buyout provide express script opportunity cross sell client basis furthermore buyout widen express script ability drive value use specialty medication notably specialty medication be used treat complex chronic condition medicine be exorbitantly expensive form fastest grow part pharmaceutical expense express script enter mbm spacembm be exclusive platform check specialty drug spending mbm also provide care service patient ensure safe efficient timely outcome deal express script aim eradicate long medical procedure lack coordinate evidence base care target healthcare industry represent worth annually management be more time larger pharmacy segment pbm market be expect maintain solid trend report market research report biz pbm market see cagr so latest development be strategic fit keep bountiful opportunity niche space mind financial acquisition be expect prove accretive express script adjust diluted earning share exclude transaction related expense amortization intangible guidance raisedexpres script increase previously issue consolidated full year adjust ep guidance range reflect growth consolidated adjust ep result midpoint range company have also provide adjust earning diluted share guidance range reflect growth midpoint update adjust ep guidance range share price estimate revision trendexpress script stock have outperformed broader industry last month stock have gain period compare industry gain company recent earning estimate revision trend have be encourage well current quarter have see estimate go last day compare revision opposite direction consensus estimate current quarter earning have rise zack rank key picksexpress script carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology luminex sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
2590,ESRX,second quarter report cycle be full swing multiple company come quarterly financial number picture have emerge so far be quite encourage season remain track end strong note high proportion company have report better expect earning share current report cycle generally earning beat lead appreciation stock price give highly bullish backdrop investor add outperformer respective portfolio healthy return however task be far easy plethora company present market moreover complexity associate stock market make even more difficult individual investor select outperformer absence proper guidance be guide broker requisite guidance design winning portfolio come broker broker not only scrutinize publicly available financial document also attend company conference call other presentation broker arrive recommendation buy sell hold stock thoroughly analyze nitty gritty associate company be natural investor be guide direction estimate revision decide course action particular stock estimate revision serve important pointer regard price stock fact rating upgrade generally lead stock price appreciation similarly price stock plummet follow rating downgrade estimate move north number reason favorable earning performance bullish guidance product launch favorable macro scenario make most broker opinionswe have design screen shortlist stock base improve analyst recommendation upward revision earning estimate last week also price sale ratio be strong complementary valuation metric presence analyst information have be include price sale ratio take care company top line make strategy foolproof screening criterium rating total week top give list top company have witness net upgrade last week change week top give top stock have witness earning estimate revision past week upcoming quarter have also add follow screening parameter ensure strategy be winning price sale bot lower ratio better company meeting criterium be bottom universe stock respect ratio price greater stock trading not likely create significant interest most investor average daily volume greater share last trading day volume have be significant ensure be easily trade market value mil top give stock be top term market capitalization com adr canadian com take adr canadian stock here be stock make screen st loui mo base express script hold company esrx free report be largest pharmacy benefit manager pbm north america have impressive record respect earning have surpass zack consensus estimate last quarters average carry zack rank hold see complete list today zack rank strong buy stock here abercrombie fitch co anf free report operate specialty retailer premium high quality casual apparel man woman kid network store unite state multiple store canada europe asia australia middle east zack rank stock have impressive expect earning share growth rate year new base commercial vehicle group inc cvgi free report supply interior system vision safety solution other cab related product global commercial vehicle market last quarter zack rank company have post earning cent share expectation be breakeven dxp enterprise inc dxpe free report supply maintenance repair operate product equipment service industrial customer last day zack consensus estimate zack rank buy company rise cent plain gp holding pagp free report subsidiary be involved primarily transportation storage marketing crude oil refine product zack consensus estimate zack rank stock have increase cent share last day get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
2591,ESRX,st loui mo base pharmacy benefit manager express script hold company esrx free report post second quarter adjust earning share beating zack consensus estimate furthermore adjust earning jump share year quarter revenue miss zack consensus estimate be roughly year year basis gross profit second quarter be flat year year adjust selling general administrative expense be prior year quarter total adjust claim amount second quarter flat year year company ebitda earning interest tax depreciation amortization witness rise second quarter upside be drive operational cost improvement backed focus technology digital tool home delivery specialty service balance company exit quarter cash cash equivalent compare end total debt end quarter be versus end fact company be strive reduce debt level express script hold company price consensus ep surprise express script hold company price consensus ep surprise express script hold company quoteguidance raise company raise guidance adjust earning fiscal adjust earning share be project band previously provide range represent increase mid point range come guidance third quarter express script expect total adjust claim range adjust earning diluted share third quarter be estimate range represent growth year year basis furthermore company anticipate compound annual ebitda growth rate core pbm business exclude contribution anthem other transition client express script likely lose script recently announce biggest customer lead health insurer anthem inc antm free report be not likely extend pharmacy benefit management agreement be slate expiration end anthem sue express script overcharge drug operational failure management anthem refuse participate further discussion pricing concession probable adjustment agreement meanwhile second quarter anthem generate revenue compare second quarter takewe be highly upbeat company core pharmacy benefit management long term outlook include ongoing volatile healthcare market trend inflation patent expiration lower industry utilization growth other headwind furthermore expect express script continue benefit increase generic utilization shift mail order strong specialty growth age population brand drug be become increasingly expensive due double digit brand inflation continue rise price specialty drug overwhelming regulatory burden be actually pave way manifold prospect generic key picksnotably express script currently have zack rank hold better rank stock broader medical sector include insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world second trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
2592,ESRX,earning report second quarter be pour result company already paint strong earning picture be likely look rosier course report cycle latest earning trend total earning member constitute index total market capitalization report so far be year year rise revenue go scorecard company deliver earning beat surpass revenue estimate healthcare fall medical ambit be sector group jul total medical sector report second quarter result beat ratio be strong company surpass bottom line expectation sector have be limelight change power white house president donald trump be eager repeal replace health care reform act more popularly know obamacare have inject fresh dose uncertainty stock continue be focus repeal replace obamacare scenario play lot have be happen part medical sector effort repeal replace obamacare fail meet much success basically collapse meantime healthcare corner continue benefit patient gain obamacare player industry be also actively engage merger acquisition achieve fast pace growth new product launch improve service expansion ancillary business cost control measure accrue top line nevertheless high bad debt increase investment technological innovation integration cost related acquisition high interest expense debt funded acquisition put pressure bottom line let take peek healthcare company be gear report second quarter result jul hca healthcare inc hca free report have earning esp most accurate estimate be zack consensus estimate company have zack rank hold negative esp make surprise prediction difficult uncover best stock buy sell re report earning esp filter last quarter hca healthcare meet zack consensus estimate time however company be unlikely come beat respect surprise trend hca healthcare surpass expectation last quarters average positive surprise company commercial volume have be stress past few quarters effort have be make address weakness don expect see major improvement business second quarter last quarter company report consecutive quarter equivalent admission growth hca healthcare expect trend continue second quarter read more hca healthcare earning beat estimate hca holding inc price ep surprise hca holding inc price ep surprise hca holding inc quoteexpress script hold company esrx free report have earning esp most accurate estimate be penny zack consensus estimate make surprise prediction difficult company zack rank see complete list today zack rank stock here last quarter express script beat zack consensus estimate time however company be unlikely come beat respect surprise trend express script surpass expectation last quarters average positive surprise expect express script continue benefit increase generic utilization shift mail order strong specialty growth age population flipside express script face intense competition pbm industry read more store express script esrx free report earning express script hold company price ep surprise express script hold company price ep surprise express script hold company quotequest diagnostic inc dgx free report have earning esp most accurate estimate be line zack consensus estimate make surprise prediction difficult company zack rank last quarter quest diagnostic beat zack consensus estimate time however company be unlikely come beat respect surprise trend quest diagnostic surpass expectation last quarters average surprise recent past quest diagnostic witness significant growth infectious disease testing prescription drug monitoring industry lead wellness business expect growth driver remain active second quarter well drive same metric do precede quarter read more quest diagnostic pull surprise earning quest diagnostic incorporate price ep surprise quest diagnostic incorporate price ep surprise quest diagnostic incorporate quoteuniversal health service inc uhs free report have earning esp most accurate estimate be line zack consensus estimate make surprise prediction difficult company zack rank last quarter universal health beat zack consensus estimate time however company be unlikely come beat respect surprise trend universal health surpass expectation last quarters miss average be negative earning surprise universal health be likely have witness rise revenue adjust patient day behavioral health division continue previous quarter trend company acute care division be expect deliver decent performance back adjust admission growth universal health effort enhance shareholder value share repurchase boost bottom line limit share count read more universal health earning card universal health service inc price ep surprise universal health service inc price ep surprise universal health service inc quotemore stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
2593,ESRX,pharmacy benefit manager express script hold company esrx free report be schedule report second quarter result jul market close st loui mo base company be largest pharmacy benefit manager pbm north america meanwhile company earning exceed zack consensus estimate almost last report quarter stock have deliver positive earning surprise past quarters average express script stock have underperform zack classify medical service industry last month specifically stock lose period compare industry gain moreover current rate be way lower same time frame indicate loom concern ahead express script hold company price ep surprise express script hold company price ep surprise express script hold company quotelet take look thing be shape prior second quarter earning announcement factor playsecond quarter outlook second quarter express script expect total adjust claim range adjust earning diluted share second quarter be estimate band represent growth year year basis furthermore company anticipate compound annual ebitda growth band core pbm business favorable macroeconomic scenario expect express script continue benefit increase generic utilization shift mail order strong specialty growth age population brand drug be become increasingly expensive due double digit brand inflation thus continue rise price specialty drug increase regulatory burden have be drive demand generic key catalyst company cutthroat competition niche space flipside express script face intense competition pbm industry company face competition independent pbms medimpact navitus health solution moreover niche space be dominate player cvs aetna cigna other expect intensify competition mar second quarter revenue estimate revision trend express script estimate revision trend lack luster moment current quarter analyst moved south compare upward revision last month fact last month current quarter estimate decline almost share probable loss biggest customer be too early gauge loss express script be verge lose biggest customer lead health insurer anthem inc antm follow series legal conundrum anthem be longer expect extend pharmacy benefit management agreement withexpress script be slate expiration end management express script lose almost revenue related anthem contract second quarter earning whispersbuoy factor proven model do not conclusively show express script be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate be not case here see zack esp earning esp express script be most accurate estimate be peg zack consensus estimate stand uncover best stock buy sell re report earning esp filter zack rank express script currently carry zack rank favorable zack rank increase predictive power esp company negative esp make surprise prediction difficult meanwhile caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock warrant lookhere be few company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp zack rank stryker corporation syk free report have earning esp zack rank top pick ride hottest tech trend zack just release special report guide space have already begin transform entire economy last year be generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money make right trade early download report top tech stock
2594,ESRX,express script hold company esrx free report announce launch month pilot program fall simplify pharmacy experience patient innovative cost effective network be likely improve patient outcome bolster company exist relationship pharmacy share price announcement share express script have jump close notably year time share have rally compare industry mere gain pilot program script be keep stone unturned maintain lead position global pharmacy benefit management industry latest development promise build retail pharmacy network unite state postulate pilot program pharmacy be willing take part be able assess own performance identify possible loophole web portal express script hold company price consensus express script hold company price consensus express script hold company quoteper management pilot program enhance clinical experience usable patient datum program also focus augment medication therapy reduce patient cost refine medical adherence better patient outcome notably pilot program standard measurement be recognize pharmacy quality alliance pqa management company ability work pharmacy value chain lead newer healthcare outcome generate saving healthcare prospectsper study market market global healthcare market be project reach cagr majority demand healthcare solution be drive grow need reduce healthcare cost adhere regulatory requirement set government organization conclusionper estimate government national health expenditure hit work person surge healthcare expense be project period hence be conclude express script move have be timely strategic zack rank key picksexpress script carry zack rank hold better rank stock broader medical space be pharm bhvn free report bio rad laboratory inc bio free report envision healthcare corporation evhc free report have expect earning growth rate current quarter stock sport zack rank strong buy see complete list today zack rank stock here bio rad have expect long term earning growth rate stock have zack rank buy envision have expect long term earning growth rate stock have zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2595,ESRX,merger acquisition activity globe picked rapidly first quarter thank tax reform faster economic growth europe preliminary thomson reuter datum global merger acquisition have strongest start ever totale first quarter be past year mark fourth quarter have surpass past year unite state volume climb europe volume double meanwhile asia see increase however number deal drop year year accord report research firm mergermarket activity world have hit year high record first quarter deal globally totale be strongest start year represent year year increase value healthcare space have so far be forefront amazon move pharmaceutical sphere have spur major pharmacy retailer consolidate regard health insurer cigna ci free report acquire largest pharmacy benefit manager express script hold esrx free report deal be expect close end year deal drug chain pharmacy giant cvs health corp cvs free report be also process acquire nation third largest health insurer aetna aet free report deal be expect close second half year read cigna buy express script healthcare etfs focus large agreement be german utility eon deal acquire rwe ag renewable energy business innogy boom be likely continue give accelerate economy still low interest rate tax reform allow company bring offshore cash back home potential cost saving merger be further fuel urge merge current ultra competitive environment tap investor easily take advantage surge deal employ merger arbitrage strategy portfolio strategy look tap price differential spread stock price target company public announcement propose acquisition price offer acquirer pay stock target company be especially true give investor go long target acquire company short acquire company deal be complete share target company increase full deal price case slightly deal price give investor nice profit have highlighted merger etfs ride surge increase deal make compelling option investor seek implement low correlation strategy portfolio iq merger arbitrage etf mna free report fund offer capital appreciation investing global company have be public announcement takeover acquirer same time provide short exposure global equity partial equity market hedge be do tracking iq merger arbitrage index fund have holding basket largest allocation blue buffalo pet product rockwell collin col free report long side firm combine make share product have amassed asset base trade average volume share day charge bps annual fee etf have lose year date see hedge fund etfs here proshare merger etf mrgr free report product provide exposure global merger arbitrage strategy seek capture spread price stock company target trade propose acquisition such target be announce value cash stock acquire company have propose pay stock target spread be easily do merger arbitrage index fund hold well diversify portfolio stock technology industrial healthcare financial be top sector etf have be able manage asset worth see light volume just share day bottom line investor capitalize merger arbitrage trading particular target company stock etfs provide diversify exposure basket form lower risk further be excellent choice investor rocky market due low correlation overall market read trade tension not stay safe etfs be company merger acquisition deal generally move independently ignore other issue influence movement other stock result investor definitely focus product relatively higher return type market want key etf info deliver straight inbox zack free fund newsletter brief top news analysis well top perform etfs week get free
2596,ESRX,express script hold company esrx free report be big mover last session company see share rise day move come solid volume too far more share change hand normal session stock remain volatile trade range past month time frame witness sharp increase friday zack consensus estimate current quarter have see upward versus downward movement past month consensus estimate have remain unchanged same time frame upward revision suggest more solid trading be ahead express script so make sure keep eye stock go forward see recent jump turn more strength road express script currently have zack rank hold earning esp be positive express script hold company price script hold company price consensus express script hold company quotea better rank stock medical service industry be pra health science inc prah free report carry zack rank strong buy see complete list today zack rank strong buy stock here be esrx go predict see other think downzack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
2597,ESRX,hologic inc holx free report have be healthy growth trajectory late company progress domestic international market strong pipeline product well huge future prospect gyn surgical molecular diagnostic segment make attractive pick moment therefore zack rank buy stock boast solid prospect drive share higher term stock have market cap company expect growth rate be company have average positive earning surprise last quarters also have long term expect earning growth rate company estimate revision trend current year have be positive past couple month analyst moved north southbound estimate witness earning estimate have be raise share same time frame let find recent favorable trend be sustainable hologic first quarter fiscal performance be quite promising primarily strength molecular diagnostic headquarter bedford company global growth be drive increase market share utilization fully automate panther system continue solid uptake aptima woman health product notably aptima woman health assay be dominant testing lab detect chlamydium gonorrhea hpv human papillomavirus trichomona hologic inc price hologic inc price hologic inc quote however performance gyn surgical space be disappointing report quarter majorly due external factor moreover extra selling day prior year period left significantly adverse effect year year comparison situation also grow tougher quarter review company register windfall gain year quarter recall competitive product accordingly hologic have underperform broader industry last month stock have lose broader industry rise nonetheless hologic gyn surgical business show huge future prospect fact be upbeat recent commercial launch myosure manual device unite state addition same myosure product portfolio consist myosure myosure reach myosure xl myosure lite device myosure continue show solid growth company pursue string developmental strategy surgical space notably hologic have appoint new leadership month team have upgrade sale talent structure growth boost incentive other key pickssome other top rank stock broader medical space be athenahealth inc athn free report express script hold company esrx free report bioverativ inc sporting zack rank strong buy see complete list today zack rank stock here athenahealth have expect long term growth rate past month stock have gain express script have project long term growth rate past month stock have return bioverativ have expect long term growth rate past month stock have return zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
2598,ESRX,orthofix international ofix free report report fourth quarter adjust earning share ep cent continue operation figure be ahead zack consensus estimate couple cent adjust earning improve year year primarily strong sale growth company biologic spine fixation strategic business unit sbu exclude time item net income continue operation fourth quarter come cent share show remarkable year year improvement net loss continue operation cent sale detailsorthofix fourth quarter sale improve constant exchange rate cer figure also beat zack consensus estimate sale be primarily drive better expect performance company sbus significant contribution biologic spine fixation sbu fourth quarter company post biostim sale reflect same cer growth prior year period biologic sbu sale totale same cer year quarter upside result strong sale trinity elite allograft banking expand distributor network extremity fixation sale be quarter review show improvement cer fourth quarter company particularly realize strong revenue growth outside extremity fixation stocking distribution orthofix international price consensus ep surprise orthofix international price consensus ep surprise orthofix international quote orthofix report spine fixation sbu sale reflect cer growth year earlier quarter uptick be attribute new product launch adopt strategic initiative marginsin fourth quarter gross margin expand basis point bps solid top line growth be major factor have boost gross margin sale marketing expense rise year year general administrative expense be lead lower legal settlement cost report period well core expense reduction due outside restructure initiative lower professional fee company also witness rise research development expense accordingly adjust operate margin expand bps owing increase operate expense cash exit cash cash equivalent compare end full year net cash provide operate activity be compare year exclude capital expenditure free cash flow be compare unfavorably free cash flow due capex have provide guidance full year sale be expect band zack consensus estimate full year revenue be peg higher guide range adjust ep continue operation be expect range zack consensus estimate full year adjust ep stand close upper end company project range company exit fourth quarter solid note earning sale beating zack consensus estimate top line be substantially drive strength biologic spine fixation business expect continue back improve performance sale partner expand distributorship network introduction product year have remain successful orthofix be company transform spine fixation sbu deliver exceptional growth sale momentum addition robust stream new product period company have already launch product have even schedule be release ahead strong current year guidance be indicative enhance prospect flip side currency fluctuation competitive landscape macroeconomic headwind continue challenge company moreover higher operate expense be matter concern orthofix also heavy dependence third party final distribution product expose company increase risk zack rank key picksorthofix carry zack rank hold better rank stock broader medical space be athenahealth inc athn free report express script hold company esrx free report bioverativ inc sporting zack rank strong buy see complete list today zack rank stock here athenahealth have expect long term growth rate past month stock have gain express script have project long term growth rate past month stock have return bioverativ have expect long term growth rate past month stock have soar zack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
2599,ESRX,walgreen boot alliance inc wba free report have be gain investor confidence consistently positive result stock have lose year versus broader industry fall ahead second quarter fiscal earning schedule mar note company currently have market cap year historical growth rate be also favorable compare industry consider solid prospect zack rank buy stock be attractive bet investor moment company estimate revision trend current year have be positive last day analyst revise estimate upward movement opposite direction estimate revision earning increase share style score walgreen boot sport growth score be reflective company solid prospect research show stock growth style score combine zack rank strong buy offer best upside potential regard walgreen boot have favorable net margin net income sale compare industry moreover project sale growth rate surpass industry rate factor favorlet take look possible growth propeller solid boot exit first quarter promising note better expect earning revenue be also encourage uptick sale retail pharmacy international segment moreover walgreen boot have be gain strategic tie up bring more patient pharmacy strong retail pharmacy usa businessover recent past have observed walgreen boot retail pharmacy usa division witness comparable prescription growth benefitting strength retail prescription market several plan development early benefit new pharmacy contract well increase volume owing previously announce pharmacy partnership have be drive growth space moreover rise expenditure prescription drug grow demand specialty drug have be boost retail pharmacy market express script deal prospect promising be encourage walgreen boot plan expand exist group purchasing effort express script hold company esrx free report ensure availability specialty brand drug biosimilar have potential lower production cost move be consider prudent timely guangzhou pharmaceutical investment strategicwe be upbeat company expand global footprint decision acquire stake sinopharm hold guoda drugstore co ltd guoda subsidiary china national accord medicine corporation ltd completion investment provide strong impetus walgreen boot worldwide retail pharmacy business notably shanghai base guoda be large national pharmacy chain china be retail pharmacy platform china national pharmaceutical group corporation cnpgc moreover company acceptance proposal sell part investment chinese wholesale partner guangzhou pharmaceutical corporation huge cash return buoy optimism other key picksother top rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report bio rad laboratory sport zack rank see complete list today zack rank stock here company have long term expect earning growth rate athenahealth be zack rank player company have long term expect earning growth rate today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
2600,ESRX,follow cigna corp ci free report announcement buy pharmacy benefit manager express script hold co esrx free report rating agency best moody have sprung action term deal cigna pay cash share stock newly combine company closure express script shareholder own approximately combine company best have place review negative implication financial strength rating fsr excellent long term issuer credit rating long term icr key life health subsidiary health maintenance organization new european insurance company cigna fsr long term icrs cigna supplemental benefit company well cigna healthspr company have also receive same treatment best have place review negative implication long term icr bbb long short term issue credit rating long term ir short term ir cigna move send share decline close last trading session announcement deal stock have lose industry growth rating agency concern stem cigna higher leverage ratio due use new debt finance express script transaction funding expectedly cause leverage ratio go goodwill intangible equity ratio likely exceed company capacity service debt measure interest coverage ratio fall level be still consider strong deal be biggest cigna history significant execution risk be also fear customer loss express script dent combine entity growth extent last week rating agency moody investor service place cigna debt rating review downgrade senior baa well insurance financial strength rating operate subsidiary initial skepticism rating agency believe cigna be able secure back favorable rating utilize synergy acquisition pay back debt transaction be expect result total cost synergy double digit accretion earning first year closure result cigna expect deal increase earning share cigna carry zack rank buy other stock worth consider same space be centene corp cnc free report unitedhealth group inc unh free report centene sport zack rank strong buy unitedhealth hold same rank cigna see complete list today zack rank stock here centene beat earning estimate report quarters average positive surprise unitedhealth surpass earning estimate trail quarters average positive surprise breaking news cryptocurrency now bigger total market cap cryptos recently surpass more increase previous month re now bigger morgan stanley goldman sachs even visa new asset class expand even more rapidly new investor continue pour wall street become increasingly involved zack have just name company enable investor take advantage explosive growth cryptocurrency stock market click here access stock
2601,ESRX,investment market have scale new high latest republican tax cut robust economic growth home abroad fact medtech sector be look forward latest decision senate postpone industry wide excise tax medical device tax year bill also delay cadillac tax tax employer insurance medical device tax impose excise tax medtech manufacturer reduce research development prospect not just abatement taxe medtech fraternity have also be ride high ongoing merger acquisition trend space fact various report suggest have be key catalyst healthcare space late datum provide biospectrum asia activity medtech space surge increase value aggregate more focuswe believe strategy reduce pricing pressure competition medtech space further company strong acquisition policy expand customer base faster moderate leverage enhance cash flow glance major acquisition recent past becton dickinson company acquisition bard johnson johnson buyout actelion deserve mention further health insurer be try collaborate pharmacy benefit manager streamline cut cost drug supply chain regard latest buyout express script cigna follow just month drug chain pharmacy giant cvs health corp announce plan acquire nation third largest health insurer aetna be important combine postponement taxe solid policy medtech sector be poise grow come quarters screening parametersin order save investor time consume process identify best perform medtech stock have take help zack stock screener have select stock have favorable growth style score carry zack rank strong buy buy see complete list today zack rank stock here research show stock style score combine zack rank offer best investment opportunity furthermore select stock boast vgm score zack style score system stand value growth momentum vgm score be simply weight combination parameter be comprehensive tool allow investor filter standard score system pick winning stock medtech growth stock focusamedisys inc am free report stock carry zack rank additionally stock have growth score vgm score long term expect earning growth rate hold promise be upbeat company solid performance recently launch personal care segment favorable demographic trend strategic acquisition bode well company past month amedisys have be outperform industry belong last trading session company gain compare growth industry hca healthcare inc hca free report zack rank stock promise long term expect earning growth notably company have growth style score vgm score company strong revenue guidance instill confidence investor company expect revenue range hca healthcare share have outperformed industry stock gain nearly past month outperform industry growth express script hold company esrx free report sport zack rank promise long term expect earning growth rate company have growth score vgm score company have be benefit rise patient claim strong customer retention lately express script solid guidance hold promise full year adjust earning be estimate band reflect growth year year express script stock have outperformed industry past month specifically stock gain compare industry growth phibro animal health corporation pahc free report zack rank company have long term expect earning growth rate growth score stock boast vgm score be also encourage raise guidance fiscal bullish trend be expect continue company anticipate generate net sale compare previous fiscal last month phibro have be trading industry currently stock have gain compare growth industry universal health service inc uhs free report stock have zack rank growth score company have long term expect earning growth rate stock also have vgm score year acquisition have play key role build universal health growth trajectory strong guidance be also encourage month time share universal health have gain nearly compare industry growth hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
2602,ESRX,integrate medical care pharmacy benefit roof express script hold company esrx free report recently announce be get acquire cigna corporation ci free report global health insurance company acquisition be expect be complete dec post acquisition combine company invest charitable foundation support community operate definitive agreement cigna take express script cash stock transaction worth notably include cigna assumption approximately debt express script express script be largest pharmacy benefit manager express script sport zack rank strong buy see complete list today zack rank stock here express script stock have outperformed industry past year specifically company share have gain compare industry rally term deal cigna pay cash share stock newly combine company closure express script shareholder own approximately combine company transaction result total cost synergy double digit accretion earning first year closure result cigna expect deal increase earning share latest acquisition have be undertake solely enhance customer base improve patient provider alignment express script hold company price express script hold company price express script hold company quoteu healthcare lead gamemerger acquisition have be key driver healthcare space lately glance major acquisition recent past becton dickinson company bdx free report acquisition bard johnson johnson buyout actelion deserve mention fact health insurer be try consolidate pharmacy benefit manager streamline cut cost drug supply chain notably latest buyout express script come just month drug chain pharmacy giant cvs health corp cvs free report agree take nation third largest health insurer aetna come post acquisition impact believe latest development big threat unitedhealth group incorporate unh largest health insurer own pharmacy benefit unit cvs health complete merger aetna move be also expect nullify threat amazon com inc be make huge expansion world pharmacy business recently commerce giant announce joint venture jpmorgan chase co warren buffett berkshire hathaway curb medical cost employee be moody rating express script moody investor service rating service arm moody corporation place baa senior unsecured long term rating express script notably obligation rate baa be subject moderate credit risk however latest rating have be keep review tag direction uncertain moody moody have not rate express script high credit risk solid position lead pharmacy benefit manager moderate leverage strong cash flow however moody be worry express script high customer concentration pricing pressure further company ongoing dispute anthem inc largest customer be concern moody express script experience decline script volume higher typical customer loss other challenge include fewer generic drug introduction softening mail order growth trend client focus cost saving transparency hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
2603,ESRX,initiative reduce excessive opioid prescribe express script hold company esrx free report announce day analysis advanced opioid management program program be initiate last september address national opioid epidemic situation express script aim curb opioid opioid epidemic opioid crisis be rapid increase use prescription prescription opioid drug unite state canada notably opioid be diverse class strong painkiller often detrimental health fact report stat opioid more half person america next decade express script advanced opioid management program aim protect person used opioid medication mainly patient take opioid first time part advanced opioid management program express script therapeutic resource center pharmacist be also provide proactive counsele safe opioid use patient own home notably first day review nearly reduction be observed average day supply patient receive opioid prescription first time day supply prescription claim launch program day supply claim start program management company be proactively address national opioid epidemic reduce excessive improper opioid prescribe well promote greater compliance cdc guideline june express script announce new advanced opioid management solution address nation opioid addiction epidemic work comprehensively patient prescriber pharmacy aim be minimize early exposure prevent progression overuse abuse accord report persistence market research global opioid market have be estimate reach worth cagr stock performance estimate revisionexpres script stock have outperformed broader industry last month specifically stock have gain period compare industry gain moreover current rate be way higher also estimate revision trend current year remain favorable estimate move south last month compare movement opposite direction company current estimate moved past month zack rank key picksexpress script carry zack rank hold few better rank stock broader medical sector be amedisys inc am free report bio rad laboratory inc bio free report intuitive surgical inc isrg free report bio rad laboratory flaunt zack rank strong buy see complete list today zack rank stock here company have long term expect earning growth rate amedisys have long term expect earning growth rate stock carry zack rank buy intuitive surgical have long term expect earning growth rate stock carry zack rank wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
2604,ESRX,role pharmacy benefit manager pbm healthcare sector have be evolve be just third party administrator prescription drug program pbms have come long way pbms currently play major role manage pharmaceutical spending enhance health benefit end user notably pbms be mainly accountable development formulary discuss discount major drug manufacturer pharmacy contract firm also play important role settlement prescription drug claim congressional budget office cbo estimate pbms have potential save much total drug spending relative unmanaged purchasing datum publish economic benefit pharmacy benefit manager orszag green undoubtedly pbm market be expect continue solid trend report market research report biz pbm market see cagr factor drive pbmhistorically have be number factor support growth pbm market rise healthcare expenditure higher cost drug other healthcare service have drive demand pbms act middleman payer other entity system be also encourage center medicare medicaid service report publish advisory board rise healthcare spending report healthcare spending be project rise represent gross domestic product base assumption affordable care act continue pbm market largely benefit age population tend depend drug pharmacy benefit plan report technavio nearly population be age year buoy optimism many analyst believe rise expenditure prescription drug grow demand specialty drug have also be strengthen pbm market center medicare medicaid service report publish advisory board predict continuation trend report prescription drug spending be project grow roughly economic report pharmacy ad pharmacy benefit manager specialty drug account third pharmacy industry revenue merger acquisition change pbm landscapethe pbm market have always be dominate handful large player cvs merger caremark rx form cvs caremark now cvs health cvs free report have huge impact function scope pbms again cvs health announce historic decision acquire health insurance giant aetna aet free report person support merger view vertical integration instead horizontal lead efficiency gain solid cost cut cvs health pbm business notably horizontal integration increase chance monopolistic practice market follow announcement cvs aetna deal lead health service company optum part unitedhealth group unh free report announce decision acquire davita medical group lead independent medical group subsidiary davita inc dva free report moreover be be speculate wal mart store inc wmt free report soon announce acquisition health well be company humana inc hum free report counter competition stock scoop upas pbm industry be constantly expand industry be worth keep eye here be pbm company promising prospect cvs health headquarter woonsocket ri cvs health subsidiary provide integrate pharmacy health care service lead pbm company have market cap earning be estimate grow next year apart aetna deal earlier cvs health have announce plan set new store performance base pharmacy network fix cvs pharmacy walgreen boot alliance inc wba free report well community base independently own pharmacy unite state initiative company intend promote cost save enhance clinical outcome eventually reduce cost cvs pbm customer cvs health corporation price cvs health corporation price cvs health corporation quoteexpress script esrx free report headquarter saint loui mo express script operate pbm company unite state canada europe company have market cap earning be estimate grow next year notably company pbm segment offer clinical solution specialize pharmacy care home delivery specialty pharmacy retail network pharmacy administration benefit design consultation drug utilization review drug formulary management administration group purchasing organization consumer health drug information service moreover segment provide medicare medicaid health insurance marketplace product company recently announce plan acquire privately hold evidence base medical benefit management service provider evicore healthcare notably integrate evicore medical benefit management mbm platform pbm offer express script intend combat rise healthcare cost express script hold company price express script hold company price express script hold company quoterite aid corporation rad free report operate retail pharmacy pharmacy service segment rite aid own chain retail drugstore unite state company have market cap notably company pharmacy service segment provide pbm service range pharmacy related service segment also provide prescription adjudication service other pbms offer integrate mail order specialty compound pharmacy service provide infertility treatment well drug benefit medicare part program rite aid corporation price rite aid corporation price rite aid corporation quotebottom company have solid prospect be expose challenge legal regulation reimbursement pressure speculate entry amazon com inc amzn free report pbm market make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2605,ESRX,dec issue update research report cardinal health inc cah free report stock carry zack rank hold cardinal health follow acquisition drive strategy focus investing key business gain traction boost profit line company recently enter agreement buy radioactive diagnostic drug lymphoseek navidea be also encourage note cardinal health be pursue growth joint venture long term supply agreement company enter long term agreement henry schein latter purchase cardinal health medical supply physician practice collaboration be expect drive cardinal health earning long haul meanwhile cardinal health pharmaceutical segment have be gain solid client retention loss only few key customer walgreen boot alliance inc wba free report express script hold company esrx free report recently cordis cardinal health company medinol announce receipt fda approval elunir drug eluting stent de treat narrowing blockage coronary artery cardinal health also recently launch opioid action program cardinal health share price movement last year have fail impress stock have lose almost compare unfavorably broader industry gain cardinal health face risk lose considerable business case loss major customer turn severely impair revenue also cardinal health face tough competition business segment instance pharmaceutical supply chain business face competition like mckesson abc free report well several smaller medical surgical distributor such henry schein owen minor see complete list today zack rank strong buy stock here more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
2606,ESRX,third quarter earning have already crossed halfway mark oct company report result strong earning number latest earning trend third quarter result member have report result account index total market capitalization total earning company be year year rise revenue beating earning share estimate oct total medical sector sector group report third quarter result beat ratio be strong company surpass bottom line expectation sector sector have be limelight ever donald trump become president trump intention repeal replace health care reform act popularly know obamacare have result uncertain future whole sector result medical stock continue be focus healthcare industry substantially benefit strong membership base support medicare expansion obamacare aggressive inorganic strategy have help player achieve fast pace growth addition new product launch improve service expansion ancillary business expense management strategy be expect add top line however medical stock face threat rise level bad debt demand increase investment technological innovation integration cost related acquisition high interest expense debt funded acquisition be likely put pressure bottom line stock comparelet take sneak peek medical sector stock be set report quarterly earning oct expect third quarter earning express script hold company esrx free report show decline revenue pharmacy benefit manager pbm segment be major revenue component zack consensus estimate pbm revenue stand reflect decline year quarter moreover zack consensus estimate pbm product network be peg year year zack consensus estimate pbm service revenue be year year lackluster performance segment be likely mar express script revenue third quarter company guidance third quarter total adjust claim be expect range notably zack consensus estimate total claim stand sequentially adjust earning diluted share third quarter be estimate range represent growth year year basis exclude contribution anthem other transition client express script announce biggest customer lead health insurer anthem inc antm free report be not likely extend pharmacy benefit management agreement be slate expiration end management express script lose almost revenue related anthem contract third quarter express script have right combination main ingredient positive earning esp zack rank buy notably earning esp express script be uncover best stock buy sell re report earning esp filter express script hold company price ep surprise express script hold company price ep surprise express script hold company quotewe expect centene corporation cnc free report third quarter earning be aid solid medicaid expansion past few quarters centene have be witness consistent growth membership have be drive overall top line company expect uptrend continue third quarter well impact revenue positively zack consensus estimate total membership be currently peg reflect year year growth major contributor rise membership be centene continuously grow medicaid base medicaid expansion provision affordable care act have benefit centene be drive centene intention continue exchange other health insurer humana inc hum free report many more be exit third quarter be also likely witness further expansion medicaid business third quarter company successfully reprocure new statewide medicaid contract georgia nevada zack consensus estimate medicaid membership presently stand reflect year year growth moreover centene have be take several cost save initiative be reduce level expense margin be likely be aid lower expense third quarter zack consensus estimate total general administrative expense ratio be currently peg compare second quarter centene also have right combination main ingredient positive earning esp zack rank strong buy strengthen possibility beat notably earning esp centene be centene corporation price ep surprise centene corporation price ep surprise centene corporation quotewill make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2607,ESRX,express script hold company esrx free report be big mover last session company see share rise nearly day move come solid volume too far more share change hand normal session continue recent uptrend company stock be now past month time frame company have see change come estimate revision past few week zack consensus estimate current quarter have also remain unchanged recent price action be encourage so make sure keep close watch firm future express script currently have zack rank hold earning esp be express script hold company price express script hold company price express script hold company quoteinvestor interested medical service industry consider pra health science inc prah free report have zack rank strong buy see complete list today zack rank stock here be esrx go predict see other think downlooking stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
2608,ESRX,express script hold company esrx free report be schedule report third quarter result oct market close result be expect show decline revenue pharmacy benefit manager pbm segment major revenue component majorly affect earning let take look thing be shape release zack consensus estimate pbm revenue stand reflect decline sequentially year quarter st loui mo base company be largest pbm north america pbm be highly competitive industry report market research project pbm market see cagr take account express script have be consistently try expand core pbm business company complete acquisition mymatrixx pharmacy benefit solution provider worker compensation industry recently furthermore company anticipate compound annual ebitda growth rate core pbm business zack consensus estimate net sale stand year year basis express script hold company price consensus express script hold company price consensus express script hold company quote factor playcome major component zack consensus estimate pbm product network stand year year zack consensus estimate pbm service revenue stand year year lackluster performance segment be likely mar express script revenue third quarter come guidance third quarter express script expect total adjust claim range notably zack consensus estimate total claim stand sequentially adjust earning diluted share third quarter be estimate range represent growth year year basis exclude contribution anthem other transition client regard express script announce biggest customer lead health insurer anthem inc antm free report be not likely extend pharmacy benefit management agreement be slate expiration end management express script lose almost revenue related anthem contract third quarter anthem sue express script overcharge drug operational failure meanwhile second quarter anthem generate revenue compare second quarter here be quantitative model predict express script have right combination main ingredient positive earning esp zack rank buy notably earning esp express script be uncover best stock buy sell re report earning esp filter fact zack consensus estimate earning reflect increase year year basis other stock considerhere be few other medical stock worth consider have right combination element post earning beat quarter abbott free report have earning esp zack rank see complete list today zack rank strong buy stock here henry schein inc hsic free report have earning esp zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
2609,ESRX,express script hold company esrx free report recently inked agreement acquire privately hold evicore healthcare investor include general atlantic ta associate ridgemont equity partner transaction be expect close fourth quarter evicore provide evidence base integrate medical benefit management service mbm solution drive cost reduction quality care outcome notably evicore operate standalone business unit express script express script pharmacy benefit management couple evicore complementary medical benefit management be likely build comprehensive patient benefit management pbm solution buyout provide express cross sell client basis financial acquisition be expect prove accretive express script adjust diluted earning share first full year operation exclude transaction related expense amortization intangible accord company deal be likely take care be spend healthcare annually industry pbm be highly competitive industry report market research project pharmacy benefit management market see cagr accord market market report global healthcare provider network management market value cagr period take account express script have be consistently try expand core pbm business company recently announce plan expand customize worker compensation pharmacy solution acquisition mymatrixx pharmacy benefit solution provider worker compensation industry furthermore company anticipate compound annual ebitda growth rate core pbm business however express script announce biggest customer lead health insurer anthem inc antm be not likely extend pharmacy benefit management agreement be slate expiration end price script stock have underperform broader industry last year specifically stock have lose period industry gain zack rank key picksexpress script currently carry zack rank hold few better rank stock medical sector be abbott free report idexx laboratory inc idxx free report thermo fisher scientific inc tmo free report abbott idexx laboratory thermo fisher carry zack rank buy see complete list today zack rank strong buy stock here abbott have long term expect earning growth rate stock have rally roughly last year idexx laboratory have long term expect earning growth rate stock have gain last year thermo fisher have long term expect earning growth rate stock have gain last year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
2610,ESRX,benchmark end negative territory monday follow slump healthcare financial sector share general electric decline drag dow lower however share apple gain follow speculation gain new tax code propose trump administration dow jone industrial average djia close decline index inx decrease close meanwhile nasdaq composite index ixic close decrease total share be trade monday lower last session average share decline issue outnumber advancer nyse ratio nasdaq decliner outnumber advancer ratio cboe vix increase close nasdaq post lossesthe lose almost point end negative territory monday trading just point intraday record earlier session major sector end negative territory healthcare financial lead decliner health care select sector spdr etf xlv financial select sector spdr etf xlf be respectively share medtronic mdt free report express script hold esrx free report decline respectively be biggest draghunt healthcare sector moreover financial sector tank share blackrock blk free report citigroup free report bank america bac free report well fargo wfc free report decline respectively see complete list today zack rank strong buy stock here share ge weigh dow shed almost point finish negative territory share general electric ge free report tank almost weigh heavily blue chip index share auto maker plunge follow news ceo jeff bornstein plan step post end year follow be marketing chief ge beth comstock international executive john rice step respective post carmaker also announce have give board position activist investment firm trian fund management trump new tax code keep market boostedin announcement earlier month trump aide unveil new reform tax policy effectively lower taxe business individual proposal seek decrease corporate tax rate moreover pass business taxe currently categorize individual tax code be slash subsequently plan also reveal current personal tax slab be reduce only respectively boost gain broader market investor remain highly hopeful new tax code be sign law stock make lng project come online achieve new milestoneenergy behemoth chevron corporation cvx free report recently commence production wheatstone lng project western australia read more phillip announce share repurchase program worth bmidstream energy player phillip psx free report have receive consent new share repurchase program board director read more today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
2611,ESRX,value investing be easily most popular way find great stock market environment wouldn want find stock be fly radar be compelling buy offer tantalize discount compare fair value way find company be look several key metric financial ratio many be crucial value stock selection process let put express script hold company esrx free report stock equation find be good choice value oriented investor right now investor subscribe methodology look elsewhere top pick pe ratioa key metric value investor always look be price earning ratio pe short show much investor be willing pay dollar earning give stock be easily most popular financial ratio world best use pe ratio be compare stock current pe ratio ratio have be past compare average industry sector compare market whole front express script hold have trail month pe ratio see chart level actually compare pretty favorably market large pe stand focus long term pe trend express script hold current pe level put midpoint past year further stock pe also compare favorably industry trail month pe ratio stand very least indicate stock be relatively undervalue right now compare peer also point express script hold have forward pe ratio price relative year earning just so be fair say slightly more value oriented path be ahead express script hold stock term too peg ratiowhile earning be certainly important be essential know much be pay growth earning well easily do peg ratio ratio expect future earning growth rate peg ratio give more complete picture valuation stock ratio express script hold peg ratio stand just compare industry average suggest decent undervalue trading relative earning growth potential right now broad value outlookin aggregate express script hold currently have value score putt top stock cover look make express script hold solid choice value investor other key metric make pretty clear too example peg ratio express script hold be just level be far lower industry average peg ratio be modify pe ratio take account stock earning growth rate clearly esrx be solid choice value front multiple angle stock overall express script hold be good choice value investor be plenty other factor consider investing name particular be worth note company have growth score momentum score give esrx zack vgm score overarch fundamental grade read more zack style score here meanwhile company recent earning estimate have be encourage current quarter have see estimate go higher past day compare lower full year estimate have see same time period have have just small impact consensus estimate current quarter consensus estimate have remain unchanged past month full year estimate have inched see consensus estimate trend recent price action stock chart express script hold company price consensus express script hold company price consensus express script hold company quotedespite somewhat upward trend stock have just zack rank hold be be look better performance company term bottom lineexpress script hold be inspire choice value investor be hard beat incredible lineup statistic front moreover strong industry rank top more industry further strengthen growth potential so zack rank believe bullish analyst sentiment favorable industry factor make value stock compelling pickwill make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
2612,ESRX,express script hold company esrx free report post third quarter adjust earning share be line zack consensus estimate further adjust earning jump share year quarter revenue miss zack consensus estimate be also lower year period gross profit third quarter be flat year year adjust selling general administrative expense be prior year quarter total adjust claim amount third quarter flat year year st loui mo base pharmacy benefit manager ebitda earning interest tax depreciation amortization witness rise third quarter upside be drive operational cost improvement backed focus technology digital tool home delivery specialty service express script hold company price consensus ep surprise express script hold company price consensus ep surprise express script hold company quotebalance company exit quarter cash cash equivalent compare end total debt end quarter be versus end fact company be strive reduce debt level guidance raisedexpres script increase guidance full year adjust earning share range range represent increase adjust earning share result mid point range fourth quarter adjust earning share be estimate range represent growth fourth quarter company expect total adjust claim fourth quarter range express script likely lose script recently announce biggest customer lead health insurer anthem inc antm free report be not likely extend pharmacy benefit management agreement slate expiration end anthem sue express script overcharge drug operational failure management anthem refuse participate further discussion pricing concession probable adjustment agreement takewe be highly upbeat company core pharmacy benefit management long term outlook include ongoing volatile healthcare market trend inflation patent expiration lower industry utilization growth other headwind further expect express script continue benefit increase generic utilization shift mail order strong specialty growth age population brand drug be become increasingly expensive due double digit brand inflation continue rise price specialty drug overwhelming regulatory burden be pave way manifold prospect generic key picksnotably express script currently have zack rank sell better rank stock broader medical sector include enteromedic inc luminex corporation lmnx free report stock sport zack rank strong buy see complete list today zack rank stock here enteromedic have average earning beat trail quarters company have solid return past month luminex come positive earning surprise last quarter stock have long term expect earning growth rate zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
2613,ESRX,tuesday share express script hold co esrx free report be fall late morning trading company announce plan purchase privately hold medical benefit management company evicore healthcare express script be largest stand alone pharmacy benefit manager hope deal help grow adjust diluted earning share first full year operation company also explain deal be attractive entry point grow market evicore work health plan order decrease number medically unnecessary expensive test think imaging scan manage medical benefit person have employee rise cost healthcare be most important issue face american today tim wentworth ceo express script say statement together evicore express script be even more powerful partner manage cost patient payer bring closer goal become nation lead patient benefit manager evicore ceo john arlotta think company be uniquely position help improve healthcare issue company operate standalone business unit express script deal also come interesting time healthcare pharmacy space leader express script await possible decision commerce player amazon com amzn free report not move pharmacy benefit also read amazon be next big pharmacy giant express script be buy evicore current investor include general atlantic ta associate ridgemont equity partner deal be expect close fourth quarter be approve regulator esrx be currently hold zack rank share company have fall so far today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
2614,ESRX,st loui mo base pharmacy benefit manager express script hold company esrx free report recently announce result new diabetes study diabetes dilemma trend diabetes medication use study person follow oral diabetes medication experience significantly fewer emergency room visit inpatient hospitalization further report reveal spend nearly less total healthcare cost compare nonadherent patient strong criticism be voiced high price specialty drug focus be better management healthcare cost consumer be become increasingly proactive healthcare decision study express script emphasize need necessary patient spending medication feel lead experience average increase diabetes drug spend regard remind investor company safeguard suite pharmacy solution be design better manage specialty spending thereby establish higher standard patient outcome portfolio also include hepatitis cure value program cholesterol care value program oncology care value program express script inflation protection program past month company have underperform broader industry stock have gain only compare rise industry belong go forward be highly upbeat company core pharmacy benefit management long term outlook include ongoing volatile healthcare market trend inflation patent expiration lower industry utilization growth other headwind furthermore expect express script continue benefit increase generic utilization shift mail order strong specialty growth age population brand drug be become increasingly expensive due double digit brand inflation constant rise price specialty drug overwhelming regulatory burden be actually pave way manifold prospect generic however express script recently announce biggest customer lead health insurer anthem inc antm free report be not likely extend pharmacy benefit management agreement be slate expiration end anthem sue express script overcharge drug operational failure management anthem refuse participate further discussion pricing concession probable adjustment agreement meanwhile second quarter anthem generate revenue worth compare second quarter zack rank key picksnotably express script currently have zack rank hold few better rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report lantheus holding idexx laboratory carry zack rank buy see complete list today zack rank strong buy stock here lantheus holding have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have rally last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
2615,ESRX,have be month last earning report express script hold company esrx free report share have lose time frame underperform market recent negative trend continue lead stock next earning release be due dive investor analyst have react late let take quick look most recent earning report order get better handle important catalyst express script earning top fy view upst loui mo base pharmacy benefit manager express script post second quarter adjust earning share beating zack consensus estimate furthermore adjust earning jump share year quarter revenue miss zack consensus estimate be roughly year year basis gross profit second quarter be flat year year adjust selling general administrative expense be prior year quarter total adjust claim amount second quarter flat year year company ebitda earning interest tax depreciation amortization witness rise second quarter upside be drive operational cost improvement backed focus technology digital tool home delivery specialty service balance company exit quarter cash cash equivalent compare end total debt end quarter be versus end fact company be strive reduce debt level guidance company raise guidance adjust earning fiscal adjust earning share be project band previously provide range represent increase mid point range come guidance third quarter express script expect total adjust claim range adjust earning diluted share third quarter be estimate range represent growth year year basis furthermore company anticipate compound annual ebitda growth rate core pbm business exclude contribution anthem other transition client express script likely lose script recently announce biggest customer lead health insurer anthem inc be not likely extend pharmacy benefit management agreement be slate expiration end anthem sue express script overcharge drug operational failure management anthem refuse participate further discussion pricing concession probable adjustment agreement meanwhile second quarter anthem generate revenue compare second quarter have estimate be move then follow release investor have witness upward trend fresh estimate have be revision higher current quarter compare lower express script hold company price consensus express script hold company price consensus express script hold company quotevgm scoresat time express script stock have average growth score however momentum be do bit better stock be allocate grade value side putt top investment strategy overall stock have aggregate vgm score aren focuse strategy score be be interested base score stock be primarily suitable value investor also be suitable look momentum lesser degree growth outlookestimate have be trend upward stock magnitude revision also look promising notably stock have zack rank hold expect line return stock next few month
